<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/css" href="gpml.css" ?>
<!DOCTYPE set SYSTEM "gpml.dtd">
<set>

<import resource="GENIAontology.daml" prefix="G"></import>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95369245</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="IL-2_gene_expression" sem="G#other_name"><cons lex="IL-2_gene" sem="G#DNA_domain_or_region">IL-2 gene</cons> expression</cons> and <cons lex="NF-kappa_B_activation" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons> activation</cons> through <cons lex="CD28" sem="G#protein_molecule">CD28</cons> requires reactive oxygen production by <cons lex="5-lipoxygenase" sem="G#protein_molecule">5-lipoxygenase</cons>.</sentence>
</title>
<abstract>
<sentence>Activation of the <cons lex="CD28_surface_receptor" sem="G#protein_family_or_group"><cons lex="CD28" sem="G#protein_molecule">CD28</cons> surface receptor</cons> provides a major costimulatory signal for <cons lex="T_cell_activation" sem="G#other_name">T cell activation</cons> resulting in enhanced production of <cons lex="interleukin-2" sem="G#protein_molecule">interleukin-2</cons> (<cons lex="IL-2" sem="G#protein_molecule">IL-2</cons>) and <cons lex="cell_proliferation" sem="G#other_name">cell proliferation</cons>.</sentence>
<sentence>In <cons lex="primary_T_lymphocyte" sem="G#cell_type">primary T lymphocytes</cons> we show that <cons lex="CD28" sem="G#protein_molecule">CD28</cons> ligation leads to the rapid intracellular formation of <cons lex="reactive_oxygen_intermediate" sem="G#inorganic">reactive oxygen intermediates</cons> (<cons lex="ROI" sem="G#inorganic">ROIs</cons>) which are required for <cons lex="CD28-mediated_activation" sem="G#other_name"><cons lex="CD28" sem="G#protein_molecule">CD28</cons>-mediated activation</cons> of the <cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons>/<cons lex="CD28-responsive_complex" sem="G#protein_complex"><cons lex="CD28" sem="G#protein_molecule">CD28</cons>-responsive complex</cons> and <cons lex="IL-2_expression" sem="G#other_name"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> expression</cons>.</sentence>
<sentence>Delineation of the <cons lex="CD28_signaling_cascade" sem="G#other_name"><cons lex="CD28" sem="G#protein_molecule">CD28</cons> signaling cascade</cons> was found to involve <cons lex="protein_tyrosine_kinase_activity" sem="G#other_name"><cons lex="protein_tyrosine_kinase" sem="G#protein_family_or_group">protein tyrosine kinase</cons> activity</cons>, followed by the activation of <cons lex="phospholipase_A2" sem="G#protein_molecule">phospholipase A2</cons> and <cons lex="5-lipoxygenase" sem="G#protein_molecule">5-lipoxygenase</cons>.</sentence>
<sentence>Our data suggest that <cons lex="lipoxygenase_metabolite" sem="G#protein_family_or_group"><cons lex="lipoxygenase" sem="G#protein_molecule">lipoxygenase</cons> metabolites</cons> activate <cons lex="ROI_formation" sem="G#other_name"><cons lex="ROI" sem="G#inorganic">ROI</cons> formation</cons> which then induce <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> expression via <cons lex="NF-kappa_B_activation" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons> activation</cons>.</sentence>
<sentence>These findings should be useful for <cons lex="therapeutic_strategies" sem="G#other_name">therapeutic strategies</cons> and the development of <cons lex="immunosuppressants" sem="G#other_name">immunosuppressants</cons> targeting the <cons lex="CD28_costimulatory_pathway" sem="G#other_name"><cons lex="CD28" sem="G#protein_molecule">CD28</cons> costimulatory pathway</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95333264</bibliomisc>
</articleinfo>
<title>
<sentence>The <cons lex="peri-kappa_B_site" sem="G#DNA_domain_or_region">peri-kappa B site</cons> mediates <cons lex="human_immunodeficiency_virus_type_2_enhancer_activation" sem="G#other_name"><cons lex="human_immunodeficiency_virus_type_2_enhancer" sem="G#DNA_domain_or_region"><cons lex="human_immunodeficiency_virus_type_2" sem="G#virus">human immunodeficiency virus type 2</cons> enhancer</cons> activation</cons> in <cons lex="monocyte" sem="G#cell_type">monocytes</cons> but not in <cons lex="T_cell" sem="G#cell_type">T cells</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="human_immunodeficiency_virus_type_2" sem="G#virus">Human immunodeficiency virus type 2</cons> (<cons lex="HIV-2" sem="G#virus">HIV-2</cons>), like <cons lex="HIV-1" sem="G#virus">HIV-1</cons>, causes <cons lex="AIDS" sem="G#other_name">AIDS</cons> and is associated with <cons lex="AIDS" sem="G#other_name">AIDS</cons> cases primarily in West Africa.</sentence>
<sentence><cons lex="HIV-1" sem="G#virus">HIV-1</cons> and <cons lex="HIV-2" sem="G#virus">HIV-2</cons> display significant differences in <cons lex="nucleic_acid_sequence" sem="G#DNA_N/A">nucleic acid sequence</cons> and in the natural history of clinical disease.</sentence>
<sentence>Consistent with these differences, we have previously demonstrated that the <cons lex="enhancer/promoter_region" sem="G#DNA_domain_or_region">enhancer/promoter region</cons> of <cons lex="HIV-2" sem="G#virus">HIV-2</cons> functions quite differently from that of <cons lex="HIV-1" sem="G#virus">HIV-1</cons>.</sentence>
<sentence>Whereas activation of the <cons lex="HIV-1_enhancer" sem="G#DNA_domain_or_region"><cons lex="HIV-1" sem="G#virus">HIV-1</cons> enhancer</cons> following <cons lex="T-cell_stimulation" sem="G#other_name">T-cell stimulation</cons> is mediated largely through binding of the <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> <cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons> to two adjacent <cons lex="kappa_B_site" sem="G#DNA_domain_or_region">kappa B sites</cons> in the <cons lex="HIV-1_long_terminal_repeat" sem="G#DNA_domain_or_region"><cons lex="HIV-1" sem="G#virus">HIV-1</cons> long terminal repeat</cons>, activation of the <cons lex="HIV-2_enhancer" sem="G#DNA_domain_or_region"><cons lex="HIV-2" sem="G#virus">HIV-2</cons> enhancer</cons> in <cons lex="monocyte" sem="G#cell_type">monocytes</cons> and <cons lex="T_cell" sem="G#cell_type">T cells</cons> is dependent on four <cons lex="cis-acting_element" sem="G#DNA_domain_or_region">cis-acting elements</cons>: a single <cons lex="kappa_B_site" sem="G#DNA_domain_or_region">kappa B site</cons>, two <cons lex="purine-rich_binding_site" sem="G#DNA_domain_or_region">purine-rich binding sites</cons>, <cons lex="PuB1" sem="G#DNA_domain_or_region">PuB1</cons> and <cons lex="PuB2" sem="G#DNA_domain_or_region">PuB2</cons>, and a <cons lex="pets_site" sem="G#DNA_domain_or_region">pets site</cons>.</sentence>
<sentence>We have now identified a novel <cons lex="cis-acting_element" sem="G#DNA_family_or_group">cis-acting element</cons> within the <cons lex="HIV-2_enhancer" sem="G#DNA_domain_or_region"><cons lex="HIV-2" sem="G#virus">HIV-2</cons> enhancer</cons>, immediately upstream of the <cons lex="kappa_B_site" sem="G#DNA_domain_or_region">kappa B site</cons>, designated <cons lex="peri-kappa_B" sem="G#DNA_domain_or_region">peri-kappa B</cons>.</sentence>
<sentence>This site is conserved among isolates of <cons lex="HIV-2" sem="G#virus">HIV-2</cons> and the closely related <cons lex="simian_immunodeficiency_virus" sem="G#virus">simian immunodeficiency virus</cons>, and <cons lex="transfection_assay" sem="G#other_name">transfection assays</cons> show this site to mediate <cons lex="HIV-2_enhancer_activation" sem="G#other_name"><cons lex="HIV-2_enhancer" sem="G#DNA_domain_or_region"><cons lex="HIV-2" sem="G#virus">HIV-2</cons> enhancer</cons> activation</cons> following stimulation of <cons lex="monocytic_cell_line" sem="G#cell_line">monocytic</cons> but not <cons lex="T-cell_line" sem="G#cell_line">T-cell lines</cons>.</sentence>
<sentence>This is the first description of an <cons lex="HIV-2_enhancer_element" sem="G#DNA_domain_or_region"><cons lex="HIV-2" sem="G#virus">HIV-2</cons> enhancer element</cons> which displays such monocyte specificity, and no comparable <cons lex="enhancer_element" sem="G#DNA_domain_or_region">enhancer element</cons> has been clearly defined for <cons lex="HIV-1" sem="G#virus">HIV-1</cons>.</sentence>
<sentence>While a <cons lex="nuclear_factor" sem="G#protein_family_or_group">nuclear factor</cons>(s) from both <cons lex="peripheral_blood_monocyte" sem="G#cell_type">peripheral blood <cons lex="monocyte" sem="G#cell_type">monocytes</cons></cons> and <cons lex="T_cell" sem="G#cell_type">T cells</cons> binds the <cons lex="peri-kappa_B_site" sem="G#DNA_domain_or_region">peri-kappa B site</cons>, <cons lex="electrophoretic_mobility_shift_assay" sem="G#other_name">electrophoretic mobility shift assays</cons> suggest that either a different protein binds to this site in <cons lex="monocyte" sem="G#cell_type">monocytes</cons> versus <cons lex="T_cell" sem="G#cell_type">T cells</cons> or that the protein recognizing this <cons lex="enhancer_element" sem="G#DNA_domain_or_region">enhancer element</cons> undergoes <cons lex="differential_modification" sem="G#other_name">differential modification</cons> in <cons lex="monocyte" sem="G#cell_type">monocytes</cons> and <cons lex="T_cell" sem="G#cell_type">T cells</cons>, thus supporting the transfection data.</sentence>
<sentence>Further, while specific constitutive binding to the <cons lex="peri-kappa_B_site" sem="G#DNA_domain_or_region">peri-kappa B site</cons> is seen in <cons lex="monocyte" sem="G#cell_type">monocytes</cons>, stimulation with <cons lex="phorbol_ester" sem="G#other_organic_compound">phorbol esters</cons> induces additional, specific binding.</sentence>
<sentence>Understanding the <cons lex="monocyte-specific_function" sem="G#other_name">monocyte-specific function</cons> of the <cons lex="peri-kappa_B_factor" sem="G#protein_molecule">peri-kappa B factor</cons> may ultimately provide insight into the different role <cons lex="monocyte" sem="G#cell_type">monocytes</cons> and <cons lex="T_cell" sem="G#cell_type">T cells</cons> play in <cons lex="HIV_pathogenesis" sem="G#other_name">HIV pathogenesis</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95343554</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="E1A_gene_expression" sem="G#other_name"><cons lex="E1A_gene" sem="G#DNA_domain_or_region">E1A gene</cons> expression</cons> induces susceptibility to killing by <cons lex="NK_cell" sem="G#cell_type">NK cells</cons> following immortalization but not <cons lex="adenovirus_infection" sem="G#other_name"><cons lex="adenovirus" sem="G#virus">adenovirus</cons> infection</cons> of <cons lex="human_cell" sem="G#cell_type">human cells</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="adenovirus_(Ad)_infection" sem="G#other_name"><cons lex="adenovirus" sem="G#virus">Adenovirus</cons> (Ad) infection</cons> and <cons lex="E1A_transfection" sem="G#other_name"><cons lex="E1A" sem="G#protein_molecule">E1A</cons> transfection</cons> were used to model changes in susceptibility to <cons lex="NK_cell_killing" sem="G#other_name">NK cell killing</cons> caused by transient vs stable <cons lex="E1A_expression" sem="G#other_name"><cons lex="E1A" sem="G#protein_molecule">E1A</cons> expression</cons> in <cons lex="human_cell" sem="G#cell_type">human cells</cons>.</sentence>
<sentence>Only stably <cons lex="transfected_target_cell" sem="G#cell_line">transfected target cells</cons> exhibited cytolytic susceptibility, despite expression of equivalent levels of <cons lex="E1A_protein" sem="G#protein_family_or_group">E1A proteins</cons> in <cons lex="Ad-infected_target" sem="G#cell_line">Ad-infected targets</cons>.</sentence>
<sentence>The inability of <cons lex="E1A_gene" sem="G#DNA_domain_or_region">E1A gene</cons> products to induce <cons lex="cytolytic_susceptibility" sem="G#other_name">cytolytic susceptibility</cons> during infection was not explained by an inhibitory effect of viral infection on otherwise susceptible <cons lex="target_cell" sem="G#cell_type">target cells</cons> or by <cons lex="viral_gene" sem="G#DNA_domain_or_region">viral gene</cons> effects on <cons lex="class_I_MHC_antigen_expression" sem="G#other_name"><cons lex="class_I_MHC_antigen" sem="G#protein_family_or_group">class I MHC antigen</cons> expression</cons> on <cons lex="target_cell" sem="G#cell_type">target cells</cons>.</sentence>
<sentence>This differential effect of <cons lex="E1A_expression" sem="G#other_name"><cons lex="E1A" sem="G#protein_molecule">E1A</cons> expression</cons> on the cytolytic phenotypes of infected and stably transfected <cons lex="human_cell" sem="G#cell_type">human cells</cons> suggests that <cons lex="human_NK_cell" sem="G#cell_type">human <cons lex="NK_cell" sem="G#cell_type">NK cells</cons></cons> provide an effective immunologic barrier against the in vivo survival and <cons lex="neoplastic_progression" sem="G#other_name">neoplastic progression</cons> of <cons lex="E1A-immortalized_cell" sem="G#cell_line">E1A-immortalized cells</cons> that may emerge from the reservoir of <cons lex="persistently_infected_cell" sem="G#cell_type">persistently infected cells</cons> in the <cons lex="human_host" sem="G#multi_cell">human host</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95347379</bibliomisc>
</articleinfo>
<title>
<sentence>Distinct signaling properties identify functionally different <cons lex="CD4_epitope" sem="G#protein_family_or_group">CD4 epitopes</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="CD4_coreceptor" sem="G#protein_molecule">CD4 coreceptor</cons> interacts with <cons lex="non-polymorphic_region" sem="G#protein_domain_or_region">non-polymorphic regions</cons> of <cons lex="major_histocompatibility_complex_class_II_molecule" sem="G#protein_family_or_group">major histocompatibility complex class II molecules</cons> on <cons lex="antigen-presenting_cell" sem="G#cell_type">antigen-presenting cells</cons> and contributes to <cons lex="T_cell_activation" sem="G#other_name">T cell activation</cons>.</sentence>
<sentence>We have investigated the effect of <cons lex="CD4_triggering" sem="G#other_name"><cons lex="CD4" sem="G#protein_molecule">CD4</cons> triggering</cons> on <cons lex="T_cell_activating_signal" sem="G#other_name">T cell activating signals</cons> in a <cons lex="lymphoma_model" sem="G#other_name">lymphoma model</cons> using <cons lex="monoclonal_antibody" sem="G#protein_family_or_group">monoclonal antibodies</cons> (<cons lex="mAb" sem="G#protein_domain_or_region">mAb</cons>) which recognize different <cons lex="CD4_epitope" sem="G#protein_family_or_group">CD4 epitopes</cons>.</sentence>
<sentence>We demonstrate that <cons lex="CD4_triggering" sem="G#other_name"><cons lex="CD4" sem="G#protein_molecule">CD4</cons> triggering</cons> delivers signals capable of activating the <cons lex="NF-AT_transcription_factor" sem="G#protein_molecule">NF-AT transcription factor</cons> which is required for <cons lex="interleukin-2_gene_expression" sem="G#other_name"><cons lex="interleukin-2" sem="G#protein_molecule">interleukin-2</cons> gene expression</cons>.</sentence>
<sentence>Whereas different <cons lex="anti-CD4_mAb" sem="G#protein_family_or_group">anti-CD4 mAb</cons> or <cons lex="HIV-1_gp120" sem="G#protein_molecule"><cons lex="HIV-1" sem="G#virus">HIV-1</cons> gp120</cons> could all trigger activation of the <cons lex="protein_tyrosine_kinase" sem="G#protein_family_or_group">protein tyrosine kinases</cons> <cons lex="p56lck" sem="G#protein_molecule">p56lck</cons> and <cons lex="p59fyn" sem="G#protein_molecule">p59fyn</cons> and phosphorylation of the <cons lex="Shc_adaptor_protein" sem="G#protein_molecule">Shc adaptor protein</cons>, which mediates signals to <cons lex="Ras" sem="G#protein_family_or_group">Ras</cons>, they differed significantly in their ability to activate <cons lex="NF-AT" sem="G#protein_molecule">NF-AT</cons>.</sentence>
<sentence>Lack of full activation of <cons lex="NF-AT" sem="G#protein_molecule">NF-AT</cons> could be correlated to a dramatically reduced capacity to induce <cons lex="calcium_flux" sem="G#other_name"><cons lex="calcium" sem="G#atom">calcium</cons> flux</cons> and could be complemented with a <cons lex="calcium_ionophore" sem="G#other_organic_compound">calcium ionophore</cons>.</sentence>
<sentence>The results identify functionally distinct <cons lex="epitope" sem="G#protein_family_or_group">epitopes</cons> on the <cons lex="CD4_coreceptor" sem="G#protein_molecule">CD4 coreceptor</cons> involved in activation of the <cons lex="Ras/protein_kinase_C_and_calcium_pathway" sem="G#other_name"><cons lex="Ras/protein_kinase_C" sem="G#protein_molecule"><cons lex="Ras/protein_kinase_C_pathway" sem="G#other_name"><cons lex="Ras" sem="G#protein_molecule">Ras</cons><cons lex="protein_kinase_C" sem="G#protein_molecule">/protein kinase C</cons></cons></cons> and <cons lex="calcium_pathway" sem="G#other_name">calcium pathways</cons></cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95280913</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="ligand-dependent_repression" sem="G#other_name">Ligand-dependent repression</cons> of the <cons lex="erythroid_transcription_factor" sem="G#protein_family_or_group">erythroid transcription factor</cons> <cons lex="GATA-1" sem="G#protein_molecule">GATA-1</cons> by the <cons lex="estrogen_receptor" sem="G#protein_family_or_group">estrogen receptor</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="high-dose_estrogen_administration" sem="G#other_name">High-dose estrogen administration</cons> induces <cons lex="anemia" sem="G#other_name">anemia</cons> in <cons lex="mammal" sem="G#multi_cell">mammals</cons>.</sentence>
<sentence>In chickens, estrogens stimulate outgrowth of <cons lex="bone_marrow-derived_erythroid_progenitor_cell" sem="G#cell_type">bone marrow-derived erythroid progenitor cells</cons> and delay their <cons lex="maturation" sem="G#other_name">maturation</cons>.</sentence>
<sentence>This delay is associated with <cons lex="down-regulation" sem="G#other_name">down-regulation</cons> of many <cons lex="erythroid_cell-specific_gene" sem="G#DNA_family_or_group">erythroid cell-specific genes</cons>, including <cons lex="(AND alpha-globin beta-globin)" sem="(AND G#DNA_domain_or_region G#DNA_domain_or_region)"><cons lex="alpha-*">alpha-</cons> and <cons lex="beta-*">beta-</cons><cons lex="*globin">globin</cons></cons>, <cons lex="band_3" sem="G#DNA_N/A">band 3</cons>, <cons lex="band_4.1" sem="G#DNA_N/A">band 4.1</cons>, and the <cons lex="erythroid_cell-specific_histone" sem="G#protein_molecule">erythroid cell-specific histone</cons> <cons lex="H5" sem="G#protein_molecule">H5</cons>.</sentence>
<sentence>We show here that estrogens also reduce the number of <cons lex="erythroid_progenitor_cell" sem="G#cell_type">erythroid progenitor cells</cons> in <cons lex="primary_human_bone_marrow_culture" sem="G#cell_line">primary human bone marrow cultures</cons>.</sentence>
<sentence>To address potential mechanisms by which <cons lex="estrogen" sem="G#lipid">estrogens</cons> suppress <cons lex="erythropoiesis" sem="G#other_name">erythropoiesis</cons>, we have examined their effects on <cons lex="GATA-1" sem="G#protein_molecule">GATA-1</cons>, an <cons lex="erythroid_transcription_factor" sem="G#protein_family_or_group">erythroid transcription factor</cons> that participates in the regulation of the majority of <cons lex="erythroid_cell-specific_gene" sem="G#DNA_domain_or_region">erythroid cell-specific genes</cons> and is necessary for full maturation of <cons lex="erythrocyte" sem="G#cell_type">erythrocytes</cons>.</sentence>
<sentence>We demonstrate that the <cons lex="transcriptional_activity" sem="G#other_name">transcriptional activity</cons> of <cons lex="GATA-1" sem="G#protein_molecule">GATA-1</cons> is strongly repressed by the <cons lex="estrogen_receptor" sem="G#protein_family_or_group">estrogen receptor</cons> (<cons lex="ER" sem="G#protein_family_or_group">ER</cons>) in a ligand-dependent manner and that this <cons lex="repression" sem="G#other_name">repression</cons> is reversible in the presence of <cons lex="4-hydroxytamoxifen" sem="G#other_organic_compound">4-hydroxytamoxifen</cons>.</sentence>
<sentence><cons lex="ER-mediated_repression" sem="G#other_name"><cons lex="ER" sem="G#protein_family_or_group">ER</cons>-mediated repression</cons> of <cons lex="GATA-1_activity" sem="G#other_name"><cons lex="GATA-1" sem="G#protein_molecule">GATA-1</cons> activity</cons> occurs on an <cons lex="artificial_promoter" sem="G#DNA_molecule">artificial promoter</cons> containing a single <cons lex="GATA-binding_site" sem="G#DNA_domain_or_region">GATA-binding site</cons>, as well as in the context of an <cons lex="intact_promoter" sem="G#DNA_domain_or_region">intact promoter</cons> which is normally regulated by <cons lex="GATA-1" sem="G#protein_molecule">GATA-1</cons>.</sentence>
<sentence><cons lex="GATA-1" sem="G#protein_molecule">GATA-1</cons> and <cons lex="ER" sem="G#protein_family_or_group">ER</cons> bind to each other in vitro in the absence of DNA.</sentence>
<sentence>In <cons lex="coimmunoprecipitation_experiment" sem="G#other_name">coimmunoprecipitation experiments</cons> using transfected <cons lex="COS_cell" sem="G#cell_line">COS cells</cons>, <cons lex="GATA-1" sem="G#protein_molecule">GATA-1</cons> and <cons lex="ER" sem="G#protein_family_or_group">ER</cons> associate in a <cons lex="ligand-dependent_manner" sem="G#other_name">ligand-dependent manner</cons>.</sentence>
<sentence>Mapping experiments indicate that <cons lex="GATA-1" sem="G#protein_molecule">GATA-1</cons> and the <cons lex="ER" sem="G#protein_family_or_group">ER</cons> form at least two contacts, which involve the finger region and the <cons lex="N-terminal_activation_domain" sem="G#protein_domain_or_region">N-terminal activation domain</cons> of <cons lex="GATA-1" sem="G#protein_molecule">GATA-1</cons>.</sentence>
<sentence>We speculate that <cons lex="estrogen" sem="G#lipid">estrogens</cons> exert effects on <cons lex="erythropoiesis" sem="G#other_name">erythropoiesis</cons> by modulating <cons lex="GATA-1_activity" sem="G#other_name"><cons lex="GATA-1" sem="G#protein_molecule">GATA-1</cons> activity</cons> through <cons lex="protein-protein_interaction" sem="G#other_name">protein-protein interaction</cons> with the <cons lex="ER" sem="G#protein_family_or_group">ER</cons>.</sentence>
<sentence>(ABSTRACT TRUNCATED AT 250 WORDS)</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95256242</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="mouse_interleukin-2_receptor_alpha_gene_expression" sem="G#other_name"><cons lex="mouse_interleukin-2_receptor_alpha_gene" sem="G#DNA_domain_or_region">Mouse <cons lex="interleukin-2" sem="G#protein_molecule">interleukin-2</cons> receptor alpha gene</cons> expression</cons>.</sentence>
<sentence><cons lex="interleukin-1" sem="G#protein_molecule">Interleukin-1</cons> and <cons lex="interleukin-2" sem="G#protein_molecule">interleukin-2</cons> control transcription via distinct <cons lex="cis-acting_element" sem="G#DNA_family_or_group">cis-acting elements</cons>.</sentence>
</title>
<abstract>
<sentence>We have shown that <cons lex="interleukin-1" sem="G#protein_molecule">interleukin-1</cons> (<cons lex="IL-1" sem="G#protein_molecule">IL-1</cons>) and <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> control <cons lex="IL-2_receptor_alpha_(IL-2R_alpha)_gene_transcription" sem="G#other_name"><cons lex="IL-2_receptor_alpha_(IL-2R_alpha)_gene" sem="G#DNA_domain_or_region"><cons lex="IL-2 receptor alpha" sem="G#protein_molecule">IL-2 receptor alpha</cons> (<cons lex="IL-2R alpha" sem="G#protein_molecule">IL-2R alpha</cons>) gene</cons> transcription</cons> in <cons lex="CD4-CD8-_murine_T_lymphocyte_precursor" sem="G#cell_line">CD4-CD8- murine T lymphocyte precursors</cons>.</sentence>
<sentence>Here we map the <cons lex="cis-acting_element" sem="G#DNA_family_or_group">cis-acting elements</cons> that mediate interleukin responsiveness of the <cons lex="mouse_IL-2R_alpha_gene" sem="G#DNA_domain_or_region"><cons lex="mouse_IL-2R_alpha" sem="G#protein_molecule">mouse IL-2R alpha</cons> gene</cons> using a <cons lex="thymic_lymphoma-derived_hybridoma" sem="G#cell_line">thymic lymphoma-derived hybridoma</cons> (<cons lex="PC60" sem="G#cell_line">PC60</cons>).</sentence>
<sentence>The transcriptional response of the <cons lex="IL-2R_alpha_gene" sem="G#DNA_domain_or_region">IL-2R alpha gene</cons> to stimulation by <cons lex="IL-1" sem="G#protein_molecule">IL-1</cons> + <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> is biphasic.</sentence>
<sentence><cons lex="IL-1" sem="G#protein_molecule">IL-1</cons> induces a rapid, <cons lex="protein_synthesis-independent_appearance" sem="G#other_name">protein synthesis-independent appearance</cons> of <cons lex="IL-2R_alpha_mRNA" sem="G#RNA_molecule"><cons lex="IL-2R_alpha" sem="G#protein_molecule">IL-2R alpha</cons> mRNA</cons> that is blocked by inhibitors of <cons lex="NF-kappa_B_activation" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons> activation</cons>.</sentence>
<sentence>It also primes cells to become <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> responsive and thereby prepares the second phase, in which <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> induces a 100-fold further increase in <cons lex="IL-2R_alpha_transcript" sem="G#RNA_family_or_group"><cons lex="IL-2R_alpha" sem="G#protein_molecule">IL-2R alpha</cons> transcripts</cons>.</sentence>
<sentence><cons lex="transient_transfection_experiment" sem="G#other_name">Transient transfection experiments</cons> show that several elements in the <cons lex="promoter-proximal_region" sem="G#DNA_domain_or_region">promoter-proximal region</cons> of the <cons lex="IL-2R_alpha_gene" sem="G#DNA_domain_or_region"><cons lex="IL-2R_alpha" sem="G#protein_molecule">IL-2R alpha</cons> gene</cons> contribute to <cons lex="IL-1" sem="G#protein_molecule">IL-1</cons> responsiveness, most importantly an <cons lex="NF-kappa_B_site" sem="G#DNA_domain_or_region"><cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons> site</cons> conserved in the <cons lex="(AND human_gene mouse_gene)" sem="(AND G#DNA_family_or_group G#DNA_family_or_group)"><cons lex="human*">human</cons> and <cons lex="mouse*">mouse</cons> <cons lex="*gene">gene</cons></cons>.</sentence>
<sentence><cons lex="IL-2_responsiveness" sem="G#other_name"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> responsiveness</cons>, on the other hand, depends on a <cons lex="78-nucleotide_segment" sem="G#DNA_domain_or_region">78-nucleotide segment</cons> 1.3 kilobases upstream of the <cons lex="major_transcription_start_site" sem="G#DNA_domain_or_region">major transcription start site</cons>.</sentence>
<sentence>This segment functions as an <cons lex="IL-2-inducible_enhancer" sem="G#DNA_domain_or_region">IL-2-inducible enhancer</cons> and lies within a region that becomes <cons lex="DNase_I_hypersensitive" sem="G#other_name"><cons lex="DNase_I" sem="G#protein_molecule">DNase I</cons> hypersensitive</cons> in normal <cons lex="T_cell" sem="G#cell_type">T cells</cons> in which <cons lex="IL-2R_alpha_expression" sem="G#other_name"><cons lex="IL-2R_alpha" sem="G#protein_molecule">IL-2R alpha</cons> expression</cons> has been induced.</sentence>
<sentence><cons lex="IL-2_responsiveness" sem="G#other_name"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> responsiveness</cons> requires three distinct <cons lex="element" sem="G#DNA_domain_or_region">elements</cons> within the <cons lex="enhancer" sem="G#DNA_domain_or_region">enhancer</cons>.</sentence>
<sentence>Two of these are potential binding sites for <cons lex="STAT_protein" sem="G#protein_family_or_group">STAT proteins</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95338146</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="hematopoietic_lineage_commitment" sem="G#other_name"><cons lex="hematopoietic_lineage" sem="G#cell_type">Hematopoietic lineage</cons> commitment</cons>: role of <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons>.</sentence>
</title>
<abstract>
<sentence>This review focuses on the roles of <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> in <cons lex="hematopoietic_lineage_commitment" sem="G#other_name">hematopoietic lineage commitment</cons>.</sentence>
<sentence>A brief introduction to <cons lex="lineage_commitment" sem="G#other_name">lineage commitment</cons> and <cons lex="asymmetric_cell_division" sem="G#other_name">asymmetric cell division</cons> is followed by a discussion of several methods used to identify <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> important in specifying <cons lex="hematopoietic_cell_type" sem="G#cell_type">hematopoietic cell types</cons>.</sentence>
<sentence>Next is presented a discussion of the use of <cons lex="embryonic_stem_cells" sem="G#cell_type">embryonic stem cells</cons> in the analysis of <cons lex="hematopoietic_gene_expression" sem="G#other_name"><cons lex="hematopoietic_gene" sem="G#DNA_domain_or_region">hematopoietic gene</cons> expression</cons> and the use of <cons lex="targeted_gene_disruption" sem="G#other_name">targeted gene disruption</cons> to analyze the role of <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> in <cons lex="hematopoiesis" sem="G#other_name">hematopoiesis</cons>.</sentence>
<sentence>Finally, the status of our current knowledge concerning the roles of <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> in the commitment to <cons lex="(AND erythroid_cell_type myeloid_cell_type lymphoid_cell_type)" sem="(AND G#cell_type G#cell_type G#cell_type)"><cons lex="erythroid*">erythroid</cons>, <cons lex="myeloid*">myeloid</cons> and <cons lex="lymphoid*">lymphoid</cons> <cons lex="*cell_type">cell types</cons></cons> is summarized.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95266275</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="Epstein-Barr_virus_replicative_gene_transcription" sem="G#other_name"><cons lex="Epstein-Barr_virus" sem="G#virus">Epstein-Barr virus</cons> replicative gene transcription</cons> during <cons lex="de_novo_infection" sem="G#other_name">de novo infection</cons> of <cons lex="human_thymocyte" sem="G#cell_type">human thymocytes</cons>: <cons lex="simultaneous_early_expression" sem="G#other_name">simultaneous early expression</cons> of <cons lex="BZLF-1" sem="G#protein_molecule">BZLF-1</cons> and its repressor <cons lex="RAZ" sem="G#protein_molecule">RAZ</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="Epstein-Barr_virus" sem="G#virus">Epstein-Barr virus</cons> (<cons lex="EBV" sem="G#virus">EBV</cons>) is known to infect <cons lex="B_cell" sem="G#cell_type">B cells</cons> and <cons lex="epithelial_cell" sem="G#cell_type">epithelial cells</cons>.</sentence>
<sentence>We and others have shown that <cons lex="EBV" sem="G#virus">EBV</cons> can also infect a subset of <cons lex="thymocyte" sem="G#cell_type">thymocytes</cons>.</sentence>
<sentence>Infection of <cons lex="thymocyte" sem="G#cell_type">thymocytes</cons> was accompanied by the appearance of <cons lex="linear_EBV_genome" sem="G#DNA_family_or_group">linear <cons lex="EBV" sem="G#virus">EBV</cons> genome</cons> within 8 hr of infection.</sentence>
<sentence>Circularization of the <cons lex="EBV_genome" sem="G#DNA_family_or_group"><cons lex="EBV" sem="G#virus">EBV</cons> genome</cons> was not detected.</sentence>
<sentence>This is in contrast to the infection in <cons lex="B_cell" sem="G#cell_type">B cells</cons> where the genome can circularize within 24 hr of infection.</sentence>
<sentence>The appearance of the <cons lex="BamHI_ZLF-1_gene_product" sem="G#protein_molecule">BamHI ZLF-1 gene product</cons>, <cons lex="ZEBRA" sem="G#protein_molecule">ZEBRA</cons>, by <cons lex="RT-PCR" sem="G#other_name">RT-PCR</cons>, was observed within 8 hr of infection.</sentence>
<sentence>The appearance of a novel <cons lex="fusion_transcript" sem="G#protein_family_or_group">fusion transcript</cons> (<cons lex="RAZ" sem="G#protein_molecule">RAZ</cons>), which comprised regions of the <cons lex="BZLF-1_locus" sem="G#DNA_domain_or_region"><cons lex="BZLF-1" sem="G#protein_molecule">BZLF-1</cons> locus</cons> and the adjacent <cons lex="BRLF-1_locus" sem="G#DNA_domain_or_region">BRLF-1 locus</cons>, was detected by <cons lex="RT-PCR" sem="G#other_name">RT-PCR</cons>.</sentence>
<sentence><cons lex="ZEBRA_protein" sem="G#protein_molecule"><cons lex="ZEBRA" sem="G#protein_molecule">ZEBRA</cons> protein</cons> was also identified in infected <cons lex="thymocyte" sem="G#cell_type">thymocytes</cons> by <cons lex="immunoprecipitation" sem="G#other_name">immunoprecipitation</cons>.</sentence>
<sentence>In addition, we demonstrated that the <cons lex="EBNA-1_gene" sem="G#DNA_domain_or_region"><cons lex="EBNA-1" sem="G#protein_molecule">EBNA-1</cons> gene</cons> in infected <cons lex="thymocyte" sem="G#cell_type">thymocytes</cons> was transcribed from the <cons lex="Fp_promoter" sem="G#DNA_domain_or_region">Fp promoter</cons>, rather than from the <cons lex="Cp/Wp_promoter" sem="G#DNA_domain_or_region">Cp/Wp promoter</cons> which is used in <cons lex="latently_infected_B_cell" sem="G#cell_type">latently infected <cons lex="B_cell" sem="G#cell_type">B cells</cons></cons>.</sentence>
<sentence>Transcripts encoding <cons lex="gp350/220" sem="G#protein_molecule">gp350/220</cons>, the <cons lex="major_coat_protein" sem="G#protein_family_or_group">major coat protein</cons> of <cons lex="EBV" sem="G#virus">EBV</cons>, were identified, but we did not find any evidence of transcription from the <cons lex="LMP-2A" sem="G#DNA_domain_or_region">LMP-2A</cons> or <cons lex="EBER-1_loci" sem="G#DNA_domain_or_region">EBER-1 loci</cons> in infected <cons lex="thymocyte" sem="G#cell_type">thymocytes</cons>.</sentence>
<sentence>These observations suggest that de novo <cons lex="EBV_infection" sem="G#other_name"><cons lex="EBV" sem="G#virus">EBV</cons> infection</cons> of <cons lex="thymocyte" sem="G#cell_type">thymocytes</cons> differs from infection of <cons lex="B_cell" sem="G#cell_type">B cells</cons>.</sentence>
<sentence>The main difference is that with <cons lex="thymocyte" sem="G#cell_type">thymocytes</cons>, no evidence could be found that the <cons lex="virus" sem="G#virus">virus</cons> ever circularizes.</sentence>
<sentence>Rather, <cons lex="EBV" sem="G#virus">EBV</cons> remains in a <cons lex="linear_configuration" sem="G#other_name">linear configuration</cons> from which <cons lex="replicative_gene" sem="G#DNA_family_or_group">replicative genes</cons> are transcribed.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95236292</bibliomisc>
</articleinfo>
<title>
<sentence>Identification and purification of <cons lex="human_Stat_protein" sem="G#protein_family_or_group">human Stat proteins</cons> activated in response to <cons lex="interleukin-2" sem="G#protein_molecule">interleukin-2</cons>.</sentence>
</title>
<abstract>
<sentence>A key <cons lex="cytokine" sem="G#protein_family_or_group">cytokine</cons> induced during the <cons lex="immune_response" sem="G#other_name">immune response</cons> is <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons>.</sentence>
<sentence>Following <cons lex="T_cell_activation" sem="G#other_name">T cell activation</cons>, the genes encoding <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> and the various chains of its receptor are transcriptionally induced.</sentence>
<sentence>In turn, secreted <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> serves to stimulate the proliferation and differentiation of <cons lex="T_lymphocyte" sem="G#cell_type">T lymphocytes</cons>.</sentence>
<sentence>Several recent studies have implicated Jak kinases in the <cons lex="signaling_pathway" sem="G#other_name">signaling pathway</cons> induced by <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons>.</sentence>
<sentence>Following this lead, we set out to identify <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> induced in response to <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons>.</sentence>
<sentence><cons lex="human_peripheral_blood_lymphocyte" sem="G#cell_type">Human peripheral blood lymphocytes</cons> were observed to contain several <cons lex="IL-2-inducible_DNA_binding_activity" sem="G#other_name"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons>-inducible DNA binding activities</cons>.</sentence>
<sentence>Similar activities were also observed in a <cons lex="transformed_human_lymphocyte_line" sem="G#cell_line">transformed human lymphocyte line</cons>, termed <cons lex="YT" sem="G#cell_line">YT</cons>.</sentence>
<sentence>We have purified these activities and found that the principal <cons lex="IL-2-inducible_component" sem="G#protein_family_or_group"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons>-inducible component</cons> bears significant relatedness to a <cons lex="prolactin-induced_transcription_factor" sem="G#protein_molecule">prolactin-induced transcription factor</cons> first identified in <cons lex="sheep_mammary_gland_tissue" sem="G#cell_type">sheep mammary gland tissue</cons>.</sentence>
<sentence>We hypothesize that activation of this protein, designated <cons lex="hStat5" sem="G#protein_molecule">hStat5</cons>, helps govern the biological effects of <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> during the <cons lex="immune_response" sem="G#other_name">immune response</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95197524</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="E2F-1" sem="G#protein_molecule">E2F-1</cons> and a <cons lex="cyclin-like_DNA_repair_enzyme" sem="G#protein_family_or_group">cyclin-like DNA repair enzyme</cons>, <cons lex="uracil-DNA_glycosylase" sem="G#protein_molecule">uracil-DNA glycosylase</cons>, provide evidence for an <cons lex="autoregulatory_mechanism_for_transcription" sem="G#other_name">autoregulatory mechanism for transcription</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="cell_cycle-dependent_transcription_factor" sem="G#protein_family_or_group">cell cycle-dependent transcription factor</cons>, <cons lex="E2F-1" sem="G#protein_molecule">E2F-1</cons>, regulates the <cons lex="cyclin" sem="G#protein_family_or_group">cyclin</cons>-like species of the <cons lex="DNA_repair_enzyme" sem="G#protein_family_or_group">DNA repair enzyme</cons> <cons lex="uracil-DNA_glycosylase_(UDG)_gene" sem="G#DNA_domain_or_region"><cons lex="uracil-DNA_glycosylase" sem="G#protein_molecule">uracil-DNA glycosylase</cons> (<cons lex="UDG" sem="G#protein_molecule">UDG</cons>) gene</cons> in <cons lex="human_osteosarcoma_(Saos-2)_cell" sem="G#cell_line">human osteosarcoma (<cons lex="Saos-2" sem="G#cell_line">Saos-2</cons>) cells</cons>.</sentence>
<sentence>We demonstrate, through the deletion of the <cons lex="human_UDG_promoter_sequence" sem="G#DNA_domain_or_region">human <cons lex="UDG" sem="G#protein_molecule">UDG</cons> promoter sequences</cons>, that expression of <cons lex="E2F-1" sem="G#protein_molecule">E2F-1</cons> activates the <cons lex="UDG_promoter" sem="G#DNA_domain_or_region"><cons lex="UDG" sem="G#protein_molecule">UDG</cons> promoter</cons> through several <cons lex="E2F_site" sem="G#DNA_domain_or_region"><cons lex="E2F" sem="G#protein_family_or_group">E2F</cons> sites</cons>.</sentence>
<sentence>The <cons lex="major_putative_downstream_site" sem="G#DNA_domain_or_region">major putative downstream site</cons> for <cons lex="E2F" sem="G#protein_family_or_group">E2F</cons>, located in the <cons lex="first_exon" sem="G#DNA_domain_or_region">first exon</cons>, serves as a target for <cons lex="E2F-1/DP1_complex" sem="G#protein_complex">E2F-1/DP1 complex</cons> binding in vitro.</sentence>
<sentence>We also provide evidence for the functional relationship between the <cons lex="cyclin-like_UDG_gene_product" sem="G#protein_molecule">cyclin-like <cons lex="UDG" sem="G#protein_molecule">UDG</cons> gene product</cons> and <cons lex="E2F" sem="G#protein_family_or_group">E2F</cons>.</sentence>
<sentence>High levels of <cons lex="UDG_expression" sem="G#other_name"><cons lex="UDG" sem="G#protein_molecule">UDG</cons> expression</cons> in a <cons lex="transient_transfection_assay" sem="G#other_name">transient transfection assay</cons> result in the <cons lex="down-regulation" sem="G#other_name">down-regulation</cons> of <cons lex="transcriptional_activity" sem="G#other_name">transcriptional activity</cons> through <cons lex="elements" sem="G#DNA_domain_or_region">elements</cons> specific for <cons lex="E2F-mediated_transcription" sem="G#other_name"><cons lex="E2F" sem="G#protein_family_or_group">E2F</cons>-mediated transcription</cons>.</sentence>
<sentence><cons lex="Overexpression" sem="G#other_name">Overexpression</cons> of <cons lex="UDG" sem="G#protein_molecule">UDG</cons> in <cons lex="Saos_2_cell" sem="G#cell_line">Saos 2 cells</cons> was observed to delay growth late in <cons lex="G1_phase" sem="G#other_name">G1 phase</cons> and transiently arrest these cells from progressing into the <cons lex="S_phase" sem="G#other_name">S phase</cons>.</sentence>
<sentence>This hypothetical model integrates one mechanism of <cons lex="DNA_repair" sem="G#other_name">DNA repair</cons> with the <cons lex="cell_cycle_control" sem="G#other_name">cell cycle control</cons> of <cons lex="gene_transcription" sem="G#other_name">gene transcription</cons>, likely through <cons lex="E2F" sem="G#protein_family_or_group">E2F</cons>.</sentence>
<sentence>This implicates <cons lex="E2F" sem="G#protein_family_or_group">E2F</cons> as a multifunctional target for proteins and enzymes, possibly, responsive to <cons lex="DNA_damage" sem="G#other_name">DNA damage</cons> through the negative effect of <cons lex="UDG" sem="G#protein_molecule">UDG</cons> on <cons lex="E2F-mediated_transcriptional_activity" sem="G#other_name"><cons lex="E2F" sem="G#protein_family_or_group">E2F</cons>-mediated transcriptional activity</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95370702</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="(AND Cellular_mechanism molecular_mechanism)" sem="(AND G#other_name G#other_name)"><cons lex="cellular*">Cellular</cons> and <cons lex="molecular*">molecular</cons> <cons lex="*mechanism">mechanisms</cons></cons> of <cons lex="IFN-gamma_production" sem="G#other_name"><cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons> production</cons> induced by <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> and <cons lex="IL-12" sem="G#protein_molecule">IL-12</cons> in a <cons lex="human_NK_cell_line" sem="G#cell_line">human NK cell line</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="Interferon-gamma" sem="G#protein_molecule">Interferon-gamma</cons> (<cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons>) is an important <cons lex="immunoregulatory_protein" sem="G#protein_molecule">immunoregulatory protein</cons> produced predominantly by <cons lex="T_cell" sem="G#cell_type">T cells</cons> and <cons lex="large_granular_lymphocyte" sem="G#cell_type">large granular lymphocytes</cons> (<cons lex="LGL" sem="G#cell_type">LGL</cons>) in response to different <cons lex="extracellular_signal" sem="G#other_name">extracellular signals</cons>.</sentence>
<sentence>In particular, two <cons lex="interleukin" sem="G#protein_family_or_group">interleukins</cons> (<cons lex="IL" sem="G#protein_family_or_group">ILs</cons>), <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> and <cons lex="IL-12" sem="G#protein_molecule">IL-12</cons>, have been shown to be potent inducers of <cons lex="IFN-gamma_gene_expression" sem="G#other_name"><cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons> gene expression</cons> in both <cons lex="T_cell" sem="G#cell_type">T cells</cons> and <cons lex="LGL" sem="G#cell_type">LGL</cons>.</sentence>
<sentence>Although it has been reported that there are some <cons lex="T_cell_line" sem="G#cell_line">T cell lines</cons> that produce <cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons> in response to <cons lex="(AND IL-2_stimulation IL-12_stimulation)" sem="(AND G#other_name G#other_name)"><cons lex="IL-2*">IL-2</cons> and <cons lex="IL-12*">IL-12</cons> <cons lex="*stimulation">stimulation</cons></cons>, there has as yet been no report of a <cons lex="natural_killer_(NK)_cell_line" sem="G#cell_line">natural killer (NK) cell line</cons> that responds in a similar manner.</sentence>
<sentence>In this report we present evidence that the <cons lex="cell_line_NK3.3" sem="G#cell_line">cell line NK3.3</cons> derived from <cons lex="human_NK_cell" sem="G#cell_type">human NK cells</cons>, responds to both <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> and <cons lex="IL-12" sem="G#protein_molecule">IL-12</cons>, as measured by increases in <cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons> and <cons lex="granulocyte-macrophage_colony-stimulating_factor" sem="G#protein_molecule">granulocyte-macrophage colony-stimulating factor</cons> (<cons lex="GM-CSF" sem="G#protein_molecule">GM-CSF</cons>) <cons lex="(AND cytoplasmic_mRNA_expression cytoplasmic_protein_expression)" sem="(AND G#other_name G#other_name)"><cons lex="cytoplasmic*">cytoplasmic</cons> <cons lex="*mRNA*">mRNA</cons> and <cons lex="*protein*">protein</cons> <cons lex="*expression">expression</cons></cons>.</sentence>
<sentence>In addition, when used together <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> and <cons lex="IL-12" sem="G#protein_molecule">IL-12</cons> synergized in the induction of <cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons> and <cons lex="GM-CSF" sem="G#protein_molecule">GM-CSF</cons> and this synergy was attributed to an increased accumulation and stability of the <cons lex="IFN-gamma_and_GM-CSF_mRNA" sem="G#RNA_molecule"><cons lex="IFN-gamma" sem="G#protein_molecule"><cons lex="IFN-gamma_mRNA" sem="G#RNA_molecule">IFN-gamma</cons></cons> and <cons lex="GM-CSF_mRNA" sem="G#RNA_molecule"><cons lex="GM-CSF" sem="G#protein_molecule">GM-CSF</cons> mRNAs</cons></cons>.</sentence>
<sentence>To investigate the signaling pathways involved in the gene induction, five inhibitors, <cons lex="cyclosporin_A" sem="G#other_organic_compound">cyclosporin A</cons> (<cons lex="CsA" sem="G#other_organic_compound">CsA</cons>), <cons lex="transforming_growth_factor-beta" sem="G#protein_molecule">transforming growth factor-beta</cons>, <cons lex="cycloheximide" sem="G#other_organic_compound">cycloheximide</cons>, <cons lex="genistein" sem="G#other_organic_compound">genistein</cons>, and <cons lex="staurosporine_A" sem="G#other_organic_compound">staurosporine A</cons>, were used in analyzing the effects of <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> and <cons lex="IL-12" sem="G#protein_molecule">IL-12</cons> on <cons lex="NK3.3_cell" sem="G#cell_line">NK3.3 cells</cons>.</sentence>
<sentence>The results suggest that activation of <cons lex="protein_kinase_C" sem="G#protein_molecule">protein kinase C</cons>, but not <cons lex="new_protein_synthesis" sem="G#other_name">new protein synthesis</cons>, is required for <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> induction of <cons lex="(AND IFN-gamma_cytoplasmic_mRNA GM-CSF_cytoplasmic_mRNA)" sem="(AND G#RNA_molecule G#RNA_molecule)"><cons lex="IFN-gamma*">IFN-gamma</cons> and <cons lex="GM-CSF*">GM-CSF</cons> <cons lex="*cytoplasmic_mRNA">cytoplasmic mRNA</cons></cons>.</sentence>
<sentence>In contrast, <cons lex="IL-12_induction" sem="G#other_name"><cons lex="IL-12" sem="G#protein_molecule">IL-12</cons> induction</cons> of <cons lex="IFN-gamma_cytoplasmic_mRNA" sem="G#RNA_molecule"><cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons> cytoplasmic mRNA</cons> appears to only partially depend on activation of <cons lex="protein_kinase_C" sem="G#protein_molecule">protein kinase C</cons>.</sentence>
<sentence>Furthermore, both <cons lex="transforming_growth_factor-beta" sem="G#protein_molecule">transforming growth factor-beta</cons> and <cons lex="genistein" sem="G#other_organic_compound">genistein</cons>, a <cons lex="tyrosine_kinase_inhibitor" sem="G#other_name">tyrosine kinase inhibitor</cons>, could suppress <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> and <cons lex="IL-12" sem="G#protein_molecule">IL-12</cons> signaling but <cons lex="CsA" sem="G#other_organic_compound">CsA</cons> was generally inactive.</sentence>
<sentence>It also was observed that suppression of <cons lex="cytokine_gene_expression" sem="G#other_name"><cons lex="cytokine_gene" sem="G#DNA_family_or_group">cytokine gene</cons> expression</cons> by these agents was independent of the <cons lex="inhibition_of_proliferation" sem="G#other_name">inhibition of proliferation</cons>.</sentence>
<sentence>In addition, <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> but not <cons lex="IL-12" sem="G#protein_molecule">IL-12</cons> induced <cons lex="nuclear_factor" sem="G#protein_family_or_group">nuclear factors</cons> <cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons> and <cons lex="AP1" sem="G#protein_molecule">AP1</cons>, and regulation of the <cons lex="nuclear_level" sem="G#other_name">nuclear levels</cons> of these two <cons lex="DNA_binding_protein_complex" sem="G#protein_complex">DNA binding protein complexes</cons> is correlated with <cons lex="(AND IFN-gamma_gene_expression GM-CSF_gene_expression)" sem="(AND G#other_name G#other_name)"><cons lex="IFN-gamma*">IFN-gamma</cons> and <cons lex="GM-CSF*">GM-CSF</cons> <cons lex="*gene_expression">gene expression</cons></cons>.</sentence>
<sentence>These data indicate that <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> and <cons lex="IL-12" sem="G#protein_molecule">IL-12</cons> may have distinct <cons lex="signaling_pathway" sem="G#other_name">signaling pathways</cons> leading to the induction of <cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons> and <cons lex="GM-CSF_gene_expression" sem="G#other_name"><cons lex="GM-CSF" sem="G#protein_molecule">GM-CSF</cons> gene expression</cons>, and that the <cons lex="NK3.3_cell_line" sem="G#cell_line">NK3.3 cell line</cons> may serve as a novel model for dissecting the <cons lex="biochemical_and_molecular_event" sem="G#other_name">biochemical and molecular events</cons> involved in these pathways.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95349600</bibliomisc>
</articleinfo>
<title>
<sentence>A <cons lex="functional_T-cell_receptor_signaling_pathway" sem="G#other_name">functional <cons lex="T-cell_receptor" sem="G#protein_family_or_group">T-cell receptor</cons> signaling pathway</cons> is required for <cons lex="p95vav_activity" sem="G#other_name"><cons lex="p95vav" sem="G#protein_molecule">p95vav</cons> activity</cons>.</sentence>
</title>
<abstract>
<sentence>Stimulation of the <cons lex="T-cell_antigen_receptor" sem="G#protein_molecule">T-cell antigen receptor</cons> (<cons lex="TCR" sem="G#protein_molecule">TCR</cons>) induces activation of multiple <cons lex="tyrosine_kinase" sem="G#protein_molecule">tyrosine kinases</cons>, resulting in <cons lex="phosphorylation" sem="G#other_name">phosphorylation</cons> of numerous <cons lex="intracellular_substrate" sem="G#other_organic_compound">intracellular substrates</cons>.</sentence>
<sentence>One substrate is <cons lex="p95vav" sem="G#protein_molecule">p95vav</cons>, which is expressed exclusively in <cons lex="(AND hematopoietic_cell trophoblast_cell)" sem="(AND G#cell_type G#cell_type)"><cons lex="hematopoietic*">hematopoietic</cons> and <cons lex="trophoblast*">trophoblast</cons> <cons lex="*cell">cells</cons></cons>.</sentence>
<sentence>It contains a number of <cons lex="structural_motif" sem="G#protein_substructure">structural motifs</cons>, including <cons lex="Src_homology_2,_Src_homology_3,_and_pleckstrin_homology_domain" sem="G#protein_domain_or_region"><cons lex="Src_homology_2_domain" sem="G#protein_domain_or_region">Src homology 2</cons>, <cons lex="Src_homology_3_domain" sem="G#protein_domain_or_region">Src homology 3</cons>, and <cons lex="pleckstrin_homology_domain" sem="G#protein_domain_or_region">pleckstrin homology domains</cons></cons> and a <cons lex="putative_guanine_nucleotide_exchange_domain" sem="G#protein_domain_or_region">putative guanine nucleotide exchange domain</cons>.</sentence>
<sentence>The role of <cons lex="p95vav" sem="G#protein_molecule">p95vav</cons> in <cons lex="TCR-mediated_signaling_processes" sem="G#other_name"><cons lex="TCR" sem="G#protein_molecule">TCR</cons>-mediated signaling processes</cons> is unclear.</sentence>
<sentence>Here, we show that overexpression of <cons lex="p95vav" sem="G#protein_molecule">p95vav</cons> alone in Jurkat <cons lex="T_cell" sem="G#cell_type">T cells</cons> leads to activation of the <cons lex="nuclear_factor" sem="G#protein_family_or_group">nuclear factors</cons>, including <cons lex="NFAT" sem="G#protein_family_or_group">NFAT</cons>, involved in <cons lex="interleukin-2_expression" sem="G#other_name"><cons lex="interleukin-2" sem="G#protein_molecule">interleukin-2</cons> expression</cons>.</sentence>
<sentence>Furthermore, <cons lex="p95vav" sem="G#protein_molecule">p95vav</cons> synergizes with <cons lex="TCR_stimulation" sem="G#other_name"><cons lex="TCR" sem="G#protein_molecule">TCR</cons> stimulation</cons> in inducing <cons lex="(AND NFAT-dependent_transcription interleukin-2-dependent_transcription)" sem="(AND G#other_name G#other_name)"><cons lex="NFAT-*">NFAT-</cons> and <cons lex="interleukin-2-*">interleukin-2-</cons><cons lex="*dependent_transcription">dependent transcription</cons></cons>.</sentence>
<sentence>In contrast, <cons lex="NFAT_activation" sem="G#other_name"><cons lex="NFAT" sem="G#protein_family_or_group">NFAT</cons> activation</cons> by a <cons lex="G-protein-coupled_receptor" sem="G#protein_family_or_group">G-protein-coupled receptor</cons> is not modulated by <cons lex="p95vav_overexpression" sem="G#other_name"><cons lex="p95vav" sem="G#protein_molecule">p95vav</cons> overexpression</cons>, suggesting that the effect is specific to the <cons lex="TCR_signaling_pathway" sem="G#other_name"><cons lex="TCR" sem="G#protein_molecule">TCR</cons> <cons lex="signaling_pathway" sem="G#other_name">signaling pathways</cons></cons>.</sentence>
<sentence>Although removal of the <cons lex="first_67_amino_acid" sem="G#protein_domain_or_region">first 67 amino acids</cons> of <cons lex="p95vav" sem="G#protein_molecule">p95vav</cons> activates its <cons lex="transforming_potential" sem="G#other_name">transforming potential</cons> in <cons lex="NIH_3T3_cell" sem="G#cell_line">NIH 3T3 cells</cons>, this region appears to be required for its function in <cons lex="T_cell" sem="G#cell_type">T cells</cons>.</sentence>
<sentence>We further demonstrate that the <cons lex="p95vav-induced_NFAT_activation" sem="G#other_name"><cons lex="p95vav" sem="G#protein_molecule">p95vav</cons>-induced <cons lex="NFAT" sem="G#protein_family_or_group">NFAT</cons> activation</cons> is not mimicked by <cons lex="Ras_activation" sem="G#other_name"><cons lex="Ras" sem="G#protein_family_or_group">Ras</cons> activation</cons>, though its function is dependent upon <cons lex="Ras" sem="G#protein_family_or_group">Ras</cons> and <cons lex="Raf" sem="G#protein_family_or_group">Raf</cons>.</sentence>
<sentence>Furthermore, the <cons lex="activating_function" sem="G#other_name">activating function</cons> of <cons lex="p95vav" sem="G#protein_molecule">p95vav</cons> is blocked by <cons lex="FK506" sem="G#other_organic_compound">FK506</cons>, suggesting that its activity also depends on <cons lex="calcineurin" sem="G#protein_molecule">calcineurin</cons>.</sentence>
<sentence>To further dissect <cons lex="p95vav_involvement" sem="G#other_name"><cons lex="p95vav" sem="G#protein_molecule">p95vav</cons> involvement</cons> in <cons lex="TCR_signaling" sem="G#other_name"><cons lex="TCR" sem="G#protein_molecule">TCR</cons> signaling</cons>, we analyzed various <cons lex="Jurkat_mutant" sem="G#cell_line">Jurkat mutants</cons> deficient in <cons lex="TCR_signaling_function" sem="G#other_name"><cons lex="TCR" sem="G#protein_molecule">TCR</cons> signaling function</cons> or <cons lex="TCR_expression" sem="G#other_name"><cons lex="TCR" sem="G#protein_molecule">TCR</cons> expression</cons> and showed that an intact <cons lex="TCR_signaling_pathway" sem="G#other_name"><cons lex="TCR" sem="G#protein_molecule">TCR</cons> signaling pathway</cons> is required for <cons lex="p95vav" sem="G#protein_molecule">p95vav</cons> to function.</sentence>
<sentence>However, <cons lex="overexpression" sem="G#other_name">overexpression</cons> of <cons lex="p95vav" sem="G#protein_molecule">p95vav</cons> does not appear to influence <cons lex="TCR-induced_protein_tyrosine_phosphorylation" sem="G#other_name"><cons lex="TCR" sem="G#protein_molecule">TCR</cons>-induced protein <cons lex="tyrosine" sem="G#amino_acid_monomer">tyrosine</cons> <cons lex="phosphorylation" sem="G#other_name">phosphorylation</cons></cons> or increases in <cons lex="cytoplasmic_free_calcium" sem="G#atom">cytoplasmic free calcium</cons>.</sentence>
<sentence>Taken together, our data suggest that <cons lex="p95vav" sem="G#protein_molecule">p95vav</cons> plays an important role at an yet <cons lex="unidentified_proximal_position" sem="G#other_name">unidentified proximal position</cons> in the <cons lex="TCR_signaling_cascade" sem="G#other_name"><cons lex="TCR" sem="G#protein_molecule">TCR</cons> signaling cascade</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95329717</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="(AND positive_regulation negative_regulation)" sem="(AND G#other_name G#other_name)"><cons lex="positive*">Positive</cons> and <cons lex="negative*">negative</cons> <cons lex="*regulation">regulation</cons></cons> of <cons lex="granulocyte-macrophage_colony-stimulating_factor_promoter_activity" sem="G#other_name"><cons lex="granulocyte-macrophage_colony-stimulating_factor" sem="G#protein_molecule">granulocyte-macrophage colony-stimulating factor</cons> promoter activity</cons> by <cons lex="AML1-related_transcription_factor" sem="G#protein_molecule">AML1-related transcription factor</cons>, <cons lex="PEBP2" sem="G#protein_molecule">PEBP2</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="granulocyte-macrophage_colony-stimulating_factor_(GM-CSF)_gene_promoter" sem="G#DNA_domain_or_region"><cons lex="granulocyte-macrophage_colony-stimulating_factor" sem="G#protein_molecule">granulocyte-macrophage colony-stimulating factor</cons> (<cons lex="GM-CSF" sem="G#protein_molecule">GM-CSF</cons>) gene promoter</cons> contains a consensus sequence for the <cons lex="polyomavirus_enhancer_binding-protein_2_(PEBP2)_transcription_factor" sem="G#protein_molecule"><cons lex="polyomavirus_enhancer_binding-protein_2" sem="G#protein_molecule">polyomavirus enhancer binding-protein 2</cons> (<cons lex="PEBP2" sem="G#protein_molecule">PEBP2</cons>) transcription factor</cons>, which consists of <cons lex="(AND alpha_subunit beta_subunit)" sem="(AND G#protein_subunit G#protein_subunit)"><cons lex="alpha*">alpha</cons> and <cons lex="beta*">beta</cons> <cons lex="*subunit">subunits</cons></cons>.</sentence>
<sentence>There are at least two genes, <cons lex="alpha_A" sem="G#DNA_domain_or_region">alpha A</cons> and <cons lex="alpha_B" sem="G#DNA_domain_or_region">alpha B</cons>, encoding the <cons lex="alpha_subunit" sem="G#protein_subunit">alpha subunit</cons>.</sentence>
<sentence><cons lex="alpha_B" sem="G#DNA_domain_or_region">alpha B</cons> is the <cons lex="mouse_homologue" sem="G#DNA_family_or_group">mouse homologue</cons> of <cons lex="human_AML1_gene" sem="G#DNA_domain_or_region">human AML1 gene</cons> detected at the breakpoints of <cons lex="(AND t(8;21)_myeloid_leukemia t(3;21)_myeloid_leukemia)" sem="(AND G#other_artificial_source G#other_artificial_source)"><cons lex="t(8;21)*">t(8;21)</cons> and <cons lex="t(3;21)*">t(3;21)</cons> <cons lex="*myeloid_leukemia">myeloid leukemias</cons></cons>.</sentence>
<sentence>We examined <cons lex="alpha_A1" sem="G#protein_subunit">alpha A1</cons> (an <cons lex="alpha_A-gene_product" sem="G#protein_family_or_group"><cons lex="alpha_A" sem="G#DNA_domain_or_region">alpha A</cons>-gene product</cons>) and <cons lex="alpha_B1" sem="G#protein_subunit">alpha B1</cons> and <cons lex="alpha_B2" sem="G#protein_subunit">alpha B2</cons> (two <cons lex="alpha_B-encoded_isomer" sem="G#protein_family_or_group"><cons lex="alpha_B" sem="G#DNA_domain_or_region"><cons lex="alpha_B" sem="G#protein_subunit">alpha B</cons></cons>-encoded isomers</cons>) for their effects on the <cons lex="GM-CSF_promoter" sem="G#DNA_domain_or_region">GM-CSF promoter</cons>.</sentence>
<sentence><cons lex="PEBP2_alpha_A1" sem="G#protein_molecule"><cons lex="PEBP2" sem="G#protein_molecule">PEBP2</cons> <cons lex="alpha_A1" sem="G#protein_subunit">alpha A1</cons></cons>, <cons lex="alpha_B1" sem="G#protein_subunit">alpha B1</cons>, and <cons lex="alpha_B2_protein" sem="G#protein_family_or_group">alpha B2 proteins</cons> bound the <cons lex="PEBP2_site" sem="G#DNA_domain_or_region"><cons lex="PEBP2" sem="G#protein_molecule">PEBP2</cons> site</cons> within the <cons lex="mouse_GM-CSF_promoter" sem="G#DNA_domain_or_region">mouse <cons lex="GM-CSF" sem="G#protein_molecule">GM-CSF</cons> promoter</cons>.</sentence>
<sentence><cons lex="PEBP2_alpha_A1" sem="G#protein_molecule"><cons lex="PEBP2" sem="G#protein_molecule">PEBP2</cons> <cons lex="alpha_A1" sem="G#protein_subunit">alpha A1</cons></cons> and <cons lex="alpha_B1" sem="G#protein_subunit">alpha B1</cons> enhanced the expression of the <cons lex="GM-CSF_promoter-driven_reporter_plasmid" sem="G#DNA_molecule"><cons lex="GM-CSF" sem="G#protein_molecule">GM-CSF</cons> promoter-driven reporter plasmid</cons> in <cons lex="(AND unstimulated_human_Jurkat_T_cell 12-O-tetradecanoylphorbol_13-acetate/phytohemagglutinin-stimulated_human_Jurkat_T_cell)" sem="(AND G#cell_line G#cell_line)"><cons lex="unstimulated*">unstimulated</cons> and <cons lex="12-O-tetradecanoylphorbol_13-acetate/phytohemagglutinin-stimulated*">12-O-tetradecanoylphorbol 13-acetate/phytohemagglutinin-stimulated</cons> <cons lex="*human_Jurkat_T_cell">human Jurkat T cells</cons></cons>.</sentence>
<sentence>In contrast, the <cons lex="promoter_activity" sem="G#other_name">promoter activity</cons> was suppressed by <cons lex="alpha_B2" sem="G#protein_subunit">alpha B2</cons>.</sentence>
<sentence>Coexpression of <cons lex="alpha_B1" sem="G#protein_subunit">alpha B1</cons> and <cons lex="alpha_B2" sem="G#protein_subunit">alpha B2</cons> showed that the <cons lex="promoter_activity" sem="G#other_name">promoter activity</cons> could be determined by the <cons lex="alpha_B1/alpha_B2_ratio" sem="G#other_name"><cons lex="alpha_B1" sem="G#protein_subunit">alpha B1</cons><cons lex="alpha_B2" sem="G#protein_subunit">/alpha B2</cons> ratio</cons>.</sentence>
<sentence><cons lex="Jurkat_cell_extract" sem="G#cell_component">Jurkat cell extract</cons> contained <cons lex="PEBP2_site-binding_protein" sem="G#protein_family_or_group"><cons lex="PEBP2" sem="G#protein_molecule">PEBP2</cons> site-binding protein</cons>(s) that cross-reacted with <cons lex="antimouse_alpha_A1_antibody" sem="G#protein_family_or_group">antimouse <cons lex="alpha_A1" sem="G#protein_subunit">alpha A1</cons> antibodies</cons>.</sentence>
<sentence><cons lex="Northern_blot_analysis" sem="G#other_name">Northern blot analysis</cons> indicated the expression of human <cons lex="PEBP2_alpha_A" sem="G#protein_molecule"><cons lex="PEBP2" sem="G#protein_molecule">PEBP2</cons> alpha A</cons>, <cons lex="alpha_B" sem="G#DNA_domain_or_region"><cons lex="alpha_B" sem="G#protein_subunit">alpha B</cons></cons> (<cons lex="AML1" sem="G#DNA_domain_or_region">AML1</cons>), and <cons lex="beta_gene" sem="G#DNA_domain_or_region">beta genes</cons> in <cons lex="Jurkat_cell" sem="G#cell_line">Jurkat cells</cons>.</sentence>
<sentence>Although further studies are required to determine the precise role of <cons lex="PEBP2" sem="G#protein_molecule">PEBP2</cons> in the <cons lex="GM-CSF_promoter_activity" sem="G#other_name"><cons lex="GM-CSF" sem="G#protein_molecule">GM-CSF</cons> <cons lex="promoter_activity" sem="G#other_name">promoter activity</cons></cons>, the present findings suggested the importance of the relative ratio of different <cons lex="PEBP2_isoform" sem="G#protein_family_or_group"><cons lex="PEBP2" sem="G#protein_molecule">PEBP2</cons> isoforms</cons> in regulating the levels of the <cons lex="promoter_activity" sem="G#other_name">promoter activity</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:96075792</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons> priming of <cons lex="monocyte" sem="G#cell_type">monocytes</cons> enhances <cons lex="LPS-induced_TNF_production" sem="G#other_name"><cons lex="LPS" sem="G#lipid">LPS</cons>-induced <cons lex="TNF" sem="G#protein_family_or_group">TNF</cons> production</cons> by augmenting both <cons lex="transcription" sem="G#other_name">transcription</cons> and <cons lex="MRNA_stability" sem="G#other_name">MRNA stability</cons>.</sentence>
</title>
<abstract>
<sentence>The induction of <cons lex="cytokine_expression" sem="G#other_name"><cons lex="cytokine" sem="G#protein_family_or_group">cytokine</cons> expression</cons> in <cons lex="monocyte" sem="G#cell_type">monocytes</cons>/<cons lex="macrophage" sem="G#cell_type">macrophages</cons> by <cons lex="bacterial_endotoxin" sem="G#protein_family_or_group">bacterial endotoxin</cons> or <cons lex="lipopolysaccharide" sem="G#lipid">lipopolysaccharide</cons> is a critical, highly regulated <cons lex="host_defence_response" sem="G#other_name">host defence response</cons>.</sentence>
<sentence>The augmentation of <cons lex="LPS" sem="G#lipid">LPS</cons> responses by <cons lex="interferon_gamma" sem="G#protein_molecule">interferon gamma</cons> (<cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons>), referred to as priming, is well established.</sentence>
<sentence>However, the mechanism(s) by which priming occurs is poorly defined.</sentence>
<sentence>Using <cons lex="tumour_necrosis_factor_(TNF)_induction" sem="G#other_name"><cons lex="tumour_necrosis_factor" sem="G#protein_family_or_group">tumour necrosis factor</cons> (<cons lex="TNF" sem="G#protein_family_or_group">TNF</cons>) induction</cons> as a model, experiments were designed to analyse in detail the <cons lex="priming_effect" sem="G#other_name">priming effect</cons> on the <cons lex="LPS" sem="G#lipid">LPS</cons> response in <cons lex="human_monocyte" sem="G#cell_type">human <cons lex="monocyte" sem="G#cell_type">monocytes</cons></cons>.</sentence>
<sentence>Priming by <cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons> was primarily manifested at the level of <cons lex="TNF_mRNA_accumulation" sem="G#other_name"><cons lex="TNF_mRNA" sem="G#RNA_family_or_group"><cons lex="TNF" sem="G#protein_family_or_group">TNF</cons> mRNA</cons> accumulation</cons>.</sentence>
<sentence><cons lex="IFN-gamma_pre-treatment" sem="G#other_name"><cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons> pre-treatment</cons> affected the magnitude rather than the sensitivity of the <cons lex="LPS_response" sem="G#other_name"><cons lex="LPS" sem="G#lipid">LPS</cons> response</cons>.</sentence>
<sentence>Priming occurred after several hours of <cons lex="treatment" sem="G#other_name">treatment</cons>, and the <cons lex="primed_state" sem="G#other_name">primed state</cons> was induced by either <cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons> or <cons lex="GM-CSF" sem="G#protein_molecule">GM-CSF</cons>, but not <cons lex="M-CSF" sem="G#protein_molecule">M-CSF</cons>.</sentence>
<sentence>Primed <cons lex="monocyte" sem="G#cell_type">monocytes</cons> transcribed <cons lex="TNF_mRNA" sem="G#RNA_family_or_group"><cons lex="TNF" sem="G#protein_family_or_group">TNF</cons> mRNA</cons> at a higher rate than freshly isolated <cons lex="monocyte" sem="G#cell_type">monocytes</cons> upon activation with <cons lex="LPS" sem="G#lipid">LPS</cons>.</sentence>
<sentence>The increased <cons lex="transcriptional_rate" sem="G#other_name">transcriptional rate</cons> correlated with a marked increase in <cons lex="nuclear_factor-kappa_B_activity" sem="G#other_name"><cons lex="nuclear_factor-kappa_B" sem="G#protein_molecule">nuclear factor-kappa B</cons> activity</cons> in these cells as determined by <cons lex="electrophoretic_mobility_shift_assay" sem="G#other_name">electrophoretic mobility shift assay</cons> using a <cons lex="consensus_NF-kappa_B_oligonucleotide" sem="G#DNA_molecule">consensus <cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons> oligonucleotide</cons>.</sentence>
<sentence>An additional significant finding was than <cons lex="TNF_mRNA" sem="G#RNA_family_or_group"><cons lex="TNF" sem="G#protein_family_or_group">TNF</cons> mRNA</cons> induced in <cons lex="primed_cell" sem="G#cell_line">primed cells</cons> was much more stable than in <cons lex="unprimed_cell" sem="G#cell_line">unprimed cells</cons> (T1/2 increased 6-8-fold).</sentence>
<sentence>Consistent with the increased <cons lex="mRNA_stability" sem="G#other_name"><cons lex="mRNA" sem="G#RNA_family_or_group">mRNA</cons> stability</cons>, the duration of <cons lex="mRNA_accumulation" sem="G#other_name"><cons lex="mRNA" sem="G#RNA_family_or_group">mRNA</cons> accumulation</cons> was longer following <cons lex="LPS" sem="G#lipid">LPS</cons> stimulation in primed <cons lex="monocyte" sem="G#cell_type">monocytes</cons>, in addition to being of greater magnitude.</sentence>
<sentence>Finally, primed and unprimed cells possessed a differential sensitivity to the <cons lex="kinase_inhibitor_H-89" sem="G#other_organic_compound">kinase inhibitor H-89</cons>.</sentence>
<sentence><cons lex="H-89" sem="G#other_organic_compound">H-89</cons> substantially suppressed <cons lex="LPS-induced_TNF_mRNA_accumulation" sem="G#other_name"><cons lex="LPS" sem="G#lipid">LPS</cons>-induced <cons lex="TNF_mRNA" sem="G#RNA_family_or_group"><cons lex="TNF" sem="G#protein_family_or_group">TNF</cons> mRNA</cons> accumulation</cons> in <cons lex="unprimed_cell" sem="G#cell_line">unprimed cells</cons>, but had no effect on <cons lex="primed_monocyte" sem="G#cell_line">primed <cons lex="monocyte" sem="G#cell_type">monocytes</cons></cons> following <cons lex="LPS_stimulation" sem="G#other_name"><cons lex="LPS" sem="G#lipid">LPS</cons> stimulation</cons>.</sentence>
<sentence>(ABSTRACT TRUNCATED AT 250 WORDS)</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95280917</bibliomisc>
</articleinfo>
<title>
<sentence>A <cons lex="Myc-associated_zinc_finger_protein_binding_site" sem="G#DNA_domain_or_region"><cons lex="Myc-associated_zinc_finger_protein" sem="G#protein_family_or_group">Myc-associated zinc finger protein</cons> binding site</cons> is one of four important <cons lex="functional_region" sem="G#DNA_domain_or_region">functional regions</cons> in the <cons lex="CD4_promoter" sem="G#DNA_domain_or_region"><cons lex="CD4" sem="G#protein_molecule">CD4</cons> promoter</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="CD4_promoter" sem="G#DNA_domain_or_region"><cons lex="CD4" sem="G#protein_molecule">CD4</cons> promoter</cons> plays an important role in the <cons lex="developmental_control" sem="G#other_name">developmental control</cons> of <cons lex="CD4_transcription" sem="G#other_name"><cons lex="CD4" sem="G#protein_molecule">CD4</cons> transcription</cons>.</sentence>
<sentence>In this report, we show that the minimal <cons lex="CD4_promoter" sem="G#DNA_domain_or_region"><cons lex="CD4" sem="G#protein_molecule">CD4</cons> promoter</cons> has four <cons lex="factor_binding_site" sem="G#DNA_domain_or_region">factor binding sites</cons>, each of which is required for full function.</sentence>
<sentence>Using <cons lex="(AND biochemical_analysis mutagenesis_analysis)" sem="(AND G#other_name G#other_name)"><cons lex="biochemical*">biochemical</cons> and <cons lex="mutagenesis*">mutagenesis</cons> <cons lex="*analysis">analyses</cons></cons>, we determined that multiple <cons lex="nuclear_factor" sem="G#protein_family_or_group">nuclear factors</cons> bind to these independent sites.</sentence>
<sentence>We determined that an <cons lex="initiator-like_sequence" sem="G#DNA_domain_or_region">initiator-like sequence</cons> present at the <cons lex="cap_site" sem="G#DNA_domain_or_region">cap site</cons> and an <cons lex="Ets_consensus_sequence" sem="G#DNA_domain_or_region">Ets consensus sequence</cons> are required for full <cons lex="promoter_function" sem="G#other_name"><cons lex="promoter" sem="G#DNA_domain_or_region">promoter</cons> function</cons>.</sentence>
<sentence>We also demonstrate that the <cons lex="Myc-associated_zinc_finger_protein" sem="G#protein_molecule">Myc-associated <cons lex="zinc_finger" sem="G#protein_substructure">zinc finger</cons> protein</cons> (<cons lex="MAZ" sem="G#protein_molecule">MAZ</cons>) appears to be the <cons lex="predominant_factor" sem="G#protein_family_or_group">predominant factor</cons> binding to one of these sites.</sentence>
<sentence>This last site closely resembles the <cons lex="ME1a1_G3AG4AG3_motif" sem="G#DNA_domain_or_region">ME1a1 G3AG4AG3 motif</cons> previously shown to be a critical element in the <cons lex="P2_promoter" sem="G#DNA_domain_or_region">P2 promoter</cons> of the <cons lex="c-myc_gene" sem="G#DNA_domain_or_region">c-myc gene</cons>.</sentence>
<sentence>We therefore believe that the <cons lex="MAZ_transcription_factor" sem="G#protein_family_or_group"><cons lex="MAZ" sem="G#protein_molecule">MAZ</cons> transcription factor</cons> is also likely to play an important role in the control of <cons lex="developmental_expression" sem="G#other_name">developmental expression</cons> of the <cons lex="CD4_gene" sem="G#DNA_domain_or_region"><cons lex="CD4" sem="G#protein_molecule">CD4</cons> gene</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95263486</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="erythropoietin" sem="G#protein_molecule">Erythropoietin</cons> stimulates transcription of the <cons lex="TAL1/SCL_gene" sem="G#DNA_domain_or_region">TAL1/SCL gene</cons> and <cons lex="phosphorylation" sem="G#other_name">phosphorylation</cons> of its <cons lex="protein_product" sem="G#protein_domain_or_region">protein products</cons>.</sentence>
</title>
<abstract>
<sentence>Activation of the <cons lex="TAL1_(or_SCL)_gene" sem="G#DNA_domain_or_region">TAL1 (or SCL) gene</cons>, originally identified through its involvement by a <cons lex="recurrent_chromosomal_translocation" sem="G#other_name">recurrent chromosomal translocation</cons>, is the most frequent <cons lex="molecular_lesion" sem="G#DNA_N/A">molecular lesion</cons> recognized in <cons lex="T-cell_acute_lymphoblastic_leukemia" sem="G#other_name">T-cell acute lymphoblastic leukemia</cons>.</sentence>
<sentence>The <cons lex="protein_product" sem="G#protein_family_or_group">protein products</cons> of this gene contain the <cons lex="basic-helix-loop-helix_motif" sem="G#protein_family_or_group">basic-helix-loop-helix motif</cons> characteristic of a large family of <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> that bind to the <cons lex="canonical_DNA_sequence_CANNTG" sem="G#DNA_domain_or_region">canonical DNA sequence CANNTG</cons> as <cons lex="protein_heterodimer" sem="G#protein_family_or_group">protein heterodimers</cons>.</sentence>
<sentence><cons lex="TAL1_expression" sem="G#other_name"><cons lex="TAL1" sem="G#protein_molecule">TAL1</cons> expression</cons> by <cons lex="erythroid_cell" sem="G#cell_type">erythroid cells</cons> in vivo and in <cons lex="chemical-induced_erythroleukemia_cell_line" sem="G#cell_line">chemical-induced erythroleukemia cell lines</cons> in vivo suggested the gene might regulate aspects of <cons lex="erythroid_differentiation" sem="G#other_name">erythroid differentiation</cons>.</sentence>
<sentence>Since the terminal events of <cons lex="erythropoiesis" sem="G#other_name">erythropoiesis</cons> are controlled by the <cons lex="glycoprotein_hormone_erythropoietin" sem="G#protein_molecule">glycoprotein hormone erythropoietin</cons> (<cons lex="Epo" sem="G#protein_molecule">Epo</cons>), we investigated whether the expression or activity of the <cons lex="TAL1_gene" sem="G#DNA_domain_or_region"><cons lex="TAL1" sem="G#protein_molecule">TAL1</cons> gene</cons> and its <cons lex="protein_product" sem="G#protein_family_or_group">protein products</cons> were affected by <cons lex="Epo" sem="G#protein_molecule">Epo</cons> in <cons lex="splenic_erythroblast" sem="G#cell_type">splenic erythroblasts</cons> from <cons lex="mice" sem="G#multi_cell">mice</cons> infected with an anemia-inducing strain of Friend virus (FVA cells).</sentence>
<sentence><cons lex="Epo" sem="G#protein_molecule">Epo</cons> elicited a rapid, dose-related increase in <cons lex="TAL1_mRNA" sem="G#RNA_family_or_group"><cons lex="TAL1" sem="G#protein_molecule">TAL1</cons> mRNA</cons> by increasing <cons lex="transcription" sem="G#other_name">transcription</cons> of the gene and stabilizing one of its <cons lex="mRNA" sem="G#RNA_family_or_group">mRNAs</cons>.</sentence>
<sentence>An <cons lex="Epo-inducible_TAL1_DNA_binding_activity" sem="G#other_name"><cons lex="Epo" sem="G#protein_molecule">Epo</cons>-inducible <cons lex="TAL1" sem="G#protein_molecule">TAL1</cons> DNA binding activity</cons> was identified in <cons lex="FVA_cell_nuclear_extract" sem="G#cell_component">FVA cell nuclear extracts</cons> that subsequently decayed despite accumulating <cons lex="mRNA" sem="G#RNA_family_or_group">mRNA</cons> and <cons lex="protein" sem="G#protein_N/A">protein</cons>.</sentence>
<sentence>Induction of <cons lex="DNA_binding_activity" sem="G#other_name">DNA binding activity</cons> was associated temporally with <cons lex="Epo-induced_phosphorylation" sem="G#other_name"><cons lex="Epo" sem="G#protein_molecule">Epo</cons>-induced <cons lex="phosphorylation" sem="G#other_name">phosphorylation</cons></cons> of <cons lex="nuclear_TAL1_protein" sem="G#protein_molecule">nuclear <cons lex="TAL1" sem="G#protein_molecule">TAL1</cons> protein</cons>.</sentence>
<sentence>These results indicate that <cons lex="Epo" sem="G#protein_molecule">Epo</cons> acts at both <cons lex="(AND transcriptional_level posttranscriptional_level)" sem="(AND G#other_name G#other_name)"><cons lex="transcriptional*">transcriptional</cons> and <cons lex="posttranscriptional*">posttranscriptional</cons> <cons lex="*level">levels</cons></cons> on the <cons lex="TAL1" sem="G#protein_molecule">TAL1</cons> locus in <cons lex="Friend_virus-induced_erythroblast" sem="G#cell_line"><cons lex="Friend_virus" sem="G#virus">Friend virus</cons>-induced erythroblasts</cons> and establish a link between <cons lex="Epo_signaling_mechanism" sem="G#other_name"><cons lex="Epo" sem="G#protein_molecule">Epo</cons> signaling mechanisms</cons> and a member of a family of <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> involved in the differentiation of <cons lex="diverse_cell_lineage" sem="G#cell_type">diverse cell lineages</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95397944</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="nonradioactive_quantification" sem="G#other_name">Nonradioactive quantification</cons> of <cons lex="glucocorticoid_receptor_expression" sem="G#other_name"><cons lex="glucocorticoid_receptor" sem="G#protein_domain_or_region">glucocorticoid receptor</cons> expression</cons> during differentiation of human <cons lex="monocytic_cell" sem="G#cell_type">monocytic cells</cons> (<cons lex="U937" sem="G#cell_line">U937</cons>).</sentence>
</title>
<abstract>
<sentence>We describe a method for relative quantification of specific <cons lex="mRNA" sem="G#RNA_family_or_group">mRNA</cons> using a <cons lex="nonradioactive_assay" sem="G#other_name">nonradioactive assay</cons> based on <cons lex="DNA_strand_competition" sem="G#other_name">DNA strand competition</cons> between identical sequences of <cons lex="biotin-_and_fluorescein-labeled_amplicon" sem="G#other_organic_compound">biotin- and fluorescein-labeled amplicon</cons> (probe) and <cons lex="unlabeled_amplicon" sem="G#other_organic_compound">unlabeled amplicon</cons> (target) during <cons lex="hybridization" sem="G#other_name">hybridization</cons>.</sentence>
<sentence>As the target quantity increased, that of the <cons lex="double-labeled_probe" sem="G#other_organic_compound">double-labeled probe</cons> decreased in accordance with the mass action law.</sentence>
<sentence>This technique was successfully applied to evaluate differences in <cons lex="glucocorticoid_receptor_expression" sem="G#other_name"><cons lex="glucocorticoid_receptor" sem="G#protein_domain_or_region">glucocorticoid receptor</cons> expression</cons> in <cons lex="U937_cell" sem="G#cell_line">U937 cells</cons> before and after the addition of potent <cons lex="differentiation_inducer" sem="G#other_name">differentiation inducers</cons>: <cons lex="12-O-tetradecanoylphorbol_13-acetate" sem="G#other_organic_compound">12-O-tetradecanoylphorbol 13-acetate</cons> (<cons lex="TPA" sem="G#other_organic_compound">TPA</cons>) and a combination of <cons lex="all-trans_retinoic_acid" sem="G#other_organic_compound">all-trans retinoic acid</cons> (<cons lex="RA" sem="G#other_organic_compound">RA</cons>) and <cons lex="1,25-dihydroxyvitamin_D2" sem="G#other_organic_compound">1,25-dihydroxyvitamin D2</cons> (<cons lex="VD" sem="G#other_organic_compound">VD</cons>).</sentence>
<sentence>We observed that <cons lex="TPA" sem="G#other_organic_compound">TPA</cons> treatment was associated with an increase in specific binding of <cons lex="[3H]dexamethasone" sem="G#lipid">[3H]dexamethasone</cons> and up-regulation of <cons lex="GR_mRNA" sem="G#RNA_family_or_group"><cons lex="GR" sem="G#protein_family_or_group">GR</cons> mRNA</cons> while no enhanced <cons lex="GR_expression" sem="G#other_name"><cons lex="GR" sem="G#protein_family_or_group">GR</cons> expression</cons> was perceived with <cons lex="RA/VD_treatment" sem="G#other_name">RA/VD treatment</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95266282</bibliomisc>
</articleinfo>
<title>
<sentence>Induction of <cons lex="Sp1_phosphorylation" sem="G#other_name"><cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> <cons lex="phosphorylation" sem="G#other_name">phosphorylation</cons></cons> and <cons lex="NF-kappa_B-independent_HIV_promoter_domain_activity" sem="G#other_name"><cons lex="NF-kappa_B-independent_HIV_promoter" sem="G#DNA_domain_or_region"><cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons>-independent <cons lex="HIV" sem="G#virus">HIV</cons> promoter</cons> domain activity</cons> in <cons lex="T_lymphocyte" sem="G#cell_type">T lymphocytes</cons> stimulated by <cons lex="okadaic_acid" sem="G#other_organic_compound">okadaic acid</cons>.</sentence>
</title>
<abstract>
<sentence>In contrast to the purely <cons lex="enhancer-dependent_effect" sem="G#other_name">enhancer-dependent effect</cons> of <cons lex="cytokine" sem="G#protein_family_or_group">cytokines</cons> such as <cons lex="TNF" sem="G#protein_family_or_group">TNF</cons> on the activity of the <cons lex="HIV_regulatory_region" sem="G#DNA_domain_or_region"><cons lex="HIV" sem="G#virus">HIV</cons> regulatory region</cons> (<cons lex="LTR" sem="G#DNA_domain_or_region">LTR</cons>), we observed that <cons lex="okadaic_acid" sem="G#other_organic_compound">okadaic acid</cons> (<cons lex="OKA" sem="G#other_organic_compound">OKA</cons>) activates <cons lex="HIV_transcription" sem="G#other_name"><cons lex="HIV" sem="G#virus">HIV</cons> transcription</cons> through both the enhancer, responding to the factor <cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons>, and the <cons lex="promoter_domain" sem="G#DNA_domain_or_region">promoter domain</cons> of the <cons lex="LTR" sem="G#DNA_domain_or_region">LTR</cons>.</sentence>
<sentence>The inducibility of <cons lex="HIV_LTR-driven_luciferase_expression_construct" sem="G#DNA_family_or_group"><cons lex="HIV_LTR" sem="G#DNA_domain_or_region"><cons lex="HIV" sem="G#virus">HIV</cons> LTR</cons>-driven <cons lex="luciferase" sem="G#protein_molecule">luciferase</cons> expression constructs</cons> in <cons lex="lymphoblastoid_cell" sem="G#cell_type">lymphoblastoid cells</cons> stimulated by <cons lex="OKA" sem="G#other_organic_compound">OKA</cons> depended on both <cons lex="functional_Sp1_binding_element" sem="G#DNA_domain_or_region">functional <cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> binding elements</cons> and the ability of the <cons lex="TATA_box" sem="G#DNA_domain_or_region">TATA box</cons> to bind the protein <cons lex="TBP" sem="G#protein_molecule">TBP</cons>.</sentence>
<sentence>In both <cons lex="(AND transformed_lymphocyte normal_lymphocyte)" sem="(AND G#cell_type G#cell_type)"><cons lex="transformed*">transformed</cons> and <cons lex="normal*">normal</cons> <cons lex="*lymphocyte">lymphocytes</cons></cons>, <cons lex="OKA_stimulation" sem="G#other_name"><cons lex="OKA" sem="G#other_organic_compound">OKA</cons> stimulation</cons> induced intense <cons lex="phosphorylation" sem="G#other_name">phosphorylation</cons> of the constitutively expressed <cons lex="Sp1_protein" sem="G#protein_molecule"><cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> protein</cons> in the <cons lex="nucleus" sem="G#cell_component">nucleus</cons>, a property of <cons lex="OKA" sem="G#other_organic_compound">OKA</cons> not shared by <cons lex="TNF" sem="G#protein_family_or_group">TNF</cons>, <cons lex="phorbol_ester" sem="G#other_organic_compound">phorbol ester</cons>, or <cons lex="PHA" sem="G#protein_molecule">PHA</cons> and <cons lex="interleukin_2" sem="G#protein_molecule">interleukin 2</cons>.</sentence>
<sentence>Responsiveness of <cons lex="LTR_construct" sem="G#DNA_family_or_group">LTR constructs</cons> deleted of <cons lex="kappa_B_element" sem="G#DNA_family_or_group">kappa B elements</cons> to <cons lex="HIV_Tat_expression" sem="G#other_name"><cons lex="HIV_Tat" sem="G#protein_molecule"><cons lex="HIV" sem="G#virus">HIV</cons> Tat</cons> expression</cons> was increased upon <cons lex="(BUT_NOT OKA_stimulation TNF_stimulation)" sem="(BUT_NOT G#other_name G#other_name)"><cons lex="OKA" sem="G#other_organic_compound"><cons lex="OKA*">OKA</cons></cons> but not <cons lex="TNF" sem="G#protein_family_or_group"><cons lex="TNF*">TNF</cons></cons> <cons lex="*stimulation">stimulation</cons></cons>.</sentence>
<sentence>Our results suggest that <cons lex="SP1" sem="G#protein_molecule">SP1</cons> <cons lex="phosphorylation" sem="G#other_name">phosphorylation</cons> induced by <cons lex="OKA" sem="G#other_organic_compound">OKA</cons>, a selective inhibitor of the <cons lex="serine-threonine_phosphatase" sem="G#protein_family_or_group">serine-threonine phosphatase</cons> <cons lex="PP2A" sem="G#protein_molecule">PP2A</cons>, facilitates the formation of a <cons lex="transcription_complex" sem="G#protein_complex">transcription complex</cons> involving general <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons>, <cons lex="HIV_Tat" sem="G#protein_molecule"><cons lex="HIV" sem="G#virus">HIV</cons> Tat</cons>, and <cons lex="Sp1_protein" sem="G#protein_family_or_group"><cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> proteins</cons>.</sentence>
<sentence>The formation of this complex would increase, independently of an in synergy with <cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons>, the low <cons lex="basal_activity" sem="G#other_name">basal activity</cons> of the <cons lex="HIV_LTR" sem="G#DNA_domain_or_region"><cons lex="HIV" sem="G#virus">HIV</cons> LTR</cons> observed in <cons lex="normal_T_lymphocyte" sem="G#cell_type">normal <cons lex="T_lymphocyte" sem="G#cell_type">T lymphocytes</cons></cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95236293</bibliomisc>
</articleinfo>
<title>
<sentence>The role of <cons lex="shared_receptor_motif" sem="G#protein_substructure">shared receptor motifs</cons> and <cons lex="common_Stat_protein" sem="G#protein_family_or_group">common Stat proteins</cons> in the generation of <cons lex="cytokine_pleiotropy" sem="G#other_name"><cons lex="cytokine" sem="G#protein_family_or_group">cytokine</cons> pleiotropy</cons> and redundancy by <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons>, <cons lex="IL-4" sem="G#protein_molecule">IL-4</cons>, <cons lex="IL-7" sem="G#protein_molecule">IL-7</cons>, <cons lex="IL-13" sem="G#protein_molecule">IL-13</cons>, and <cons lex="IL-15" sem="G#protein_molecule">IL-15</cons>.</sentence>
</title>
<abstract>
<sentence>To understand the molecular bases for <cons lex="(AND cytokine_redundancy cytokine_pleiotropy)" sem="(AND G#other_name G#other_name)"><cons lex="cytokine*">cytokine</cons> <cons lex="*redundancy">redundancy</cons> and <cons lex="*pleiotropy">pleiotropy</cons></cons>, we have compared the <cons lex="Stat_protein" sem="G#protein_family_or_group">Stat proteins</cons> activated in <cons lex="peripheral_blood_lymphocyte" sem="G#cell_type">peripheral blood lymphocytes</cons> (<cons lex="PBL" sem="G#cell_type">PBLs</cons>) by <cons lex="cytokine" sem="G#protein_family_or_group">cytokines</cons> with shared and distinct actions.</sentence>
<sentence><cons lex="interleukin-2" sem="G#protein_molecule">Interleukin-2</cons> (<cons lex="IL-2" sem="G#protein_molecule">IL-2</cons>) rapidly activated <cons lex="Stat5" sem="G#protein_molecule">Stat5</cons> in fresh <cons lex="PBL" sem="G#cell_type">PBL</cons>, and <cons lex="Stat3" sem="G#protein_molecule">Stat3</cons> and <cons lex="Stat5" sem="G#protein_molecule">Stat5</cons> in <cons lex="preactivated_PBL" sem="G#cell_type">preactivated PBL</cons>.</sentence>
<sentence><cons lex="IL-7" sem="G#protein_molecule">IL-7</cons> and <cons lex="IL-15" sem="G#protein_molecule">IL-15</cons> induced the same complexes as <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons>, a feature explained by the existence of similar <cons lex="tyrosine-phosphorylated_motif" sem="G#protein_substructure"><cons lex="tyrosine" sem="G#amino_acid_monomer">tyrosine</cons>-phosphorylated motifs</cons> in the <cons lex="cytoplasmic_domain" sem="G#protein_domain_or_region">cytoplasmic domains</cons> of <cons lex="IL-2R_beta" sem="G#protein_molecule">IL-2R beta</cons> and <cons lex="IL-7R" sem="G#protein_molecule">IL-7R</cons> that can serve as docking sites for <cons lex="Stat_protein" sem="G#protein_family_or_group">Stat proteins</cons>.</sentence>
<sentence><cons lex="IL-13" sem="G#protein_molecule">IL-13</cons> Induced the same complexes as <cons lex="IL-4" sem="G#protein_molecule">IL-4</cons>, a finding explained by our studies implicating <cons lex="IL-4R" sem="G#protein_molecule">IL-4R</cons> as a shared component of the <cons lex="receptor" sem="G#protein_family_or_group">receptors</cons>.</sentence>
<sentence>These studies demonstrate that a single <cons lex="cytokine" sem="G#protein_family_or_group">cytokine</cons> can activate different combinations of <cons lex="Stat_protein" sem="G#protein_family_or_group">Stat proteins</cons> under different <cons lex="physiological_condition" sem="G#other_name">physiological conditions</cons>, and also indicate two mechanisms by which distinct <cons lex="cytokine" sem="G#protein_family_or_group">cytokines</cons> can activate the same <cons lex="Stat_protein" sem="G#protein_family_or_group">Stat protein</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95184007</bibliomisc>
</articleinfo>
<title>
<sentence>Control of <cons lex="I_kappa_B-alpha_proteolysis" sem="G#other_name"><cons lex="I_kappa_B-alpha" sem="G#protein_molecule">I kappa B-alpha</cons> proteolysis</cons> by site-specific, signal-induced <cons lex="phosphorylation" sem="G#other_name">phosphorylation</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="I_kappa_B-alpha" sem="G#protein_molecule">I kappa B-alpha</cons> inhibits <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> <cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons> by retaining it in the <cons lex="cytoplasm" sem="G#cell_component">cytoplasm</cons>.</sentence>
<sentence>Various stimuli, typically those associated with stress or pathogens, rapidly inactivate <cons lex="I_kappa_B-alpha" sem="G#protein_molecule">I kappa B-alpha</cons>.</sentence>
<sentence>This liberates <cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons> to translocate to the <cons lex="nucleus" sem="G#cell_component">nucleus</cons> and initiate <cons lex="transcription" sem="G#other_name">transcription</cons> of <cons lex="gene" sem="G#DNA_family_or_group">genes</cons> important for the defense of the organism.</sentence>
<sentence>Activation of <cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons> correlates with <cons lex="phosphorylation" sem="G#other_name">phosphorylation</cons> of <cons lex="I_kappa_B-alpha" sem="G#protein_molecule">I kappa B-alpha</cons> and requires the <cons lex="proteolysis" sem="G#other_name">proteolysis</cons> of this inhibitor.</sentence>
<sentence>When either <cons lex="serine-32" sem="G#amino_acid_monomer">serine-32</cons> or <cons lex="serine-36" sem="G#amino_acid_monomer">serine-36</cons> of <cons lex="I_kappa_B-alpha" sem="G#protein_molecule">I kappa B-alpha</cons> was mutated, the protein did not undergo <cons lex="signal-induced_phosphorylation" sem="G#other_name">signal-induced <cons lex="phosphorylation" sem="G#other_name">phosphorylation</cons></cons> or <cons lex="degradation" sem="G#other_name">degradation</cons>, and <cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons> could not be activated.</sentence>
<sentence>These results suggest that <cons lex="phosphorylation" sem="G#other_name">phosphorylation</cons> at one or both of these <cons lex="residue" sem="G#amino_acid_monomer">residues</cons> is critical for activation of <cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95388524</bibliomisc>
</articleinfo>
<title>
<sentence>Regulation of <cons lex="transcription" sem="G#other_name">transcription</cons> of the <cons lex="human_erythropoietin_receptor_gene" sem="G#DNA_domain_or_region">human erythropoietin receptor gene</cons> by proteins binding to <cons lex="GATA-1_and_Sp1_motif" sem="G#DNA_domain_or_region"><cons lex="GATA-1_motif" sem="G#DNA_domain_or_region">GATA-1</cons> and <cons lex="Sp1_motif" sem="G#DNA_domain_or_region">Sp1 motifs</cons></cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="erythropoietin" sem="G#protein_molecule">Erythropoietin</cons> (<cons lex="Epo" sem="G#protein_molecule">Epo</cons>), the primary regulator of the production of <cons lex="erythroid_cell" sem="G#cell_type">erythroid cells</cons>, acts by binding to a <cons lex="cell_surface_receptor" sem="G#protein_family_or_group">cell surface receptor</cons> (<cons lex="EpoR" sem="G#protein_molecule">EpoR</cons>) on <cons lex="erythroid_progenitor" sem="G#cell_type">erythroid progenitors</cons>.</sentence>
<sentence>We used <cons lex="deletion_analysis" sem="G#other_name">deletion analysis</cons> and <cons lex="transfection_assay" sem="G#other_name">transfection assays</cons> with <cons lex="reporter_gene_construct" sem="G#DNA_family_or_group">reporter gene constructs</cons> to examine the <cons lex="transcription_control_element" sem="G#DNA_domain_or_region">transcription control elements</cons> in the <cons lex="5'_flanking_region" sem="G#DNA_domain_or_region">5' flanking region</cons> of the <cons lex="human_EpoR_gene" sem="G#DNA_domain_or_region">human <cons lex="EpoR" sem="G#protein_molecule">EpoR</cons> gene</cons>.</sentence>
<sentence>In <cons lex="erythroid_cell" sem="G#cell_type">erythroid cells</cons> most of the <cons lex="transcription_activity" sem="G#other_name">transcription activity</cons> was contained in a <cons lex="150_bp_promoter" sem="G#DNA_domain_or_region">150 bp promoter</cons> fragment with <cons lex="binding_site" sem="G#DNA_domain_or_region">binding sites</cons> for <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> <cons lex="AP2" sem="G#protein_molecule">AP2</cons>, <cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> and the <cons lex="erythroid-specific_GATA-1" sem="G#protein_molecule">erythroid-specific GATA-1</cons>.</sentence>
<sentence>The <cons lex="150_bp_hEpoR_promoter" sem="G#DNA_domain_or_region">150 bp hEpoR promoter</cons> exhibited high and low activity in erythroid <cons lex="OCIM1" sem="G#cell_line">OCIM1</cons> and <cons lex="K562_cell" sem="G#cell_line">K562 cells</cons>, respectively, reflecting the high and low levels of constitutive <cons lex="hEpoR_expression" sem="G#other_name"><cons lex="hEpoR" sem="G#protein_molecule">hEpoR</cons> expression</cons>.</sentence>
<sentence>The <cons lex="(AND GATA-1_binding_site Sp1_binding_site)" sem="(AND G#DNA_domain_or_region G#DNA_domain_or_region)"><cons lex="GATA-1*">GATA-1</cons> and <cons lex="Sp1*">Sp1</cons> <cons lex="*binding_site">binding sites</cons></cons> in this promoter lacking a <cons lex="TATA_sequence" sem="G#DNA_domain_or_region">TATA sequence</cons> were necessary for a high level of <cons lex="transcription_activation" sem="G#other_name">transcription activation</cons>.</sentence>
<sentence><cons lex="Protein-DNA_binding_study" sem="G#other_name">Protein-DNA binding studies</cons> suggested that <cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> and two other <cons lex="CCGCCC_binding_protein" sem="G#protein_family_or_group">CCGCCC binding proteins</cons> from <cons lex="(AND erythroid_cell non-erythroid_cell)" sem="(AND G#cell_type G#cell_type)"><cons lex="erythroid*">erythroid</cons> and <cons lex="non-erythroid*">non-erythroid</cons> <cons lex="*cell">cells</cons></cons> could bind to the <cons lex="Sp1_binding_motif" sem="G#DNA_domain_or_region"><cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> binding motif</cons>.</sentence>
<sentence>By increasing <cons lex="GATA-1_level" sem="G#other_name"><cons lex="GATA-1" sem="G#protein_molecule">GATA-1</cons> levels</cons> via <cons lex="co-transfection" sem="G#other_name">co-transfection</cons>, we were able to transactivate the <cons lex="hEpoR_promoter" sem="G#DNA_domain_or_region">hEpoR promoter</cons> in <cons lex="K562_cell" sem="G#cell_line">K562 cells</cons> and <cons lex="non-erythroid_cell" sem="G#cell_type">non-erythroid cells</cons>, but not in the highly active <cons lex="OCIM1_cell" sem="G#cell_type">OCIM1 cells</cons>, although <cons lex="GATA-1_mRNA_level" sem="G#other_name"><cons lex="GATA-1_mRNA" sem="G#RNA_molecule"><cons lex="GATA-1" sem="G#protein_molecule">GATA-1</cons> mRNA</cons> levels</cons> were comparable in <cons lex="OCIM1" sem="G#cell_line">OCIM1</cons> and <cons lex="K562" sem="G#cell_line">K562</cons>.</sentence>
<sentence>Interestingly, when we mutated the <cons lex="Sp1_site" sem="G#DNA_domain_or_region"><cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> site</cons>, resulting in a marked decrease in <cons lex="hEpoR_promoter_activity" sem="G#other_name"><cons lex="hEpoR_promoter" sem="G#DNA_domain_or_region">hEpoR promoter</cons> activity</cons>, we could restore <cons lex="transactivation" sem="G#other_name">transactivation</cons> by increasing <cons lex="GATA-1_level" sem="G#other_name"><cons lex="GATA-1" sem="G#protein_molecule">GATA-1</cons> levels</cons> in <cons lex="OCIM1_cell" sem="G#cell_type">OCIM1 cells</cons>.</sentence>
<sentence>These data suggest that while <cons lex="GATA-1" sem="G#protein_molecule">GATA-1</cons> can transactivate the <cons lex="EpoR_promoter" sem="G#DNA_domain_or_region"><cons lex="EpoR" sem="G#protein_molecule">EpoR</cons> promoter</cons>, the level of <cons lex="hEpoR_gene_expression" sem="G#other_name"><cons lex="hEpoR_gene" sem="G#DNA_domain_or_region">hEpoR gene</cons> expression</cons> does not depend on <cons lex="GATA-1" sem="G#protein_molecule">GATA-1</cons> alone.</sentence>
<sentence>Rather, <cons lex="hEpoR_transcription_activity" sem="G#other_name"><cons lex="hEpoR" sem="G#protein_molecule">hEpoR</cons> transcription activity</cons> depends on coordination between <cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> and <cons lex="GATA-1" sem="G#protein_molecule">GATA-1</cons> with other <cons lex="cell-specific_factor" sem="G#protein_family_or_group">cell-specific factors</cons>, including possibly other <cons lex="Sp1-like_binding_protein" sem="G#protein_family_or_group"><cons lex="Sp1" sem="G#protein_molecule">Sp1</cons>-like binding proteins</cons>, to provide high level, <cons lex="tissue-specific_expression" sem="G#other_name">tissue-specific expression</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95365382</bibliomisc>
</articleinfo>
<title>
<sentence>Overexpression of <cons lex="DR-nm23" sem="G#protein_molecule">DR-nm23</cons>, a protein encoded by a member of the <cons lex="nm23_gene_family" sem="G#DNA_family_or_group">nm23 gene family</cons>, inhibits <cons lex="granulocyte_differentiation" sem="G#other_name"><cons lex="granulocyte" sem="G#cell_type">granulocyte</cons> differentiation</cons> and induces <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> in <cons lex="32Dc13_myeloid_cell" sem="G#cell_line">32Dc13 myeloid cells</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="chronic_myelogenous_leukemia" sem="G#other_name">Chronic myelogenous leukemia</cons> evolves in two clinically distinct stages: a <cons lex="chronic_phase" sem="G#other_name">chronic</cons> and a <cons lex="blast_crisis_phase" sem="G#other_name">blast crisis phase</cons>.</sentence>
<sentence>The molecular changes associated with <cons lex="chronic_phase" sem="G#other_name">chronic phase</cons> to <cons lex="blast_crisis" sem="G#other_name">blast crisis</cons> transition are largely unknown.</sentence>
<sentence>We have identified a <cons lex="cDNA_clone" sem="G#DNA_family_or_group">cDNA clone</cons>, <cons lex="DR-nm23" sem="G#protein_molecule">DR-nm23</cons>, differentially expressed in a <cons lex="blast-crisis_cDNA_library" sem="G#DNA_family_or_group">blast-crisis cDNA library,</cons> which has approximately 70% sequence similarity to the <cons lex="putative_metastatic_suppressor_gene" sem="G#DNA_family_or_group">putative metastatic suppressor genes</cons>, <cons lex="nm23-H1" sem="G#DNA_domain_or_region">nm23-H1</cons> and <cons lex="nm23-H2" sem="G#DNA_domain_or_region">nm23-H2</cons>.</sentence>
<sentence>The deduced <cons lex="amino_acid_sequence_similarity" sem="G#other_name"><cons lex="amino_acid_sequence" sem="G#protein_N/A">amino acid sequence</cons> similarity</cons> to the proteins encoded by these two latter genes is approximately 65% and includes domains and <cons lex="amino_acid_residue" sem="G#amino_acid_monomer">amino acid residues</cons> (the <cons lex="leucine_zipper-like_domain" sem="G#protein_domain_or_region">leucine zipper-like</cons> and the <cons lex="RGD_domain" sem="G#protein_domain_or_region">RGD domain</cons>, a <cons lex="serine" sem="G#amino_acid_monomer">serine</cons> and a <cons lex="histidine" sem="G#amino_acid_monomer">histidine</cons> residue in the <cons lex="NH2-" sem="G#protein_domain_or_region">NH2-</cons> and in the <cons lex="COOH-terminal_portion" sem="G#protein_domain_or_region">COOH-terminal portion</cons> of the protein, respectively) postulated to be important for <cons lex="nm23_function" sem="G#other_name"><cons lex="nm23" sem="G#protein_molecule">nm23</cons> function</cons>.</sentence>
<sentence><cons lex="DR-nm23_mRNA" sem="G#RNA_molecule"><cons lex="DR-nm23" sem="G#protein_molecule">DR-nm23</cons> mRNA</cons> is preferentially expressed at early stages of <cons lex="myeloid_differentiation" sem="G#other_name">myeloid differentiation</cons> of <cons lex="highly_purified_CD34+_cell" sem="G#cell_line">highly purified CD34+ cells</cons>.</sentence>
<sentence>Its constitutive expression in the <cons lex="myeloid_precursor_32Dc13_cell_line" sem="G#cell_line">myeloid precursor 32Dc13 cell line</cons>, which is <cons lex="growth-factor_dependent" sem="G#other_name">growth-factor dependent</cons> for both <cons lex="proliferation" sem="G#other_name">proliferation</cons> and <cons lex="differentiation" sem="G#other_name">differentiation</cons>, results in inhibition of <cons lex="granulocytic_differentiation" sem="G#other_name">granulocytic <cons lex="differentiation" sem="G#other_name">differentiation</cons></cons> induced by <cons lex="granulocyte_colony-stimulating_factor" sem="G#protein_molecule"><cons lex="granulocyte" sem="G#cell_type">granulocyte</cons> colony-stimulating factor</cons> and causes <cons lex="apoptotic_cell_death" sem="G#other_name">apoptotic cell death</cons>.</sentence>
<sentence>These results are consistent with a role for <cons lex="DR-nm23" sem="G#protein_molecule">DR-nm23</cons> in <cons lex="normal_hematopoiesis" sem="G#other_name">normal hematopoiesis</cons> and raise the possibility that its <cons lex="overexpression" sem="G#other_name">overexpression</cons> contributes to <cons lex="differentiation_arrest" sem="G#other_name"><cons lex="differentiation" sem="G#other_name">differentiation</cons> arrest</cons>, a feature of <cons lex="blastic_transformation" sem="G#other_name">blastic transformation</cons> in <cons lex="chronic_myelogenous_leukemia" sem="G#other_name">chronic myelogenous leukemia</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:96032864</bibliomisc>
</articleinfo>
<title>
<sentence>An <cons lex="interferon-gamma_activation_sequence" sem="G#DNA_domain_or_region">interferon-gamma activation sequence</cons> mediates the <cons lex="transcriptional_regulation" sem="G#other_name">transcriptional regulation</cons> of the <cons lex="IgG_Fc_receptor_type_IC_gene" sem="G#DNA_domain_or_region"><cons lex="IgG_Fc_receptor" sem="G#protein_family_or_group">IgG Fc receptor</cons> type IC gene</cons> by <cons lex="interferon-gamma" sem="G#protein_molecule">interferon-gamma</cons>.</sentence>
</title>
<abstract>
<sentence>Expression of the <cons lex="IgG_Fc_receptor_type_I" sem="G#protein_molecule"><cons lex="IgG_Fc_receptor" sem="G#protein_family_or_group">IgG Fc receptor</cons> type I</cons> (<cons lex="Fc_gamma_RI" sem="G#protein_molecule">Fc gamma RI</cons>) on <cons lex="myeloid_cell" sem="G#cell_type">myeloid cells</cons> is dramatically increased by treatment with <cons lex="interferon-gamma" sem="G#protein_molecule">interferon-gamma</cons> (<cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons>).</sentence>
<sentence>We observed that <cons lex="Fc_gamma_RI_transcript_levels" sem="G#other_name"><cons lex="Fc_gamma_RI" sem="G#protein_molecule">Fc gamma RI</cons> transcript levels</cons> in <cons lex="monoblast-like_U937_cell" sem="G#cell_line">monoblast-like U937 cells</cons> were elevated within 3 hr and peaked 12 hr after exposure to <cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons>.</sentence>
<sentence>Treatment of <cons lex="U937" sem="G#cell_line">U937</cons> with <cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons> for 9 hr in the presence of cycloheximide led to super-induction of <cons lex="Fc_gamma_RI" sem="G#protein_molecule">Fc gamma RI</cons> expression.</sentence>
<sentence>Nuclear run-on analysis revealed that the rate of <cons lex="Fc_gamma_RI" sem="G#protein_molecule">Fc gamma RI</cons> transcription was increased by <cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons>.</sentence>
<sentence>Genomic sequence upstream of the <cons lex="Fc_gamma_RIC_gene" sem="G#DNA_domain_or_region">Fc gamma RIC gene</cons> was cloned and subjected to <cons lex="primer_extension_analysis" sem="G#other_name">primer extension analysis</cons>, which demonstrated a single <cons lex="transcription_initiation_site" sem="G#DNA_domain_or_region">transcription initiation site</cons> without a <cons lex="TATA_box" sem="G#DNA_domain_or_region">TATA box</cons>.</sentence>
<sentence>Transient transfections of <cons lex="CAT_reporter_gene_construct" sem="G#DNA_family_or_group">CAT <cons lex="reporter_gene_construct" sem="G#DNA_family_or_group">reporter gene constructs</cons></cons> containing various <cons lex="Fc_gamma_RIC_promoter_sequence" sem="G#DNA_domain_or_region">Fc gamma RIC promoter sequences</cons> into <cons lex="U937_cell" sem="G#cell_line">U937 cells</cons> revealed that a <cons lex="20-bp_region" sem="G#DNA_domain_or_region">20-bp region</cons> surrounding the <cons lex="transcription_start_site" sem="G#DNA_domain_or_region">transcription start site</cons> (-7 to +13) was capable of mediating <cons lex="transcription_initiation" sem="G#other_name">transcription initiation</cons> and that an <cons lex="IFN-gamma_responsive_element" sem="G#DNA_domain_or_region">IFN-gamma responsive element</cons> (<cons lex="GIRE" sem="G#DNA_domain_or_region">GIRE</cons>) was present within <cons lex="74_bp_upstream" sem="G#DNA_domain_or_region">74 bp upstream</cons> of the <cons lex="transcription_initiation_site" sem="G#DNA_domain_or_region"><cons lex="transcription_initiation" sem="G#other_name">transcription initiation</cons> site</cons>.</sentence>
<sentence>A <cons lex="17-bp_sequence" sem="G#DNA_domain_or_region">17-bp sequence</cons> between positions -51 and -35 conferred <cons lex="IFN-gamma_responsiveness" sem="G#other_name"><cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons> responsiveness</cons> on a <cons lex="heterologous_promoter" sem="G#DNA_domain_or_region">heterologous promoter</cons>.</sentence>
<sentence><cons lex="double-stranded_GIRE_sequence" sem="G#DNA_domain_or_region">Double-stranded GIRE sequence</cons>, but not a <cons lex="scrambled_sequence" sem="G#DNA_family_or_group">scrambled sequence</cons>, was specifically bound by <cons lex="nuclear_protein" sem="G#protein_family_or_group">nuclear proteins</cons> from <cons lex="IFN-gamma_treated_U937_cell" sem="G#cell_line"><cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons> treated <cons lex="U937_cell" sem="G#cell_line">U937 cells</cons></cons>.</sentence>
<sentence>Gel shift experiments further showed that the <cons lex="STAT1_alpha_protein" sem="G#protein_molecule">STAT1 alpha protein</cons> bound to the <cons lex="Fc_gamma_RIC_GIRE" sem="G#DNA_domain_or_region">Fc gamma RIC GIRE</cons> in response to <cons lex="IFN-gamma_treatment" sem="G#other_name"><cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons> treatment</cons> of <cons lex="U937_cell" sem="G#cell_line">U937 cells</cons>.</sentence>
<sentence>The <cons lex="Fc_gamma_RIC_GIRE" sem="G#DNA_domain_or_region">Fc gamma RIC GIRE</cons> is homologous to the <cons lex="IFN-gamma_activation_sequence" sem="G#DNA_domain_or_region"><cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons> activation sequence</cons> (<cons lex="GAS" sem="G#DNA_domain_or_region">GAS</cons>) of the <cons lex="guanylate_binding_protein" sem="G#protein_molecule">guanylate binding protein</cons> and to <cons lex="X_box_element" sem="G#DNA_family_or_group">X box elements</cons> of <cons lex="class_II_MHC_gene" sem="G#DNA_family_or_group">class II MHC genes</cons>.</sentence>
<sentence>Our results demonstrate that <cons lex="transcriptional_regulation" sem="G#other_name">transcriptional regulation</cons> of the <cons lex="Fc_gamma_RIC_gene" sem="G#DNA_domain_or_region">Fc gamma RIC gene</cons> by <cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons> involves the binding of <cons lex="STAT1_alpha" sem="G#protein_molecule">STAT1 alpha</cons> to a <cons lex="17-bp_GAS_homology" sem="G#DNA_domain_or_region">17-bp GAS homology</cons> in the <cons lex="proximal_promoter" sem="G#DNA_domain_or_region">proximal promoter</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95327953</bibliomisc>
</articleinfo>
<title>
<sentence>Constitutively activated <cons lex="Jak-STAT_pathway" sem="G#other_name"><cons lex="Jak" sem="G#protein_family_or_group">Jak</cons><cons lex="STAT" sem="G#protein_family_or_group">-STAT</cons> pathway</cons> in <cons lex="T_cell" sem="G#cell_type">T cells</cons> transformed with <cons lex="HTLV-I" sem="G#virus">HTLV-I</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="human_T_cell_lymphotropic_virus_I" sem="G#virus">Human T cell lymphotropic virus I</cons> (<cons lex="HTLV-I" sem="G#virus">HTLV-I</cons>) is the <cons lex="etiological_agent" sem="G#other_name">etiological agent</cons> for <cons lex="adult_T_cell_leukemia" sem="G#other_name">adult T cell leukemia</cons> and <cons lex="tropical_spastic_paraparesis" sem="G#other_name">tropical spastic paraparesis</cons> (also termed <cons lex="HTLV-I-associated_myelopathy" sem="G#other_name"><cons lex="HTLV-I" sem="G#virus">HTLV-I</cons>-associated myelopathy</cons>).</sentence>
<sentence><cons lex="HTLV-I-infected_peripheral_blood_T_cell" sem="G#cell_type"><cons lex="HTLV-I" sem="G#virus">HTLV-I</cons>-infected peripheral blood <cons lex="T_cell" sem="G#cell_type">T cells</cons></cons> exhibit an initial phase of <cons lex="interleukin-2_(IL-2)-dependent_growth" sem="G#other_name"><cons lex="interleukin-2" sem="G#protein_molecule">interleukin-2</cons> (<cons lex="IL-2" sem="G#protein_molecule">IL-2</cons>)-dependent growth</cons>; over time, by an unknown mechanism, the cells become <cons lex="IL-2-independent" sem="G#other_name"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons>-independent</cons>.</sentence>
<sentence>Whereas the <cons lex="Jak_kinase" sem="G#protein_family_or_group">Jak kinases</cons> <cons lex="Jak1" sem="G#protein_molecule">Jak1</cons> and <cons lex="Jak3" sem="G#protein_molecule">Jak3</cons> and the signal transducer and activator of <cons lex="transcription_protein" sem="G#protein_family_or_group">transcription proteins</cons> <cons lex="Stat3" sem="G#protein_molecule">Stat3</cons> and <cons lex="Stat5" sem="G#protein_molecule">Stat5</cons> are activated in <cons lex="normal_T_cell" sem="G#cell_type">normal <cons lex="T_cell" sem="G#cell_type">T cells</cons></cons> in response to <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons>, this signaling pathway was constitutively activated in <cons lex="HTLV-I-transformed_cell" sem="G#cell_line"><cons lex="HTLV-I" sem="G#virus">HTLV-I</cons>-transformed cells</cons>.</sentence>
<sentence>In <cons lex="HTLV-I-infected_cord_blood_lymphocyte" sem="G#cell_line"><cons lex="HTLV-I" sem="G#virus">HTLV-I</cons>-infected cord blood lymphocytes</cons>, the transition from <cons lex="IL-2-dependent_growth" sem="G#other_name"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons>-dependent</cons> to <cons lex="IL-2-independent_growth" sem="G#other_name"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons>-independent growth</cons> correlated with the acquisition of a constitutively activated <cons lex="Jak-STAT_pathway" sem="G#other_name"><cons lex="Jak" sem="G#protein_family_or_group">Jak</cons><cons lex="STAT" sem="G#protein_family_or_group">-STAT</cons> pathway</cons>, which suggests that this pathway participates in <cons lex="HTLV-I-mediated_T_cell_transformation" sem="G#other_name"><cons lex="HTLV-I" sem="G#virus">HTLV-I</cons>-mediated T cell transformation</cons>.</sentence>
</abstract>
</article>


<article>
<articleinfo>
<bibliomisc>MEDLINE:97469932</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="glucocorticoid" sem="G#lipid">Glucocorticoids</cons> and the <cons lex="immune_function" sem="G#other_name">immune function</cons> in the <cons lex="human_immunodeficiency_virus_infection" sem="G#other_name"><cons lex="human_immunodeficiency_virus" sem="G#virus">human immunodeficiency virus</cons> infection</cons>: a study in <cons lex="(AND hypercortisolemic_patient cortisol-resistant_patient)" sem="(AND G#multi_cell G#multi_cell)"><cons lex="hypercortisolemic*">hypercortisolemic</cons> and <cons lex="cortisol-resistant*">cortisol-resistant</cons> <cons lex="*patient">patients</cons></cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="immunological_study" sem="G#other_name">Immunological studies</cons> in <cons lex="human_immunodeficiency_virus_(HIV)-positive_patient" sem="G#multi_cell"><cons lex="human_immunodeficiency_virus" sem="G#virus">human immunodeficiency virus</cons> (HIV)-positive <cons lex="patient" sem="G#multi_cell">patients</cons></cons> suggest that the disease progression is accompanied by a defective production of type <cons lex="1_cytokine" sem="G#protein_family_or_group">1 cytokines</cons> (<cons lex="interleukin-2" sem="G#protein_molecule">interleukin-2</cons> (<cons lex="IL-2" sem="G#protein_molecule">IL-2</cons>) and <cons lex="IL-12" sem="G#protein_molecule">IL-12</cons>], an increased production of <cons lex="type_2_cytokine" sem="G#protein_family_or_group">type 2 cytokines</cons> (<cons lex="IL-4" sem="G#protein_molecule">IL-4</cons>, <cons lex="IL-6" sem="G#protein_molecule">IL-6</cons>, and <cons lex="IL-10" sem="G#protein_molecule">IL-10</cons>), and an increased production of <cons lex="IgE" sem="G#protein_family_or_group">IgE</cons>.</sentence>
<sentence><cons lex="HIV_infection" sem="G#other_name">HIV infection</cons> is also associated with activation of the <cons lex="hypothalamo-pituitary-adrenal_axis_function" sem="G#other_name"><cons lex="hypothalamo-pituitary-adrenal_axis" sem="G#body_part">hypothalamo-pituitary-adrenal axis</cons> function</cons> and increased <cons lex="(AND plasma_cortisol_concentration urinary_cortisol_concentration)" sem="(AND G#other_name G#other_name)"><cons lex="plasma*">plasma</cons> and <cons lex="urinary*">urinary</cons> <cons lex="*cortisol_concentration">cortisol concentrations</cons></cons>.</sentence>
<sentence>As <cons lex="cortisol" sem="G#lipid">cortisol</cons> is involved in the <cons lex="physiological_regulation" sem="G#other_name">physiological regulation</cons> of <cons lex="cytokine" sem="G#protein_family_or_group">cytokines</cons>, a study was conducted to examine <cons lex="cytokine_pattern" sem="G#other_name"><cons lex="cytokine" sem="G#protein_family_or_group">cytokine</cons> patterns</cons> in two groups of <cons lex="hypercortisolemic_patient" sem="G#multi_cell">hypercortisolemic <cons lex="patient" sem="G#multi_cell">patients</cons></cons>, one with normal sensitivity to <cons lex="glucocorticoid" sem="G#lipid">glucocorticoids</cons> and the other with <cons lex="glucocorticoid_resistance" sem="G#other_name"><cons lex="glucocorticoid" sem="G#lipid">glucocorticoid</cons> resistance</cons>.</sentence>
<sentence>Ten HIV-infected <cons lex="patient" sem="G#multi_cell">patients</cons> with normal receptor affinity to <cons lex="glucocorticoid" sem="G#lipid">glucocorticoids</cons> (<cons lex="AIDS-C" sem="G#multi_cell">AIDS-C</cons>), 10 <cons lex="HIV-infected_patient" sem="G#multi_cell">HIV-infected <cons lex="patient" sem="G#multi_cell">patients</cons></cons> with low receptor affinity to <cons lex="glucocorticoid" sem="G#lipid">glucocorticoids</cons> (<cons lex="AIDS-GR" sem="G#multi_cell">AIDS-GR</cons>), and 20 healthy subjects were studied.</sentence>
<sentence>Receptor characteristics of <cons lex="peripheral_blood_mononuclear_cell" sem="G#cell_type">peripheral blood mononuclear cells</cons> were evaluated by <cons lex="[3H]dexamethasone_binding" sem="G#other_name"><cons lex="[3H]dexamethasone" sem="G#lipid">[3H]dexamethasone</cons> binding</cons>.</sentence>
<sentence><cons lex="serum_cortisol" sem="G#lipid">Serum <cons lex="cortisol" sem="G#lipid">cortisol</cons></cons> and <cons lex="urinary_free_cortisol" sem="G#lipid">urinary free <cons lex="cortisol" sem="G#lipid">cortisol</cons></cons> were measured by <cons lex="RIA" sem="G#other_name">RIA</cons>.</sentence>
<sentence>Serum <cons lex="ACTH" sem="G#peptide">ACTH</cons> and <cons lex="IgE" sem="G#protein_family_or_group">IgE</cons> were measured by <cons lex="immunoradiometric_assay" sem="G#other_name">immunoradiometric assay</cons>, and <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons>, <cons lex="IL-4" sem="G#protein_molecule">IL-4</cons>, and <cons lex="IL-10" sem="G#protein_molecule">IL-10</cons> <cons lex="cytokine" sem="G#protein_family_or_group">cytokines</cons> and <cons lex="interferon-gamma" sem="G#protein_molecule">interferon-gamma</cons> were measured by <cons lex="enzyme-linked_immunosorbent_assay" sem="G#other_name">enzyme-linked immunosorbent assay</cons>.</sentence>
<sentence><cons lex="AIDS-C_patient" sem="G#multi_cell">AIDS-C <cons lex="patient" sem="G#multi_cell">patients</cons></cons> showed low <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> and high <cons lex="IL-4" sem="G#protein_molecule">IL-4</cons>, <cons lex="IL-10" sem="G#protein_molecule">IL-10</cons>, and <cons lex="IgE" sem="G#protein_family_or_group">IgE</cons> <cons lex="concentratio" sem="G#other_name">concentratios</cons>; conversely, <cons lex="AIDS-GR_patient" sem="G#multi_cell">AIDS-GR <cons lex="patient" sem="G#multi_cell">patients</cons></cons> showed high <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> and low <cons lex="IL-4" sem="G#protein_molecule">IL-4</cons> and <cons lex="IgE" sem="G#protein_family_or_group">IgE</cons> <cons lex="concentration" sem="G#other_name">concentrations</cons>.</sentence>
<sentence>Thus, in <cons lex="HIV_infection" sem="G#other_name">HIV infection</cons>, elevated <cons lex="cortisol" sem="G#lipid">cortisol</cons> levels suppress <cons lex="cell-mediated_immunity" sem="G#other_name">cell-mediated immunity</cons> and stimulate <cons lex="humoral_immunity" sem="G#other_name">humoral immunity</cons>, whereas this response is not detected in <cons lex="cortisol-resistant_patient" sem="G#multi_cell"><cons lex="cortisol" sem="G#lipid">cortisol</cons>-resistant <cons lex="patient" sem="G#multi_cell">patients</cons></cons>.</sentence>
<sentence>These findings indicate that <cons lex="cortisol" sem="G#lipid">cortisol</cons> and its receptors are critically involved in the regulation of <cons lex="immune_function" sem="G#other_name">immune function</cons> in <cons lex="HIV_infection" sem="G#other_name">HIV infection</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98000233</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="monocytic_differentiation" sem="G#other_name">Monocytic differentiation</cons> of <cons lex="HL-60_promyelocytic_leukemia_cell" sem="G#cell_line">HL-60 promyelocytic leukemia cells</cons> correlates with the induction of <cons lex="Bcl-xL" sem="G#protein_molecule">Bcl-xL</cons>.</sentence>
</title>
<abstract>
<sentence>Treatment of <cons lex="human_promyelocytic_leukemia_HL-60_cell" sem="G#cell_line">human promyelocytic leukemia HL-60 cells</cons> with <cons lex="phorbol_ester" sem="G#other_organic_compound">phorbol esters</cons> ultimately induces the differentiation of these cells along the <cons lex="monocyte/macrophage_lineage" sem="G#cell_type">monocyte/macrophage lineage</cons>, whereas treatment with <cons lex="retinoic_acid" sem="G#other_organic_compound">retinoic acid</cons> or <cons lex="DMSO" sem="G#other_organic_compound">DMSO</cons> induces <cons lex="granulocytic/neutrophillic_differentiation" sem="G#other_name">granulocytic/neutrophillic differentiation</cons>.</sentence>
<sentence>In this study, we demonstrate the disparate fates of <cons lex="HL-60_cell" sem="G#cell_line">HL-60 cells</cons> treated with the <cons lex="phorbol_ester" sem="G#other_organic_compound">phorbol ester</cons> <cons lex="12,13-phorbol_dibutyric_acid" sem="G#other_organic_compound">12,13-phorbol dibutyric acid</cons> (<cons lex="PDBu" sem="G#other_organic_compound">PDBu</cons>) or <cons lex="DMSO" sem="G#other_organic_compound">DMSO</cons>.</sentence>
<sentence>After <cons lex="DMSO" sem="G#other_organic_compound">DMSO</cons> treatment, <cons lex="HL-60_cell" sem="G#cell_line">HL-60 cells</cons> eventually died via <cons lex="apoptosis" sem="G#other_name">apoptosis</cons>, whereas the viability of <cons lex="PDBu-treated_cell" sem="G#cell_line"><cons lex="PDBu" sem="G#other_organic_compound">PDBu</cons>-treated cells</cons> was not affected during the same interval.</sentence>
<sentence>The levels of the <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> effector proteins <cons lex="Bak" sem="G#protein_molecule">Bak</cons> and <cons lex="Bad" sem="G#protein_molecule">Bad</cons> were enhanced, whereas there was a slight down-regulation of the <cons lex="apoptosis_suppressor_protein" sem="G#protein_family_or_group"><cons lex="apoptosis" sem="G#other_name">apoptosis</cons> suppressor protein</cons> <cons lex="Bcl-2" sem="G#protein_molecule">Bcl-2</cons> after treatment of the cells with <cons lex="PDBu" sem="G#other_organic_compound">PDBu</cons> and <cons lex="DMSO" sem="G#other_organic_compound">DMSO</cons>.</sentence>
<sentence>Treatment with <cons lex="DMSO" sem="G#other_organic_compound">DMSO</cons> resulted in the elevation of the <cons lex="apoptosis_effector" sem="G#protein_family_or_group"><cons lex="apoptosis" sem="G#other_name">apoptosis</cons> effector</cons> <cons lex="Bax" sem="G#protein_molecule">Bax</cons>, whereas treatment with <cons lex="PDBu" sem="G#other_organic_compound">PDBu</cons> did not significantly alter the levels of this protein.</sentence>
<sentence>However, treatment of <cons lex="HL-60_cell" sem="G#cell_line">HL-60 cells</cons> with <cons lex="PDBu" sem="G#other_organic_compound">PDBu</cons> induced the rapid expression of the <cons lex="apoptosis_suppressor_protein" sem="G#protein_family_or_group"><cons lex="apoptosis" sem="G#other_name">apoptosis</cons> suppressor protein</cons> <cons lex="Bcl-xL" sem="G#protein_molecule">Bcl-xL</cons>, whereas the expression of this protein remained unaltered in <cons lex="DMSO" sem="G#other_organic_compound">DMSO</cons>-treated cells.</sentence>
<sentence>The generality of this finding was confirmed by the induction of <cons lex="Bcl-xL" sem="G#protein_molecule">Bcl-xL</cons> in <cons lex="human_myeloid_U-937_cell" sem="G#cell_line">human myeloid U-937 cells</cons>, <cons lex="human_peripheral_blood_monocyte" sem="G#cell_type">human peripheral blood monocytes</cons> exposed to <cons lex="phorbol_ester" sem="G#other_organic_compound">phorbol ester</cons>, and <cons lex="mouse_thioglycollate-activated_and_resident_peritoneal_macrophage" sem="G#cell_line">mouse thioglycollate-activated and resident peritoneal macrophages</cons>.</sentence>
<sentence><cons lex="PDBu-treated_HL-60_cell" sem="G#cell_line"><cons lex="PDBu" sem="G#other_organic_compound">PDBu</cons>-treated <cons lex="HL-60_cell" sem="G#cell_line">HL-60 cells</cons></cons> remained viable for 7 days and thereafter began to die via <cons lex="apoptosis" sem="G#other_name">apoptosis</cons>, with a concomitant down-regulation of <cons lex="Bcl-xL" sem="G#protein_molecule">Bcl-xL</cons>.</sentence>
<sentence>In conclusion, we propose that <cons lex="Bcl-xL_expression" sem="G#other_name"><cons lex="Bcl-xL" sem="G#protein_molecule">Bcl-xL</cons> expression</cons> is associated with differentiation and survival of <cons lex="hematopoietic_cell" sem="G#cell_type">hematopoietic cells</cons> along the <cons lex="monocyte/macrophage_lineage" sem="G#cell_type">monocyte/macrophage lineage</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97476217</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="monochloramine" sem="G#inorganic">Monochloramine</cons> inhibits <cons lex="phorbol_ester-inducible_neutrophil_respiratory_burst_activation" sem="G#other_name"><cons lex="phorbol_ester" sem="G#other_organic_compound">phorbol ester</cons>-inducible neutrophil respiratory burst activation</cons> and <cons lex="T_cell_interleukin-2_receptor_expression" sem="G#other_name">T cell <cons lex="interleukin-2" sem="G#protein_molecule">interleukin-2</cons> receptor expression</cons> by inhibiting inducible <cons lex="protein_kinase_C_activity" sem="G#other_name"><cons lex="protein_kinase_C" sem="G#protein_molecule">protein kinase C</cons> activity</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="monochloramine_derivative" sem="G#inorganic">Monochloramine derivatives</cons> are long lived <cons lex="physiological_oxidant" sem="G#inorganic">physiological oxidants</cons> produced by <cons lex="neutrophil" sem="G#cell_type">neutrophils</cons> during the <cons lex="respiratory_burst" sem="G#other_name">respiratory burst</cons>.</sentence>
<sentence>The effects of <cons lex="chemically_prepared_monochloramine" sem="G#inorganic">chemically prepared monochloramine</cons> (<cons lex="NH2Cl" sem="G#inorganic">NH2Cl</cons>) on <cons lex="protein_kinase_C" sem="G#protein_molecule">protein kinase C</cons> (<cons lex="PKC" sem="G#protein_molecule">PKC</cons>) and <cons lex="PKC-mediated_cellular_response" sem="G#other_name"><cons lex="PKC" sem="G#protein_molecule">PKC</cons>-mediated cellular responses</cons> were studied in <cons lex="elicited_rat_peritoneal_neutrophil" sem="G#cell_type">elicited rat peritoneal <cons lex="neutrophil" sem="G#cell_type">neutrophils</cons></cons> and <cons lex="human_Jurkat_T_cell" sem="G#cell_line">human Jurkat T cells</cons>.</sentence>
<sentence>Neutrophils pretreated with <cons lex="NH2Cl" sem="G#inorganic">NH2Cl</cons> (30-50 microM) showed a marked decrease in the respiratory burst activity induced by <cons lex="phorbol_12-myristate_13-acetate" sem="G#other_organic_compound">phorbol 12-myristate 13-acetate</cons> (<cons lex="PMA" sem="G#other_organic_compound">PMA</cons>), which is a potent <cons lex="PKC_activator" sem="G#other_organic_compound"><cons lex="PKC" sem="G#protein_molecule">PKC</cons> activator</cons>.</sentence>
<sentence>These cells, however, were viable and showed a complete respiratory burst upon <cons lex="arachidonic_acid_stimulation" sem="G#other_name"><cons lex="arachidonic_acid" sem="G#other_organic_compound">arachidonic acid</cons> stimulation</cons>, which induces the <cons lex="respiratory_burst" sem="G#other_name">respiratory burst</cons> by a <cons lex="PKC-independent_mechanism" sem="G#other_name"><cons lex="PKC" sem="G#protein_molecule">PKC</cons>-independent mechanism</cons>.</sentence>
<sentence>The <cons lex="NH2Cl-treated_neutrophil" sem="G#cell_line"><cons lex="NH2Cl" sem="G#inorganic">NH2Cl</cons>-treated neutrophils</cons> showed a decrease in both <cons lex="PKC" sem="G#protein_molecule">PKC</cons> activity and <cons lex="PMA-induced_phosphorylation" sem="G#other_name"><cons lex="PMA" sem="G#other_organic_compound">PMA</cons>-induced phosphorylation</cons> of a <cons lex="47-kDa_protein" sem="G#protein_molecule">47-kDa protein</cons>, which corresponds to the <cons lex="cytosolic_factor" sem="G#protein_family_or_group">cytosolic factor</cons> of <cons lex="NADPH_oxidase" sem="G#protein_molecule">NADPH oxidase</cons>, <cons lex="p47(phox)" sem="G#protein_molecule">p47(phox)</cons>.</sentence>
<sentence><cons lex="Jurkat_T_cell" sem="G#cell_line">Jurkat T cells</cons> pretreated with <cons lex="NH2Cl" sem="G#inorganic">NH2Cl</cons> (20-70 microM) showed a decrease in the expression of the <cons lex="interleukin-2" sem="G#protein_molecule">interleukin-2</cons> <cons lex="receptor_alpha_chain" sem="G#protein_subunit">receptor alpha chain</cons> following <cons lex="PMA" sem="G#other_organic_compound">PMA</cons> stimulation.</sentence>
<sentence>This was also accompanied by a decrease in both <cons lex="PKC_activity" sem="G#other_name"><cons lex="PKC" sem="G#protein_molecule">PKC</cons> activity</cons> and <cons lex="nuclear_transcription_factor-kappaB_activation" sem="G#other_name">nuclear transcription factor-<cons lex="kappaB" sem="G#protein_molecule">kappaB</cons> activation</cons>, also without loss of cell viability.</sentence>
<sentence>These results show that <cons lex="NH2Cl" sem="G#inorganic">NH2Cl</cons> inhibits <cons lex="PKC-mediated_cellular_response" sem="G#other_name"><cons lex="PKC" sem="G#protein_molecule">PKC</cons>-mediated cellular responses</cons> through inhibition of the <cons lex="inducible_PKC_activity" sem="G#other_name">inducible <cons lex="PKC" sem="G#protein_molecule">PKC</cons> activity</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97460018</bibliomisc>
</articleinfo>
<title>
<sentence>Evidence that calcineurin is rate-limiting for <cons lex="primary_human_lymphocyte_activation" sem="G#other_name">primary human lymphocyte activation</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="cyclosporine" sem="G#other_organic_compound">Cyclosporine</cons> (<cons lex="CsA" sem="G#other_organic_compound">CsA</cons>) is both a <cons lex="clinical_immunosuppressive_drug" sem="G#other_organic_compound">clinical immunosuppressive drug</cons> and a probe to dissect <cons lex="intracellular_signaling_pathway" sem="G#other_name">intracellular signaling pathways</cons>.</sentence>
<sentence>In vitro, <cons lex="CsA" sem="G#other_organic_compound">CsA</cons> inhibits <cons lex="lymphocyte_gene_activation" sem="G#other_name"><cons lex="lymphocyte_gene" sem="G#DNA_family_or_group">lymphocyte gene</cons> activation</cons> by inhibiting the <cons lex="phosphatase_activity" sem="G#other_name"><cons lex="phosphatase" sem="G#protein_family_or_group">phosphatase</cons> activity</cons> of <cons lex="calcineurin" sem="G#protein_molecule">calcineurin</cons> (<cons lex="CN" sem="G#protein_molecule">CN</cons>).</sentence>
<sentence>In clinical use, <cons lex="CsA_treatment" sem="G#other_name"><cons lex="CsA" sem="G#other_organic_compound">CsA</cons> treatment</cons> inhibits 50-75% of <cons lex="CN_activity" sem="G#other_name"><cons lex="CN" sem="G#protein_molecule">CN</cons> activity</cons> in <cons lex="circulating_leukocyte" sem="G#cell_type">circulating leukocytes</cons>.</sentence>
<sentence>We modeled this degree of <cons lex="CN" sem="G#protein_molecule">CN</cons> inhibition in <cons lex="primary_human_leukocyte" sem="G#cell_type">primary human leukocytes</cons> in vitro in order to study the effect of <cons lex="partial_CN_inhibition" sem="G#other_name">partial <cons lex="CN" sem="G#protein_molecule">CN</cons> inhibition</cons> on the <cons lex="downstream_signaling_event" sem="G#other_name">downstream signaling events</cons> that lead to <cons lex="gene_activation" sem="G#other_name">gene activation</cons>.</sentence>
<sentence>In <cons lex="CsA-treated_leukocyte" sem="G#cell_line"><cons lex="CsA" sem="G#other_organic_compound">CsA</cons>-treated leukocytes</cons> stimulated by <cons lex="calcium_ionophore" sem="G#other_organic_compound">calcium ionophore</cons>, the degree of reduction in <cons lex="CN_activity" sem="G#other_name"><cons lex="CN" sem="G#protein_molecule">CN</cons> activity</cons> was accompanied by a similar degree of inhibition of each event tested: <cons lex="dephosphorylation" sem="G#other_name">dephosphorylation</cons> of <cons lex="nuclear_factor_of_activated_T_cells_protein" sem="G#protein_family_or_group">nuclear factor of activated T cell proteins</cons>, <cons lex="nuclear_DNA_binding" sem="G#other_name">nuclear DNA binding</cons>, activation of a <cons lex="transfected_reporter_gene_construct" sem="G#DNA_molecule">transfected reporter gene construct</cons>, <cons lex="(AND IFN-gamma_mRNA_accumulation IL-2_mRNA_accumulation)" sem="(AND G#other_name G#other_name)"><cons lex="IFN-gamma*">IFN-gamma</cons> and <cons lex="IL-2*">IL-2</cons> <cons lex="*mRNA_accumulation">mRNA accumulation</cons></cons>, and <cons lex="IFN-gamma_production" sem="G#other_name"><cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons> production</cons>.</sentence>
<sentence>Furthermore, the degree of <cons lex="CN_inhibition" sem="G#other_name"><cons lex="CN" sem="G#protein_molecule">CN</cons> inhibition</cons> was reflected by a similar degree of reduction in <cons lex="lymphocyte_proliferation" sem="G#other_name">lymphocyte proliferation</cons> and <cons lex="IFN-gamma_production" sem="G#other_name"><cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons> production</cons> in the <cons lex="allogeneic_mixed_lymphocyte_culture" sem="G#cell_line">allogeneic mixed lymphocyte cultures</cons>.</sentence>
<sentence>These data support the conclusion that <cons lex="CN_activity" sem="G#other_name"><cons lex="CN" sem="G#protein_molecule">CN</cons> activity</cons> is rate-limiting for the activation of <cons lex="primary_human_T_lymphocyte" sem="G#cell_type">primary human T lymphocytes</cons>.</sentence>
<sentence>Thus, the reduction of <cons lex="CN_activity" sem="G#other_name"><cons lex="CN" sem="G#protein_molecule">CN</cons> activity</cons> observed in <cons lex="CsA-treated_patient" sem="G#multi_cell"><cons lex="CsA" sem="G#other_organic_compound">CsA</cons>-treated <cons lex="patient" sem="G#multi_cell">patients</cons></cons> is accompanied by a similar degree of reduction in <cons lex="lymphocyte_gene_activation" sem="G#other_name"><cons lex="lymphocyte_gene" sem="G#DNA_family_or_group">lymphocyte gene</cons> activation</cons>, and accounts for the <cons lex="immunosuppression" sem="G#other_name">immunosuppression</cons> observed.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97449280</bibliomisc>
</articleinfo>
<title>
<sentence>Selection of <cons lex="down-regulated_sequence" sem="G#DNA_family_or_group">down-regulated sequences</cons> along the <cons lex="monocytic_differentiation" sem="G#other_name">monocytic differentiation</cons> of <cons lex="leukemic_HL60_cell" sem="G#cell_line">leukemic HL60 cells</cons>.</sentence>
</title>
<abstract>
<sentence>In order to dissect the molecular mechanisms of <cons lex="monocytic_differentiation" sem="G#other_name">monocytic differentiation</cons> we have developed a <cons lex="subtractive_hybridisation_method" sem="G#other_name">subtractive hybridisation method</cons> based on a simplified '<cons lex="representational_difference_analysis" sem="G#other_name">representational difference analysis</cons>'.</sentence>
<sentence>We have selected <cons lex="16_sequence" sem="G#DNA_domain_or_region">16 sequences</cons> and confirmed their <cons lex="down-regulation" sem="G#other_name">down-regulation</cons> along the <cons lex="TPA-induced_monocytic_differentiation" sem="G#other_name"><cons lex="TPA" sem="G#other_organic_compound">TPA</cons>-induced <cons lex="monocytic_differentiation" sem="G#other_name">monocytic differentiation</cons></cons> of <cons lex="HL60_cell" sem="G#cell_line">HL60 cells</cons>.</sentence>
<sentence>Among these sequences we have identified the <cons lex="alpha-tubulin" sem="G#protein_molecule">alpha-tubulin</cons>, the <cons lex="TaxREB_protein" sem="G#protein_molecule">TaxREB protein</cons> and two <cons lex="ribosomal_protein_sequence" sem="G#DNA_domain_or_region">ribosomal protein sequences</cons> which had not been previously described as differentially expressed.</sentence>
<sentence>These results add to our knowledge about the molecules implicated along the <cons lex="monocytic_differentiation" sem="G#other_name">monocytic differentiation</cons> and <cons lex="growth_arrest" sem="G#other_name">growth arrest</cons> of <cons lex="leukemic_cell" sem="G#cell_type">leukemic cells</cons> and provide a first step in the study of their respective roles.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98104456</bibliomisc>
</articleinfo>
<title>
<sentence>Control of <cons lex="NF-kappa_B_activity" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> activity</cons> by the <cons lex="I_kappa_B_beta_inhibitor" sem="G#protein_molecule">I kappa B beta inhibitor</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> is maintained in an <cons lex="inactive_cytoplasmic_state" sem="G#other_name">inactive cytoplasmic state</cons> by <cons lex="I_kappa_B_inhibitor" sem="G#protein_family_or_group">I kappa B inhibitors</cons>.</sentence>
<sentence>In <cons lex="mammalian_cell" sem="G#cell_type">mammalian cells</cons>, <cons lex="I_kappa_B_alpha" sem="G#protein_molecule">I kappa B alpha</cons> and <cons lex="I_kappa_B_beta_protein" sem="G#protein_molecule"><cons lex="I_kappa_B_beta" sem="G#protein_molecule">I kappa B beta</cons> proteins</cons> have been purified and shown to be the inhibitors of <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> through their association with the <cons lex="(OR p65_subunit c-Rel_subunit)" sem="(OR G#protein_subunit G#protein_subunit)"><cons lex="p65*">p65</cons> or <cons lex="c-Rel*">c-Rel</cons> <cons lex="*subunit">subunits</cons></cons>.</sentence>
<sentence>In addition, we have isolated a third <cons lex="NF-kappa_B_inhibitor" sem="G#protein_family_or_group"><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> inhibitor</cons>, <cons lex="I_kappa_B_epsilon" sem="G#protein_molecule">I kappa B epsilon</cons> (1).</sentence>
<sentence>Upon treatment with a large variety of inducers, <cons lex="I_kappa_B_alpha" sem="G#protein_molecule">I kappa B alpha</cons>, <cons lex="I_kappa_B_beta" sem="G#protein_molecule">I kappa B beta</cons> are proteolytically degraded, resulting in <cons lex="NF-kappa_B_translocation" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> translocation</cons> into the <cons lex="nucleus" sem="G#cell_component">nucleus</cons>.</sentence>
<sentence>Here we show that in <cons lex="E29.1_T_cell_hybridoma" sem="G#cell_line">E29.1 T cell hybridoma</cons> <cons lex="I_kappa_B_alpha" sem="G#protein_molecule">I kappa B alpha</cons> and <cons lex="I_kappa_B_beta" sem="G#protein_molecule">I kappa B beta</cons> are equally associated with <cons lex="p65" sem="G#protein_subunit">p65</cons> and that <cons lex="I_kappa_B_beta" sem="G#protein_molecule">I kappa B beta</cons> is degraded in response to <cons lex="TNF_alpha" sem="G#protein_molecule">TNF alpha</cons> in contrast to what has been originally published.</sentence>
<sentence>Our data also suggest that, unlike <cons lex="I_kappa_B_alpha" sem="G#protein_molecule">I kappa B alpha</cons>, <cons lex="I_kappa_B_beta" sem="G#protein_molecule">I kappa B beta</cons> is constitutively phosphorylated and resynthesized as a <cons lex="hypophosphorylated_form" sem="G#protein_family_or_group">hypophosphorylated form</cons>.</sentence>
<sentence>The absence of slow migrating forms of <cons lex="I_kappa_B_beta" sem="G#protein_molecule">I kappa B beta</cons> following stimulation suggests that the <cons lex="phosphorylation" sem="G#other_name">phosphorylation</cons> does not necessarily constitute the <cons lex="signal-induced_event" sem="G#other_name">signal-induced event</cons> which targets the molecule for <cons lex="proteolysis" sem="G#other_name">proteolysis</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98080700</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="agonistic_activity" sem="G#other_name">Agonistic activity</cons> of a <cons lex="CD40-specific_single-chain_Fv" sem="G#protein_molecule">CD40-specific single-chain Fv</cons> constructed from the <cons lex="variable_region" sem="G#protein_domain_or_region">variable regions</cons> of <cons lex="mAb_G28-5" sem="G#protein_molecule">mAb G28-5</cons>.</sentence>
</title>
<abstract>
<sentence>A <cons lex="single-chain_Fv" sem="G#protein_molecule">single-chain Fv</cons> (<cons lex="sFv" sem="G#protein_molecule">sFv</cons>) was expressed from the <cons lex="variable_region" sem="G#protein_domain_or_region">variable regions</cons> of the CD40-specific <cons lex="mAb_G28-5" sem="G#protein_molecule">mAb G28-5</cons>.</sentence>
<sentence>The molecule bound <cons lex="CD40" sem="G#protein_molecule">CD40</cons> with a high affinity (2.2 nM) and was a monomer in solution.</sentence>
<sentence>Surprisingly, <cons lex="G28-5_sFv" sem="G#protein_molecule">G28-5 sFv</cons> was a potent <cons lex="CD40_agonist" sem="G#protein_family_or_group"><cons lex="CD40" sem="G#protein_molecule">CD40</cons> agonist</cons> that rapidly crosslinked <cons lex="CD40" sem="G#protein_molecule">CD40</cons> on the <cons lex="cell_surface" sem="G#cell_component">cell surface</cons> but did not crosslink <cons lex="CD40-Ig" sem="G#protein_complex"><cons lex="CD40" sem="G#protein_molecule">CD40</cons>-Ig</cons> in solution.</sentence>
<sentence><cons lex="G28-5_sFv" sem="G#protein_molecule">G28-5 sFv</cons> was a more potent agonist than <cons lex="G28-5_IgG" sem="G#protein_molecule">G28-5 IgG</cons> and was able to stimulate <cons lex="CD40" sem="G#protein_molecule">CD40</cons> responses by <cons lex="B_cell" sem="G#cell_type">B cells</cons> and monocytes.</sentence>
<sentence><cons lex="G28-5_IgG" sem="G#protein_molecule">G28-5 IgG</cons> partially blocked, whereas <cons lex="G28-5_sFv" sem="G#protein_molecule">G28-5 sFv</cons> augmented <cons lex="CD40_response" sem="G#other_name"><cons lex="CD40" sem="G#protein_molecule">CD40</cons> responses</cons> during stimulation with <cons lex="natural_ligand" sem="G#protein_family_or_group">natural ligand</cons> (<cons lex="gp39-CD8_fusion_protein" sem="G#protein_molecule">gp39-CD8 fusion protein</cons>).</sentence>
<sentence>These results indicate that the <cons lex="functional_activity" sem="G#other_name">functional activity</cons> of ligands built from the <cons lex="binding_site" sem="G#protein_domain_or_region">binding site</cons> of <cons lex="G28-5" sem="G#protein_molecule">G28-5</cons> is highly dependent upon the size and physical properties of the molecule both in solution and on the <cons lex="cell_surface" sem="G#cell_component">cell surfaces</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98068683</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="C/EBP" sem="G#protein_family_or_group">C/EBP</cons> activates the <cons lex="human_corticotropin-releasing_hormone_gene_promoter" sem="G#DNA_domain_or_region">human corticotropin-releasing hormone gene promoter</cons>.</sentence>
</title>
<abstract>
<sentence>The purpose of these studies was to identify whether transcription factors, associated with cytokine signalling, affected <cons lex="promoter_activity" sem="G#other_name">promoter activity</cons> of the <cons lex="corticotropin_releasing_hormone_(CRH)_gene" sem="G#DNA_domain_or_region">corticotropin releasing hormone (<cons lex="CRH" sem="G#protein_molecule">CRH</cons>) gene</cons>.</sentence>
<sentence>Fragments of a 3.6 kb sequence of the <cons lex="human_CRH_gene_promoter" sem="G#DNA_domain_or_region">human <cons lex="CRH" sem="G#protein_molecule">CRH</cons> gene promoter</cons> were amplified by PCR and ligated upstream of a <cons lex="CAT_reporter" sem="G#DNA_family_or_group">CAT reporter</cons>.</sentence>
<sentence>These constructs were transfected into a variety of cell lines, either alone or together, with <cons lex="transcription_factor_expression_vector" sem="G#virus"><cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> expression vectors</cons>.</sentence>
<sentence>Basal activity of a <cons lex="3070_bp_CRH_promoter_fragment" sem="G#DNA_molecule">3070 bp <cons lex="CRH" sem="G#protein_molecule">CRH</cons> promoter fragment</cons> was only seen in neuronal and <cons lex="lymphoblastoid_cell_line" sem="G#cell_line">lymphoblastoid cell lines</cons>.</sentence>
<sentence>Promoter activity was increased by the <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> <cons lex="C/EBPbeta" sem="G#protein_molecule">C/EBPbeta</cons> (<cons lex="NF-IL6" sem="G#protein_molecule">NF-IL6</cons>) and more strongly, by <cons lex="C/EBPdelta" sem="G#protein_molecule">C/EBPdelta</cons> (<cons lex="NF-IL6beta" sem="G#protein_molecule">NF-IL6beta</cons>).</sentence>
<sentence>Increased <cons lex="CRH_promoter_activity" sem="G#other_name"><cons lex="CRH" sem="G#protein_molecule">CRH</cons> <cons lex="promoter_activity" sem="G#other_name">promoter activity</cons></cons> following <cons lex="phorbol_ester_treatment" sem="G#other_name"><cons lex="phorbol_ester" sem="G#other_organic_compound">phorbol ester</cons> treatment</cons> was inhibited by a dominant negative <cons lex="NF-IL6_mutant" sem="G#protein_molecule">NF-IL6 mutant</cons>, showing that the effects of <cons lex="phorbol_ester" sem="G#other_organic_compound">phorbol ester</cons> were principally mediated by <cons lex="C/EBP" sem="G#protein_family_or_group">C/EBP</cons>.</sentence>
<sentence>Moreover, the inverse changes in the expression of <cons lex="CRH" sem="G#protein_molecule">CRH</cons> in the hypothalamus and spleens of arthritic rats were paralleled by similar inverse changes in <cons lex="NF-IL6beta_expression" sem="G#other_name"><cons lex="NF-IL6beta" sem="G#protein_molecule">NF-IL6beta</cons> expression</cons> in these organs.</sentence>
<sentence>These data show that some <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> associated with <cons lex="cytokine_signalling" sem="G#other_name"><cons lex="cytokine" sem="G#protein_family_or_group">cytokine</cons> signalling</cons> can also activate the <cons lex="CRH_promoter" sem="G#DNA_domain_or_region"><cons lex="CRH" sem="G#protein_molecule">CRH</cons> promoter</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98031856</bibliomisc>
</articleinfo>
<title>
<sentence>Aberrant splicing of the <cons lex="(AND TSG101_gene FHIT_gene)" sem="(AND G#DNA_domain_or_region G#DNA_domain_or_region)"><cons lex="TSG101*">TSG101</cons> and <cons lex="FHIT*">FHIT</cons> <cons lex="*gene">genes</cons></cons> occurs frequently in <cons lex="multiple_malignancy" sem="G#other_name">multiple malignancies</cons> and in <cons lex="normal_tissue" sem="G#tissue">normal tissues</cons> and mimics alterations previously described in <cons lex="tumour" sem="G#tissue">tumours</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="intragenic_deletion" sem="G#other_name">Intragenic deletions</cons> of <cons lex="TSG101" sem="G#DNA_domain_or_region">TSG101</cons>, the human homolog of a <cons lex="mouse_gene" sem="G#DNA_family_or_group">mouse gene</cons> (<cons lex="tsg101" sem="G#DNA_domain_or_region">tsg101</cons>) that acts to suppress malignant cell growth, were reported in <cons lex="human_breast_tumour" sem="G#cell_type">human breast <cons lex="tumour" sem="G#tissue">tumours</cons></cons>.</sentence>
<sentence>We screened <cons lex="TSG101" sem="G#DNA_domain_or_region">TSG101</cons> for somatic mutations in DNA and RNA samples isolated from a variety of <cons lex="common_human_malignancy" sem="G#other_name">common human malignancies</cons>, <cons lex="EBV-immortalised_B-cell" sem="G#cell_type">EBV-immortalised B-cells</cons>, and <cons lex="normal_lung_parenchyma" sem="G#tissue">normal lung parenchyma</cons>.</sentence>
<sentence><cons lex="intragenic_TSG101_deletion" sem="G#other_name">Intragenic <cons lex="TSG101" sem="G#DNA_domain_or_region">TSG101</cons> deletions</cons> in <cons lex="RNA_transcript" sem="G#RNA_family_or_group">RNA transcripts</cons> were frequently found in all types of samples.</sentence>
<sentence>Analysis of DNA failed to show <cons lex="genomic_rearrangement" sem="G#other_name">genomic rearrangements</cons> corresponding to transcripts containing deletions in the same samples.</sentence>
<sentence>The breakpoints of most <cons lex="transcript_deletion" sem="G#other_name">transcript deletions</cons> coincide with genuine or cryptic <cons lex="splice_site_sequence" sem="G#DNA_domain_or_region">splice site sequences</cons>, suggesting that they result from alternative or aberrant splicing.</sentence>
<sentence>A similar spectrum of <cons lex="transcript_deletion" sem="G#other_name">transcript deletions</cons> has previously been described in the <cons lex="putative_tumour_suppressor_gene" sem="G#DNA_family_or_group">putative tumour suppressor gene</cons> <cons lex="FHIT" sem="G#DNA_domain_or_region">FHIT</cons>.</sentence>
<sentence>We analysed <cons lex="FHIT" sem="G#DNA_domain_or_region">FHIT</cons> in the same series of <cons lex="RNA_sample" sem="G#RNA_family_or_group">RNA samples</cons> and detected truncated <cons lex="FHIT_transcript" sem="G#RNA_family_or_group"><cons lex="FHIT" sem="G#DNA_domain_or_region">FHIT</cons> transcripts</cons> frequently in both tumour and <cons lex="normal_tissue" sem="G#tissue">normal tissues</cons>.</sentence>
<sentence>In addition, transcripts from <cons lex="TSG101" sem="G#DNA_domain_or_region">TSG101</cons>, <cons lex="FHIT" sem="G#DNA_domain_or_region">FHIT</cons> and seven other genes were analysed in RNA isolated from <cons lex="normal_peripheral_blood_lymphocyte" sem="G#cell_type">normal peripheral blood lymphocytes</cons>.</sentence>
<sentence>Large <cons lex="TSG101" sem="G#DNA_domain_or_region">TSG101</cons> and <cons lex="FHIT" sem="G#DNA_domain_or_region">FHIT</cons> intragenic <cons lex="transcript_deletion" sem="G#other_name">transcript deletions</cons> were detected and these appeared to be the predominant transcript in <cons lex="'aged'_lymphocyte" sem="G#cell_type">'aged' lymphocytes</cons>.</sentence>
<sentence>Similar alterations were not detected in transcripts of the other genes which were analysed.</sentence>
<sentence>Our findings demonstrate that <cons lex="(AND truncated_TSG101_transcript truncated_FHIT_transcript)" sem="(AND G#RNA_molecule G#RNA_molecule)"><cons lex="truncated*">truncated</cons> <cons lex="*TSG101*">TSG101</cons> and <cons lex="*FHIT*">FHIT</cons> <cons lex="*transcript">transcripts</cons></cons> are commonly detected in both normal and <cons lex="malignant_tissue" sem="G#tissue">malignant tissues</cons> and that a significant fraction of these are likely to be the result of aberrant splicing.</sentence>
<sentence>While we cannot exclude that alterations in <cons lex="TSG101" sem="G#DNA_domain_or_region">TSG101</cons> and <cons lex="FHIT" sem="G#DNA_domain_or_region">FHIT</cons> occur during <cons lex="cancer_development" sem="G#other_name">cancer development</cons>, our data indicate that in this context the commonly observed <cons lex="transcript_abnormality" sem="G#other_name">transcript abnormalities</cons> are misleading.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98014713</bibliomisc>
</articleinfo>
<title>
<sentence>Inhibition of <cons lex="proliferation" sem="G#other_name">proliferation</cons> and <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> of <cons lex="(AND human_T_lymphocyte rat_T_lymphocyte)" sem="(AND G#cell_type G#cell_type)"><cons lex="human*">human</cons> and <cons lex="rat*">rat</cons> <cons lex="*T_lymphocyte">T lymphocytes</cons></cons> by <cons lex="curcumin" sem="G#other_organic_compound">curcumin</cons>, a <cons lex="curry_pigment" sem="G#other_organic_compound">curry pigment</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="curcumin" sem="G#other_organic_compound">Curcumin</cons> (<cons lex="diferuoylmethane" sem="G#other_organic_compound">diferuoylmethane</cons>), the <cons lex="yellow_pigment" sem="G#other_organic_compound">yellow pigment</cons> in the <cons lex="rhizome" sem="G#body_part">rhizome</cons> of <cons lex="tumeric" sem="G#multi_cell">tumeric</cons> (<cons lex="Curcuma_longa" sem="G#multi_cell">Curcuma longa</cons>), an ingredient of <cons lex="curry_spice" sem="G#other_organic_compound">curry spice</cons>, is known to exhibit a variety of pharmacological effects including <cons lex="(AND antitumor_activity antiinflammatory_activity antiinfectious_activity)" sem="(AND G#other_name G#other_name G#other_name)"><cons lex="antitumor*">antitumor</cons>, <cons lex="antiinflammatory*">antiinflammatory</cons>, and <cons lex="antiinfectious*">antiinfectious</cons> <cons lex="*activity">activities</cons></cons>.</sentence>
<sentence>Although its precise mode of action remains elusive, <cons lex="curcumin" sem="G#other_organic_compound">curcumin</cons> has been shown to suppress the activity of the <cons lex="AP-1" sem="G#protein_molecule">AP-1</cons> <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> in cells stimulated to proliferate.</sentence>
<sentence>In this study, we observed that <cons lex="curcumin" sem="G#other_organic_compound">curcumin</cons> (50 microM) inhibited <cons lex="proliferation" sem="G#other_name">proliferation</cons> of <cons lex="rat_thymocyte" sem="G#cell_type">rat thymocytes</cons> stimulated with <cons lex="concanavalin_A" sem="G#other_organic_compound">concanavalin A</cons> (<cons lex="Con_A" sem="G#other_organic_compound">Con A</cons>) as well as that of <cons lex="human_Jurkat_lymphoblastoid_cell" sem="G#cell_type">human Jurkat lymphoblastoid cells</cons> in the <cons lex="logarithmic_growth_phase" sem="G#other_name">logarithmic growth phase</cons>.</sentence>
<sentence>The pigment also inhibited <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> in <cons lex="dexamethasone-treated_rat_thymocyte" sem="G#cell_line">dexamethasone-treated <cons lex="rat_thymocyte" sem="G#cell_type">rat thymocytes</cons></cons> and in <cons lex="UV-irradiated_Jurkat_cell" sem="G#cell_line">UV-irradiated Jurkat cells</cons> as judged by <cons lex="DNA_ladder_formation" sem="G#other_name">DNA ladder formation</cons>, <cons lex="cellular_morphological_change" sem="G#other_name">cellular morphological changes</cons>, and <cons lex="flow_cytometry_analysis" sem="G#other_name">flow cytometry analysis</cons>.</sentence>
<sentence>The inhibition of <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> by <cons lex="curcumin" sem="G#other_organic_compound">curcumin</cons> in <cons lex="rat_thymocyte" sem="G#cell_type">rat thymocytes</cons> was accompanied by partial suppression of <cons lex="AP-1_activity" sem="G#other_name"><cons lex="AP-1" sem="G#protein_molecule">AP-1</cons> activity</cons>.</sentence>
<sentence>Complete suppression of <cons lex="AP-1_activity" sem="G#other_name"><cons lex="AP-1" sem="G#protein_molecule">AP-1</cons> activity</cons> was observed in <cons lex="Con_A-treated,_proliferating_thymocyte" sem="G#cell_line"><cons lex="Con_A" sem="G#other_organic_compound">Con A</cons>-treated, proliferating thymocytes</cons>.</sentence>
<sentence>The capacity of <cons lex="curcumin" sem="G#other_organic_compound">curcumin</cons> to inhibit both cell growth and death strongly implies that these two biological processes share a common pathway at some point and that <cons lex="curcumin" sem="G#other_organic_compound">curcumin</cons> affects a common step, presumably involving a modulation of the <cons lex="AP-1" sem="G#protein_molecule">AP-1</cons> <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97465516</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="interleukin-7" sem="G#protein_molecule">Interleukin-7</cons> upregulates the <cons lex="interleukin-2-gene_expression" sem="G#other_name"><cons lex="interleukin-2-gene" sem="G#DNA_domain_or_region">interleukin-2-gene</cons> expression</cons> in <cons lex="activated_human_T_lymphocyte" sem="G#cell_type">activated human T lymphocytes</cons> at the transcriptional level by enhancing the <cons lex="DNA_binding_activity" sem="G#other_name">DNA binding activities</cons> of both nuclear factor of <cons lex="activated_T_cell" sem="G#cell_type">activated T cells</cons> and <cons lex="activator_protein-1" sem="G#protein_molecule">activator protein-1</cons>.</sentence>
</title>
<abstract>
<sentence>In the present report, we studied the role of the <cons lex="stromal-derived_cytokine_interleukin-7" sem="G#protein_molecule"><cons lex="stromal-derived_cytokine" sem="G#protein_family_or_group">stromal-derived cytokine</cons> <cons lex="interleukin-7" sem="G#protein_molecule">interleukin-7</cons></cons> (<cons lex="IL-7" sem="G#protein_molecule">IL-7</cons>) in the <cons lex="IL-2-gene_regulation" sem="G#other_name"><cons lex="IL-2-gene" sem="G#DNA_domain_or_region">IL-2-gene</cons> regulation</cons> in <cons lex="activated_T_lymphocyte" sem="G#cell_type">activated T lymphocytes</cons>.</sentence>
<sentence>Production of <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> requires the formation of <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> involved in the <cons lex="IL-2-gene_regulation" sem="G#other_name"><cons lex="IL-2-gene" sem="G#DNA_domain_or_region"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons>-gene</cons> regulation</cons>.</sentence>
<sentence><cons lex="T-cell_receptor_(TCR)/CD3_engagement" sem="G#other_name"><cons lex="T-cell_receptor" sem="G#protein_family_or_group">T-cell receptor</cons> <cons lex="(TCR)/CD3" sem="G#protein_complex">(TCR)/CD3</cons> engagement</cons> results in the activation of nuclear factor of <cons lex="activated_T_cell" sem="G#cell_type">activated T cells</cons> (<cons lex="NFAT" sem="G#protein_family_or_group">NFAT</cons>), <cons lex="activator_protein-1" sem="G#protein_molecule">activator protein-1</cons> (<cons lex="AP-1" sem="G#protein_molecule">AP-1</cons>), and <cons lex="nuclear_factor_kappaB" sem="G#protein_complex">nuclear factor kappaB</cons> (<cons lex="NFkappaB" sem="G#protein_complex">NFkappaB</cons>), whereas the <cons lex="CD28_responsive_complex" sem="G#protein_complex">CD28 responsive complex</cons> (<cons lex="CD28RC" sem="G#protein_complex">CD28RC</cons>) is activated in response to the <cons lex="CD28_signal" sem="G#other_name"><cons lex="CD28" sem="G#protein_molecule">CD28</cons> signal</cons>.</sentence>
<sentence>Costimulation of <cons lex="phytohemagglutinin/anti-CD28_activated_T_lymphocyte" sem="G#cell_line"><cons lex="phytohemagglutinin" sem="G#protein_molecule">phytohemagglutinin</cons>/anti-CD28 <cons lex="activated_T_lymphocyte" sem="G#cell_type">activated T lymphocytes</cons></cons> with <cons lex="IL-7" sem="G#protein_molecule">IL-7</cons> induces a fivefold enhanced <cons lex="IL-2-mRNA_accumulation" sem="G#other_name"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons>-mRNA accumulation</cons> and a 2.5-fold <cons lex="enhanced_protein_secretion" sem="G#other_name">enhanced protein secretion</cons>.</sentence>
<sentence>The <cons lex="IL-2-gene_transcription_rate" sem="G#other_name"><cons lex="IL-2-gene" sem="G#DNA_domain_or_region"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons>-gene</cons> transcription rate</cons> is increased 3.4-fold, indicating that the effect of <cons lex="IL-7" sem="G#protein_molecule">IL-7</cons> is in part mediated at the transcriptional level.</sentence>
<sentence>The molecular mechanisms underlying the <cons lex="IL-7_effect" sem="G#other_name"><cons lex="IL-7" sem="G#protein_molecule">IL-7</cons> effect</cons> involve the upregulation of the DNA binding activity of <cons lex="NFAT" sem="G#protein_family_or_group">NFAT</cons> (60%) and <cons lex="AP-1" sem="G#protein_molecule">AP-1</cons> (120%), without affecting the activities of <cons lex="NFkappaB" sem="G#protein_complex">NFkappaB</cons> and <cons lex="CD28RC" sem="G#protein_complex">CD28RC</cons>, which was confirmed by <cons lex="transfection_assay" sem="G#other_name">transfection assays</cons>.</sentence>
<sentence>We also show that the <cons lex="IL-7" sem="G#protein_molecule">IL-7</cons>-induced enhancement of the <cons lex="AP-1-DNA_binding_activity" sem="G#other_name"><cons lex="AP-1" sem="G#protein_molecule">AP-1</cons>-DNA binding activity</cons> is not <cons lex="cyclosporin_A-sensitive" sem="G#other_name">cyclosporin A-sensitive</cons>.</sentence>
<sentence>Since <cons lex="AP-1" sem="G#protein_molecule">AP-1</cons> is part of the <cons lex="NFAT_complex" sem="G#protein_complex">NFAT complex</cons>, we conclude that the <cons lex="IL-7-signaling_pathway" sem="G#other_name"><cons lex="IL-7" sem="G#protein_molecule">IL-7</cons>-signaling pathway</cons> is involved in the activation of the <cons lex="(AND fos_protein jun_protein)" sem="(AND G#protein_family_or_group G#protein_family_or_group)"><cons lex="fos*">fos</cons> and <cons lex="jun*">jun</cons> <cons lex="*protein">proteins</cons></cons> of which <cons lex="AP-1" sem="G#protein_molecule">AP-1</cons> consists.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98001085</bibliomisc>
</articleinfo>
<title>
<sentence>The spatial distribution of <cons lex="human_immunoglobulin_gene" sem="G#DNA_family_or_group">human immunoglobulin genes</cons> within the <cons lex="nucleus" sem="G#cell_component">nucleus</cons>: evidence for <cons lex="gene_topography" sem="G#other_name">gene topography</cons> independent of <cons lex="cell_type" sem="G#other_name">cell type</cons> and <cons lex="transcriptional_activity" sem="G#other_name">transcriptional activity</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="three-dimensional_positioning" sem="G#other_name">three-dimensional positioning</cons> of <cons lex="immunoglobulin_(Ig)_gene" sem="G#DNA_family_or_group">immunoglobulin (Ig) genes</cons> within the <cons lex="nucleus" sem="G#cell_component">nucleus</cons> of <cons lex="human_cell" sem="G#cell_type">human cells</cons> was investigated using in <cons lex="situ_hybridization" sem="G#other_name">situ hybridization</cons> and <cons lex="confocal_microscopy" sem="G#other_name">confocal microscopy</cons>.</sentence>
<sentence>The visualization of <cons lex="(AND heavy_chain_gene light_chain_gene)" sem="(AND G#DNA_family_or_group G#DNA_family_or_group)"><cons lex="heavy*">heavy</cons> and <cons lex="light*">light</cons> <cons lex="*chain_gene">chain genes</cons></cons> in <cons lex="B-lymphoid_cell" sem="G#cell_type">B-lymphoid cells</cons> showed that the three <cons lex="Ig_gene" sem="G#DNA_family_or_group">Ig genes</cons> are differentially and nonrandomly distributed in different nuclear subvolumes: the <cons lex="kappa_gene" sem="G#DNA_family_or_group">kappa genes</cons> were found to be preferentially confined to an outer nuclear volume, whereas the <cons lex="(AND gamma_gene lambda_gene)" sem="(AND G#DNA_family_or_group G#DNA_family_or_group)"><cons lex="gamma*">gamma</cons> and <cons lex="lambda*">lambda</cons> <cons lex="*gene">genes</cons></cons> consistently occupied more central positions within the <cons lex="nucleus" sem="G#cell_component">nucleus</cons>, the <cons lex="lambda_gene" sem="G#DNA_family_or_group">lambda genes</cons> being more interior when compared with the <cons lex="gamma_gene" sem="G#DNA_family_or_group">gamma genes</cons>.</sentence>
<sentence>The data further show that these overall topographical distributions are independent of <cons lex="gene_transcriptional_activity" sem="G#other_name">gene <cons lex="transcriptional_activity" sem="G#other_name">transcriptional activity</cons></cons> and are conserved in <cons lex="different_cell_type" sem="G#cell_type">different cell types</cons>.</sentence>
<sentence>Although subtle <cons lex="gene_movement" sem="G#other_name">gene movements</cons> within those defined <cons lex="topographical_region" sem="G#other_name">topographical regions</cons> cannot be excluded by this study, the results indicate that tissue specificity of <cons lex="gene_expression" sem="G#other_name">gene expression</cons> is not accompanied by drastic changes in <cons lex="gene_nuclear_topography" sem="G#other_name">gene nuclear topography</cons>, rather suggesting that <cons lex="gene_organization" sem="G#other_name">gene organization</cons> within the <cons lex="nucleus" sem="G#cell_component">nucleus</cons> may be primarily dependent on structural constraints imposed on the respective <cons lex="chromosome" sem="G#DNA_molecule">chromosomes</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97472344</bibliomisc>
</articleinfo>
<title>
<sentence>Dominant <cons lex="cytotoxic_T_lymphocyte_response" sem="G#other_name"><cons lex="cytotoxic_T_lymphocyte" sem="G#cell_type">cytotoxic T lymphocyte</cons> response</cons> to the <cons lex="immediate-early_trans-activator_protein" sem="G#protein_family_or_group">immediate-early trans-activator protein</cons>, <cons lex="BZLF1" sem="G#protein_molecule">BZLF1</cons>, in persistent type <cons lex="(OR A_Epstein-Barr_virus_infection B_Epstein-Barr_virus_infection)" sem="(OR G#other_name G#other_name)"><cons lex="A*">A</cons> or <cons lex="B*">B</cons> <cons lex="*Epstein-Barr_virus_infection">Epstein-Barr virus infection</cons></cons>.</sentence>
</title>
<abstract>
<sentence>Five <cons lex="healthy_human_leukocyte_antigen-B8_(HLA-B8)-positive_virus_carrier" sem="G#multi_cell">healthy human leukocyte antigen-B8 (HLA-B8)-positive virus carriers</cons> were studied to investigate the <cons lex="CD8+_cytotoxic_T_lymphocyte_(CTL)_response" sem="G#other_name"><cons lex="CD8+_cytotoxic_T_lymphocyte" sem="G#cell_type">CD8+ cytotoxic T lymphocyte</cons> (CTL) response</cons> to an <cons lex="HLA-B8-restricted_peptide" sem="G#peptide">HLA-B8-restricted peptide</cons>, <cons lex="RAKFKQLLQ" sem="G#peptide">RAKFKQLLQ</cons>, located in the <cons lex="Epstein-Barr_virus_(EBV)_immediate-early_trans-activator_protein" sem="G#protein_molecule"><cons lex="Epstein-Barr_virus" sem="G#virus">Epstein-Barr virus</cons> (<cons lex="EBV" sem="G#virus">EBV</cons>) immediate-early trans-activator protein</cons>, <cons lex="BZLF1" sem="G#protein_molecule">BZLF1</cons>.</sentence>
<sentence>Of the 5 <cons lex="virus_carrier" sem="G#multi_cell">virus carriers</cons>, 4 were infected with <cons lex="type_A_EBV" sem="G#virus">type A</cons> and 1 with <cons lex="type_B_EBV" sem="G#virus">type B EBV</cons>.</sentence>
<sentence>Using <cons lex="limiting-dilution_analysis" sem="G#other_name">limiting-dilution analysis</cons> of <cons lex="peripheral_blood_mononuclear_cell" sem="G#cell_type">peripheral blood mononuclear cells</cons>, a high <cons lex="RAKFKQLLQ-specific_CTL_precursor_frequency" sem="G#other_name"><cons lex="RAKFKQLLQ" sem="G#peptide">RAKFKQLLQ</cons>-specific CTL precursor frequency</cons> was demonstrated after specific <cons lex="peptide" sem="G#peptide">peptide</cons> or autologous <cons lex="lymphoblastoid_cell_line_stimulation" sem="G#other_name">lymphoblastoid cell line stimulation</cons> in both <cons lex="(AND type_A_EBV_carrier type_B_EBV_carrier)" sem="(AND G#multi_cell G#multi_cell)"><cons lex="type_A*">type A</cons> and <cons lex="type_B*">type B</cons> <cons lex="*EBV_carrier">EBV carriers</cons></cons>.</sentence>
<sentence>The <cons lex="RAKFKQLLQ" sem="G#peptide">RAKFKQLLQ</cons>-specific <cons lex="CTL_precursor_frequencie" sem="G#other_name">CTL precursor frequencies</cons> in all 5 <cons lex="person" sem="G#multi_cell">persons</cons> were at least as dominant as those observed with two other <cons lex="EBV-associated,_HLA-B8-restricted_latent_epitope" sem="G#protein_domain_or_region">EBV-associated, HLA-B8-restricted latent epitopes</cons>, <cons lex="FLRGRAYGL" sem="G#peptide">FLRGRAYGL</cons> and <cons lex="QAKWRLQTL" sem="G#peptide">QAKWRLQTL</cons>.</sentence>
<sentence>These findings show that <cons lex="healthy_virus_carrier" sem="G#multi_cell">healthy <cons lex="virus_carrier" sem="G#multi_cell">virus carriers</cons></cons> maintain a high frequency of <cons lex="BZLF1-specific_memory_T_cell" sem="G#cell_type"><cons lex="BZLF1" sem="G#protein_molecule">BZLF1</cons>-specific memory T cells</cons>, potentially to control virus spread from <cons lex="lytically_infected_cell" sem="G#cell_type">lytically infected cells</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97460074</bibliomisc>
</articleinfo>
<title>
<sentence>The <cons lex="DNA_binding_domain" sem="G#protein_domain_or_region">DNA binding domain</cons> of the <cons lex="A-MYB" sem="G#protein_molecule">A-MYB</cons> <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> is responsible for its <cons lex="B_cell-specific_activity" sem="G#other_name">B cell-specific activity</cons> and binds to a <cons lex="B_cell_110-kDa_nuclear_protein" sem="G#protein_molecule">B cell 110-kDa nuclear protein</cons>.</sentence>
</title>
<abstract>
<sentence>Expression studies as well as the use of <cons lex="transgenic_animal" sem="G#other_artificial_source">transgenic animals</cons> have demonstrated that the <cons lex="A-MYB" sem="G#protein_molecule">A-MYB</cons> <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> plays central and specific role in the regulation of <cons lex="mature_B_cell_proliferation" sem="G#other_name"><cons lex="mature_B_cell" sem="G#cell_type">mature B cell</cons> <cons lex="proliferation" sem="G#other_name">proliferation</cons></cons> and/or <cons lex="differentiation" sem="G#other_name">differentiation</cons>.</sentence>
<sentence>Furthermore, it is highly expressed in <cons lex="Burkitt's_lymphoma_cell" sem="G#cell_line">Burkitt's lymphoma cells</cons> and may participate in the pathogenesis of this disease.</sentence>
<sentence>We have therefore investigated the <cons lex="transcriptional_activity" sem="G#other_name">transcriptional activity</cons> of <cons lex="A-MYB" sem="G#protein_molecule">A-MYB</cons> and its regulation in several <cons lex="human_lymphoid_cell_line" sem="G#cell_line">human lymphoid cell lines</cons> using co-transfection assays and show that <cons lex="A-MYB" sem="G#protein_molecule">A-MYB</cons> is <cons lex="transcriptionally_active" sem="G#other_name">transcriptionally active</cons> in all the <cons lex="B_cell_line" sem="G#cell_line">B cell lines</cons> studied, but not in <cons lex="T_cell" sem="G#cell_type">T cells</cons>.</sentence>
<sentence>In particular the best <cons lex="responder_cell_line" sem="G#cell_line">responder cell line</cons> was the <cons lex="Burkitt's_cell_line_Namalwa" sem="G#cell_line">Burkitt's cell line Namalwa</cons>.</sentence>
<sentence>The activity of <cons lex="A-MYB" sem="G#protein_molecule">A-MYB</cons> in <cons lex="(AND_NOT B_cell T_cell)" sem="(AND_NOT G#cell_type G#cell_type)"><cons lex="B*">B</cons> and not <cons lex="T*">T</cons> <cons lex="*cell">cells</cons></cons> was observed when either an artificial construct or the <cons lex="c-MYC_promoter" sem="G#DNA_domain_or_region">c-MYC promoter</cons> was used as a reporter.</sentence>
<sentence>Furthermore, the <cons lex="functional_domain" sem="G#protein_domain_or_region">functional domains</cons> responsible for <cons lex="DNA_binding" sem="G#other_name">DNA binding</cons>, <cons lex="transactivation" sem="G#other_name">transactivation</cons>, and <cons lex="negative_regulation" sem="G#other_name">negative regulation</cons>, <cons lex="previously_characterized_in_a_fibroblast_context" sem="G#other_name">previously characterized in a fibroblast context</cons>, were found to have similar activity in <cons lex="B_cell" sem="G#cell_type">B cells</cons>.</sentence>
<sentence>The region of <cons lex="A-MYB" sem="G#protein_molecule">A-MYB</cons> responsible for the <cons lex="B_cell_specific_activity" sem="G#other_name">B cell specific activity</cons> was defined to be the <cons lex="N-terminal_218_amino_acids" sem="G#protein_domain_or_region">N-terminal 218 amino acids</cons> containing the <cons lex="DNA_binding_domain" sem="G#protein_domain_or_region">DNA binding domain</cons>.</sentence>
<sentence>Finally, a <cons lex="110-kDa_protein" sem="G#protein_molecule">110-kDa protein</cons> has been identified in the <cons lex="nucleus" sem="G#cell_component">nuclei</cons> of all the <cons lex="(BUT_NOT B_cell_line T_cell_line)" sem="(BUT_NOT G#cell_line G#cell_line)"><cons lex="B*">B</cons>, but not <cons lex="T*">T</cons>, <cons lex="*cell_line">cell lines</cons></cons> that specifically binds to this <cons lex="A-MYB_N-terminal_domain" sem="G#protein_domain_or_region"><cons lex="A-MYB" sem="G#protein_molecule">A-MYB</cons> N-terminal domain</cons>.</sentence>
<sentence>We hypothesize that this <cons lex="110-kDa_protein" sem="G#protein_molecule">110-kDa protein</cons> may be a functionally important <cons lex="B_cell-specific_co-activator" sem="G#protein_family_or_group">B cell-specific co-activator</cons> of <cons lex="A-MYB" sem="G#protein_molecule">A-MYB</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97444155</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="transcription_factor_Egr-1_activity" sem="G#other_name">Transcription factor <cons lex="Egr-1" sem="G#protein_molecule">Egr-1</cons> activity</cons> down-regulates <cons lex="(AND Fas_expression CD23_expression)" sem="(AND G#other_name G#other_name)"><cons lex="Fas*">Fas</cons> and <cons lex="CD23*">CD23</cons> <cons lex="*expression">expression</cons></cons> in <cons lex="B_cell" sem="G#cell_type">B cells</cons>.</sentence>
</title>
<abstract>
<sentence>Activation of mature <cons lex="B_cell" sem="G#cell_type">B cells</cons> via <cons lex="Ag_receptor_cross-linking" sem="G#other_name"><cons lex="Ag_receptor" sem="G#protein_family_or_group">Ag receptor</cons> cross-linking</cons> induces <cons lex="transient_expression" sem="G#other_name">transient expression</cons> of the <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> <cons lex="Egr-1" sem="G#protein_molecule">Egr-1</cons>.</sentence>
<sentence>Although the <cons lex="activating_signal" sem="G#other_name">activating signals</cons> leading to <cons lex="Egr-1_induction" sem="G#other_name"><cons lex="Egr-1" sem="G#protein_molecule">Egr-1</cons> induction</cons> have been studied extensively, little is known about the genes that are placed further downstream within this <cons lex="activation_cascade" sem="G#other_name">activation cascade</cons> and that are transcriptionally regulated by <cons lex="Egr-1" sem="G#protein_molecule">Egr-1</cons>.</sentence>
<sentence>To identify such <cons lex="target_gene" sem="G#DNA_family_or_group">target genes</cons>, we established <cons lex="Egr-1-overexpressing_transfectant" sem="G#cell_line"><cons lex="Egr-1" sem="G#protein_molecule">Egr-1</cons>-overexpressing transfectants</cons> from the <cons lex="murine_B_cell_line_K46" sem="G#cell_line">murine B cell line K46</cons> and from <cons lex="human_Ramos_B_cell" sem="G#cell_line">human Ramos B cells</cons>.</sentence>
<sentence>All clones derived from <cons lex="K46_B_cell" sem="G#cell_line">K46 B cells</cons> showed increased expression of <cons lex="CD44" sem="G#protein_molecule">CD44</cons>.</sentence>
<sentence>Most interestingly, expression of <cons lex="CD95" sem="G#protein_molecule">CD95</cons> (<cons lex="Fas/Apo-1" sem="G#protein_molecule"><cons lex="Fas" sem="G#protein_molecule">Fas</cons>/Apo-1</cons>) and of <cons lex="CD23" sem="G#protein_molecule">CD23</cons> was down-regulated in all <cons lex="K46_transfectant" sem="G#cell_line">K46 transfectants</cons>.</sentence>
<sentence>As a consequence, they became resistant to <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> induced by <cons lex="anti-CD95_Ab_treatment" sem="G#other_name"><cons lex="anti-CD95_Ab" sem="G#protein_family_or_group">anti-CD95 Ab</cons> treatment</cons>.</sentence>
<sentence>Similarly, the <cons lex="Egr-1-expressing_Ramos_cell" sem="G#cell_line"><cons lex="Egr-1" sem="G#protein_molecule">Egr-1</cons>-expressing Ramos cells</cons> showed reduced levels of <cons lex="CD95_expression" sem="G#other_name"><cons lex="CD95" sem="G#protein_molecule">CD95</cons> expression</cons>.</sentence>
<sentence>Thus, <cons lex="Egr-1" sem="G#protein_molecule">Egr-1</cons> seems to control the expression of <cons lex="downstream_target_gene" sem="G#DNA_family_or_group">downstream target genes</cons> not only as a transcriptional activator, but also as a <cons lex="repressor_molecule" sem="G#protein_family_or_group">repressor molecule</cons>.</sentence>
<sentence>In <cons lex="B_cell" sem="G#cell_type">B cells</cons>, <cons lex="Egr-1" sem="G#protein_molecule">Egr-1</cons> therefore plays a critical role in integrating the short-lived signal delivered by triggering of the <cons lex="Ag_receptor" sem="G#protein_family_or_group">Ag receptor</cons> into phenotypic changes, including repression of <cons lex="CD95" sem="G#protein_molecule">CD95</cons> and <cons lex="CD23_transcription" sem="G#other_name"><cons lex="CD23" sem="G#protein_molecule">CD23</cons> transcription</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98104455</bibliomisc>
</articleinfo>
<title>
<sentence>Regulation of <cons lex="NF-kappa_B_activity" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> activity</cons> by <cons lex="(AND I_kappa_B_alpha_stability I_kappa_B_beta_stability)" sem="(AND G#other_name G#other_name)"><cons lex="I_kappa_B_alpha*">I kappa B alpha</cons> and <cons lex="I_kappa_B_beta*">I kappa B beta</cons> <cons lex="*stability">stability</cons></cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="transcription_factor" sem="G#protein_family_or_group">Transcription factor</cons> <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> must be released from <cons lex="cytoplasmic_inhibitory_molecule" sem="G#protein_family_or_group">cytoplasmic inhibitory molecules</cons> (<cons lex="I_kappa_B" sem="G#protein_family_or_group">I kappa Bs</cons>) in order to move to the nucleus and to activate its <cons lex="target_gene" sem="G#DNA_family_or_group">target genes</cons>.</sentence>
<sentence>Little is known about the mechanisms regulating the maintenance of <cons lex="constitutive_nuclear_NF-kappa_B" sem="G#protein_family_or_group">constitutive nuclear <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons></cons> in some cell-types and of sustained nuclear <cons lex="NF-kappa_B_activity" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> activity</cons> after stimulation.</sentence>
<sentence>Increased turnover has been implicated in the regulation of <cons lex="constitutive_NF-kappa_B_activity" sem="G#other_name">constitutive <cons lex="NF-kappa_B_activity" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> activity</cons></cons> in <cons lex="mature_B_cell" sem="G#cell_type">mature B cells</cons>.</sentence>
<sentence>We therefore compared the turnover of <cons lex="I_kappa_B_alpha" sem="G#protein_molecule">I kappa B alpha</cons> and <cons lex="I_kappa_B_beta" sem="G#protein_molecule">I kappa B beta</cons> in <cons lex="mature_B_cell" sem="G#cell_type">mature B cells</cons> and <cons lex="HeLa_cell" sem="G#cell_line">HeLa cells</cons>.</sentence>
<sentence>Both proteins display a high turnover in <cons lex="B_cell" sem="G#cell_type">B cells</cons> although <cons lex="I_kappa_B_beta" sem="G#protein_molecule">I kappa B beta</cons> is considerably more stable than <cons lex="I_kappa_B_alpha" sem="G#protein_molecule">I kappa B alpha</cons>.</sentence>
<sentence>The half-life of both inhibitors is increased in <cons lex="HeLa_cell" sem="G#cell_line">HeLa cells</cons>.</sentence>
<sentence>In contrast, all other <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons>/I kappa B molecules tested are relatively stable in both cell-types.</sentence>
<sentence>The elevated turnover of endogenous <cons lex="I_kappa_B_alpha" sem="G#protein_molecule">I kappa B alpha</cons> in <cons lex="Namalwa_cell" sem="G#cell_type">Namalwa cells</cons> is inhibited by a proteasome inhibitor and thus seems to be driven by the same degradation machinery as the slower turnover in <cons lex="non-B_cell" sem="G#cell_type">non-B cells</cons>.</sentence>
<sentence>Furthermore, we investigated the processes involved in persistent activation of <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons>.</sentence>
<sentence>TNF-alpha signaling leads to a rapid depletion of <cons lex="cellular_I_kappa_B_beta_pool" sem="G#other_name">cellular <cons lex="I_kappa_B_beta" sem="G#protein_molecule">I kappa B beta</cons> pools</cons>.</sentence>
<sentence><cons lex="I_kappa_B_alpha" sem="G#protein_molecule">I kappa B alpha</cons> is efficiently resynthesized whereas <cons lex="I_kappa_B_beta" sem="G#protein_molecule">I kappa B beta</cons> levels stay low for a prolonged time.</sentence>
<sentence><cons lex="NF-kappa_B_binding_activity" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> binding activity</cons> can be detected for several hours after stimulation.</sentence>
<sentence>We found that removal of the <cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons> containing medium causes a rapid decrease in <cons lex="nuclear_NF-kappa_B" sem="G#protein_complex">nuclear <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons></cons>.</sentence>
<sentence>A phosphoform of newly synthesized <cons lex="I_kappa_B_alpha" sem="G#protein_molecule">I kappa B alpha</cons> is visible when degradation by the <cons lex="proteasome" sem="G#protein_complex">proteasome</cons> is inhibited and new <cons lex="I_kappa_B_alpha" sem="G#protein_molecule">I kappa B alpha</cons> displays the same properties regarding <cons lex="phosphorylation" sem="G#other_name">phosphorylation</cons> and <cons lex="degradation" sem="G#other_name">degradation</cons> in response to a second inducer.</sentence>
<sentence>There is no significant difference in the turnover of pre- and post-inductive <cons lex="I_kappa_B_alpha" sem="G#protein_molecule">I kappa B alpha</cons>.</sentence>
<sentence>These observations suggest that resynthesis of <cons lex="I_kappa_B_alpha" sem="G#protein_molecule">I kappa B alpha</cons> and removal of the stimulus are obligatory steps for the inactivation of <cons lex="nuclear_NF_kappa_B" sem="G#protein_complex">nuclear NF kappa B</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98079330</bibliomisc>
</articleinfo>
<title>
<sentence>Selection of a diverse <cons lex="TCR_repertoire" sem="G#protein_family_or_group"><cons lex="TCR" sem="G#protein_family_or_group">TCR</cons> repertoire</cons> in response to an <cons lex="Epstein-Barr_virus-encoded_transactivator_protein" sem="G#protein_family_or_group"><cons lex="Epstein-Barr_virus" sem="G#virus">Epstein-Barr virus</cons>-encoded transactivator protein</cons> <cons lex="BZLF1" sem="G#protein_molecule">BZLF1</cons> by <cons lex="CD8+_cytotoxic_T_lymphocyte" sem="G#cell_type">CD8+ cytotoxic T lymphocytes</cons> during primary and persistent infection.</sentence>
</title>
<abstract>
<sentence>We investigated the <cons lex="CD8+_cytotoxic_T_lymphocyte_(CTL)_repertoire" sem="G#protein_family_or_group"><cons lex="CD8+_cytotoxic_T_lymphocyte" sem="G#cell_type">CD8+ cytotoxic T lymphocyte</cons> (CTL) repertoire</cons> to an <cons lex="HLA_B8-restricted_peptide" sem="G#peptide">HLA B8-restricted peptide</cons>, <cons lex="RAKFKQLLQ" sem="G#peptide">RAKFKQLLQ</cons>, located in the <cons lex="Epstein-Barr_virus_(EBV)_immediate-early_protein" sem="G#protein_family_or_group"><cons lex="Epstein-Barr_virus" sem="G#virus">Epstein-Barr virus</cons> (EBV) immediate-early protein</cons>, <cons lex="BZLF1" sem="G#protein_molecule">BZLF1</cons>.</sentence>
<sentence>Repertoire selection was monitored by determining the <cons lex="TCR_beta_chain_sequence" sem="G#protein_domain_or_region">TCR beta chain sequences</cons> of <cons lex="RAKFKQLLQ-specific_CTL" sem="G#cell_line"><cons lex="RAKFKQLLQ" sem="G#peptide">RAKFKQLLQ</cons>-specific CTL</cons> established from <cons lex="primary_infected_and_healthy_virus_carrier" sem="G#multi_cell">primary infected and healthy virus carriers</cons>.</sentence>
<sentence><cons lex="PCR_analysis" sem="G#other_name">PCR analysis</cons> of <cons lex="spontaneous_EBV-transformed_lymphoblastoid_cell_line" sem="G#cell_line">spontaneous <cons lex="EBV" sem="G#virus">EBV</cons>-transformed lymphoblastoid cell lines</cons> (<cons lex="LCL" sem="G#cell_line">LCL</cons>) from three <cons lex="individual" sem="G#multi_cell">individuals</cons> with primary infection showed that two were infected with <cons lex="(AND type_A___EBV_ one_with_type_B_EBV)" sem="(AND G#virus G#virus)"><cons lex="type_A*">type A</cons> and <cons lex="one_with_type_B*">one with type B</cons> <cons lex="*EBV">EBV</cons></cons>.</sentence>
<sentence><cons lex="(AND polyclonal_CTL clonal_CTL)" sem="(AND G#cell_line G#cell_line)"><cons lex="polyclonal*">Polyclonal</cons> and <cons lex="clonal*">clonal</cons> <cons lex="*CTL">CTL</cons></cons> that were generated by stimulating <cons lex="peripheral_blood_mononuclear_cell" sem="G#cell_type">peripheral blood mononuclear cells</cons> with an <cons lex="HLA_B8+_homozygous_LCL_lysed_T_cell_blast" sem="G#cell_line">HLA B8+ homozygous LCL lysed T cell blasts</cons> pulsed with the <cons lex="peptide" sem="G#peptide">peptide</cons>, <cons lex="RAKFKQLLQ" sem="G#peptide">RAKFKQLLQ</cons>; lysis of certain <cons lex="HLA_B8+_LCL_target" sem="G#other_name">HLA B8+ LCL targets</cons> was associated with the abundance of <cons lex="BZLF1_transcript" sem="G#RNA_molecule"><cons lex="BZLF1" sem="G#protein_molecule">BZLF1</cons> transcripts</cons>.</sentence>
<sentence><cons lex="TCR_beta_analysis" sem="G#other_name"><cons lex="TCR_beta" sem="G#DNA_domain_or_region">TCR beta</cons> analysis</cons> showed that while there was <cons lex="loop_length_restriction" sem="G#other_name">loop length restriction</cons> in the putative peptide contact site of all responding <cons lex="beta_chain" sem="G#protein_subunit">beta chains</cons>, diverse and <cons lex="unique_(non-recurrent)_TCR_beta_clonotype" sem="G#cell_line">unique (non-recurrent) <cons lex="TCR_beta_clonotype" sem="G#cell_line">TCR beta clonotypes</cons></cons> were selected in <cons lex="individual" sem="G#multi_cell">individuals</cons> during <cons lex="primary_infection" sem="G#other_name">primary infection</cons> and continued to emerge after <cons lex="long-term_virus_exposure" sem="G#other_name">long-term virus exposure</cons>.</sentence>
<sentence><cons lex="TCR-contact_site_heterogeneity" sem="G#other_name"><cons lex="TCR" sem="G#protein_family_or_group">TCR</cons>-contact site heterogeneity</cons> was excluded as the selective force in diversity generation since the epitope-encoded sequences were found to be identical within <cons lex="endogenous_virus_isolates" sem="G#virus">endogenous virus isolates</cons>.</sentence>
<sentence>In this first study of <cons lex="TCR_repertoire" sem="G#protein_family_or_group"><cons lex="TCR" sem="G#protein_family_or_group">TCR</cons> repertoire</cons> selection for an <cons lex="EBV_lytic_antigen" sem="G#protein_family_or_group"><cons lex="EBV" sem="G#virus">EBV</cons> lytic antigen</cons>, a <cons lex="BZLF1" sem="G#protein_molecule">BZLF1</cons>-reactive component of diverse clonotypes was identified in primary <cons lex="(OR type_A__EBV_infection type_B_EBV_infection)" sem="(OR G#other_name G#other_name)"><cons lex="type_A*">type A</cons> or <cons lex="type_B*">type B</cons> <cons lex="*EBV_infection">EBV infection</cons></cons> which was sustained in the <cons lex="EBV-specific_memory_response" sem="G#other_name"><cons lex="EBV" sem="G#virus">EBV</cons>-specific memory response</cons> throughout <cons lex="life-long_infection" sem="G#other_name">life-long infection</cons>.</sentence>
<sentence>This diversity selection is likely to play a critical role in maintaining a <cons lex="balanced_viral_load" sem="G#other_name">balanced viral load</cons> throughout <cons lex="EBV_persistence" sem="G#other_name"><cons lex="EBV" sem="G#virus">EBV</cons> persistence</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98062932</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="molecular_mechanism" sem="G#other_name">Molecular mechanisms</cons> of <cons lex="anoxia/reoxygenation-induced_neutrophil_adherence" sem="G#other_name">anoxia/reoxygenation-induced neutrophil adherence</cons> to <cons lex="cultured_endothelial_cell" sem="G#cell_line">cultured endothelial cells</cons>.</sentence>
</title>
<abstract>
<sentence>The objectives of this study were to (1) determine the time course of <cons lex="neutrophil_adhesion" sem="G#other_name">neutrophil adhesion</cons> to monolayers of <cons lex="human_umbilical_vein_endothelial_cell" sem="G#cell_line">human umbilical vein endothelial cells</cons> (<cons lex="HUVEC" sem="G#cell_line">HUVECs</cons>) that were exposed to 60 minutes of <cons lex="anoxia" sem="G#other_name">anoxia</cons> followed by 30 to 600 minutes of reoxygenation and (2) define the mechanisms responsible for both the early (minutes) and late (hours) <cons lex="hyperadhesivity" sem="G#other_name">hyperadhesivity</cons> of <cons lex="postanoxic_HUVEC" sem="G#cell_line">postanoxic <cons lex="HUVEC" sem="G#cell_line">HUVECs</cons></cons> to <cons lex="human_neutrophil" sem="G#cell_type">human neutrophils</cons>.</sentence>
<sentence>The results clearly demonstrate that <cons lex="anoxia/reoxygenation" sem="G#other_name"><cons lex="anoxia" sem="G#other_name">anoxia</cons>/reoxygenation</cons> (<cons lex="A/R" sem="G#other_name">A/R</cons>) leads to a biphasic increase in <cons lex="neutrophil_adhesion" sem="G#other_name">neutrophil adhesion</cons> to <cons lex="HUVEC" sem="G#cell_line">HUVECs</cons>, with peak responses occurring at 30 minutes (phase 1) and 240 minutes (phase 2) after <cons lex="reoxygenation" sem="G#other_name">reoxygenation</cons>.</sentence>
<sentence><cons lex="oxypurinol" sem="G#other_organic_compound">Oxypurinol</cons> and <cons lex="catalase" sem="G#protein_family_or_group">catalase</cons> inhibited <cons lex="phase-1_adhesion" sem="G#other_name">phase-1 adhesion</cons>, suggesting a role for <cons lex="xanthine_oxidase" sem="G#protein_molecule">xanthine oxidase</cons> and <cons lex="H2O2" sem="G#inorganic">H2O2</cons>.</sentence>
<sentence>In comparison, <cons lex="platelet_activating_factor" sem="G#protein_family_or_group">platelet activating factor</cons> (<cons lex="PAF" sem="G#protein_family_or_group">PAF</cons>) contributed to both phases of <cons lex="neutrophil_adhesion" sem="G#other_name">neutrophil adhesion</cons>.</sentence>
<sentence><cons lex="anti-intercellular_adhesion_molecule-1" sem="G#protein_molecule">Anti-intercellular adhesion molecule-1</cons> (<cons lex="ICAM-1" sem="G#protein_molecule">ICAM-1</cons>) and <cons lex="anti-P-selectin_antibody" sem="G#protein_family_or_group">anti-P-selectin antibodies</cons> (<cons lex="monoclonal_antibody" sem="G#protein_family_or_group">monoclonal antibodies</cons> [<cons lex="mAb" sem="G#protein_family_or_group">mAbs</cons>]) attenuated phase-1 <cons lex="neutrophil_adhesion" sem="G#other_name">neutrophil adhesion</cons>, consistent with roles for constitutively expressed <cons lex="ICAM-1" sem="G#protein_molecule">ICAM-1</cons> and enhanced <cons lex="surface_expression" sem="G#other_name">surface expression</cons> of preformed <cons lex="P-selectin" sem="G#protein_molecule">P-selectin</cons>.</sentence>
<sentence>Phase-2 <cons lex="neutrophil_adhesion" sem="G#other_name">neutrophil adhesion</cons> was attenuated by an <cons lex="anti-E-selectin_mAb" sem="G#protein_molecule">anti-E-selectin mAb</cons>, indicating a dominant role of this adhesion molecule in the <cons lex="late_phase_response" sem="G#other_name">late phase response</cons>.</sentence>
<sentence>Pretreatment with <cons lex="actinomycin_D" sem="G#other_organic_compound">actinomycin D</cons> and <cons lex="cycloheximide" sem="G#other_organic_compound">cycloheximide</cons> or with competing <cons lex="ds-oligonucleotide" sem="G#polynucleotide">ds-oligonucleotides</cons> containing the <cons lex="nuclear_factor-kappa_B" sem="G#protein_complex">nuclear factor-kappa B</cons> or <cons lex="activator_protein-1" sem="G#protein_molecule">activator protein-1</cons> <cons lex="cognate_DNA_sequence" sem="G#DNA_family_or_group">cognate DNA sequences</cons> significantly attenuated <cons lex="phase-2_response" sem="G#other_name">phase-2 response</cons>, suggesting a role for <cons lex="de_novo_macromolecule_synthesis" sem="G#other_name">de novo macromolecule synthesis</cons>.</sentence>
<sentence>Surface expression of <cons lex="ICAM-1" sem="G#protein_molecule">ICAM-1</cons>, <cons lex="P-selectin" sem="G#protein_molecule">P-selectin</cons>, and <cons lex="E-selectin" sem="G#protein_molecule">E-selectin</cons> on <cons lex="HUVEC" sem="G#cell_line">HUVECs</cons> correlated with the <cons lex="(AND phase-1_neutrophil_adhesion_response phase-2_neutrophil_adhesion_response)" sem="(AND G#other_name G#other_name)"><cons lex="phase*">phase</cons><cons lex="*-1*">-1</cons> and <cons lex="*-2*">-2</cons> <cons lex="*neutrophil_adhesion_response">neutrophil adhesion responses</cons></cons>.</sentence>
<sentence>Collectively, these findings indicate that <cons lex="A/R" sem="G#other_name">A/R</cons> elicits a <cons lex="two-phase_neutrophil-endothelial_cell_adhesion_response" sem="G#other_name">two-phase neutrophil-endothelial cell adhesion response</cons> that involves <cons lex="transcription-independent_surface_transcription" sem="G#other_name">transcription-independent</cons> and <cons lex="transcription-dependent_surface_expression" sem="G#other_name">transcription-dependent <cons lex="surface_expression" sem="G#other_name">surface expression</cons></cons> of different <cons lex="endothelial_cell_adhesion_molecule" sem="G#protein_family_or_group">endothelial cell adhesion molecules</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98031743</bibliomisc>
</articleinfo>
<title>
<sentence>Characterization of <cons lex="CD40_signaling_determinant" sem="G#other_name"><cons lex="CD40" sem="G#protein_molecule">CD40</cons> signaling determinants</cons> regulating <cons lex="nuclear_factor-kappa_B" sem="G#protein_complex">nuclear factor-kappa B</cons> activation in <cons lex="B_lymphocyte" sem="G#cell_type">B lymphocytes</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="CD40" sem="G#protein_molecule">CD40</cons> signaling to <cons lex="B_cell" sem="G#cell_type">B cells</cons> is important for generating an effective <cons lex="humoral_immune_response" sem="G#other_name">humoral immune response</cons>.</sentence>
<sentence><cons lex="CD40" sem="G#protein_molecule">CD40</cons> ligation leads to <cons lex="B_cell_activation_event" sem="G#other_name">B cell activation events</cons> such as <cons lex="proliferation" sem="G#other_name">proliferation</cons>, <cons lex="Ig_secretion" sem="G#other_name">Ig secretion</cons>, <cons lex="isotype_switching" sem="G#other_name">isotype switching</cons>, and <cons lex="up-regulation" sem="G#other_name">up-regulation</cons> of <cons lex="cell_surface_molecule" sem="G#protein_family_or_group">cell surface molecules</cons>, as well as the generation of <cons lex="memory_B_cell" sem="G#cell_type">memory B cells</cons>.</sentence>
<sentence>Many of these events are dependent upon the ability of <cons lex="CD40" sem="G#protein_molecule">CD40</cons> to activate the transcription factor <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> (<cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons>).</sentence>
<sentence>To define the <cons lex="CD40" sem="G#protein_molecule">CD40</cons> signaling components upstream of <cons lex="NF-kappa_B_activation" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> activation</cons> and the functional consequences downstream of <cons lex="NF-kappa_B_activation" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> activation</cons>, we examined <cons lex="mouse_B_cell_transfectant" sem="G#cell_line">mouse B cell transfectants</cons> expressing <cons lex="(OR wild-type_CD40 mutant_human_CD40)" sem="(OR G#protein_molecule G#protein_molecule)"><cons lex="wild-type*">wild-type</cons> or <cons lex="mutant_human*">mutant human</cons> <cons lex="*CD40">CD40</cons></cons>.</sentence>
<sentence>Analysis of <cons lex="CD40_cytoplasmic_domain_truncation" sem="G#other_name"><cons lex="CD40_cytoplasmic_domain" sem="G#protein_domain_or_region"><cons lex="CD40" sem="G#protein_molecule">CD40</cons> cytoplasmic domain</cons> truncation</cons> and point mutants defined a <cons lex="10-amino_acid_CD40_cytoplasmic_signaling_determinant" sem="G#protein_domain_or_region">10-amino acid <cons lex="CD40" sem="G#protein_molecule">CD40</cons> cytoplasmic signaling determinant</cons> required for <cons lex="NF-kappa_B_activation" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> activation</cons>.</sentence>
<sentence>A <cons lex="threonine_residue" sem="G#amino_acid_monomer">threonine residue</cons> at <cons lex="position_234" sem="G#protein_domain_or_region">position 234</cons>, previously shown to be important for <cons lex="CD40" sem="G#protein_molecule">CD40</cons> association with <cons lex="TNF_receptor-associated_factor_2" sem="G#protein_molecule">TNF receptor-associated factor 2</cons> (<cons lex="TRAF2" sem="G#protein_molecule">TRAF2</cons>), <cons lex="TRAF3" sem="G#protein_molecule">TRAF3</cons>, and <cons lex="TRAF5" sem="G#protein_molecule">TRAF5</cons>, was not required for <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> activation.</sentence>
<sentence>This suggests that in <cons lex="B_cell" sem="G#cell_type">B cells</cons>, <cons lex="CD40-induced_NF-kappa_B_activation" sem="G#other_name"><cons lex="CD40" sem="G#protein_molecule">CD40</cons>-induced <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> activation</cons> can occur independently of <cons lex="TRAF2" sem="G#protein_molecule">TRAF2</cons> and <cons lex="TRAF5" sem="G#protein_molecule">TRAF5</cons> association.</sentence>
<sentence><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> activation was independent of the <cons lex="transmembrane_domain" sem="G#protein_domain_or_region">transmembrane domain</cons> of <cons lex="CD40" sem="G#protein_molecule">CD40</cons>, suggesting that it is independent of <cons lex="p23" sem="G#protein_molecule">p23</cons>, a molecule that associates with <cons lex="CD40" sem="G#protein_molecule">CD40</cons> in a region other than the <cons lex="cytoplasmic_domain" sem="G#protein_domain_or_region">cytoplasmic domain</cons>.</sentence>
<sentence>Proteasome-dependent inhibitory kappa B alpha (<cons lex="I_kappa_B_alpha" sem="G#protein_molecule">I kappa B alpha</cons>) and <cons lex="I_kappa_B_beta" sem="G#protein_molecule">I kappa B beta</cons> degradation occurred downstream of <cons lex="CD40_ligation" sem="G#other_name"><cons lex="CD40" sem="G#protein_molecule">CD40</cons> ligation</cons> and preceded <cons lex="CD40-mediated_NF-kappa_B_nuclear_translocation" sem="G#other_name"><cons lex="CD40" sem="G#protein_molecule">CD40</cons>-mediated <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> nuclear translocation</cons>.</sentence>
<sentence><cons lex="(OR CD40-mediated_I_kappa_B_tyrosine_phosphorylation pervanadate-mediated_I_kappa_B_tyrosine_phosphorylation)" sem="(OR G#other_name G#other_name)"><cons lex="CD40-*">CD40-</cons> or <cons lex="pervanadate-*">pervanadate-</cons><cons lex="*mediated_I_kappa_B_tyrosine_phosphorylation">mediated I kappa B tyrosine phosphorylation</cons></cons> was not detected.</sentence>
<sentence><cons lex="NF-kappa_B_activation" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> activation</cons> correlated with the ability of <cons lex="CD40" sem="G#protein_molecule">CD40</cons> to induce <cons lex="Ab_secretion" sem="G#other_name">Ab secretion</cons> and the up-regulation of <cons lex="ICAM-1" sem="G#protein_molecule">ICAM-1</cons> and <cons lex="LFA-1" sem="G#protein_molecule">LFA-1</cons>.</sentence>
<sentence>However, <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> activation was insufficient for <cons lex="CD40-mediated_up-regulation" sem="G#other_name"><cons lex="CD40" sem="G#protein_molecule">CD40</cons>-mediated up-regulation</cons> of <cons lex="B7-1" sem="G#protein_molecule">B7-1</cons>, <cons lex="Fas" sem="G#protein_molecule">Fas</cons>, and <cons lex="CD23" sem="G#protein_molecule">CD23</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98019162</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="CD30-dependent_degradation" sem="G#other_name"><cons lex="CD30" sem="G#protein_molecule">CD30</cons>-dependent degradation</cons> of <cons lex="TRAF2" sem="G#protein_molecule">TRAF2</cons>: implications for <cons lex="negative_regulation" sem="G#other_name">negative regulation</cons> of <cons lex="TRAF_signaling" sem="G#other_name"><cons lex="TRAF" sem="G#protein_family_or_group">TRAF</cons> signaling</cons> and the control of cell survival.</sentence>
</title>
<abstract>
<sentence><cons lex="CD30" sem="G#protein_molecule">CD30</cons> is a <cons lex="cell-surface_receptor" sem="G#protein_family_or_group">cell-surface receptor</cons> that can augment <cons lex="lymphocyte_activation" sem="G#other_name">lymphocyte activation</cons> and survival through its ability to induce the <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons>.</sentence>
<sentence><cons lex="CD30" sem="G#protein_molecule">CD30</cons>, however, has also been implicated in the induction of <cons lex="apoptotic_cell_death" sem="G#other_name">apoptotic cell death</cons> of <cons lex="lymphocyte" sem="G#cell_type">lymphocytes</cons>.</sentence>
<sentence>Here we show that one of the effects of <cons lex="CD30" sem="G#protein_molecule">CD30</cons> signal transduction is to render cells sensitive to <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> induced by the <cons lex="type_1_tumor_necrosis_factor_receptor" sem="G#protein_molecule">type 1 tumor necrosis factor receptor</cons> (<cons lex="TNFR1" sem="G#protein_molecule">TNFR1</cons>).</sentence>
<sentence>This sensitization is dependent on the <cons lex="TRAF-binding_site" sem="G#protein_domain_or_region">TRAF-binding sites</cons> within the <cons lex="CD30" sem="G#protein_molecule">CD30</cons> <cons lex="cytoplasmic_domain" sem="G#protein_domain_or_region">cytoplasmic domain</cons>.</sentence>
<sentence>One of the proteins that binds to these sites is <cons lex="TRAF2" sem="G#protein_molecule">TRAF2</cons>, a <cons lex="signal_transduction_molecule" sem="G#protein_family_or_group">signal transduction molecule</cons> that is also utilized by <cons lex="TNFR1" sem="G#protein_molecule">TNFR1</cons> to mediate the activation of several downstream <cons lex="kinase" sem="G#protein_family_or_group">kinases</cons> and <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons>.</sentence>
<sentence>During <cons lex="CD30_signal_transduction" sem="G#other_name"><cons lex="CD30" sem="G#protein_molecule">CD30</cons> signal transduction</cons>, we found that binding of <cons lex="TRAF2" sem="G#protein_molecule">TRAF2</cons> to the <cons lex="cytoplasmic_domain" sem="G#protein_domain_or_region">cytoplasmic domain</cons> of <cons lex="CD30" sem="G#protein_molecule">CD30</cons> results in the rapid depletion of <cons lex="TRAF2" sem="G#protein_molecule">TRAF2</cons> and the associated protein <cons lex="TRAF1" sem="G#protein_molecule">TRAF1</cons> by proteolysis.</sentence>
<sentence>These data suggest a model in which <cons lex="CD30" sem="G#protein_molecule">CD30</cons> limits its own ability to transduce cell survival signals through <cons lex="signal-coupled_depletion" sem="G#other_name">signal-coupled depletion</cons> of <cons lex="TRAF2" sem="G#protein_molecule">TRAF2</cons>.</sentence>
<sentence>Depletion of intracellular <cons lex="TRAF2" sem="G#protein_molecule">TRAF2</cons> and its <cons lex="coassociated_protein" sem="G#protein_family_or_group">coassociated proteins</cons> also increased the sensitivity of the cell to undergoing <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> during activation of <cons lex="death-inducing_receptor" sem="G#protein_family_or_group">death-inducing receptors</cons> such as <cons lex="TNFR1" sem="G#protein_molecule">TNFR1</cons>.</sentence>
<sentence>Consistent with this hypothesis, expression of a <cons lex="dominant-negative_form" sem="G#protein_family_or_group">dominant-negative form</cons> of <cons lex="TRAF2" sem="G#protein_molecule">TRAF2</cons> was found to potentiate <cons lex="TNFR1-mediated_death" sem="G#other_name"><cons lex="TNFR1" sem="G#protein_molecule">TNFR1</cons>-mediated death</cons>.</sentence>
<sentence>These studies provide a potential mechanism through which <cons lex="CD30" sem="G#protein_molecule">CD30</cons>, as well as other <cons lex="TRAF-binding_member" sem="G#protein_family_or_group">TRAF-binding members</cons> of the <cons lex="TNFR_superfamily" sem="G#protein_family_or_group">TNFR superfamily</cons>, can negatively regulate cell survival.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97467112</bibliomisc>
</articleinfo>
<title>
<sentence>Analysis of <cons lex="myeloid-associated_gene" sem="G#DNA_family_or_group">myeloid-associated genes</cons> in <cons lex="human_hematopoietic_progenitor_cell" sem="G#cell_type">human hematopoietic progenitor cells</cons>.</sentence>
</title>
<abstract>
<sentence>The distribution of <cons lex="myeloid_lineage-associated_cytokine_receptor" sem="G#protein_family_or_group">myeloid lineage-associated cytokine receptors</cons> and <cons lex="lysosomal_protein" sem="G#protein_family_or_group">lysosomal proteins</cons> was analyzed in <cons lex="human_CD34+_cord_blood_cell_(CB)_subset" sem="G#cell_line">human CD34+ cord blood cell (CB) subsets</cons> at different stages of <cons lex="myeloid_commitment" sem="G#other_name">myeloid commitment</cons> by <cons lex="reverse-transcriptase_polymerase_chain_reaction" sem="G#other_name">reverse-transcriptase polymerase chain reaction</cons> (<cons lex="RT-PCR" sem="G#other_name">RT-PCR</cons>).</sentence>
<sentence>The highly specific <cons lex="granulomonocyte-associated_lysosomal_protein" sem="G#protein_family_or_group">granulomonocyte-associated <cons lex="lysosomal_protein" sem="G#protein_family_or_group">lysosomal proteins</cons></cons> <cons lex="myeloperoxidase" sem="G#protein_molecule">myeloperoxidase</cons> (<cons lex="MPO" sem="G#protein_molecule">MPO</cons>) and <cons lex="lysozyme" sem="G#protein_molecule">lysozyme</cons> (<cons lex="LZ" sem="G#protein_molecule">LZ</cons>), as well as the <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> <cons lex="PU.1" sem="G#protein_molecule">PU.1</cons>, were already detectable in the most immature <cons lex="CD34+Thy-1+_subset" sem="G#cell_line">CD34+Thy-1+ subset</cons>.</sentence>
<sentence><cons lex="messenger_RNA_(mRNA)_level" sem="G#other_name"><cons lex="messenger_RNA" sem="G#RNA_family_or_group">Messenger RNA</cons> (<cons lex="mRNA" sem="G#RNA_family_or_group">mRNA</cons>) levels</cons> for the <cons lex="granulocyte-colony_stimulating_factor_(G-CSF)_receptor" sem="G#protein_molecule"><cons lex="granulocyte-colony_stimulating_factor" sem="G#protein_molecule">granulocyte-colony stimulating factor</cons> (<cons lex="G-CSF" sem="G#protein_molecule">G-CSF</cons>) receptor</cons>, <cons lex="granulocyte-macrophage_(GM)-CSF_receptor_alpha_subunit" sem="G#protein_subunit">granulocyte-macrophage (GM)-CSF receptor alpha subunit</cons> and <cons lex="(AND tumor_necrosis_factor_(TNF)_receptor_I_(p55) tumor_necrosis_factor_(TNF)_receptor_II_(p75))" sem="(AND G#protein_molecule G#protein_molecule)"><cons lex="tumor_necrosis_factor_(TNF)_receptor*">tumor necrosis factor (TNF) receptors</cons> <cons lex="*I_(p55)">I (p55)</cons> and <cons lex="*II_(p75)">II (p75)</cons></cons> were also detected in this subset in addition to <cons lex="c-kit" sem="G#protein_molecule">c-kit</cons> and <cons lex="flt-3" sem="G#protein_molecule">flt-3</cons>, receptors known to be expressed on <cons lex="progenitor_cell" sem="G#cell_type">progenitor cells</cons>.</sentence>
<sentence>By contrast, the <cons lex="monocyte-macrophage_colony_stimulating_factor_(M-CSF)_receptor" sem="G#protein_family_or_group">monocyte-macrophage colony stimulating factor (M-CSF) receptor</cons> was largely absent at this stage and in the <cons lex="CD34+Thy-1-CD45RA-_subset" sem="G#cell_line">CD34+Thy-1-CD45RA- subsets</cons>.</sentence>
<sentence>The <cons lex="M-CSF_receptor" sem="G#protein_molecule">M-CSF receptor</cons> was first detectable in the <cons lex="myeloid-committed_CD34+Thy-l-CD45RA+_subset" sem="G#cell_line">myeloid-committed CD34+Thy-l-CD45RA+ subset</cons>.</sentence>
<sentence>All other molecules studied were found to be expressed at this stage of differentiation.</sentence>
<sentence>Different cocktails of the identified ligands were added to <cons lex="sorted_CD34+Thy-1+_single_cell" sem="G#cell_line">sorted CD34+Thy-1+ single cells</cons>.</sentence>
<sentence>Low proliferative capacity was observed after 1 week in culture in the presence of <cons lex="stem_cell_factor" sem="G#protein_molecule">stem cell factor</cons> (<cons lex="SCF" sem="G#protein_molecule">SCF</cons>) + <cons lex="Flt-3_ligand" sem="G#protein_molecule">Flt-3 ligand</cons> (<cons lex="FL" sem="G#protein_molecule">FL</cons>) + <cons lex="G-CSF" sem="G#protein_molecule">G-CSF</cons>.</sentence>
<sentence>Addition of <cons lex="GM-CSF" sem="G#protein_molecule">GM-CSF</cons> to this basic cocktail consistently increased the clonogenic capacity of <cons lex="single_CD34+Thy-1+_cell" sem="G#cell_line">single CD34+Thy-1+ cells</cons>, and this effect was further enhanced (up to 72.3 +/- 4.3% on day 7) by the inclusion of <cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons>.</sentence>
<sentence>In conclusion, the presence of <cons lex="myeloid-associated_growth_factor_receptor_transcript" sem="G#RNA_molecule"><cons lex="myeloid-associated_growth_factor_receptor" sem="G#protein_molecule">myeloid-associated growth factor receptor</cons> transcripts</cons> in <cons lex="CD34+_CB_subset" sem="G#cell_line">CD34+ CB subsets</cons> does not discriminate the various stages of <cons lex="differentiation" sem="G#other_name">differentiation</cons>, with the exception of the <cons lex="M-CSF_receptor" sem="G#protein_molecule">M-CSF receptor</cons>.</sentence>
<sentence>In addition, we show that <cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons> is a potent costimulatory factor of the very <cons lex="immature_CD34+Thy-1+_CB_subset" sem="G#cell_line">immature CD34+Thy-1+ CB subset</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98000963</bibliomisc>
</articleinfo>
<title>
<sentence>Induction of <cons lex="endothelial_cell_surface_adhesion_molecule" sem="G#protein_family_or_group">endothelial cell surface adhesion molecules</cons> by <cons lex="tumor_necrosis_factor" sem="G#protein_family_or_group">tumor necrosis factor</cons> is blocked by protein <cons lex="tyrosine" sem="G#amino_acid_monomer">tyrosine</cons> <cons lex="phosphatase_inhibitor" sem="G#other_organic_compound">phosphatase inhibitors</cons>: role of the <cons lex="nuclear_transcription_factor_NF-kappa_B" sem="G#protein_complex">nuclear <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons></cons>.</sentence>
</title>
<abstract>
<sentence>Recent studies from our laboratory have indicated that <cons lex="protein_tyrosine_phosphatase_(PTPase)_inhibitor" sem="G#other_organic_compound"><cons lex="protein_tyrosine_phosphatase" sem="G#protein_molecule">protein tyrosine phosphatase</cons> (<cons lex="PTPase" sem="G#protein_molecule">PTPase</cons>) inhibitors</cons> can down-modulate the <cons lex="tumor_necrosis_factor_(TNF)-mediated_activation" sem="G#other_name"><cons lex="tumor_necrosis_factor" sem="G#protein_family_or_group">tumor necrosis factor</cons> (<cons lex="TNF" sem="G#protein_family_or_group">TNF</cons>)-mediated activation</cons> of the <cons lex="nuclear_transcription_factor_NF-kappa_B" sem="G#protein_complex">nuclear transcription factor NF-kappa B</cons> in <cons lex="ML-1a" sem="G#cell_line">ML-1a</cons>, a <cons lex="monocytic_cell_line" sem="G#cell_line">monocytic cell line</cons> (Singh and Aggarwal, J. Biol. Chem. 1995: 270: 10631).</sentence>
<sentence>Since <cons lex="TNF" sem="G#protein_family_or_group">TNF</cons> is one of the major inducers of various <cons lex="adhesion_molecule" sem="G#protein_family_or_group">adhesion molecules</cons> in human endothelial cells and their expression is known to require the activation of <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons>, we examined the effect of <cons lex="PTPase_inhibitor" sem="G#other_organic_compound"><cons lex="PTPase" sem="G#protein_family_or_group">PTPase</cons> inhibitors</cons> on the <cons lex="TNF-mediated_induction" sem="G#other_name"><cons lex="TNF" sem="G#protein_family_or_group">TNF</cons>-mediated induction</cons> of <cons lex="intracellular_adhesion_molecule_(ICAM)-1" sem="G#protein_molecule">intracellular adhesion molecule (ICAM)-1</cons>, <cons lex="vascular_cell_adhesion_molecule_(VCAM)-1" sem="G#protein_molecule">vascular cell adhesion molecule (VCAM)-1</cons> and <cons lex="endothelial_leukocyte_adhesion_molecule_(ELAM)-1" sem="G#protein_molecule">endothelial leukocyte adhesion molecule (ELAM)-1</cons>.</sentence>
<sentence>Like <cons lex="ML-1a" sem="G#cell_line">ML-1a</cons>, <cons lex="human_dermal_microvessel_endothelial_cell" sem="G#cell_line">human dermal microvessel endothelial cells</cons> (<cons lex="MVEC" sem="G#cell_line">MVEC</cons>) treated with <cons lex="TNF" sem="G#protein_family_or_group">TNF</cons> rapidly activated (within 30 min) <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons>; this effect was completely abolished by co-treatment with <cons lex="phenylarsine_oxide" sem="G#other_organic_compound">phenylarsine oxide</cons> (<cons lex="PAO" sem="G#other_organic_compound">PAO</cons>), a specific inhibitor of <cons lex="PTPase" sem="G#protein_family_or_group">PTPase</cons>.</sentence>
<sentence>The induction of <cons lex="ICAM-1" sem="G#protein_molecule">ICAM-1</cons>, <cons lex="VCAM-1" sem="G#protein_molecule">VCAM-1</cons>, and <cons lex="ELAM-1" sem="G#protein_molecule">ELAM-1</cons> by <cons lex="TNF" sem="G#protein_family_or_group">TNF</cons> in <cons lex="MVEC" sem="G#cell_line">MVEC</cons> occurred within 6 h and was also completely down-regulated by <cons lex="PAO" sem="G#other_organic_compound">PAO</cons> in a dose-dependent manner.</sentence>
<sentence><cons lex="PAO" sem="G#other_organic_compound">PAO</cons> was found to be effective even when added 3 h after <cons lex="TNF" sem="G#protein_family_or_group">TNF</cons>, suggesting a rapid mode of action of this inhibitor.</sentence>
<sentence>Besides <cons lex="PAO" sem="G#other_organic_compound">PAO</cons>, other inhibitors of <cons lex="PTPase" sem="G#protein_family_or_group">PTPase</cons>, including <cons lex="pervanadate" sem="G#other_organic_compound">pervanadate</cons> and diamide, also blocked <cons lex="TNF-dependent_NF-kappa_B_activation" sem="G#other_name"><cons lex="TNF" sem="G#protein_family_or_group">TNF</cons>-dependent <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> activation</cons> and induction of all the three <cons lex="adhesion_protein" sem="G#protein_family_or_group">adhesion proteins</cons>.</sentence>
<sentence>Consistent with these results, the attachment of monocytes to <cons lex="MVEC" sem="G#cell_line">MVEC</cons> was also blocked by the <cons lex="PTPase_inhibitor" sem="G#other_organic_compound"><cons lex="PTPase" sem="G#protein_family_or_group">PTPase</cons> inhibitors</cons>.</sentence>
<sentence>Thus, overall, our results demonstrate that a <cons lex="PTPase" sem="G#protein_family_or_group">PTPase</cons> is involved either directly or indirectly in the pathway leading to the induction of <cons lex="endothelial_cell_adhesion_molecule" sem="G#protein_family_or_group">endothelial cell <cons lex="adhesion_molecule" sem="G#protein_family_or_group">adhesion molecules</cons></cons> by <cons lex="TNF" sem="G#protein_family_or_group">TNF</cons>.</sentence>
<sentence>Because of their role in <cons lex="cell_adhesion" sem="G#other_name">cell adhesion</cons>, <cons lex="PTPase" sem="G#protein_family_or_group">PTPase</cons> may provide a novel target of drug development for treatment of <cons lex="inflammation" sem="G#other_name">inflammation</cons>, <cons lex="atherogenesis" sem="G#other_name">atherogenesis</cons>, and <cons lex="tumor_metastasis" sem="G#other_name">tumor metastasis</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98018275</bibliomisc>
</articleinfo>
<title>
<sentence>Regulation of <cons lex="nuclear_factor-kappa_B" sem="G#protein_complex">nuclear factor-kappa B</cons> and its inhibitor <cons lex="I_kappa_B-alpha/MAD-3" sem="G#protein_molecule">I kappa B-alpha/MAD-3</cons> in <cons lex="monocyte" sem="G#cell_type">monocytes</cons> by <cons lex="Mycobacterium_tuberculosis" sem="G#mono_cell">Mycobacterium tuberculosis</cons> and during <cons lex="human_tuberculosis" sem="G#other_name">human tuberculosis</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="blood_monocyte" sem="G#cell_type">Blood monocytes</cons> from <cons lex="patient" sem="G#multi_cell">patients</cons> with <cons lex="active_tuberculosis" sem="G#other_name">active tuberculosis</cons> are activated in vivo, as evidenced by an increase in the stimulated release of <cons lex="proinflammatory_cytokine" sem="G#protein_family_or_group">proinflammatory cytokines</cons>, such as <cons lex="TNF-alpha" sem="G#protein_molecule"><cons lex="TNF" sem="G#protein_family_or_group">TNF</cons>-alpha</cons>, and the spontaneous expression of <cons lex="IL-2R" sem="G#protein_molecule">IL-2R</cons>.</sentence>
<sentence>Further, <cons lex="monocyte" sem="G#cell_type">monocytes</cons> from <cons lex="patient" sem="G#multi_cell">patients</cons> demonstrate an augmented susceptibility to a productive infection with <cons lex="HIV-1" sem="G#virus">HIV-1</cons> in vitro.</sentence>
<sentence><cons lex="Mycobacterium_tuberculosis" sem="G#mono_cell">Mycobacterium tuberculosis</cons> and its components are strong signals to activate <cons lex="monocyte" sem="G#cell_type">monocytes</cons> to production of <cons lex="cytokine" sem="G#protein_family_or_group">cytokines</cons>.</sentence>
<sentence>In this study we examined the basis of activation of <cons lex="monocyte" sem="G#cell_type">monocytes</cons> during <cons lex="active_tuberculosis" sem="G#other_name">active tuberculosis</cons> and by <cons lex="M._tuberculosis" sem="G#mono_cell">M. tuberculosis</cons>.</sentence>
<sentence>We found a constitutive degradation of <cons lex="I_kappa_B-alpha" sem="G#protein_molecule">I kappa B-alpha</cons>, the major <cons lex="cytoplasmic_inhibitor" sem="G#protein_family_or_group">cytoplasmic inhibitor</cons> of <cons lex="nuclear_factor_kappa_B" sem="G#protein_complex">nuclear factor kappa B</cons> (<cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons>), in freshly isolated <cons lex="PBMC" sem="G#cell_type">PBMC</cons> and <cons lex="monocyte" sem="G#cell_type">monocytes</cons> from <cons lex="patient" sem="G#multi_cell">patients</cons> with tuberculosis.</sentence>
<sentence>In contrast, <cons lex="I_kappa_B-alpha_levels" sem="G#other_name"><cons lex="I_kappa_B-alpha" sem="G#protein_molecule">I kappa B-alpha</cons> levels</cons> in <cons lex="PBMC" sem="G#cell_type">PBMC</cons> and <cons lex="monocyte" sem="G#cell_type">monocytes</cons> from healthy subjects or from <cons lex="patient" sem="G#multi_cell">patients</cons> with nontuberculous pulmonary conditions were intact.</sentence>
<sentence>Further, by <cons lex="electrophoretic_mobility_shift_assay" sem="G#other_name">electrophoretic mobility shift assay</cons>, <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> was activated in <cons lex="monocyte" sem="G#cell_type">monocytes</cons> from tuberculous <cons lex="patient" sem="G#multi_cell">patients</cons>.</sentence>
<sentence>The expression of <cons lex="I_kappa_B-alpha" sem="G#protein_molecule">I kappa B-alpha</cons> gene, which is responsive to activation by <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons>, was up-regulated in <cons lex="PBMC" sem="G#cell_type">PBMC</cons> and <cons lex="monocyte" sem="G#cell_type">monocytes</cons> from <cons lex="patient" sem="G#multi_cell">patients</cons>, but not in <cons lex="mononuclear_cell" sem="G#cell_type">mononuclear cells</cons> from healthy subjects or those with <cons lex="nontuberculous_lung_disease" sem="G#other_name">nontuberculous lung diseases</cons>.</sentence>
<sentence>By contrast, the expression of other <cons lex="adherence-associated_early_gene" sem="G#DNA_family_or_group">adherence-associated early genes</cons>, such as <cons lex="IL-8" sem="G#protein_molecule">IL-8</cons> and <cons lex="IL-1_beta" sem="G#protein_molecule">IL-1 beta</cons>, was not up-regulated in <cons lex="PBMC" sem="G#cell_type">PBMC</cons> of <cons lex="tuberculous_patient" sem="G#multi_cell">tuberculous <cons lex="patient" sem="G#multi_cell">patients</cons></cons>.</sentence>
<sentence>Further, <cons lex="M._tuberculosis" sem="G#mono_cell">M. tuberculosis</cons> and its <cons lex="tuberculin" sem="G#protein_molecule">tuberculin</cons>, <cons lex="purified_protein_derivative" sem="G#protein_family_or_group">purified protein derivative</cons>, induced the degradation of <cons lex="I_kappa_B-alpha" sem="G#protein_molecule">I kappa B-alpha</cons> and the expression of <cons lex="I_kappa_B-alpha_mRNA" sem="G#RNA_molecule"><cons lex="I_kappa_B-alpha" sem="G#protein_molecule">I kappa B-alpha</cons> mRNA</cons>, and purified protein derivative induced the activation of <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> in <cons lex="monocyte" sem="G#cell_type">monocytes</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97459950</bibliomisc>
</articleinfo>
<title>
<sentence>Cooperation of <cons lex="Spi-1/PU.1" sem="G#protein_molecule">Spi-1/<cons lex="PU.1" sem="G#protein_molecule">PU.1</cons></cons> with an <cons lex="activated_erythropoietin_receptor" sem="G#protein_family_or_group">activated erythropoietin receptor</cons> inhibits <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> and <cons lex="Epo-dependent_differentiation" sem="G#other_name"><cons lex="Epo" sem="G#protein_molecule">Epo</cons>-dependent differentiation</cons> in <cons lex="primary_erythroblast" sem="G#cell_type">primary erythroblasts</cons> and induces their <cons lex="Kit_ligand-dependent_proliferation" sem="G#other_name">Kit ligand-dependent proliferation</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="Spi-1/PU.1" sem="G#protein_molecule">Spi-1/<cons lex="PU.1" sem="G#protein_molecule">PU.1</cons></cons> is a <cons lex="myeloid-_and_B-cell_specific_transcription_factor" sem="G#protein_family_or_group">myeloid- and B-cell specific <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons></cons> which is also involved in <cons lex="Friend_virus-induced_murine_erythroleukemia" sem="G#other_name"><cons lex="Friend_virus" sem="G#virus">Friend virus</cons>-induced murine erythroleukemia</cons>.</sentence>
<sentence>The <cons lex="pre-leukemic_phase" sem="G#other_name">pre-leukemic phase</cons> of <cons lex="Friend_erythroleukemia" sem="G#other_name">Friend erythroleukemia</cons> results from activation of the <cons lex="erythropoietin_receptor" sem="G#protein_molecule">erythropoietin receptor</cons> (<cons lex="EpoR" sem="G#protein_molecule">EpoR</cons>) by the <cons lex="spleen_focus_forming_virus_(SFFV)_envelope_glycoprotein" sem="G#protein_family_or_group">spleen focus forming virus (SFFV) envelope glycoprotein</cons>, followed by the emergence of leukemic clones characterized by overexpression of <cons lex="Spi-1" sem="G#protein_molecule">Spi-1</cons> and mutation of the <cons lex="p53_tumor_suppressor_gene" sem="G#DNA_domain_or_region">p53 tumor suppressor gene</cons>.</sentence>
<sentence>We developed a heterologous system to analyze the contribution of these alterations to the induction of <cons lex="primary_erythroblast_transformation" sem="G#other_name">primary erythroblast transformation</cons>.</sentence>
<sentence><cons lex="avian_erythroblast" sem="G#cell_type">Avian erythroblasts</cons> expressing the <cons lex="activated_mouse_EpoR(R129C)" sem="G#protein_molecule">activated mouse <cons lex="EpoR" sem="G#protein_molecule">EpoR</cons>(R129C)</cons> differentiated into <cons lex="erythrocyte" sem="G#cell_type">erythrocytes</cons> in response to <cons lex="hEpo" sem="G#protein_molecule">hEpo</cons>.</sentence>
<sentence>Expression of <cons lex="Spi-1" sem="G#protein_molecule">Spi-1</cons> in these cells inhibited this ability to differentiate and rescued the cells from the <cons lex="apoptotic_cell_death" sem="G#other_name">apoptotic cell death</cons> program normally induced upon <cons lex="hEpo" sem="G#protein_molecule">hEpo</cons> withdrawal.</sentence>
<sentence>Although devoid of any effect by itself, a <cons lex="mutant_p53" sem="G#protein_molecule">mutant p53</cons> cooperated with <cons lex="Spi-1" sem="G#protein_molecule">Spi-1</cons> and <cons lex="EpoR(R129C)" sem="G#protein_molecule"><cons lex="EpoR" sem="G#protein_molecule">EpoR</cons>(R129C)</cons> to reinforce both phenotypes.</sentence>
<sentence>Analysis of erythroblasts co-expressing <cons lex="Spi-1" sem="G#protein_molecule">Spi-1</cons> and the <cons lex="wild-type_mouse_EpoR" sem="G#protein_molecule">wild-type mouse <cons lex="EpoR" sem="G#protein_molecule">EpoR</cons></cons> showed that <cons lex="differentiation_arrest" sem="G#other_name">differentiation arrest</cons> and inhibition of <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> depended on specific cooperation between <cons lex="Spi-1" sem="G#protein_molecule">Spi-1</cons> and <cons lex="EpoR(R129C)" sem="G#protein_molecule"><cons lex="EpoR" sem="G#protein_molecule">EpoR</cons>(R129C)</cons>.</sentence>
<sentence>This cooperation was also required to induce the sustained <cons lex="proliferation" sem="G#other_name">proliferation</cons> of <cons lex="differentiation-blocked_erythroblast" sem="G#cell_line">differentiation-blocked erythroblasts</cons> in response to <cons lex="ligand_activation" sem="G#other_name">ligand activation</cons> of the <cons lex="endogenous_tyrosine_kinase_receptor" sem="G#protein_molecule">endogenous <cons lex="tyrosine" sem="G#amino_acid_monomer">tyrosine</cons> kinase receptor</cons> <cons lex="c-Kit" sem="G#protein_molecule">c-Kit</cons>.</sentence>
<sentence>These results show that Spi-1/<cons lex="PU.1" sem="G#protein_molecule">PU.1</cons> requires signals emanating from specific cytokine and growth factor receptors to affect the survival, <cons lex="proliferation" sem="G#other_name">proliferation</cons> and differentiation control of <cons lex="primary_erythroblast" sem="G#cell_type">primary erythroblasts</cons>.</sentence>
<sentence>They also suggest that the function of <cons lex="Spi-1/PU.1" sem="G#protein_molecule"><cons lex="Spi-1" sem="G#protein_molecule">Spi-1</cons><cons lex="PU.1" sem="G#protein_molecule">/PU.1</cons></cons> in the late phase of Friend leukemia requires specific signaling from the <cons lex="gp55-modified_EpoR" sem="G#protein_molecule"><cons lex="p55" sem="G#protein_molecule">gp55</cons>-modified <cons lex="EpoR" sem="G#protein_molecule">EpoR</cons></cons> generated during the <cons lex="early_phase" sem="G#other_name">early phase</cons> of the disease.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97445684</bibliomisc>
</articleinfo>
<title>
<sentence>The role of <cons lex="Rel/NF-kappa_B_protein" sem="G#protein_family_or_group">Rel/<cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> proteins</cons> in <cons lex="viral_oncogenesis" sem="G#other_name">viral oncogenesis</cons> and the regulation of <cons lex="viral_transcription" sem="G#other_name">viral transcription</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="Rel/NF-kappa_B" sem="G#protein_complex"><cons lex="Rel" sem="G#protein_complex">Rel</cons><cons lex="NF-kappa_B" sem="G#protein_complex">/NF-kappa B</cons></cons> is a <cons lex="ubiquitous_transcription_factor" sem="G#protein_family_or_group">ubiquitous <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons></cons> that consists of <cons lex="multiple_polypeptide_subunit" sem="G#protein_subunit">multiple polypeptide subunits</cons>, and is subject to <cons lex="complex_regulatory_mechanism" sem="G#other_name">complex regulatory mechanisms</cons> that involve <cons lex="protein-protein_interaction" sem="G#other_name">protein-protein interactions</cons>, <cons lex="phosphorylation" sem="G#other_name">phosphorylation</cons>, <cons lex="ubiquitination" sem="G#other_name">ubiquitination</cons>, <cons lex="proteolytic_degradation" sem="G#other_name">proteolytic degradation</cons>, and <cons lex="nucleocytoplasmic_translocation" sem="G#other_name">nucleocytoplasmic translocation</cons>.</sentence>
<sentence>The sophisticated control of <cons lex="Rel/NF-kappa_B_activity" sem="G#other_name"><cons lex="Rel/NF-kappa_B" sem="G#protein_complex"><cons lex="Rel" sem="G#protein_complex">Rel</cons><cons lex="NF-kappa_B" sem="G#protein_complex">/NF-kappa B</cons></cons> activity</cons> is not surprising since this <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> is involved in a wide array of cellular responses to extracellular cues, associated with growth, development, <cons lex="apoptosis" sem="G#other_name">apoptosis</cons>, and <cons lex="pathogen_invasion" sem="G#other_name">pathogen invasion</cons>.</sentence>
<sentence>Thus, it is not unexpected that this versatile cellular homeostatic switch would be affected by a variety of viral pathogens, which have evolved mechanisms to utilize various aspects of <cons lex="Rel/NF-kappa_B_activity" sem="G#other_name"><cons lex="Rel/NF-kappa_B" sem="G#protein_complex"><cons lex="Rel" sem="G#protein_complex">Rel</cons><cons lex="NF-kappa_B" sem="G#protein_complex">/NF-kappa B</cons></cons> activity</cons> to facilitate their replication, <cons lex="cell_survival" sem="G#other_name">cell survival</cons> and possibly evasion of <cons lex="immune_response" sem="G#other_name">immune responses</cons>.</sentence>
<sentence>This review will cover the <cons lex="molecular_mechanism" sem="G#other_name">molecular mechanisms</cons> that are utilized by <cons lex="mammalian_oncogenic_virus" sem="G#virus">mammalian oncogenic viruses</cons> to affect the activity of <cons lex="Rel/NF-kappa_B" sem="G#protein_complex">Rel/<cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons></cons> <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> and the role of <cons lex="Rel/NF-kappa_B" sem="G#protein_complex"><cons lex="Rel" sem="G#protein_complex">Rel</cons><cons lex="NF-kappa_B" sem="G#protein_complex">/NF-kappa B</cons></cons> in the regulation of <cons lex="viral_gene_expression" sem="G#other_name">viral gene expression</cons> and <cons lex="viral_gene_replication" sem="G#other_name">replication</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98101496</bibliomisc>
</articleinfo>
<title>
<sentence>Cellular and molecular mechanisms of <cons lex="IL-5_synthesis" sem="G#other_name"><cons lex="IL-5" sem="G#protein_molecule">IL-5</cons> synthesis</cons> in <cons lex="atopic_disease" sem="G#other_name">atopic diseases</cons>: a study with <cons lex="allergen-specific_human_helper_T_cell" sem="G#cell_line">allergen-specific human helper T cells</cons>.</sentence>
</title>
<abstract>
<sentence>BACKGROUND: <cons lex="cytokine" sem="G#protein_family_or_group">Cytokines</cons> produced by <cons lex="helper_T_cell" sem="G#cell_type">helper T cells</cons> are intimately involved in <cons lex="chronic_allergic_disease" sem="G#other_name">chronic allergic diseases</cons> associated with <cons lex="eosinophilic_inflammation" sem="G#other_name">eosinophilic inflammation</cons>.</sentence>
<sentence>OBJECTIVE: We investigated the production of <cons lex="IL-5" sem="G#protein_molecule">IL-5</cons>, a potent growth factor and chemotactic factor for <cons lex="eosinophil" sem="G#cell_type">eosinophils</cons>, by <cons lex="CD4+_T_lymphocyte" sem="G#cell_type">CD4+ T lymphocytes</cons> in <cons lex="patient" sem="G#multi_cell">patients</cons> with <cons lex="asthma" sem="G#other_name">asthma</cons>.</sentence>
<sentence>METHODS: <cons lex="allergen-specific_T_cell_clone" sem="G#cell_line">Allergen-specific T cell clones</cons> and <cons lex="T_cell_hybridoma" sem="G#cell_line">T cell hybridomas</cons> were established from the <cons lex="peripheral_blood_lymphocyte" sem="G#cell_type">peripheral blood lymphocytes</cons> of <cons lex="patient" sem="G#multi_cell">patients</cons> with <cons lex="asthma" sem="G#other_name">asthma</cons>, and the responses to various stimuli were determined.</sentence>
<sentence>RESULTS: After nonspecific stimulation, <cons lex="IL-5" sem="G#protein_molecule">IL-5</cons> production by <cons lex="CD4+_T_cell" sem="G#cell_type">CD4+ T cells</cons> from both atopic and nonatopic subjects with <cons lex="asthma" sem="G#other_name">asthma</cons> was significantly enhanced compared with that by cells from <cons lex="healthy_control" sem="G#multi_cell">healthy controls</cons>.</sentence>
<sentence><cons lex="peripheral_blood_mononuclear_cell" sem="G#cell_type">Peripheral blood mononuclear cells</cons> from <cons lex="atopic_asthma_patient" sem="G#multi_cell">atopic <cons lex="asthma" sem="G#other_name">asthma</cons> <cons lex="patient" sem="G#multi_cell">patients</cons></cons> both proliferated and produced <cons lex="IL-5" sem="G#protein_molecule">IL-5</cons> after incubation with mite allergen, suggesting that <cons lex="mite-specific_helper_T_cell" sem="G#cell_type">mite-specific <cons lex="helper_T_cell" sem="G#cell_type">helper T cells</cons></cons> were involved in the <cons lex="eosinophilic_inflammation" sem="G#other_name">eosinophilic inflammation</cons> of <cons lex="atopic_asthma" sem="G#other_name">atopic <cons lex="asthma" sem="G#other_name">asthma</cons></cons>.</sentence>
<sentence>A human <cons lex="IL-5_promoter/enhancer_luciferase_gene_construct" sem="G#DNA_molecule"><cons lex="IL-5" sem="G#protein_molecule">IL-5</cons> promoter/enhancer luciferase gene construct</cons> transfected into <cons lex="IL-5-producing_T_cell_clone" sem="G#cell_line"><cons lex="IL-5" sem="G#protein_molecule">IL-5</cons>-producing T cell clones</cons> was clearly transcribed after stimulation, indicating that the 515 base pair <cons lex="IL-5_gene_segment" sem="G#DNA_domain_or_region"><cons lex="IL-5" sem="G#protein_molecule">IL-5</cons> gene segment</cons> upstream of the coding region was sufficient to respond to <cons lex="activating_signal" sem="G#other_name">activating signals</cons> in human <cons lex="helper_T_cell" sem="G#cell_type">helper T cells</cons>.</sentence>
<sentence>The same gene segment was not transcribed in <cons lex="IL-5-nonproducing_T_cell_clone" sem="G#cell_line"><cons lex="IL-5" sem="G#protein_molecule">IL-5</cons>-nonproducing T cell clones</cons>, suggesting that <cons lex="human_T_cell_IL-5_synthesis" sem="G#other_name">human T cell <cons lex="IL-5_synthesis" sem="G#other_name"><cons lex="IL-5" sem="G#protein_molecule">IL-5</cons> synthesis</cons></cons> is regulated at the <cons lex="transcriptional_level" sem="G#other_name">transcriptional level</cons>.</sentence>
<sentence>Experiments with <cons lex="T_cell_hybridoma" sem="G#cell_line">T cell hybridomas</cons> confirmed these findings and suggested that a <cons lex="unique_transcription_factor" sem="G#protein_family_or_group">unique transcription factor</cons> may be essential for human <cons lex="IL-5_gene_transcription" sem="G#other_name"><cons lex="IL-5" sem="G#protein_molecule">IL-5</cons> gene transcription</cons>.</sentence>
<sentence>CONCLUSION: Enhanced <cons lex="IL-5_production" sem="G#other_name"><cons lex="IL-5" sem="G#protein_molecule">IL-5</cons> production</cons> by <cons lex="helper_T_cell" sem="G#cell_type">helper T cells</cons> seems to cause the <cons lex="eosinophilic_inflammation" sem="G#other_name">eosinophilic inflammation</cons> of both atopic and nonatopic <cons lex="asthma" sem="G#other_name">asthma</cons>.</sentence>
<sentence>Elucidation of <cons lex="IL-5-specific_regulatory_mechanism" sem="G#other_name"><cons lex="IL-5" sem="G#protein_molecule">IL-5</cons>-specific regulatory mechanisms</cons> may facilitate the development of novel treatments for <cons lex="allergic_disease" sem="G#other_name">allergic diseases</cons> associated with <cons lex="eosinophilic_inflammation" sem="G#other_name">eosinophilic inflammation</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98077369</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="cyclosporin_A" sem="G#other_organic_compound">Cyclosporin A</cons> inhibits <cons lex="monocyte_tissue_factor_activation" sem="G#other_name">monocyte <cons lex="tissue_factor" sem="G#protein_family_or_group">tissue factor</cons> activation</cons> in <cons lex="cardiac_transplant_recipient" sem="G#multi_cell">cardiac transplant recipients</cons>.</sentence>
</title>
<abstract>
<sentence>BACKGROUND: <cons lex="fibrin_deposition" sem="G#other_name">Fibrin deposition</cons> and <cons lex="thrombosis" sem="G#other_name">thrombosis</cons> have been implicated in both <cons lex="allograft_rejection" sem="G#other_name">allograft rejection</cons> and <cons lex="vasculopathy" sem="G#other_name">vasculopathy</cons> after <cons lex="cardiac_transplantation" sem="G#other_name">cardiac transplantation</cons>.</sentence>
<sentence>Because <cons lex="monocyte" sem="G#cell_type">monocytes</cons> play a pivotal role in the pathophysiology of <cons lex="intravascular_coagulation" sem="G#other_name">intravascular coagulation</cons> activation through their ability to synthesize <cons lex="tissue_factor" sem="G#protein_family_or_group">tissue factor</cons> (<cons lex="TF" sem="G#protein_family_or_group">TF</cons>), we asked (1) whether <cons lex="monocyte_TF_activation" sem="G#other_name">monocyte <cons lex="TF" sem="G#protein_family_or_group">TF</cons> activation</cons> occurs in <cons lex="cardiac_transplant_recipient" sem="G#multi_cell">cardiac transplant recipients</cons> and (2) whether <cons lex="monocyte_TF_expression" sem="G#other_name">monocyte <cons lex="TF_expression" sem="G#other_name"><cons lex="TF" sem="G#protein_family_or_group">TF</cons> expression</cons></cons> is affected by treatment with <cons lex="cyclosporin_A" sem="G#other_organic_compound">cyclosporin A</cons> (<cons lex="CsA" sem="G#other_organic_compound">CsA</cons>).</sentence>
<sentence>METHODS AND RESULTS: We measured levels of <cons lex="TF_activity" sem="G#other_name"><cons lex="TF" sem="G#protein_family_or_group">TF</cons> activity</cons> in <cons lex="peripheral_blood_mononuclear_cell" sem="G#cell_type">peripheral blood mononuclear cells</cons> and <cons lex="highly_purified_monocyte/macrophage" sem="G#cell_type">highly purified <cons lex="monocyte" sem="G#cell_type">monocytes</cons>/macrophages</cons> from 10 consecutive <cons lex="cardiac_transplant_recipient" sem="G#multi_cell">cardiac transplant recipients</cons> and 10 <cons lex="healthy_control_subject" sem="G#multi_cell">healthy control subjects</cons>.</sentence>
<sentence><cons lex="TF_activity" sem="G#other_name"><cons lex="TF" sem="G#protein_family_or_group">TF</cons> activity</cons> generated by both <cons lex="unstimulated_cell" sem="G#cell_line">unstimulated</cons> and <cons lex="endotoxin-stimulated_cell" sem="G#cell_line">endotoxin-stimulated cells</cons> was significantly higher in <cons lex="transplant_recipient" sem="G#multi_cell">transplant recipients</cons> than in <cons lex="control_subject" sem="G#multi_cell">control subjects</cons> (P&lt;.05).</sentence>
<sentence>Increased <cons lex="monocyte_TF_expression" sem="G#other_name">monocyte <cons lex="TF_expression" sem="G#other_name"><cons lex="TF" sem="G#protein_family_or_group">TF</cons> expression</cons></cons> in <cons lex="transplant_recipient" sem="G#multi_cell">transplant recipients</cons> was shown to be adversely affected by treatment with <cons lex="CsA" sem="G#other_organic_compound">CsA</cons>: <cons lex="TF_induction" sem="G#other_name"><cons lex="TF" sem="G#protein_family_or_group">TF</cons> induction</cons> was markedly reduced by <cons lex="CsA" sem="G#other_organic_compound">CsA</cons> serum concentrations reaching peak <cons lex="CsA_drug_level" sem="G#other_name"><cons lex="CsA" sem="G#other_organic_compound">CsA</cons> drug levels</cons>.</sentence>
<sentence>Inhibition of <cons lex="TF_induction" sem="G#other_name"><cons lex="TF" sem="G#protein_family_or_group">TF</cons> induction</cons> in the presence of high <cons lex="CsA" sem="G#other_organic_compound">CsA</cons> blood concentrations was also observed when stimulation of cells was performed with <cons lex="interferon-gamma" sem="G#protein_molecule">interferon-gamma</cons> or <cons lex="interleukin-1beta" sem="G#protein_molecule">interleukin-1beta</cons>.</sentence>
<sentence>As shown by <cons lex="reverse_transcription-polymerase_chain_reaction" sem="G#other_name">reverse transcription-polymerase chain reaction</cons> and <cons lex="electrophoretic_mobility_shift_assay" sem="G#other_name">electrophoretic mobility shift assay</cons>, respectively, treatment with <cons lex="CsA" sem="G#other_organic_compound">CsA</cons> leads to decreased <cons lex="TF_mRNA_expression" sem="G#other_name"><cons lex="TF_mRNA" sem="G#RNA_molecule"><cons lex="TF" sem="G#protein_family_or_group">TF</cons> mRNA</cons> expression</cons> and reduced activation of the <cons lex="NF-kappaB_transcription_factor" sem="G#protein_complex"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> transcription factor</cons>, which is known to contribute to the induction of the <cons lex="TF_promotor" sem="G#DNA_domain_or_region"><cons lex="TF" sem="G#protein_family_or_group">TF</cons> promotor</cons> in <cons lex="human_monocyte" sem="G#cell_type">human <cons lex="monocyte" sem="G#cell_type">monocytes</cons></cons>.</sentence>
<sentence>CONCLUSIONS: This study demonstrates that <cons lex="TF_activation" sem="G#other_name"><cons lex="TF" sem="G#protein_family_or_group">TF</cons> activation</cons>, occurring in <cons lex="mononuclear_cell" sem="G#cell_type">mononuclear cells</cons> of <cons lex="cardiac_transplant_recipient" sem="G#multi_cell">cardiac <cons lex="transplant_recipient" sem="G#multi_cell">transplant recipients</cons></cons>, is inhibited by treatment with <cons lex="CsA" sem="G#other_organic_compound">CsA</cons>.</sentence>
<sentence>Inhibition of <cons lex="monocyte_TF_induction" sem="G#other_name">monocyte <cons lex="TF" sem="G#protein_family_or_group">TF</cons> induction</cons> by <cons lex="CsA" sem="G#other_organic_compound">CsA</cons> may contribute to its successful use in <cons lex="cardiac_transplant_medicine" sem="G#other_organic_compound">cardiac transplant medicine</cons> and might be useful in managing further settings of <cons lex="vascular_pathology" sem="G#other_name">vascular pathology</cons> also known to involve <cons lex="TF_expression" sem="G#other_name"><cons lex="TF" sem="G#protein_family_or_group">TF</cons> expression</cons> and <cons lex="NF-kappaB_activation" sem="G#other_name"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> activation</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98063340</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> and <cons lex="IL-7" sem="G#protein_molecule">IL-7</cons> induce <cons lex="heterodimerization" sem="G#other_name">heterodimerization</cons> of <cons lex="STAT5_isoform" sem="G#protein_family_or_group">STAT5 isoforms</cons> in <cons lex="human_peripheral_blood_T_lymphoblast" sem="G#cell_type">human peripheral blood T lymphoblasts</cons>.</sentence>
</title>
<abstract>
<sentence>Despite differences in <cons lex="T_cell_response" sem="G#other_name">T cell responses</cons> induced by <cons lex="interleukin_(IL)-2" sem="G#protein_molecule">interleukin (IL)-2</cons> and <cons lex="IL-7" sem="G#protein_molecule">IL-7</cons>, both <cons lex="cytokine" sem="G#protein_family_or_group">cytokines</cons> modulate <cons lex="T_cell_function" sem="G#other_name">T cell functions</cons> by activation of <cons lex="signal_transducers_and_activators_of_transcription_(STAT)_protein" sem="G#protein_family_or_group">signal transducers and activators of transcription (STAT) proteins</cons>.</sentence>
<sentence>We examined the contribution of the two isoforms of <cons lex="STAT5" sem="G#protein_molecule">STAT5</cons>, <cons lex="STAT5A" sem="G#protein_molecule">STAT5A</cons> and <cons lex="STAT5B" sem="G#protein_molecule">STAT5B</cons>, to <cons lex="(AND IL-2-induced_activation IL-7-induced_activation)" sem="(AND G#other_name G#other_name)"><cons lex="IL-2-*">IL-2-</cons> and <cons lex="IL-7-*">IL-7-</cons><cons lex="*induced_activation">induced activation</cons></cons> of <cons lex="human_peripheral_blood_T_lymphoblast" sem="G#cell_type">human peripheral blood T lymphoblasts</cons>.</sentence>
<sentence>Both <cons lex="cytokine" sem="G#protein_family_or_group">cytokines</cons> induced assembly of <cons lex="STAT5A" sem="G#protein_molecule">STAT5A</cons> and <cons lex="STAT5B" sem="G#protein_molecule">STAT5B</cons> containing complexes capable of binding to the <cons lex="interferon-gamma_activation_sequence" sem="G#DNA_domain_or_region"><cons lex="interferon-gamma" sem="G#protein_molecule">interferon-gamma</cons> activation sequence</cons> (<cons lex="GAS" sem="G#DNA_domain_or_region">GAS</cons>), and these complexes rapidly translocated (within 1 min) into the nucleus of <cons lex="(OR IL-2-treated_cell IL-7-treated_cell)" sem="(OR G#cell_line G#cell_line)"><cons lex="IL-2-*">IL-2-</cons> or <cons lex="IL-7-*">IL-7-</cons><cons lex="*treated_cell">treated cells</cons></cons>.</sentence>
<sentence>The kinetics of this translocation were delayed in <cons lex="IL-7-treated_cell" sem="G#cell_line"><cons lex="IL-7" sem="G#protein_molecule">IL-7</cons>-treated</cons> as compared to <cons lex="IL-2-treated_cell" sem="G#cell_line"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons>-treated cells</cons>.</sentence>
<sentence><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> and <cons lex="IL-7" sem="G#protein_molecule">IL-7</cons> were equivalent in their ability to induce <cons lex="tyrosine_phosphorylation" sem="G#other_name"><cons lex="tyrosine" sem="G#amino_acid_monomer">tyrosine</cons> phosphorylation</cons> of <cons lex="STAT5A" sem="G#protein_molecule">STAT5A</cons> and <cons lex="STAT5B" sem="G#protein_molecule">STAT5B</cons> and to facilitate binding of these <cons lex="STAT" sem="G#protein_family_or_group">STATs</cons> to an <cons lex="immobilized_GAS_element" sem="G#DNA_domain_or_region">immobilized GAS element</cons>.</sentence>
<sentence>Both <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> and <cons lex="IL-7" sem="G#protein_molecule">IL-7</cons> induced substantial amounts of <cons lex="STAT5A" sem="G#protein_molecule">STAT5A</cons><cons lex="STAT5B" sem="G#protein_molecule">/STAT5B</cons> <cons lex="heterodimerization" sem="G#other_name">heterodimerization</cons>.</sentence>
<sentence>Moreover, we observed constitutive association of <cons lex="STAT3" sem="G#protein_molecule">STAT3</cons> with each <cons lex="STAT5_isomer" sem="G#protein_family_or_group">STAT5 isomer</cons>.</sentence>
<sentence>These data suggest that <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> and <cons lex="IL-7" sem="G#protein_molecule">IL-7</cons> induce assembly of <cons lex="STAT_heterodimer" sem="G#protein_complex">STAT heterodimers</cons> in a similar manner and that <cons lex="subsequent_cellular_response" sem="G#other_name">subsequent cellular responses</cons> may be driven by induction of similar sets of <cons lex="gene" sem="G#DNA_domain_or_region">genes</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98030550</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="yranscription_factor" sem="G#protein_family_or_group">Transcription factor</cons> <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> regulates inducible <cons lex="Oct-2_gene_expression" sem="G#other_name"><cons lex="Oct-2_gene" sem="G#DNA_domain_or_region"><cons lex="Oct-2" sem="G#protein_molecule">Oct-2</cons> gene</cons> expression</cons> in <cons lex="precursor_B_lymphocyte" sem="G#cell_type">precursor B lymphocytes</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="POU_transcription_factor" sem="G#protein_family_or_group">POU transcription factors</cons> <cons lex="Oct-1" sem="G#protein_molecule">Oct-1</cons> and <cons lex="Oct-2" sem="G#protein_molecule">Oct-2</cons> regulate the activity of <cons lex="octamer-dependent_promoter" sem="G#DNA_domain_or_region">octamer-dependent promoters</cons>, including those that direct transcription from rearranged <cons lex="immunoglobulin_gene" sem="G#protein_family_or_group">immunoglobulin genes</cons>.</sentence>
<sentence>Unlike <cons lex="Oct-1" sem="G#protein_molecule">Oct-1</cons>, which is constitutively expressed in many cell types, <cons lex="Oct-2_expression" sem="G#other_name"><cons lex="Oct-2" sem="G#protein_molecule">Oct-2</cons> expression</cons> is restricted primarily to <cons lex="B_lymphocyte" sem="G#cell_type">B lymphocytes</cons> and can be induced in <cons lex="precursor_B_cell" sem="G#cell_type">precursor B cells</cons> by stimulation with <cons lex="bacterial_lipopolysaccharide" sem="G#lipid">bacterial lipopolysaccharide</cons> (<cons lex="LPS" sem="G#lipid">LPS</cons>).</sentence>
<sentence>However, the precise factors that mediate this induction mechanism remain unknown.</sentence>
<sentence>In the present study, we monitored <cons lex="Oct-2_expression" sem="G#other_name"><cons lex="Oct-2" sem="G#protein_molecule">Oct-2</cons> expression</cons> in cells arrested for the activation of <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons>, an <cons lex="LPS-responsive_member" sem="G#protein_family_or_group"><cons lex="LPS" sem="G#lipid">LPS</cons>-responsive member</cons> of the <cons lex="Rel_transcription_factor_family" sem="G#protein_family_or_group">Rel transcription factor family</cons>.</sentence>
<sentence>Despite stimulation with <cons lex="LPS" sem="G#lipid">LPS</cons>, disruption of the <cons lex="NF-kappaB_signaling_pathway" sem="G#other_name"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> signaling pathway</cons> in <cons lex="precursor_B_cell" sem="G#cell_type">precursor B cells</cons> led to the loss of inducible <cons lex="Oct-2_DNA_binding_activity" sem="G#other_name"><cons lex="Oct-2" sem="G#protein_molecule">Oct-2</cons> DNA binding activity</cons> in vitro and the suppression of <cons lex="Oct-2-directed_transcription" sem="G#other_name"><cons lex="Oct-2" sem="G#protein_molecule">Oct-2</cons>-directed transcription</cons> in vivo.</sentence>
<sentence>This biochemical defect correlated with a specific block to <cons lex="Oct-2_gene_expression" sem="G#other_name"><cons lex="Oct-2_gene" sem="G#DNA_domain_or_region"><cons lex="Oct-2" sem="G#protein_molecule">Oct-2</cons> gene</cons> expression</cons> at the level of transcription, whereas the expression of <cons lex="Oct-1" sem="G#protein_molecule">Oct-1</cons> was unaffected.</sentence>
<sentence>The finding that <cons lex="Oct-2" sem="G#protein_molecule">Oct-2</cons> is under <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> control highlights an important cross-talk mechanism involving two distinct <cons lex="transcription_factor_family" sem="G#protein_family_or_group">transcription factor families</cons> that <cons lex="regulate_B_lymphocyte_function" sem="G#other_name">regulate <cons lex="B_lymphocyte" sem="G#cell_type">B lymphocyte</cons> function</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98013637</bibliomisc>
</articleinfo>
<title>
<sentence>Suppression of <cons lex="MHC_class_II_expression" sem="G#other_name"><cons lex="MHC_class_II" sem="G#protein_family_or_group">MHC class II</cons> expression</cons> by <cons lex="human_class_II_trans-activator_construct" sem="G#DNA_family_or_group">human class II trans-activator constructs</cons> lacking the <cons lex="N-terminal_domain" sem="G#protein_domain_or_region">N-terminal domain</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="class_II_trans-activator" sem="G#protein_molecule">class II trans-activator</cons> (<cons lex="CIITA" sem="G#protein_molecule">CIITA</cons>) is a <cons lex="bi-_or_multi-functional_domain_protein" sem="G#protein_family_or_group">bi- or multi-functional domain protein</cons> which plays a critical role in the expression of <cons lex="MHC_class_II_gene" sem="G#DNA_family_or_group">MHC class II genes</cons>.</sentence>
<sentence>We report that removal of the <cons lex="N-terminal_151_amino_acid" sem="G#protein_domain_or_region">N-terminal 151 amino acids</cons>, encompassing all of the <cons lex="acidic_domain" sem="G#protein_domain_or_region">acidic domain</cons> but leaving intact the <cons lex="proline/serine/threonine-rich_domain" sem="G#protein_domain_or_region"><cons lex="proline" sem="G#amino_acid_monomer">proline</cons>/<cons lex="serine" sem="G#amino_acid_monomer">serine</cons>/<cons lex="threonine" sem="G#amino_acid_monomer">threonine</cons>-rich domain</cons>, results in a mutant protein with <cons lex="potent_suppressive_property" sem="G#other_name">potent suppressive properties</cons> for <cons lex="MHC_class_II_expression" sem="G#other_name"><cons lex="MHC_class_II" sem="G#protein_family_or_group">MHC class II</cons> expression</cons>.</sentence>
<sentence><cons lex="HeLa_cell" sem="G#cell_line">HeLa cells</cons> stably or transiently transfected with <cons lex="mutant_CIITA_construct" sem="G#DNA_family_or_group">mutant <cons lex="CIITA" sem="G#protein_molecule">CIITA</cons> constructs</cons> showed up to 99% suppression of <cons lex="MHC_class_II_antigen_induction" sem="G#other_name"><cons lex="MHC_class_II" sem="G#protein_family_or_group">MHC class II</cons> antigen induction</cons> by <cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons> and marked suppression of <cons lex="HLA-DRA_mRNA_expression" sem="G#other_name"><cons lex="HLA-DRA_mRNA" sem="G#RNA_molecule">HLA-DRA mRNA</cons> expression</cons>.</sentence>
<sentence>Transient transfection of a B lymphoma line resulted in up to 89% reduction of constitutive <cons lex="MHC_class_II_expression" sem="G#other_name"><cons lex="MHC_class_II" sem="G#protein_family_or_group">MHC class II</cons> expression</cons> within 5 days and suppression of <cons lex="HLA-DRA_mRNA_synthesis" sem="G#other_name"><cons lex="HLA-DRA_mRNA" sem="G#RNA_molecule">HLA-DRA mRNA</cons> synthesis</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98006327</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="helenalin" sem="G#other_organic_compound">Helenalin</cons>, an <cons lex="anti-inflammatory_sesquiterpene_lactone" sem="G#other_organic_compound">anti-inflammatory sesquiterpene lactone</cons> from <cons lex="Arnica" sem="G#multi_cell">Arnica</cons>, selectively inhibits <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> [see comments]</sentence>
</title>
<abstract>
<sentence><cons lex="alcoholic_extract" sem="G#other_organic_compound">Alcoholic extracts</cons> prepared form <cons lex="Arnicae_flos" sem="G#multi_cell">Arnicae flos</cons>, the collective name for <cons lex="flowerhead" sem="G#body_part">flowerheads</cons> from <cons lex="Arnica_montana" sem="G#multi_cell">Arnica montana</cons> and <cons lex="A._chamissonis" sem="G#body_part">A. chamissonis</cons> ssp. foliosa, are used therapeutically as <cons lex="anti-inflammatory_remedy" sem="G#other_name">anti-inflammatory remedies</cons>.</sentence>
<sentence>The active ingredients mediating the <cons lex="pharmacological_effect" sem="G#other_name">pharmacological effect</cons> are mainly <cons lex="sesquiterpene_lactone" sem="G#other_organic_compound">sesquiterpene lactones</cons>, such as <cons lex="helenalin" sem="G#other_organic_compound">helenalin</cons>, <cons lex="11alpha,13-dihydrohelenalin" sem="G#other_organic_compound">11alpha,13-dihydrohelenalin</cons>, <cons lex="chamissonolid" sem="G#other_organic_compound">chamissonolid</cons> and their <cons lex="ester_derivative" sem="G#other_organic_compound">ester derivatives</cons>.</sentence>
<sentence>While these compounds affect various <cons lex="cellular_process" sem="G#other_name">cellular processes</cons>, current data do not fully explain how <cons lex="sesquiterpene_lactone" sem="G#other_organic_compound">sesquiterpene lactones</cons> exert their <cons lex="anti-inflammatory_effect" sem="G#other_name">anti-inflammatory effect</cons>.</sentence>
<sentence>We show here that <cons lex="helenalin" sem="G#other_organic_compound">helenalin</cons>, and, to a much lesser degree, <cons lex="11alpha,13-dihydrohelenalin" sem="G#other_organic_compound">11alpha,13-dihydrohelenalin</cons> and <cons lex="chamissonolid" sem="G#other_organic_compound">chamissonolid</cons>, inhibit activation of <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons>.</sentence>
<sentence>This difference in efficacy, which correlates with the compounds' <cons lex="anti-inflammatory_potency" sem="G#other_name">anti-inflammatory potency</cons> in vivo, may be explained by differences in structure and conformation.</sentence>
<sentence><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons>, which resides in an inactive, <cons lex="cytoplasmic_complex" sem="G#protein_complex">cytoplasmic complex</cons> in <cons lex="unstimulated_cell" sem="G#cell_line">unstimulated cells</cons>, is activated by <cons lex="phosphorylation" sem="G#other_name">phosphorylation</cons> and <cons lex="degradation" sem="G#other_name">degradation</cons> of its <cons lex="inhibitory_subunit" sem="G#protein_subunit">inhibitory subunit</cons>, <cons lex="IkappaB" sem="G#protein_subunit">IkappaB</cons>.</sentence>
<sentence><cons lex="helenalin" sem="G#other_organic_compound">Helenalin</cons> inhibits <cons lex="NF-kappaB_activation" sem="G#other_name"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> activation</cons> in response to four different stimuli in <cons lex="T-cell" sem="G#cell_type">T-cells</cons>, <cons lex="B-cell" sem="G#cell_type">B-cells</cons> and <cons lex="epithelial_cell" sem="G#cell_type">epithelial cells</cons> and abrogates <cons lex="kappaB-driven_gene_expression" sem="G#other_name"><cons lex="kappaB" sem="G#protein_molecule">kappaB</cons>-driven gene expression</cons>.</sentence>
<sentence>This inhibition is selective, as the activity of four other <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons>, <cons lex="Oct-1" sem="G#protein_molecule">Oct-1</cons>, <cons lex="TBP" sem="G#protein_molecule">TBP</cons>, <cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> and <cons lex="STAT_5" sem="G#protein_molecule">STAT 5</cons> was not affected.</sentence>
<sentence>We show that inhibition is not due to a direct modification of the active <cons lex="NF-kappaB_heterodimer" sem="G#protein_complex"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> heterodimer</cons>.</sentence>
<sentence>Rather, <cons lex="helenalin" sem="G#other_organic_compound">helenalin</cons> modifies the <cons lex="NF-kappaB/IkappaB_complex" sem="G#protein_complex">NF-kappaB/<cons lex="IkappaB" sem="G#protein_subunit">IkappaB</cons> complex</cons>, preventing the release of <cons lex="IkappaB" sem="G#protein_subunit">IkappaB</cons>.</sentence>
<sentence>These data suggest a molecular mechanism for the <cons lex="anti-inflammatory_effect" sem="G#other_name">anti-inflammatory effect</cons> of <cons lex="sesquiterpene_lactone" sem="G#other_organic_compound">sesquiterpene lactones</cons>, which differs from that of other <cons lex="nonsteroidal_anti-inflammatory_drug" sem="G#other_organic_compound">nonsteroidal anti-inflammatory drugs</cons> (<cons lex="NSAID" sem="G#other_organic_compound">NSAIDs</cons>), <cons lex="indomethacin" sem="G#other_organic_compound">indomethacin</cons> and <cons lex="acetyl_salicylic_acid" sem="G#other_organic_compound">acetyl salicylic acid</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98001728</bibliomisc>
</articleinfo>
<title>
<sentence>The <cons lex="tax_protein" sem="G#protein_molecule">tax protein</cons> of <cons lex="human_T-cell_leukemia_virus_type_1" sem="G#virus">human T-cell leukemia virus type 1</cons> mediates the transactivation of the <cons lex="c-sis/platelet-derived_growth_factor-B_promoter" sem="G#DNA_domain_or_region">c-sis/platelet-derived growth factor-B promoter</cons> through interactions with the <cons lex="zinc_finger_transcription_factor" sem="G#protein_family_or_group">zinc finger <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons></cons> <cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> and <cons lex="NGFI-A/Egr-1" sem="G#protein_molecule">NGFI-A/Egr-1</cons>.</sentence>
</title>
<abstract>
<sentence>Transcriptional up-regulation of the <cons lex="c-sis/platelet-derived_growth_factor-B_(PDGF-B)_proto-oncogene" sem="G#DNA_domain_or_region"><cons lex="c-sis/platelet-derived_growth_factor-B" sem="G#protein_molecule">c-sis/platelet-derived growth factor-B</cons> (<cons lex="PDGF-B" sem="G#protein_molecule">PDGF-B</cons>) proto-oncogene</cons> by the <cons lex="Tax_protein" sem="G#protein_molecule">Tax protein</cons> of <cons lex="human_T-cell_leukemia_virus_type_1" sem="G#virus">human T-cell leukemia virus type 1</cons> has been implicated as one possible mechanism of <cons lex="cellular_transformation" sem="G#other_name">cellular transformation</cons> by <cons lex="human_T-cell_leukemia_virus_type_1" sem="G#virus">human T-cell leukemia virus type 1</cons>.</sentence>
<sentence>In previous work, we identified an essential site in the <cons lex="c-sis/PDGF-B_promoter" sem="G#DNA_domain_or_region"><cons lex="c-sis/PDGF-B" sem="G#protein_molecule">c-sis/PDGF-B</cons> promoter</cons>, <cons lex="Tax-responsive_element_1" sem="G#DNA_domain_or_region">Tax-responsive element 1</cons> (<cons lex="TRE1" sem="G#DNA_domain_or_region">TRE1</cons>), necessary for transactivation by <cons lex="Tax" sem="G#protein_molecule">Tax</cons>.</sentence>
<sentence>We also identified <cons lex="Sp1" sem="G#protein_molecule">Sp1</cons>, Sp3, and <cons lex="NGFI-A/Egr-1" sem="G#protein_molecule">NGFI-A/Egr-1</cons> as the <cons lex="primary_nuclear_transcription_factor" sem="G#protein_family_or_group">primary nuclear <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons></cons> binding to <cons lex="TRE1" sem="G#DNA_domain_or_region">TRE1</cons> which mediate <cons lex="Tax_responsiveness" sem="G#other_name"><cons lex="Tax" sem="G#protein_molecule">Tax</cons> responsiveness</cons>.</sentence>
<sentence>In the present work, we have investigated the mechanism(s) whereby <cons lex="Tax" sem="G#protein_molecule">Tax</cons> transactivates the <cons lex="c-sis/PDGF-B_proto-oncogene" sem="G#DNA_domain_or_region"><cons lex="c-sis/PDGF-B" sem="G#protein_molecule">c-sis/PDGF-B</cons> proto-oncogene</cons>.</sentence>
<sentence><cons lex="in_vitro_transcription_assay" sem="G#other_name">In vitro transcription assays</cons> showed that <cons lex="Tax" sem="G#protein_molecule">Tax</cons> was able to significantly increase the <cons lex="transcriptional_activity" sem="G#other_name">transcriptional activity</cons> of a template containing the <cons lex="-257_to_+74_region" sem="G#DNA_domain_or_region">-257 to +74 region</cons> of the <cons lex="c-sis/PDGF-B_promoter" sem="G#DNA_domain_or_region"><cons lex="c-sis/PDGF-B" sem="G#protein_molecule">c-sis/PDGF-B</cons> promoter</cons>.</sentence>
<sentence>Electrophoretic mobility shift assay analysis showed that <cons lex="Tax" sem="G#protein_molecule">Tax</cons> increased the DNA binding activity of both <cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> and <cons lex="NGFI-A/Egr-1" sem="G#protein_molecule">NGFI-A/Egr-1</cons> using a <cons lex="TRE1_probe" sem="G#DNA_molecule"><cons lex="TRE1" sem="G#DNA_domain_or_region">TRE1</cons> probe</cons>.</sentence>
<sentence>Analysis of <cons lex="Tax_mutant" sem="G#protein_family_or_group"><cons lex="Tax" sem="G#protein_molecule">Tax</cons> mutants</cons> showed that two mutants, <cons lex="IEXC29S" sem="G#protein_molecule">IEXC29S</cons> and <cons lex="IEXL320G" sem="G#protein_molecule">IEXL320G</cons>, were unable to significantly transactivate the <cons lex="c-sis/PDGF-B_promoter" sem="G#DNA_domain_or_region"><cons lex="c-sis/PDGF-B" sem="G#protein_molecule">c-sis/PDGF-B</cons> promoter</cons>.</sentence>
<sentence>Finally, co-immunoprecipitation analysis revealed that <cons lex="Tax" sem="G#protein_molecule">Tax</cons> is able to stably bind to both <cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> and <cons lex="NGFI-A/Egr-1" sem="G#protein_molecule">NGFI-A/Egr-1</cons>.</sentence>
<sentence>Interestingly, <cons lex="co-immunoprecipitation_analysis" sem="G#other_name">co-immunoprecipitation analysis</cons> also revealed that <cons lex="Tax" sem="G#protein_molecule">Tax</cons> mutant <cons lex="IEXC29S" sem="G#protein_molecule">IEXC29S</cons> is unable to interact with <cons lex="NGFI-A/Egr-1" sem="G#protein_molecule">NGFI-A/Egr-1</cons>, whereas <cons lex="Tax" sem="G#protein_molecule">Tax</cons> mutant <cons lex="IEXL320G" sem="G#protein_molecule">IEXL320G</cons> is able to interact with <cons lex="NGFI-A/Egr-1" sem="G#protein_molecule">NGFI-A/Egr-1</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98018226</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="nuclear_localization" sem="G#other_name">Nuclear localization</cons> of <cons lex="RelB" sem="G#protein_molecule">RelB</cons> is associated with effective <cons lex="antigen-presenting_cell_function" sem="G#other_name">antigen-presenting cell function</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="dendritic_cell" sem="G#cell_type">Dendritic cells</cons> (<cons lex="DC" sem="G#cell_type">DC</cons>) are potent <cons lex="APC" sem="G#cell_type">APCs</cons> that enter resting tissues as precursors and, after <cons lex="Ag_exposure" sem="G#other_name">Ag exposure</cons>, differentiate and migrate to draining <cons lex="lymph_node" sem="G#body_part">lymph nodes</cons>.</sentence>
<sentence>The phenotype of <cons lex="RelB_knockout_mouse" sem="G#other_artificial_source"><cons lex="RelB" sem="G#protein_molecule">RelB</cons> knockout mice</cons> implicates this member of the <cons lex="NF_kappa_B/Rel_family" sem="G#protein_family_or_group">NF kappa B/Rel family</cons> in <cons lex="DC_differentiation" sem="G#other_name"><cons lex="DC" sem="G#cell_type">DC</cons> differentiation</cons>.</sentence>
<sentence>To further elucidate the role of <cons lex="RelB" sem="G#protein_molecule">RelB</cons> in <cons lex="DC_differentiation" sem="G#other_name"><cons lex="DC" sem="G#cell_type">DC</cons> differentiation</cons>, <cons lex="mRNA" sem="G#RNA_family_or_group">mRNA</cons>, <cons lex="intracellular_protein_expression" sem="G#other_name">intracellular protein expression</cons>, and <cons lex="DNA_binding_activity" sem="G#other_name">DNA binding activity</cons> of <cons lex="RelB" sem="G#protein_molecule">RelB</cons> were examined in immature and differentiated <cons lex="human_DC" sem="G#cell_type">human <cons lex="DC" sem="G#cell_type">DC</cons></cons>, as well as other <cons lex="PB_mononuclear_cell_population" sem="G#cell_type">PB mononuclear cell populations</cons>.</sentence>
<sentence><cons lex="RelB" sem="G#protein_molecule">RelB</cons> protein and <cons lex="RelB_mRNA" sem="G#RNA_molecule">mRNA</cons> were detected constitutively in <cons lex="lymphocyte" sem="G#cell_type">lymphocytes</cons> and in <cons lex="activated_monocyte" sem="G#cell_type">activated monocytes</cons>, <cons lex="differentiated_DC" sem="G#cell_type">differentiated <cons lex="DC" sem="G#cell_type">DC</cons></cons>, and <cons lex="monocyte-derived_DC" sem="G#cell_line">monocyte-derived <cons lex="DC" sem="G#cell_type">DC</cons></cons>.</sentence>
<sentence>Immunohistochemical staining demonstrated <cons lex="RelB" sem="G#protein_molecule">RelB</cons> within the <cons lex="differentiated_lymph_node_interdigitating_DC" sem="G#cell_type">differentiated <cons lex="lymph_node" sem="G#body_part">lymph node</cons> interdigitating <cons lex="DC" sem="G#cell_type">DC</cons></cons> and <cons lex="follicular_DC" sem="G#cell_type">follicular <cons lex="DC" sem="G#cell_type">DC</cons></cons>, but not <cons lex="undifferentiated_DC" sem="G#cell_type">undifferentiated <cons lex="DC" sem="G#cell_type">DC</cons></cons> in <cons lex="normal_skin" sem="G#tissue">normal skin</cons>.</sentence>
<sentence>Active nuclear <cons lex="RelB" sem="G#protein_molecule">RelB</cons> was detected by <cons lex="supershift_assay" sem="G#other_name">supershift assay</cons> only in differentiated <cons lex="DC" sem="G#cell_type">DC</cons> derived from either <cons lex="PB_precursor" sem="G#cell_type">PB precursors</cons> or <cons lex="monocyte" sem="G#cell_type">monocytes</cons> and in <cons lex="activated_B_cell" sem="G#cell_type">activated B cells</cons>.</sentence>
<sentence>These <cons lex="RelB+_APC" sem="G#cell_type"><cons lex="RelB" sem="G#protein_molecule">RelB</cons>+ APC</cons> were potent stimulators of the <cons lex="MLR" sem="G#protein_family_or_group">MLR</cons>.</sentence>
<sentence>The data indicate that <cons lex="RelB" sem="G#protein_molecule">RelB</cons> expression is regulated both transcriptionally and post-translationally in <cons lex="myeloid_cell" sem="G#cell_type">myeloid cells</cons>.</sentence>
<sentence>Within the nucleus, <cons lex="RelB" sem="G#protein_molecule">RelB</cons> may specifically transactivate genes that are critical for <cons lex="APC_function" sem="G#other_name"><cons lex="APC" sem="G#cell_type">APC</cons> function</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97458245</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="NF-AT_activation" sem="G#other_name"><cons lex="NF-AT" sem="G#protein_molecule">NF-AT</cons> activation</cons> induced by a <cons lex="CAML-interacting_member" sem="G#other_name"><cons lex="CAML" sem="G#protein_molecule">CAML</cons>-interacting member</cons> of the <cons lex="tumor_necrosis_factor_receptor_superfamily" sem="G#protein_family_or_group">tumor necrosis factor receptor superfamily</cons>.</sentence>
</title>
<abstract>
<sentence>Activation of the <cons lex="nuclear_factor_of_activated_T_cells" sem="G#protein_molecule">nuclear factor of activated T cells</cons> <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> (<cons lex="NF-AT" sem="G#protein_molecule">NF-AT</cons>) is a key event underlying <cons lex="lymphocyte_action" sem="G#other_name">lymphocyte action</cons>.</sentence>
<sentence>The <cons lex="CAML_(calcium-modulator_and_cyclophilin_ligand)_protein" sem="G#protein_molecule">CAML (calcium-modulator and cyclophilin ligand) protein</cons> is a coinducer of <cons lex="NF-AT_activation" sem="G#other_name"><cons lex="NF-AT" sem="G#protein_molecule">NF-AT</cons> activation</cons> when overexpressed in <cons lex="Jurkat_T_cell" sem="G#cell_line">Jurkat T cells</cons>.</sentence>
<sentence>A member of the <cons lex="tumor_necrosis_factor_receptor_superfamily" sem="G#protein_family_or_group">tumor necrosis factor receptor superfamily</cons> was isolated by virtue of its affinity for <cons lex="CAML" sem="G#protein_molecule">CAML</cons>.</sentence>
<sentence>Cross-linking of this <cons lex="lymphocyte-specific_protein" sem="G#protein_family_or_group">lymphocyte-specific protein</cons>, designated <cons lex="TACI" sem="G#protein_molecule">TACI</cons> (<cons lex="transmembrane_activator_and_CAML-interactor" sem="G#protein_molecule">transmembrane activator and <cons lex="CAML" sem="G#protein_molecule">CAML</cons>-interactor</cons>), on the surface of <cons lex="transfected_Jurkat_cell" sem="G#cell_line">transfected Jurkat cells</cons> with <cons lex="TACI-specific_antibody" sem="G#protein_family_or_group"><cons lex="TACI" sem="G#protein_molecule">TACI</cons>-specific antibodies</cons> led to activation of the <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> <cons lex="NF-AT" sem="G#protein_molecule">NF-AT</cons>, <cons lex="AP-1" sem="G#protein_molecule">AP-1</cons>, and <cons lex="NFkappaB" sem="G#protein_complex">NFkappaB</cons>.</sentence>
<sentence><cons lex="TACI-induced_activation" sem="G#other_name"><cons lex="TACI" sem="G#protein_molecule">TACI</cons>-induced activation</cons> of <cons lex="NF-AT" sem="G#protein_molecule">NF-AT</cons> was specifically blocked by a <cons lex="dominant-negative_CAML_mutant" sem="G#protein_molecule">dominant-negative <cons lex="CAML" sem="G#protein_molecule">CAML</cons> mutant</cons>, thus implicating <cons lex="CAML" sem="G#protein_molecule">CAML</cons> as a <cons lex="signaling_intermediate" sem="G#other_name">signaling intermediate</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97445683</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="Rel/NF-kappa_B" sem="G#protein_complex">Rel/NF-kappa B</cons> <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> and the control of <cons lex="apoptosis" sem="G#other_name">apoptosis</cons>.</sentence>
</title>
<abstract>
<sentence>The process of <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> is used to eliminate <cons lex="unwanted_cell" sem="G#cell_type">unwanted cells</cons> from a wide variety of organisms.</sentence>
<sentence>Various <cons lex="extracellular_signal" sem="G#other_name">extracellular signals</cons>, often converging in common <cons lex="intracellular_pathway" sem="G#other_name">intracellular pathways</cons>, can induce <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> in a <cons lex="cell-type-specific_fashion" sem="G#other_name">cell-type-specific fashion</cons>.</sentence>
<sentence>Recent work from several laboratories has demonstrated that <cons lex="Rel/NF-kappa_B" sem="G#protein_complex">Rel/NF-kappa B</cons> <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> regulate <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> in many cell types.</sentence>
<sentence>In most cells, <cons lex="Rel/NF-kappa_B" sem="G#protein_complex">Rel/NF-kappa B</cons> <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> appear to mediate <cons lex="survival_signal" sem="G#other_name">survival signals</cons> that protect cells from <cons lex="apoptosis" sem="G#other_name">apoptosis</cons>; however, under some circumstances, activation of these factors may also promote <cons lex="apoptosis" sem="G#other_name">apoptosis</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98101492</bibliomisc>
</articleinfo>
<title>
<sentence>A <cons lex="thiol_antioxidant" sem="G#other_organic_compound">thiol antioxidant</cons> regulates <cons lex="IgE_isotype" sem="G#protein_family_or_group">IgE isotype</cons> switching by inhibiting activation of <cons lex="nuclear_factor-kappaB" sem="G#protein_complex">nuclear factor-kappaB</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="binding_site" sem="G#DNA_domain_or_region">binding site</cons> for <cons lex="nuclear_factor-kappaB" sem="G#protein_complex">nuclear factor-kappaB</cons> (<cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons>) is present at the <cons lex="promoter_region" sem="G#DNA_domain_or_region">promoter region</cons> of the <cons lex="germline_Cepsilon_gene" sem="G#DNA_domain_or_region">germline Cepsilon gene</cons>, but there is little information on whether this factor is involved in regulating <cons lex="IgE_synthesis" sem="G#other_name"><cons lex="IgE" sem="G#protein_family_or_group">IgE</cons> synthesis</cons> by <cons lex="human_B_cell" sem="G#cell_type">human B cells</cons>.</sentence>
<sentence>Accordingly, we studied the role of <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> in <cons lex="germline_Cepsilon_transcription" sem="G#other_name"><cons lex="germline_promotor" sem="G#DNA_domain_or_region">germline</cons> Cepsilon transcription</cons> by using two <cons lex="human_Burkitt's_lymphoma_B_cell_line" sem="G#cell_line">human Burkitt's lymphoma B cell lines</cons>, <cons lex="DND39" sem="G#cell_line">DND39</cons> and <cons lex="DG75" sem="G#cell_line">DG75</cons>.</sentence>
<sentence>In both <cons lex="cell_line" sem="G#cell_line">cell lines</cons>, <cons lex="n-acetyl-L-cysteine" sem="G#amino_acid_monomer">n-acetyl-L-cysteine</cons> (<cons lex="NAC" sem="G#amino_acid_monomer">NAC</cons>), a potent <cons lex="thiol_antioxidant" sem="G#other_organic_compound">thiol antioxidant</cons>, inhibited the triggering of the <cons lex="nuclear_expression" sem="G#other_name">nuclear expression</cons> of <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> by <cons lex="IL-4" sem="G#protein_molecule">IL-4</cons> and by <cons lex="anti-CD40_monoclonal_antibody" sem="G#protein_molecule">anti-CD40 monoclonal antibody</cons>.</sentence>
<sentence>Although <cons lex="IL-4" sem="G#protein_molecule">IL-4</cons> activated <cons lex="signal_transducers_and_activators_of_transcription_(STAT)_6" sem="G#protein_molecule">signal transducers and activators of transcription (STAT) 6</cons> in addition to <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons>, <cons lex="NAC_treatment" sem="G#other_name"><cons lex="NAC" sem="G#amino_acid_monomer">NAC</cons> treatment</cons> or the transfection of <cons lex="decoy_oligodeoxynucleotide" sem="G#polynucleotide">decoy oligodeoxynucleotides</cons> for <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> or <cons lex="STAT6" sem="G#protein_molecule">STAT6</cons> only partly blocked <cons lex="IL-4-induced_germline_Cepsilon_transcription" sem="G#other_name"><cons lex="IL-4" sem="G#protein_molecule">IL-4</cons>-induced <cons lex="germline_promotor" sem="G#DNA_domain_or_region">germline</cons> Cepsilon transcription</cons>.</sentence>
<sentence>However, these two <cons lex="decoy_oligodeoxynucleotide" sem="G#polynucleotide">decoy oligodeoxynucleotides</cons> together almost completely abrogated <cons lex="IL-4-induced_germline_Cepsilon_transcription" sem="G#other_name"><cons lex="IL-4" sem="G#protein_molecule">IL-4</cons>-induced <cons lex="germline_promotor" sem="G#DNA_domain_or_region">germline</cons> Cepsilon transcription</cons>.</sentence>
<sentence>Of note, <cons lex="CD40-mediated_enhancement" sem="G#other_name"><cons lex="CD40" sem="G#protein_molecule">CD40</cons>-mediated enhancement</cons> of <cons lex="IL-4-driven_germline_Cepsilon_transcription" sem="G#other_name"><cons lex="IL-4" sem="G#protein_molecule">IL-4</cons>-driven <cons lex="germline_promotor" sem="G#DNA_domain_or_region">germline</cons> Cepsilon transcription</cons> was markedly decreased by <cons lex="NAC" sem="G#amino_acid_monomer">NAC</cons> or by a <cons lex="decoy_oligodeoxynucleotide" sem="G#polynucleotide">decoy oligodeoxynucleotide</cons> for <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons>.</sentence>
<sentence>The effect of <cons lex="NAC" sem="G#amino_acid_monomer">NAC</cons> was also examined on deletional switch recombination underlying the isotype switch to <cons lex="IgE" sem="G#protein_family_or_group">IgE</cons>.</sentence>
<sentence><cons lex="NAC" sem="G#amino_acid_monomer">NAC</cons> inhibited the generation of <cons lex="Smu/Sepsilon_switch_fragment" sem="G#protein_family_or_group">Smu/Sepsilon switch fragments</cons> in normal <cons lex="human_B_cell" sem="G#cell_type">human B cells</cons> costimulated with <cons lex="IL-4" sem="G#protein_molecule">IL-4</cons> and <cons lex="anti-CD40_monoclonal_antibody" sem="G#protein_molecule">anti-CD40 monoclonal antibody</cons>.</sentence>
<sentence>It also abolished <cons lex="IL-4-induced_upregulation" sem="G#other_name"><cons lex="IL-4" sem="G#protein_molecule">IL-4</cons>-induced upregulation</cons> of <cons lex="CD40" sem="G#protein_molecule">CD40</cons> but promoted upregulation of CD23.</sentence>
<sentence>These results suggest that coordination of <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> and <cons lex="STAT6" sem="G#protein_molecule">STAT6</cons> may be required for induction of <cons lex="germline_Cepsilon_transcription" sem="G#other_name"><cons lex="germline_promotor" sem="G#DNA_domain_or_region">germline</cons> Cepsilon transcription</cons> by <cons lex="IL-4" sem="G#protein_molecule">IL-4</cons>, and that <cons lex="CD40-mediated_NF-kappaB_activation" sem="G#other_name"><cons lex="CD40" sem="G#protein_molecule">CD40</cons>-mediated <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> activation</cons> may be important in regulating both enhancement of <cons lex="germline_Cepsilon_transcription" sem="G#other_name"><cons lex="germline_promotor" sem="G#DNA_domain_or_region">germline</cons> Cepsilon transcription</cons> and class switching to <cons lex="IgE" sem="G#protein_family_or_group">IgE</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98045094</bibliomisc>
</articleinfo>
<title>
<sentence>Pathogenesis.</sentence>
</title>
<abstract>
<sentence>There are many hypotheses concerning the pathogenesis of <cons lex="endometriosis" sem="G#other_name">endometriosis</cons>, though no single theory can explain all cases.</sentence>
<sentence>It is likely that <cons lex="several_mechanism" sem="G#other_name">several mechanisms</cons> are involved.</sentence>
<sentence>Early studies concentrated on the <cons lex="histogenesis" sem="G#other_name">histogenesis</cons> of the <cons lex="endometriotic_lesion" sem="G#tissue">endometriotic lesion</cons>.</sentence>
<sentence>Recent evidence has implicated components of the <cons lex="immune_system" sem="G#body_part">immune system</cons> in the pathogenesis of <cons lex="endometriosis" sem="G#other_name">endometriosis</cons>.</sentence>
<sentence>This review considers the evidence for different theories of the <cons lex="histogenesis" sem="G#other_name">histogenesis</cons> of <cons lex="endometriosis" sem="G#other_name">endometriosis</cons> and discusses possible <cons lex="immune_factor" sem="G#other_name">immune factors</cons> that may be involved in the <cons lex="pathophysiology" sem="G#other_name">pathophysiology</cons> of the <cons lex="disease" sem="G#other_name">disease</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98062912</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="ATF1" sem="G#protein_molecule">ATF1</cons> and <cons lex="CREB" sem="G#protein_molecule">CREB</cons> trans-activate a <cons lex="cell_cycle_regulated_histone_H4_gene" sem="G#DNA_domain_or_region">cell cycle regulated <cons lex="histone_H4" sem="G#protein_molecule">histone H4</cons> gene</cons> at a <cons lex="distal_nuclear_matrix_associated_promoter_element" sem="G#DNA_domain_or_region">distal nuclear matrix associated promoter element</cons>.</sentence>
</title>
<abstract>
<sentence>Proteins of the ATF/<cons lex="CREB" sem="G#protein_molecule">CREB</cons> class of <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> stimulate gene expression of several <cons lex="cell_growth-related_gene" sem="G#DNA_family_or_group">cell growth-related genes</cons> through <cons lex="protein_kinase_A-related_cAMP_response_element" sem="G#DNA_family_or_group">protein kinase A-related cAMP response elements</cons>.</sentence>
<sentence>The <cons lex="promoter_activity" sem="G#other_name">promoter activity</cons> of <cons lex="cell_cycle_regulated_histone_H4_gene" sem="G#DNA_domain_or_region">cell cycle regulated histone H4 genes</cons> is regulated by at least four <cons lex="principal_cis-acting_element" sem="G#DNA_family_or_group">principal cis-acting elements</cons> which mediate <cons lex="G1/S_phase_control" sem="G#other_name">G1/S phase control</cons> and/or enhancement of transcription during the <cons lex="cell_cycle" sem="G#other_name">cell cycle</cons>.</sentence>
<sentence>Using <cons lex="protein-DNA_interaction_assay" sem="G#other_name">protein-DNA interaction assays</cons> we show that the <cons lex="H4_promoter" sem="G#DNA_domain_or_region">H4 promoter</cons> contains two ATF/<cons lex="CREB" sem="G#protein_molecule">CREB</cons> recognition motifs which interact with <cons lex="CREB" sem="G#protein_molecule">CREB</cons>, <cons lex="ATF1" sem="G#protein_molecule">ATF1</cons>, and <cons lex="ATF2" sem="G#protein_molecule">ATF2</cons> but not with <cons lex="ATF4/CREB2" sem="G#protein_molecule">ATF4/CREB2</cons>.</sentence>
<sentence>One <cons lex="ATF/CRE_motif" sem="G#DNA_domain_or_region">ATF/CRE motif</cons> is located in the <cons lex="distal_promoter" sem="G#DNA_domain_or_region">distal promoter</cons> at the <cons lex="nuclear_matrix-associated_Site_IV" sem="G#DNA_domain_or_region">nuclear matrix-associated Site IV</cons>, and the second motif is present in the <cons lex="proximal_promoter" sem="G#DNA_domain_or_region">proximal promoter</cons> at <cons lex="Site_I" sem="G#DNA_domain_or_region">Site I</cons>.</sentence>
<sentence>Both <cons lex="ATF/CRE_motif" sem="G#DNA_domain_or_region">ATF/CRE motifs</cons> overlap <cons lex="binding_sequence" sem="G#DNA_domain_or_region">binding sequences</cons> for the <cons lex="multifunctional_YY1_transcription_factor" sem="G#protein_molecule">multifunctional YY1 transcription factor</cons>, which has previously been shown to be nuclear matrix associated.</sentence>
<sentence>Subnuclear fractionation reveals that there are two <cons lex="ATF1_isoform" sem="G#protein_family_or_group"><cons lex="ATF1" sem="G#protein_molecule">ATF1</cons> isoforms</cons> which appear to differ with respect to DNA binding activity and partition selectively between <cons lex="(AND nuclear_matrix_compartment nuclear_nonmatrix_compartment)" sem="(AND G#cell_component G#cell_component)"><cons lex="nuclear*">nuclear</cons> <cons lex="*matrix*">matrix</cons> and <cons lex="*nonmatrix*">nonmatrix</cons> <cons lex="*compartment">compartments</cons></cons>, consistent with the role of the <cons lex="nuclear_matrix" sem="G#cell_component">nuclear matrix</cons> in regulating <cons lex="gene_expression" sem="G#other_name">gene expression</cons>.</sentence>
<sentence>Site-directed mutational studies demonstrate that <cons lex="Site_I" sem="G#DNA_domain_or_region">Site I</cons> and <cons lex="Site_IV" sem="G#DNA_domain_or_region">Site IV</cons> together support <cons lex="(AND ATF1-induced_trans-activation CREB-induced_trans-activation)" sem="(AND G#other_name G#other_name)"><cons lex="ATF1-*">ATF1-</cons> and <cons lex="CREB-*">CREB-</cons><cons lex="*induced_trans-activation">induced trans-activation</cons></cons> of the <cons lex="H4_promoter" sem="G#DNA_domain_or_region">H4 promoter</cons>.</sentence>
<sentence>Thus, our data establish that <cons lex="ATF/CREB_factor" sem="G#protein_family_or_group">ATF/CREB factors</cons> functionally modulate <cons lex="histone_H4_gene_transcription" sem="G#other_name"><cons lex="histone_H4_gene" sem="G#DNA_domain_or_region">histone H4 gene</cons> transcription</cons> at <cons lex="(AND distal_promoter_element proximal_promoter_element)" sem="(AND G#DNA_domain_or_region G#DNA_domain_or_region)"><cons lex="distal*">distal</cons> and <cons lex="proximal*">proximal</cons> <cons lex="*promoter_element">promoter elements</cons></cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98030794</bibliomisc>
</articleinfo>
<title>
<sentence>Is celiac disease due to <cons lex="molecular_mimicry" sem="G#other_name">molecular mimicry</cons> between <cons lex="gliadin_peptide-HLA_class_II_molecule-T_cell_interaction" sem="G#other_name"><cons lex="gliadin_peptide" sem="G#peptide">gliadin peptide</cons><cons lex="HLA_class_II_molecule" sem="G#protein_family_or_group">-HLA class II molecule</cons>-T cell interactions</cons> and those of some <cons lex="unidentified_superantigen" sem="G#protein_family_or_group">unidentified superantigen</cons>?</sentence>
</title>
<abstract>
<sentence>This paper presents a new hypothesis for the etiology and pathogenesis of <cons lex="celiac_disease" sem="G#other_name">celiac disease</cons> (<cons lex="CD" sem="G#other_name">CD</cons>).</sentence>
<sentence>It is our contention that <cons lex="CD" sem="G#other_name">CD</cons> is triggered by the binding of one or more <cons lex="gliadin_peptide" sem="G#peptide">gliadin peptides</cons> to <cons lex="CD-associated_HLA_class_II_molecule" sem="G#protein_family_or_group"><cons lex="CD" sem="G#other_name">CD</cons>-associated HLA class II molecules</cons>.</sentence>
<sentence>Furthermore, we propose that these putative <cons lex="CD_peptide" sem="G#peptide"><cons lex="CD" sem="G#other_name">CD</cons> peptides</cons> bind to <cons lex="oligosaccharide_residue" sem="G#carbohydrate">oligosaccharide residues</cons> on <cons lex="HLA_class_II_molecule" sem="G#protein_family_or_group">HLA class II molecules</cons> distal to the <cons lex="peptide-binding_groove" sem="G#protein_complex">peptide-binding groove</cons> invoking recognition and binding by specialized subsets of <cons lex="gamma_delta_T_cell_receptor-bearing_lymphocyte" sem="G#cell_type">gamma delta T cell receptor-bearing lymphocytes</cons>.</sentence>
<sentence>The binding of these <cons lex="gamma_delta_T_cell" sem="G#cell_type">gamma delta T cells</cons> serves as a signal for abrogation of oral tolerance to <cons lex="ingested_protein" sem="G#protein_family_or_group">ingested proteins</cons> setting in motion a series of <cons lex="immune_response" sem="G#other_name">immune responses</cons> directed against the <cons lex="small_intestinal_epithelium" sem="G#tissue">small intestinal epithelium</cons> of <cons lex="CD_patient" sem="G#multi_cell"><cons lex="CD" sem="G#other_name">CD</cons> patients</cons>.</sentence>
<sentence><cons lex="CD_patient" sem="G#multi_cell"><cons lex="CD" sem="G#other_name">CD</cons> patients</cons> are victimized by this <cons lex="self-distructed_immune_response" sem="G#other_name">self-distructed immune response</cons> because of inheritance of certain combinations of <cons lex="(AND HLA-DQ_haplotype DR_haplotype)" sem="(AND G#other_name G#other_name)"><cons lex="HLA-DQ*">HLA-DQ</cons> and <cons lex="DR*">DR</cons> <cons lex="*haplotype">haplotypes</cons></cons>.</sentence>
<sentence>Dimers encoded by <cons lex="HLA-DR_haplotype" sem="G#other_name"><cons lex="HLA-DR" sem="G#protein_molecule">HLA-DR</cons> haplotypes</cons> may be the <cons lex="primary_restriction_element" sem="G#DNA_family_or_group">primary restriction elements</cons> for lectin-like, <cons lex="gliadin_peptide" sem="G#peptide">gliadin peptides</cons> while the degree of <cons lex="immune_suppression" sem="G#other_name">immune suppression</cons> (or lack thereof) to ingested <cons lex="gliadin" sem="G#peptide">gliadins</cons> is governed by inherited <cons lex="HLA-DQ_haplotype" sem="G#other_name"><cons lex="HLA-DQ" sem="G#DNA_domain_or_region">HLA-DQ</cons> haplotypes</cons>.</sentence>
<sentence>Finally, we speculate that <cons lex="molecular_mimicry" sem="G#other_name">molecular mimicry</cons> between one or more <cons lex="gliadin_peptide" sem="G#peptide">gliadin peptides</cons> and some, as yet unidentified, <cons lex="(OR bacterial_superantigen viral_superantigen)" sem="(OR G#protein_family_or_group G#protein_family_or_group)"><cons lex="bacterial*">bacterial</cons> or <cons lex="viral*">viral</cons> <cons lex="*superantigen">superantigen</cons></cons> plays a role in <cons lex="disease_pathogenesis" sem="G#other_name">disease pathogenesis</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98062995</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="Epstein-Barr_virus" sem="G#virus">Epstein-Barr virus</cons> <cons lex="latent_membrane_protein-1" sem="G#protein_molecule">latent membrane protein-1</cons> triggers <cons lex="AP-1_activity" sem="G#other_name"><cons lex="AP-1" sem="G#protein_molecule">AP-1</cons> activity</cons> via the <cons lex="c-Jun_N-terminal_kinase_cascade" sem="G#other_name"><cons lex="c-Jun" sem="G#protein_molecule">c-Jun</cons> N-terminal kinase cascade</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="Epstein-Barr_virus" sem="G#virus">Epstein-Barr virus</cons> <cons lex="latent_membrane_protein-1" sem="G#protein_molecule">latent membrane protein-1</cons> (<cons lex="LMP-1" sem="G#protein_molecule">LMP-1</cons>) is an <cons lex="integral_membrane_protein" sem="G#protein_family_or_group">integral membrane protein</cons> which transforms <cons lex="fibroblast" sem="G#cell_type">fibroblasts</cons> and is essential for <cons lex="EBV-mediated_B-cell_immortalization" sem="G#other_name">EBV-mediated B-cell immortalization</cons>.</sentence>
<sentence><cons lex="LMP-1" sem="G#protein_molecule">LMP-1</cons> has been shown to trigger cellular <cons lex="NF-kappa_B_activity" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> activity</cons> which, however, cannot fully explain the <cons lex="oncogenic_potential" sem="G#other_name">oncogenic potential</cons> of <cons lex="LMP-1" sem="G#protein_molecule">LMP-1</cons>.</sentence>
<sentence>Here we show that <cons lex="LMP-1" sem="G#protein_molecule">LMP-1</cons> induces the activity of the <cons lex="AP-1_transcription_factor" sem="G#protein_molecule"><cons lex="AP-1" sem="G#protein_molecule">AP-1</cons> transcription factor</cons>, a dimer of <cons lex="Jun/Jun_or_Jun/Fos_protein" sem="G#protein_complex"><cons lex="Jun/Jun" sem="G#protein_complex">Jun/Jun</cons> or <cons lex="Jun/Fos" sem="G#protein_complex">Jun/Fos</cons> proteins</cons>.</sentence>
<sentence><cons lex="LMP-1" sem="G#protein_molecule">LMP-1</cons> effects on <cons lex="AP-1" sem="G#protein_molecule">AP-1</cons> are mediated through activation of the <cons lex="c-Jun_N-terminal_kinase_(JNK)_cascade" sem="G#other_name"><cons lex="c-Jun" sem="G#protein_molecule">c-Jun</cons> N-terminal kinase (<cons lex="JNK" sem="G#protein_molecule">JNK</cons>) cascade</cons>, but not the <cons lex="extracellular_signal-regulated_kinase_(Erk)_pathway" sem="G#other_name"><cons lex="extracellular_signal-regulated_kinase" sem="G#protein_molecule">extracellular signal-regulated kinase</cons> (<cons lex="Erk" sem="G#protein_molecule">Erk</cons>) pathway</cons>.</sentence>
<sentence>Consequently, <cons lex="LMP-1" sem="G#protein_molecule">LMP-1</cons> triggers the activity of the <cons lex="c-Jun_N-terminal_transactivation_domain" sem="G#protein_domain_or_region"><cons lex="c-Jun" sem="G#protein_molecule">c-Jun</cons> N-terminal transactivation domain</cons> which is known to be activated upon <cons lex="JNK-mediated_phosphorylation" sem="G#other_name"><cons lex="JNK" sem="G#protein_molecule">JNK</cons>-mediated phosphorylation</cons>.</sentence>
<sentence>Deletion analysis indicates that the 55 <cons lex="C-terminal_amino_acid" sem="G#protein_domain_or_region">C-terminal amino acids</cons> of the <cons lex="LMP-1_molecule" sem="G#protein_molecule"><cons lex="LMP-1" sem="G#protein_molecule">LMP-1</cons> molecule</cons>, but not its <cons lex="TRAF_interaction_domain" sem="G#protein_domain_or_region">TRAF interaction domain</cons>, are essential for <cons lex="AP-1_activation" sem="G#other_name"><cons lex="AP-1" sem="G#protein_molecule">AP-1</cons> activation</cons>.</sentence>
<sentence><cons lex="JNK-mediated_transcriptional_activation" sem="G#other_name"><cons lex="JNK" sem="G#protein_molecule">JNK</cons>-mediated transcriptional activation</cons> of <cons lex="AP-1" sem="G#protein_molecule">AP-1</cons> is the direct output of <cons lex="LMP-1-triggered_signaling" sem="G#other_name"><cons lex="LMP" sem="G#protein_family_or_group">LMP</cons>-1-triggered signaling</cons>, as shown by an inducible <cons lex="LMP-1_mutant" sem="G#protein_family_or_group"><cons lex="LMP-1" sem="G#protein_molecule">LMP-1</cons> mutant</cons>.</sentence>
<sentence>Using a <cons lex="tetracycline-regulated_LMP-1_allele" sem="G#DNA_domain_or_region">tetracycline-regulated <cons lex="LMP-1" sem="G#protein_molecule">LMP-1</cons> allele</cons>, we demonstrate that <cons lex="JNK" sem="G#protein_molecule">JNK</cons> is also an effector of <cons lex="non-cytotoxic_LMP-1_signaling" sem="G#other_name">non-cytotoxic <cons lex="LMP-1" sem="G#protein_molecule">LMP-1</cons> signaling</cons> in <cons lex="B_cell" sem="G#cell_type">B cells</cons>, the physiological target cells of <cons lex="EBV" sem="G#virus">EBV</cons>.</sentence>
<sentence>In summary, our data reveal a novel effector of <cons lex="LMP-1" sem="G#protein_molecule">LMP-1</cons>, the <cons lex="SEK/JNK/c-Jun/AP-1_pathway" sem="G#other_name">SEK/<cons lex="JNK" sem="G#protein_molecule">JNK</cons>/<cons lex="c-Jun" sem="G#protein_molecule">c-Jun</cons>/<cons lex="AP-1" sem="G#protein_molecule">AP-1</cons> pathway</cons>, which contributes to our understanding of the immortalizing and <cons lex="transforming_potential" sem="G#other_name">transforming potential</cons> of <cons lex="LMP-1" sem="G#protein_molecule">LMP-1</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97451158</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="abnormal_apoptosis" sem="G#other_name">Abnormal apoptosis</cons> and <cons lex="cell_cycle" sem="G#other_name">cell cycle</cons> progression in <cons lex="human" sem="G#multi_cell">humans</cons> exposed to <cons lex="methyl_tertiary-butyl_ether" sem="G#other_organic_compound">methyl tertiary-butyl ether</cons> and <cons lex="benzene_contaminating_water" sem="G#other_organic_compound"><cons lex="benzene" sem="G#other_organic_compound">benzene</cons> contaminating water</cons>.</sentence>
</title>
<abstract>
<sentence>1. In this study we hypothesized that in individuals with certain genetic makeup, <cons lex="MTBE" sem="G#other_organic_compound">MTBE</cons>, <cons lex="benzene" sem="G#other_organic_compound">benzene</cons> or their metabolites act as adducts and may induce <cons lex="programmed_cell_death" sem="G#other_name">programmed cell death</cons>.</sentence>
<sentence>2. Our study involved a group of 60 <cons lex="(AND male_subject female_subject)" sem="(AND G#multi_cell G#multi_cell)"><cons lex="male*">male</cons> and <cons lex="female*">female</cons> <cons lex="*subject">subjects</cons></cons> who were exposed to <cons lex="MTBE" sem="G#other_organic_compound">MTBE</cons> and <cons lex="benzene-contaminated_water_concentration" sem="G#other_name"><cons lex="benzene-contaminated_water" sem="G#other_organic_compound"><cons lex="benzene" sem="G#other_organic_compound">benzene</cons>-contaminated water</cons> concentrations</cons> up to 76 PPB for <cons lex="MTBE" sem="G#other_organic_compound">MTBE</cons> and 14 PPB for <cons lex="benzene" sem="G#other_organic_compound">benzene</cons>, for a period of 5 to 8 years.</sentence>
<sentence>For comparison, we recruited a control group consisting of 32 healthy <cons lex="male" sem="G#multi_cell">males</cons> and <cons lex="female" sem="G#multi_cell">females</cons> with similar age distribution and without a history of exposure to <cons lex="MTBE" sem="G#other_organic_compound">MTBE</cons> or <cons lex="benzene" sem="G#other_organic_compound">benzene</cons>.</sentence>
<sentence>3. <cons lex="peripheral_blood_lymphocyte" sem="G#cell_type">Peripheral blood lymphocytes</cons> (<cons lex="PBL" sem="G#cell_type">PBL</cons>) of both groups were tested for the percentage of <cons lex="apoptotic_cell" sem="G#cell_type">apoptotic cells</cons> and <cons lex="cell_cycle_progression" sem="G#other_name"><cons lex="cell_cycle" sem="G#other_name">cell cycle</cons> progression</cons> using <cons lex="flow_cytometry" sem="G#other_name">flow cytometry</cons>.</sentence>
<sentence>4. When <cons lex="apoptotic_lymphocyte" sem="G#cell_type">apoptotic lymphocytes</cons> from <cons lex="exposed_individual" sem="G#multi_cell">exposed individuals</cons> were compared to <cons lex="apoptotic_lymphocyte" sem="G#cell_type">apoptotic lymphocytes</cons> from the control group, statistically-significant differences between each mean group were detected (26.4 +/- 1.8 and 12.1 +/- 1.3, respectively), indicating an increased rate of apoptosis in 80.5% of <cons lex="exposed_individual" sem="G#multi_cell">exposed individuals</cons> (P &lt; 0.0001, Mann-Whitney U-Test).</sentence>
<sentence><cons lex="MTBE" sem="G#other_organic_compound">MTBE</cons> and <cons lex="benzene-induced_apoptosis" sem="G#other_name"><cons lex="benzene" sem="G#other_organic_compound">benzene</cons>-induced apoptosis</cons> is attributed to a discrete block within the <cons lex="cell_cycle_progression" sem="G#other_name"><cons lex="cell_cycle" sem="G#other_name">cell cycle</cons> progression</cons>.</sentence>
<sentence>Because <cons lex="cell_cycle" sem="G#other_name">cell cycle</cons> analysis showed that in <cons lex="PBL" sem="G#cell_type">PBL</cons> from <cons lex="chemically-exposed_individual" sem="G#multi_cell">chemically-<cons lex="exposed_individual" sem="G#multi_cell">exposed individuals</cons></cons>, between 20-50% of cells were accumulated at the S-G2/M boundaries.</sentence>
<sentence>5. One of the <cons lex="signaling_molecule" sem="G#protein_family_or_group">signaling molecules</cons> which mediates <cons lex="programmed_cell_death" sem="G#other_name">programmed cell death</cons> is <cons lex="nuclear_factor_Kappa-B" sem="G#protein_complex">nuclear factor Kappa-B</cons> (<cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons>).</sentence>
<sentence><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> was examined as one of the many <cons lex="molecular_mechanism" sem="G#other_name">molecular mechanisms</cons> for mediating cell death by <cons lex="MTBE" sem="G#other_organic_compound">MTBE</cons> and <cons lex="benzene" sem="G#other_organic_compound">benzene</cons>.</sentence>
<sentence>Indeed, addition of inhibitors of <cons lex="NF-kappa_B_activation" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> activation</cons> <cons lex="pyrrolidine_dithiocarbamate" sem="G#other_organic_compound">pyrrolidine dithiocarbamate</cons> (<cons lex="PDTC" sem="G#other_organic_compound">PDTC</cons>), to the <cons lex="lymphocyte" sem="G#cell_type">lymphocytes</cons> of the <cons lex="chemically-exposed_group" sem="G#multi_cell">chemically-exposed group</cons> was capable of inhibiting <cons lex="programmed_cell_death" sem="G#other_name">programmed cell death</cons> by 40%.</sentence>
<sentence>This reversal of <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> almost to the control level by inhibitor of <cons lex="NF-kappa_B_activation" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> activation</cons> may indicate involvement of this <cons lex="signaling_molecule" sem="G#protein_family_or_group">signaling molecule</cons> in <cons lex="MTBE" sem="G#other_organic_compound">MTBE</cons> and <cons lex="benzene_induction" sem="G#other_name"><cons lex="benzene" sem="G#other_organic_compound">benzene</cons> induction</cons> of <cons lex="programmed_cell_death" sem="G#other_name">programmed cell death</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98001686</bibliomisc>
</articleinfo>
<title>
<sentence>Purification and characterization of the <cons lex="human_SR_31747A-binding_protein" sem="G#protein_molecule">human SR 31747A-binding protein</cons>.</sentence>
<sentence>A <cons lex="nuclear_membrane_protein" sem="G#protein_molecule">nuclear membrane protein</cons> related to <cons lex="yeast_sterol_isomerase" sem="G#protein_molecule">yeast sterol isomerase</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="SR_31747A" sem="G#other_organic_compound">SR 31747A</cons>, defined as a sigma ligand, is a novel <cons lex="immunosuppressive_agent" sem="G#other_organic_compound">immunosuppressive agent</cons> that blocks proliferation of <cons lex="(AND human_lymphocyte mouse_lymphocyte)" sem="(AND G#cell_type G#cell_type)"><cons lex="human*">human</cons> and <cons lex="mouse*">mouse</cons> <cons lex="*lymphocyte">lymphocytes</cons></cons>.</sentence>
<sentence>Using a <cons lex="radiolabeled_chemical_probe" sem="G#other_organic_compound">radiolabeled chemical probe</cons>, we here purified a target of <cons lex="SR_31747A" sem="G#other_organic_compound">SR 31747A</cons> and called it <cons lex="SR_31747A-binding_protein" sem="G#protein_molecule"><cons lex="SR_31747A" sem="G#other_organic_compound">SR 31747A</cons>-binding protein</cons> (<cons lex="SR-BP" sem="G#protein_molecule">SR-BP</cons>).</sentence>
<sentence><cons lex="purified_SR-BP" sem="G#protein_molecule">Purified <cons lex="SR-BP" sem="G#protein_molecule">SR-BP</cons></cons> retained its binding properties and migrated on <cons lex="SDS-polyacrylamide_gel" sem="G#other_organic_compound">SDS-polyacrylamide gel</cons> as a <cons lex="Mr_28,000_protein" sem="G#protein_molecule">Mr 28,000 protein</cons>.</sentence>
<sentence>Cloning of the <cons lex="cDNA" sem="G#DNA_family_or_group">cDNA</cons> encoding <cons lex="human_SR-BP" sem="G#protein_molecule">human <cons lex="SR-BP" sem="G#protein_molecule">SR-BP</cons></cons> shows an <cons lex="open_reading_frame" sem="G#DNA_domain_or_region">open reading frame</cons> for a <cons lex="223-amino_acid_protein" sem="G#protein_molecule">223-amino acid protein</cons>, which is homologous to the recently cloned <cons lex="sigma_1_receptor" sem="G#protein_molecule">sigma 1 receptor</cons>.</sentence>
<sentence>Interestingly, the deduced <cons lex="amino_acid_sequence" sem="G#protein_N/A">amino acid sequence</cons> was found to be related to <cons lex="fungal_C8-C7_sterol_isomerase" sem="G#protein_molecule">fungal C8-C7 sterol isomerase</cons>, encoded by the <cons lex="ERG2_gene" sem="G#DNA_domain_or_region">ERG2 gene</cons>.</sentence>
<sentence>The <cons lex="ERG2_gene_product" sem="G#protein_molecule"><cons lex="ERG2_gene" sem="G#DNA_domain_or_region">ERG2 gene</cons> product</cons> has been identified recently as the <cons lex="molecular_target" sem="G#other_name">molecular target</cons> of <cons lex="SR_31747A" sem="G#other_organic_compound">SR 31747A</cons> that mediates <cons lex="antiproliferative_effect" sem="G#other_name">antiproliferative effects</cons> of the drug in <cons lex="yeast" sem="G#mono_cell">yeast</cons>.</sentence>
<sentence>Northern blot analysis of <cons lex="SR-BP" sem="G#protein_molecule">SR-BP</cons> <cons lex="gene_expression" sem="G#other_name">gene expression</cons> revealed a single transcript of <cons lex="2_kilobase" sem="G#RNA_molecule">2 kilobases</cons> which was widely expressed among <cons lex="organ" sem="G#body_part">organs</cons>, with the highest abundance in <cons lex="liver" sem="G#body_part">liver</cons> and the lowest abundance in <cons lex="brain" sem="G#body_part">brain</cons>.</sentence>
<sentence>Subcellular localization analysis in various cells, using a <cons lex="specific_monoclonal_antibody" sem="G#protein_molecule">specific monoclonal antibody</cons> raised against <cons lex="SR-BP" sem="G#protein_molecule">SR-BP</cons>, demonstrated that this protein was associated with the <cons lex="nuclear_envelope" sem="G#cell_component">nuclear envelope</cons>.</sentence>
<sentence>When studying the binding of <cons lex="SR_31747A" sem="G#other_organic_compound">SR 31747A</cons> on <cons lex="membrane" sem="G#cell_component">membranes</cons> from <cons lex="yeast" sem="G#mono_cell">yeast</cons> expressing <cons lex="SR-BP" sem="G#protein_molecule">SR-BP</cons>, we found a <cons lex="pharmacological_profile" sem="G#other_name">pharmacological profile</cons> of <cons lex="sigma_1_receptor" sem="G#protein_family_or_group">sigma 1 receptors</cons>; binding was displaced by <cons lex="(+)-pentazocine" sem="G#other_organic_compound">(+)-pentazocine</cons>, <cons lex="haloperidol" sem="G#other_organic_compound">haloperidol</cons>, and <cons lex="(+)-SKF_10,047" sem="G#other_organic_compound">(+)-SKF 10,047</cons>, with <cons lex="(+)-SKF_10,_047" sem="G#other_organic_compound">(+)-SKF 10, 047</cons> being a more potent competitor than <cons lex="(-)-SKF_10,047" sem="G#other_organic_compound">(-)-SKF 10,047</cons>.</sentence>
<sentence><cons lex="scatchard_plot_analysis" sem="G#other_name">Scatchard plot analysis</cons> revealed Kd values of 7.1 nM and 0.15 nM for <cons lex="(+)-pentazocine" sem="G#other_organic_compound">(+)-pentazocine</cons> and <cons lex="SR_31747A" sem="G#other_organic_compound">SR 31747A</cons>, respectively, indicating an affinity of <cons lex="SR-BP" sem="G#protein_molecule">SR-BP</cons> 50-fold higher for <cons lex="SR_31747A" sem="G#other_organic_compound">SR 31747A</cons> than for <cons lex="pentazocine" sem="G#other_organic_compound">pentazocine</cons>.</sentence>
<sentence>Additionally, we showed that <cons lex="pentazocine" sem="G#other_organic_compound">pentazocine</cons>, a <cons lex="competitive_inhibitor" sem="G#other_organic_compound">competitive inhibitor</cons> of <cons lex="SR_31747A_binding" sem="G#other_name"><cons lex="SR_31747A" sem="G#other_organic_compound">SR 31747A</cons> binding</cons>, also prevents the <cons lex="immunosuppressive_effect" sem="G#other_name">immunosuppressive effect</cons> of <cons lex="SR_31747A" sem="G#other_organic_compound">SR 31747A</cons>.</sentence>
<sentence>Taken together, these findings strongly suggest that <cons lex="SR-BP" sem="G#protein_molecule">SR-BP</cons> represents the molecular target for <cons lex="SR_31747A" sem="G#other_organic_compound">SR 31747A</cons> in <cons lex="mammalian_tissue" sem="G#tissue">mammalian tissues</cons>, which could be critical for <cons lex="T_cell_proliferation" sem="G#other_name">T cell proliferation</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97468093</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="phospholipase_C_gamma_1_overexpression" sem="G#other_name"><cons lex="phospholipase_C_gamma_1" sem="G#protein_molecule">Phospholipase C gamma 1</cons> overexpression</cons> and activation induced by <cons lex="interferon_beta" sem="G#protein_molecule">interferon beta</cons> in <cons lex="human_T_lymphocyte" sem="G#cell_type">human T lymphocytes</cons>: an <cons lex="ISGF3-independent_response" sem="G#other_name"><cons lex="ISGF3" sem="G#protein_molecule">ISGF3</cons>-independent response</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="interferon" sem="G#protein_family_or_group">Interferons</cons> exert their <cons lex="antiviral,_antiproliferative_and_immunoregulatory_activity" sem="G#other_name">antiviral, antiproliferative and <cons lex="immunoregulatory_cytokine" sem="G#protein_family_or_group">immunoregulatory</cons> activities</cons> by stimulating the expression of several genes.</sentence>
<sentence>Such genes disclose a common element within their <cons lex="promoter" sem="G#DNA_domain_or_region">promoters</cons>, defined <cons lex="Interferon_Stimulated_Response_Element" sem="G#DNA_domain_or_region">Interferon Stimulated Response Element</cons> (<cons lex="ISRE" sem="G#DNA_domain_or_region">ISRE</cons>), which binds a <cons lex="nuclear_factor" sem="G#protein_family_or_group">nuclear factor</cons>(s) translocated from the <cons lex="cytoplasm" sem="G#cell_component">cytoplasm</cons> to the <cons lex="nucleus" sem="G#cell_component">nucleus</cons> (<cons lex="ISGF3" sem="G#protein_molecule">ISGF3</cons>) after the binding of <cons lex="interferon" sem="G#protein_family_or_group">interferon</cons> (<cons lex="IFN" sem="G#protein_family_or_group">IFN</cons>) to the specific receptor.</sentence>
<sentence>Here we report the induction of the synthesis and of the <cons lex="hydrolytic_activity" sem="G#other_name">hydrolytic activity</cons> of <cons lex="phospholipase_C_gamma_1" sem="G#protein_molecule">phospholipase C gamma 1</cons> (<cons lex="PLC_gamma_1" sem="G#protein_molecule">PLC gamma 1</cons>) in <cons lex="human_T_lymphocyte" sem="G#cell_type">human T lymphocytes</cons> by <cons lex="IFN-beta" sem="G#protein_molecule">IFN-beta</cons>.</sentence>
<sentence>The increased level of <cons lex="PLC_gamma_1" sem="G#protein_molecule">PLC gamma 1</cons> becomes evident after 90 min of <cons lex="IFN-beta_treatment" sem="G#other_name"><cons lex="IFN-beta" sem="G#protein_molecule">IFN-beta</cons> treatment</cons> and is still detectable after 24 h.</sentence>
<sentence>Neither the <cons lex="PLC_gamma_1_overexpression" sem="G#other_name"><cons lex="PLC_gamma_1" sem="G#protein_molecule">PLC gamma 1</cons> overexpression</cons> induced by <cons lex="IFN" sem="G#protein_family_or_group">IFN</cons> nor the increased hydrolytic activity of the <cons lex="enzyme" sem="G#protein_family_or_group">enzyme</cons> appear to be affected by pretreatment of the cells with the <cons lex="protein_tyrosine_kinase_inhibitor" sem="G#other_organic_compound">protein <cons lex="tyrosine_kinase" sem="G#protein_family_or_group"><cons lex="tyrosine" sem="G#amino_acid_monomer">tyrosine</cons> kinase</cons> inhibitor</cons> <cons lex="genistein" sem="G#other_organic_compound">genistein</cons>, which is known to prevent the association of <cons lex="ISGF3" sem="G#protein_molecule">ISGF3</cons> components.</sentence>
<sentence>These results suggest that in <cons lex="human_T_lymphocyte" sem="G#cell_type">human T lymphocytes</cons> <cons lex="IFN-beta" sem="G#protein_molecule">IFN-beta</cons> can activate other <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons>(s) distinct from <cons lex="ISGF3" sem="G#protein_molecule">ISGF3</cons> to regulate <cons lex="PLC_gamma_1_expression" sem="G#other_name"><cons lex="PLC_gamma_1" sem="G#protein_molecule">PLC gamma 1</cons> expression</cons>.</sentence>
<sentence>In addition, the ability of this <cons lex="enzyme" sem="G#protein_family_or_group">enzyme</cons> to hydrolyse <cons lex="PIP2" sem="G#lipid">PIP2</cons>, also in the presence of <cons lex="genistein" sem="G#other_organic_compound">genistein</cons>, implies the possibility that this enzyme can exert its <cons lex="hydrolytic_activity" sem="G#other_name">hydrolytic activity</cons> independently of <cons lex="protein_tyrosine_kinase_activation" sem="G#other_name"><cons lex="protein_tyrosine_kinase" sem="G#protein_family_or_group">protein <cons lex="tyrosine" sem="G#amino_acid_monomer">tyrosine</cons> kinase</cons> activation</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97458236</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="negative_regulation" sem="G#other_name">Negative regulation</cons> by <cons lex="HLA-DO" sem="G#protein_molecule">HLA-DO</cons> of <cons lex="MHC_class_II-restricted_antigen_processing" sem="G#other_name"><cons lex="MHC_class_II" sem="G#protein_family_or_group">MHC class II</cons>-restricted antigen processing</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="HLA-DM" sem="G#protein_molecule">HLA-DM</cons> is a <cons lex="major_histocompatibility_complex_(MHC)_class_II-like_molecule" sem="G#protein_family_or_group">major histocompatibility complex (MHC) class II-like molecule</cons> that facilitates <cons lex="antigen_processing" sem="G#other_name">antigen processing</cons> by catalyzing the exchange of <cons lex="invariant_chain-derived_peptides" sem="G#peptide">invariant chain-derived peptides</cons> (<cons lex="CLIP" sem="G#peptide">CLIP</cons>) from <cons lex="class_II_molecule" sem="G#protein_family_or_group">class II molecules</cons> for <cons lex="antigenic_peptide" sem="G#peptide">antigenic peptides</cons>.</sentence>
<sentence><cons lex="HLA-DO" sem="G#protein_molecule">HLA-DO</cons> is a second <cons lex="class_II-like_molecule" sem="G#protein_family_or_group">class II-like molecule</cons> that physically associates with <cons lex="HLA-DM" sem="G#protein_molecule">HLA-DM</cons> in <cons lex="B_cell" sem="G#cell_type">B cells</cons>.</sentence>
<sentence><cons lex="HLA-DO" sem="G#protein_molecule">HLA-DO</cons> was shown to block <cons lex="HLA-DM_function" sem="G#other_name"><cons lex="HLA-DM" sem="G#protein_molecule">HLA-DM</cons> function</cons>.</sentence>
<sentence>Purified <cons lex="HLA-DM-DO_complex" sem="G#protein_complex"><cons lex="HLA-DM" sem="G#protein_molecule">HLA-DM</cons>-DO complexes</cons> could not promote peptide exchange in vitro.</sentence>
<sentence>Expression of <cons lex="HLA-DO" sem="G#protein_molecule">HLA-DO</cons> in a <cons lex="class_II+_and_DM+,_DO-_human_T_cell_line" sem="G#cell_line">class II+ and DM+, DO- human T cell line</cons> caused the accumulation of <cons lex="class_II-CLIP_complex" sem="G#protein_complex">class II-<cons lex="CLIP" sem="G#peptide">CLIP</cons> complexes</cons>, indicating that <cons lex="HLA-DO" sem="G#protein_molecule">HLA-DO</cons> blocked DM function in vivo and suggesting that <cons lex="HLA-DO" sem="G#protein_molecule">HLA-DO</cons> is an important modulator of <cons lex="class_II-restricted_antigen_processing" sem="G#other_name">class II-restricted antigen processing</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97445128</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="vitamin_D_receptor" sem="G#protein_family_or_group">Vitamin D receptor</cons>: no evidence for <cons lex="allele-specific_mRNA_stability" sem="G#other_name">allele-specific mRNA stability</cons> in cells which are heterozygous for the <cons lex="Taq_I_restriction_enzyme_polymorphism" sem="G#other_name"><cons lex="Taq_I_restriction_enzyme" sem="G#protein_molecule">Taq I restriction enzyme</cons> polymorphism</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="allelic_variation" sem="G#other_name">Allelic variations</cons> of the <cons lex="vitamin_D_receptor_(VDR)_gene" sem="G#DNA_domain_or_region"><cons lex="vitamin_D_receptor" sem="G#protein_family_or_group">vitamin D receptor</cons> (<cons lex="VDR" sem="G#protein_family_or_group">VDR</cons>) gene</cons> have been associated with the risk of developing <cons lex="prostate_cancer" sem="G#other_name">prostate cancer</cons> in <cons lex="men" sem="G#multi_cell">men</cons> and <cons lex="osteoporosis" sem="G#other_name">osteoporosis</cons> in <cons lex="postmenopausal_woman" sem="G#multi_cell">postmenopausal women</cons>.</sentence>
<sentence>Three <cons lex="RFLP" sem="G#DNA_domain_or_region">RFLPs</cons> (<cons lex="TaqI" sem="G#DNA_domain_or_region">TaqI</cons>, <cons lex="ApaI" sem="G#DNA_domain_or_region">ApaI</cons>, <cons lex="BsmI" sem="G#DNA_domain_or_region">BsmI</cons>) define two common <cons lex="haplotype" sem="G#other_name">haplotypes</cons>: <cons lex="BAt" sem="G#other_name">BAt</cons> and <cons lex="baT" sem="G#other_name">baT</cons>.</sentence>
<sentence>None of these <cons lex="polymorphism" sem="G#DNA_domain_or_region">polymorphisms</cons> change the <cons lex="translated_protein" sem="G#protein_molecule">translated protein</cons>.</sentence>
<sentence>Since <cons lex="sequence_variation" sem="G#DNA_domain_or_region">sequence variations</cons> in the <cons lex="3'_UTR" sem="G#DNA_domain_or_region">3' UTR</cons> of <cons lex="VDR" sem="G#protein_family_or_group">VDR</cons> have been linked to the different <cons lex="haplotype" sem="G#other_name">haplotypes</cons>, investigators have proposed that the stability of <cons lex="VDR_mRNA" sem="G#RNA_molecule"><cons lex="VDR" sem="G#protein_family_or_group">VDR</cons> mRNA</cons> is influenced by allelic variations.</sentence>
<sentence>Indirect evidence suggested that <cons lex="allele_T" sem="G#DNA_domain_or_region">allele T</cons> is less stable than <cons lex="allele_t" sem="G#DNA_domain_or_region">allele t</cons>.</sentence>
<sentence>In this study, we used a <cons lex="RT-PCR_based_approach" sem="G#other_name"><cons lex="RT-PCR" sem="G#other_name">RT-PCR</cons> based approach</cons> to compare the stability of the <cons lex="(AND big_T_allele small_t_allele)" sem="(AND G#DNA_domain_or_region G#DNA_domain_or_region)"><cons lex="big_T*">big T</cons> and <cons lex="small_t*">small t</cons> <cons lex="*allele">allele</cons></cons> in <cons lex="normal_heterozygous_lymphocyte" sem="G#cell_type">normal heterozygous lymphocytes</cons> and the <cons lex="heterozygous_cell_line" sem="G#cell_line">heterozygous cell lines</cons> <cons lex="NB4" sem="G#cell_line">NB4</cons> (<cons lex="myeloid_leukemia" sem="G#other_name">myeloid leukemia</cons>) and <cons lex="PC-3" sem="G#cell_line">PC-3</cons> and <cons lex="DU_145" sem="G#cell_line">DU 145</cons> (<cons lex="prostate_cancer" sem="G#other_name">prostate cancers</cons>).</sentence>
<sentence>In all three cases, we did not find a significant difference in stability.</sentence>
<sentence>Interestingly, we consistently observed 30% less <cons lex="RT-PCR_product" sem="G#DNA_molecule"><cons lex="RT-PCR" sem="G#other_name">RT-PCR</cons> product</cons> derived from the <cons lex="small_t_allele_mRNA" sem="G#RNA_molecule">small t allele mRNA</cons> in steady state, a finding which also speaks against a higher stability of the <cons lex="small_t_allele_mRNA" sem="G#RNA_molecule">small t allele mRNA</cons>.</sentence>
<sentence>These results indicate a variation in transcriptional regulation rather than <cons lex="mRNA_stability" sem="G#other_name">mRNA stability</cons> between the <cons lex="allele" sem="G#DNA_domain_or_region">alleles</cons>.</sentence>
<sentence>We hypothesize that an unknown gene or genes in linkage with the <cons lex="polymorphism" sem="G#DNA_domain_or_region">polymorphisms</cons> is (are) responsible for the relationship between risk of <cons lex="prostate_cancer" sem="G#other_name">prostate cancer</cons> and <cons lex="VDR" sem="G#protein_family_or_group">VDR</cons> <cons lex="polymorphism" sem="G#DNA_domain_or_region">polymorphisms</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98099332</bibliomisc>
</articleinfo>
<title>
<sentence>Replication of <cons lex="human_immunodeficiency_virus-1" sem="G#virus">human immunodeficiency virus-1</cons> in <cons lex="primary_human_T_cell" sem="G#cell_type">primary human T cells</cons> is dependent on the autocrine secretion of <cons lex="tumor_necrosis_factor" sem="G#protein_family_or_group">tumor necrosis factor</cons> through the control of <cons lex="nuclear_factor-kappa_B_activation" sem="G#other_name"><cons lex="nuclear_factor-kappa_B" sem="G#protein_complex">nuclear factor-kappa B</cons> activation</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="Tumor_necrosis_factor_(TNF)-alpha" sem="G#protein_molecule">Tumor necrosis factor (TNF)-alpha</cons> controls <cons lex="T-cell_activation" sem="G#other_name">T-cell activation</cons> and is a major inducer of <cons lex="human_immunodeficiency_virus_(HIV)-1" sem="G#virus">human immunodeficiency virus (HIV)-1</cons> replication in <cons lex="chronically_infected_cell" sem="G#cell_type">chronically infected cells</cons>.</sentence>
<sentence>Therefore, we have investigated its role in primary cultures of <cons lex="HIV-infected_human_T_lymphocyte" sem="G#cell_type">HIV-infected human T lymphocytes</cons> by using neutralizing <cons lex="anti-TNF-alpha_antibody" sem="G#protein_family_or_group">anti-TNF-alpha antibodies</cons> or <cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons>.</sentence>
<sentence>Primary resting T lymphocytes produced <cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons> and supported <cons lex="HIV_replication" sem="G#other_name">HIV replication</cons> after <cons lex="T-cell_receptor_activation" sem="G#other_name">T-cell receptor activation</cons>.</sentence>
<sentence>Addition of neutralizing <cons lex="anti-TNF-alpha_antibody" sem="G#protein_family_or_group">anti-<cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons> antibodies</cons> drastically reduced <cons lex="p24_antigen_release" sem="G#other_name"><cons lex="p24_antigen" sem="G#protein_molecule">p24 antigen</cons> release</cons> and prevented <cons lex="CD4+_cell_depletion" sem="G#other_name"><cons lex="CD4+" sem="G#protein_molecule">CD4+</cons> cell depletion</cons> associated with infection.</sentence>
<sentence><cons lex="Anti-TNF-alpha" sem="G#protein_molecule">Anti-<cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons></cons> also prevented <cons lex="nuclear_factor-kappa_B_(NF-kappa_B)_activation" sem="G#other_name"><cons lex="nuclear_factor-kappa_B" sem="G#protein_complex">nuclear factor-kappa B</cons> (<cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons>) activation</cons>, and a good correlation between this inhibition and inhibition of <cons lex="HIV_replication" sem="G#other_name">HIV replication</cons> was observed.</sentence>
<sentence>Moreover, supplementing the cultures with high doses of IL-2 reverted anti-<cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons> inhibition of cell proliferation but did not affect the inhibition of HIV <cons lex="p24_antigen_release" sem="G#other_name"><cons lex="p24_antigen" sem="G#protein_molecule">p24 antigen</cons> release</cons> or <cons lex="NF-kappa_B_activation" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> activation</cons> in the same cultures.</sentence>
<sentence>Moreover, <cons lex="anti-TNF-alpha" sem="G#protein_molecule">anti-<cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons></cons> inhibited <cons lex="HIV-1_long_terminal_repeat_(LTR)-driven_transcription" sem="G#other_name"><cons lex="HIV-1_long_terminal_repeat" sem="G#DNA_domain_or_region"><cons lex="HIV-1" sem="G#virus">HIV-1</cons> long terminal repeat</cons> (<cons lex="LTR" sem="G#DNA_domain_or_region">LTR</cons>)-driven transcription</cons> of a <cons lex="reporter_gene" sem="G#DNA_family_or_group">reporter gene</cons> in <cons lex="primary_T_cell" sem="G#cell_type">primary T cells</cons> in response to activation, either in the presence or the absence of <cons lex="HIV-1_Tat" sem="G#protein_molecule">HIV-1 Tat</cons>.</sentence>
<sentence>Our results support an important role for <cons lex="autocrine_TNF-alpha_secretion" sem="G#other_name">autocrine <cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons> secretion</cons> in controlling <cons lex="HIV_replication" sem="G#other_name">HIV replication</cons> in <cons lex="primary_T_cell" sem="G#cell_type">primary T cells</cons> because of its ability to maintain <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> elevated in the <cons lex="nucleus" sem="G#cell_component">nucleus</cons> of <cons lex="T_cell" sem="G#cell_type">T cells</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98042055</bibliomisc>
</articleinfo>
<title>
<sentence>Hypoxia enhances induction of <cons lex="endothelial_ICAM-1" sem="G#protein_molecule">endothelial ICAM-1</cons>: role for <cons lex="metabolic_acidosis" sem="G#other_name">metabolic acidosis</cons> and <cons lex="proteasome" sem="G#protein_complex">proteasomes</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="Intercellular_adhesion_molecule_1" sem="G#protein_molecule">Intercellular adhesion molecule 1</cons> (<cons lex="ICAM-1" sem="G#protein_molecule">ICAM-1</cons>) is an important molecule in promotion of <cons lex="polymorphonuclear_neutrophil_transendothelial_migration" sem="G#other_name">polymorphonuclear neutrophil transendothelial migration</cons> during <cons lex="inflammation" sem="G#other_name">inflammation</cons>.</sentence>
<sentence>Coincident with many <cons lex="inflammatory_disease" sem="G#other_name">inflammatory diseases</cons> is <cons lex="tissue_hypoxia" sem="G#other_name">tissue hypoxia</cons>.</sentence>
<sentence>Thus we hypothesized that combinations of <cons lex="hypoxia" sem="G#other_name">hypoxia</cons> and <cons lex="inflammatory_stimuli" sem="G#other_name">inflammatory stimuli</cons> may differentially regulate expression of <cons lex="endothelial_ICAM-1" sem="G#protein_molecule">endothelial <cons lex="ICAM-1" sem="G#protein_molecule">ICAM-1</cons></cons>.</sentence>
<sentence><cons lex="human_endothelial_cell" sem="G#cell_type">Human endothelial cells</cons> were exposed to <cons lex="hypoxia" sem="G#other_name">hypoxia</cons> in the presence or absence of added <cons lex="lipopolysaccharide" sem="G#lipid">lipopolysaccharide</cons> (<cons lex="LPS" sem="G#lipid">LPS</cons>) and examined for expression of functional <cons lex="ICAM-1" sem="G#protein_molecule">ICAM-1</cons>.</sentence>
<sentence>Although <cons lex="hypoxia" sem="G#other_name">hypoxia</cons> alone did not induce <cons lex="ICAM-1" sem="G#protein_molecule">ICAM-1</cons>, the combination of <cons lex="LPS" sem="G#lipid">LPS</cons> and <cons lex="hypoxia" sem="G#other_name">hypoxia</cons> enhanced (3 +/- 0.4-fold over normoxia) <cons lex="ICAM-1_expression" sem="G#other_name"><cons lex="ICAM-1" sem="G#protein_molecule">ICAM-1</cons> expression</cons>.</sentence>
<sentence>Combinations of <cons lex="hypoxia" sem="G#other_name">hypoxia</cons> and <cons lex="LPS" sem="G#lipid">LPS</cons> significantly increased lymphocyte binding, and such increases were inhibited by addition of <cons lex="anti-ICAM-1_antibody" sem="G#protein_family_or_group">anti-<cons lex="ICAM-1" sem="G#protein_molecule">ICAM-1</cons> antibodies</cons> or <cons lex="antisense_oligonucleotide" sem="G#polynucleotide">antisense oligonucleotides</cons>.</sentence>
<sentence><cons lex="Hypoxic_endothelia" sem="G#tissue">Hypoxic endothelia</cons> showed a &gt; 10-fold increase in sensitivity to inhibitors of <cons lex="proteasome_activation" sem="G#other_name"><cons lex="proteasome" sem="G#protein_complex">proteasome</cons> activation</cons>, and combinations of <cons lex="hypoxia" sem="G#other_name">hypoxia</cons> and <cons lex="LPS" sem="G#lipid">LPS</cons> enhanced <cons lex="proteasome-dependent_cytoplasmic-to-nuclear_localization" sem="G#other_name"><cons lex="proteasome" sem="G#protein_complex">proteasome</cons>-dependent cytoplasmic-to-nuclear localization</cons> of the <cons lex="nuclear_transcription_factor-kappa_B_p65_(Rel_A)_subunit" sem="G#protein_subunit">nuclear transcription factor-kappa B p65 (Rel A) subunit</cons>.</sentence>
<sentence>Such <cons lex="proteasome_activation" sem="G#other_name"><cons lex="proteasome" sem="G#protein_complex">proteasome</cons> activation</cons> correlated with <cons lex="hypoxia-evoked_decrease" sem="G#other_name"><cons lex="hypoxia" sem="G#other_name">hypoxia</cons>-evoked decreases</cons> in both <cons lex="(AND extracellular_pH intracellular_pH)" sem="(AND G#other_name G#other_name)"><cons lex="extracellular*">extracellular</cons> and <cons lex="intracellular*">intracellular</cons> <cons lex="*pH">pH</cons></cons>.</sentence>
<sentence>We conclude from these studies that <cons lex="endothelial_hypoxia" sem="G#other_name">endothelial <cons lex="hypoxia" sem="G#other_name">hypoxia</cons></cons> provides a novel, <cons lex="proteasome-dependent_stimulus" sem="G#other_name"><cons lex="proteasome" sem="G#protein_complex">proteasome</cons>-dependent stimulus</cons> for <cons lex="ICAM-1_induction" sem="G#other_name"><cons lex="ICAM-1" sem="G#protein_molecule">ICAM-1</cons> induction</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98058835</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="differanisole_A" sem="G#other_organic_compound">Differanisole A</cons>, a novel <cons lex="antitumor_antibiotic" sem="G#other_organic_compound">antitumor antibiotic</cons>, enhances growth inhibition and differentiation of <cons lex="human_myeloid_leukemia_cell" sem="G#cell_type">human myeloid leukemia cells</cons> induced by <cons lex="9-cis_retinoic_acid" sem="G#other_organic_compound">9-cis retinoic acid</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="differanisole_A" sem="G#other_organic_compound">Differanisole A</cons>, <cons lex="3,5-dichloro-2-hydroxy-4-methoxy-6-n-propylbenzoic_acid" sem="G#other_organic_compound">3,5-dichloro-2-hydroxy-4-methoxy-6-n-propylbenzoic acid</cons>, inhibited growth of <cons lex="human_myeloid_leukemia_cell" sem="G#cell_type">human myeloid leukemia cells</cons>.</sentence>
<sentence>The compound induced <cons lex="G1_arrest" sem="G#other_name">G1 arrest</cons> and <cons lex="granulocytic_differentiation" sem="G#other_name">granulocytic differentiation</cons> of <cons lex="HL-60_cell" sem="G#cell_line">HL-60 cells</cons>, although the differentiation-inducing effect was modest.</sentence>
<sentence><cons lex="differanisole_A" sem="G#other_organic_compound">Differanisole A</cons> and <cons lex="9-cis_retinoic_acid" sem="G#other_organic_compound">9-cis retinoic acid</cons> (<cons lex="9cisRA" sem="G#other_organic_compound">9cisRA</cons>) synergistically inhibited the growth and induced functional and morphologic differentiation of <cons lex="(AND HL-60_cell NB4_cell)" sem="(AND G#cell_line G#cell_line)"><cons lex="HL-60*">HL-60</cons> and <cons lex="NB4*">NB4</cons> <cons lex="*cell">cells</cons></cons>, whereas the combined treatment with <cons lex="differanisole_A" sem="G#other_organic_compound">differanisole A</cons> and <cons lex="all-trans_retinoic_acid" sem="G#other_organic_compound">all-trans retinoic acid</cons> or <cons lex="1alpha,25-dihydroxyvitamin_D3" sem="G#other_organic_compound">1alpha,25-dihydroxyvitamin D3</cons> was less effective.</sentence>
<sentence>Similar results were obtained in primary culture of <cons lex="leukemia_cell" sem="G#cell_type">leukemia cells</cons> from a patient with <cons lex="acute_promyelocytic_leukemia" sem="G#other_name">acute promyelocytic leukemia</cons>.</sentence>
<sentence>The synergistic effect on growth inhibition and induction of differentiation required simultaneous treatment with <cons lex="differanisole_A" sem="G#other_organic_compound">differanisole A</cons> and <cons lex="9cisRA" sem="G#other_organic_compound">9cisRA</cons>.</sentence>
<sentence><cons lex="differanisole_A" sem="G#other_organic_compound">Differanisole A</cons> and an <cons lex="RXR-specific_ligand" sem="G#other_organic_compound">RXR-specific ligand</cons> (<cons lex="Ro47-5944" sem="G#other_organic_compound">Ro47-5944</cons>) cooperatively inhibited the cell growth, while the combined effect of <cons lex="differanisole_A" sem="G#other_organic_compound">differanisole A</cons> and an <cons lex="RAR-specific_ligand" sem="G#other_organic_compound">RAR-specific ligand</cons> <cons lex="Am80" sem="G#other_organic_compound">Am80</cons> was just additive.</sentence>
<sentence><cons lex="differanisole_A" sem="G#other_organic_compound">Differanisole A</cons> in combination with <cons lex="9cisRA" sem="G#other_organic_compound">9cisRA</cons> may have implications for therapy of <cons lex="acute_promyelocytic_leukemia_patient" sem="G#multi_cell"><cons lex="acute_promyelocytic_leukemia" sem="G#other_name">acute promyelocytic leukemia</cons> patients</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98028550</bibliomisc>
</articleinfo>
<title>
<sentence>The activation of the <cons lex="JAK2/STAT5_pathway" sem="G#other_name"><cons lex="JAK2" sem="G#protein_molecule">JAK2</cons><cons lex="STAT5" sem="G#protein_molecule">/STAT5</cons> pathway</cons> is commonly involved in signaling through the <cons lex="human_IL-5_receptor" sem="G#protein_family_or_group">human IL-5 receptor</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="JAK_(Janus_kinase)_family" sem="G#protein_family_or_group">JAK (<cons lex="Janus_kinase" sem="G#protein_family_or_group">Janus kinase</cons>) family</cons> of <cons lex="protein_tyrosine_kinase" sem="G#protein_family_or_group">protein <cons lex="tyrosine" sem="G#amino_acid_monomer">tyrosine</cons> kinases</cons> and the <cons lex="STAT" sem="G#protein_family_or_group">STATs</cons> (<cons lex="signal_transducers_and_activators_of_transcription" sem="G#protein_family_or_group">signal transducers and activators of transcription</cons>) have been shown to be activated in response to a number of <cons lex="cytokine" sem="G#protein_family_or_group">cytokines</cons> and <cons lex="growth_factor" sem="G#protein_family_or_group">growth factors</cons>.</sentence>
<sentence>In this study, we evaluated the activation of <cons lex="JAK/STAT_pathway" sem="G#other_name"><cons lex="JAK" sem="G#protein_family_or_group">JAK</cons><cons lex="STAT" sem="G#protein_family_or_group">/STAT</cons> pathway</cons> upon <cons lex="human_interleukin-5_(hIL-5)_stimulation" sem="G#other_name"><cons lex="human_interleukin-5" sem="G#protein_molecule">human interleukin-5</cons> (<cons lex="hIL-5" sem="G#protein_molecule">hIL-5</cons>) stimulation</cons> of two different <cons lex="hIL-5-responsive_cell_line" sem="G#cell_line"><cons lex="hIL-5" sem="G#protein_molecule">hIL-5</cons>-responsive cell lines</cons>, <cons lex="hIL-5_receptor_alpha-subunit_(hIL-5R_alpha)_cDNA-transfected_TF-1" sem="G#cell_line"><cons lex="hIL-5_receptor_alpha-subunit" sem="G#protein_subunit"><cons lex="hIL-5" sem="G#protein_molecule">hIL-5</cons> receptor alpha-subunit</cons> (<cons lex="hIL-5R_alpha" sem="G#protein_subunit">hIL-5R alpha</cons>) cDNA-transfected TF-1</cons> (<cons lex="TF-h5R_alpha" sem="G#cell_line">TF-h5R alpha</cons>) and <cons lex="butyric-acid-treated_YY-1" sem="G#cell_line"><cons lex="butyric-acid" sem="G#other_organic_compound">butyric-acid</cons>-treated YY-1</cons> (<cons lex="YY-Bu" sem="G#cell_line">YY-Bu</cons>), and <cons lex="peripheral_eosinophil" sem="G#cell_line">peripheral eosinophils</cons>.</sentence>
<sentence><cons lex="immunoprecipitation" sem="G#other_name">Immunoprecipitation</cons> and <cons lex="electrophoretic_mobility_shift_analysis" sem="G#other_name">electrophoretic mobility shift analysis</cons> revealed that <cons lex="tyrosine_phosphorylation" sem="G#other_name"><cons lex="tyrosine" sem="G#amino_acid_monomer">tyrosine</cons> phosphorylation</cons> of <cons lex="JAK2" sem="G#protein_molecule">JAK2</cons> and activation of <cons lex="STAT5" sem="G#protein_molecule">STAT5</cons> were induced upon stimulation with <cons lex="hIL-5" sem="G#protein_molecule">hIL-5</cons> in all three cell types, while <cons lex="STAT1_activation" sem="G#other_name"><cons lex="STAT1" sem="G#protein_molecule">STAT1</cons> activation</cons> was only observed in <cons lex="eosinophil" sem="G#cell_type">eosinophils</cons>.</sentence>
<sentence>These results indicate that <cons lex="JAK2/STAT5_activation" sem="G#other_name"><cons lex="JAK2" sem="G#protein_molecule">JAK2</cons><cons lex="STAT5" sem="G#protein_molecule">/STAT5</cons> activation</cons> is a common <cons lex="JAK/STAT_pathway" sem="G#other_name"><cons lex="JAK" sem="G#protein_family_or_group">JAK</cons><cons lex="STAT" sem="G#protein_family_or_group">/STAT</cons> pathway</cons> for <cons lex="hIL-5-mediated_signal" sem="G#other_name"><cons lex="hIL-5" sem="G#protein_molecule">hIL-5</cons>-mediated signal</cons> in these cells.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98012705</bibliomisc>
</articleinfo>
<title>
<sentence>Dysregulation of <cons lex="monocytic_nuclear_factor-kappa_B" sem="G#protein_molecule">monocytic <cons lex="nuclear_factor-kappa_B" sem="G#protein_complex">nuclear factor-kappa B</cons></cons> by oxidized <cons lex="low-density_lipoprotein" sem="G#protein_complex">low-density lipoprotein</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="nuclear_factor-kappa_B_(NF-kappa_B)/Rel_transcription_factor" sem="G#protein_family_or_group">Nuclear factor-kappa B (<cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons>)/Rel transcription factors</cons> may be involved in <cons lex="atherosclerosis" sem="G#other_name">atherosclerosis</cons>, as is suggested by the presence of activated <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> in <cons lex="human_atherosclerotic_lesion" sem="G#other_name">human atherosclerotic lesions</cons>.</sentence>
<sentence>The aim of the present study was to investigate the effects of <cons lex="oxidized_LDL" sem="G#protein_family_or_group">oxidized LDL</cons> (<cons lex="oxLDL" sem="G#protein_family_or_group">oxLDL</cons>) on the <cons lex="NF-kappa_B_system" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> system</cons> in human <cons lex="THP-1_monocytic_cell" sem="G#cell_line">THP-1 monocytic cells</cons> as well as <cons lex="adherent_monocyte" sem="G#cell_type">adherent monocytes</cons>.</sentence>
<sentence>Our results demonstrate that <cons lex="short-term_incubation" sem="G#other_name">short-term incubation</cons> of these cells with <cons lex="oxLDL_activated_p50/p65" sem="G#protein_molecule"><cons lex="oxLDL" sem="G#protein_family_or_group">oxLDL</cons> activated p50/p65</cons> containing <cons lex="NF-kappa_B_dimer" sem="G#protein_complex"><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> dimers</cons> and induced the expression of the <cons lex="target_gene_IL-8" sem="G#DNA_domain_or_region">target gene IL-8</cons>.</sentence>
<sentence>This activation of <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> was inhibited by the antioxidant and <cons lex="H2O2_scavenger" sem="G#other_organic_compound"><cons lex="H2O2" sem="G#inorganic">H2O2</cons> scavenger</cons> <cons lex="pyrrolidine_dithiocarbamate" sem="G#other_organic_compound">pyrrolidine dithiocarbamate</cons> and the <cons lex="proteasome_inhibitor" sem="G#other_organic_compound"><cons lex="proteasome" sem="G#protein_complex">proteasome</cons> inhibitor</cons> <cons lex="PSI" sem="G#other_organic_compound">PSI</cons>.</sentence>
<sentence>The <cons lex="oxLDL-induced_NF-kappa_B_activation" sem="G#other_name"><cons lex="oxLDL" sem="G#protein_family_or_group">oxLDL</cons>-induced <cons lex="NF-kappa_B_activation" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> activation</cons></cons> was accompanied by an initial depletion of <cons lex="I_kappa_B-alpha" sem="G#protein_molecule">I kappa B-alpha</cons> followed by a slight transient increase in the level of this inhibitor protein.</sentence>
<sentence>In contrast, long-term treatment with <cons lex="oxLDL" sem="G#protein_family_or_group">oxLDL</cons> prevented the <cons lex="lipopolysaccharide-induced_depletion" sem="G#other_name"><cons lex="lipopolysaccharide" sem="G#lipid">lipopolysaccharide</cons>-induced depletion</cons> of <cons lex="I_kappa_B-alpha" sem="G#protein_molecule">I kappa B-alpha</cons>, accompanied by an inhibition of both <cons lex="NF-kappa_B_activation" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> activation</cons> and the expression of <cons lex="(AND tumor_necrosis_factor-alpha_gene interleukin-1_beta_gene)" sem="(AND G#DNA_domain_or_region G#DNA_domain_or_region)"><cons lex="tumor_necrosis_factor-alpha*">tumor necrosis factor-alpha</cons> and <cons lex="interleukin-1_beta*">interleukin-1 beta</cons> <cons lex="*gene">genes</cons></cons>.</sentence>
<sentence>These observations provide additional evidence that <cons lex="oxLDL" sem="G#protein_family_or_group">oxLDL</cons> is a potent modulator of <cons lex="gene_expression" sem="G#other_name">gene expression</cons> and suggest that <cons lex="(dys)regulation" sem="G#other_name">(dys)regulation</cons> of <cons lex="NF-kappa_B/Rel" sem="G#protein_complex"><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons>/Rel</cons> is likely to play an important role in <cons lex="atherogenesis" sem="G#other_name">atherogenesis</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98003050</bibliomisc>
</articleinfo>
<title>
<sentence>Suppression of <cons lex="nuclear_factor_kappa_B" sem="G#protein_complex">nuclear factor kappa B</cons> and <cons lex="CD18-mediated_leukocyte_adhesion" sem="G#other_name"><cons lex="CD18" sem="G#protein_molecule">CD18</cons>-mediated leukocyte adhesion</cons> to the <cons lex="corneal_endothelium" sem="G#tissue">corneal endothelium</cons> by <cons lex="dexamethasone" sem="G#lipid">dexamethasone</cons>.</sentence>
</title>
<abstract>
<sentence>PURPOSE: To demonstrate that <cons lex="leukocyte_adhesion" sem="G#other_name">leukocyte adhesion</cons> to <cons lex="cultured_corneal_endothelial_cell" sem="G#cell_line">cultured corneal endothelial cells</cons> is mediated by the <cons lex="CD18_antigen" sem="G#protein_molecule"><cons lex="CD18" sem="G#protein_molecule">CD18</cons> antigen</cons>, and to determine whether <cons lex="dexamethasone" sem="G#lipid">dexamethasone</cons> directly suppresses adhesion by inhibiting activation of <cons lex="nuclear_factor_kappa_B" sem="G#protein_complex">nuclear factor kappa B</cons> (<cons lex="NFkappaB" sem="G#protein_complex">NFkappaB</cons>).</sentence>
<sentence>METHODS: Cultured <cons lex="bovine_corneal_endothelium" sem="G#tissue">bovine corneal endothelium</cons> was stimulated for 6 hours by 40 micron/ml <cons lex="tumor_necrosis_factor_alpha" sem="G#protein_molecule">tumor necrosis factor alpha</cons> (<cons lex="TNFalpha" sem="G#protein_molecule">TNFalpha</cons>).</sentence>
<sentence><cons lex="dexamethasone" sem="G#lipid">Dexamethasone</cons> was added 1 hour before <cons lex="TNFalpha_stimulation" sem="G#other_name"><cons lex="TNFalpha" sem="G#protein_molecule">TNFalpha</cons> stimulation</cons> in the <cons lex="dexamethasone_group" sem="G#multi_cell"><cons lex="dexamethasone" sem="G#lipid">dexamethasone</cons> group</cons>.</sentence>
<sentence>After stimulation, neutrophils separated from a <cons lex="healthy_human_volunteer" sem="G#multi_cell">healthy human volunteer</cons> were added with or without <cons lex="anti-CD18_antibody" sem="G#protein_family_or_group">anti-<cons lex="CD18" sem="G#protein_molecule">CD18</cons> antibody</cons>.</sentence>
<sentence>The culture plate was settled for 15 minutes at 37 degrees C, and then <cons lex="neutrophil" sem="G#cell_type">neutrophils</cons> were activated by <cons lex="N-formyl-methionyl-leucyl-phenylalanine" sem="G#other_organic_compound">N-formyl-methionyl-leucyl-phenylalanine</cons> for 5 minutes.</sentence>
<sentence>Nonadherent <cons lex="neutrophil" sem="G#cell_type">neutrophils</cons> were removed by sealing and inverting the culture well.</sentence>
<sentence>The <cons lex="intracellular_localization" sem="G#other_name">intracellular localization</cons> of <cons lex="NFkappaB" sem="G#protein_complex">NFkappaB</cons> after <cons lex="TNFalpha_simulation" sem="G#other_name"><cons lex="TNFalpha" sem="G#protein_molecule">TNFalpha</cons> simulation</cons> was determined by <cons lex="confocal_immunocytochemistry" sem="G#other_name">confocal immunocytochemistry</cons> using an <cons lex="anti-p65_antibody" sem="G#protein_family_or_group">anti-p65 antibody</cons>.</sentence>
<sentence>RESULTS: <cons lex="neutrophil_adhesion" sem="G#other_name">Neutrophil adhesion</cons> to <cons lex="cultured_corneal_endothelial_cell" sem="G#cell_line">cultured corneal endothelial cells</cons> increased significantly on exposure to <cons lex="TNFalpha" sem="G#protein_molecule">TNFalpha</cons> (451.4+/-45.4 cells/mm2, n = 16) compared to control (156.7+/-27.3 cells/mm2, n = 16, P &lt; 0.01).</sentence>
<sentence>This increased adhesion was suppressed by the addition of <cons lex="anti-CD18_antibody" sem="G#protein_family_or_group">anti-<cons lex="CD18" sem="G#protein_molecule">CD18</cons> antibody</cons> (157.6+/-25.1 cells/mm2, n = 8, P &lt; 0.01) and by pretreatment with 10(-7) M <cons lex="dexamethasone" sem="G#lipid">dexamethasone</cons> (207.9+/-31.5 cells/mm2, n = 10, P &lt; 0.01).</sentence>
<sentence><cons lex="immunocytochemistry" sem="G#other_name">Immunocytochemistry</cons> 60 minutes after stimulation revealed that <cons lex="NFkappaB" sem="G#protein_complex">NFkappaB</cons> was located in the <cons lex="cytoplasm" sem="G#cell_component">cytoplasm</cons> in <cons lex="unstimulated_cell" sem="G#cell_type">unstimulated cells</cons>; however, the addition of <cons lex="TNFalpha" sem="G#protein_molecule">TNFalpha</cons> caused <cons lex="NFkappaB" sem="G#protein_complex">NFkappaB</cons> to translocate into the <cons lex="nucleus" sem="G#cell_component">nucleus</cons>.</sentence>
<sentence>Pretreatment with <cons lex="dexamethasone" sem="G#lipid">dexamethasone</cons> tapered <cons lex="NFkappaB_translocation" sem="G#other_name"><cons lex="NFkappaB" sem="G#protein_complex">NFkappaB</cons> translocation</cons> into the <cons lex="nucleus" sem="G#cell_component">nucleus</cons>.</sentence>
<sentence>CONCLUSIONS: <cons lex="leukocyte_adhesion" sem="G#other_name">Leukocyte adhesion</cons> to the <cons lex="corneal_endothelium" sem="G#tissue">corneal endothelium</cons> was shown to be mediated by <cons lex="CD18" sem="G#protein_molecule">CD18</cons> expressed on <cons lex="activated_leukocyte" sem="G#cell_type">activated leukocytes</cons>.</sentence>
<sentence>Pretreatment of the endothelium with <cons lex="dexamethasone" sem="G#lipid">dexamethasone</cons> inhibited <cons lex="leukocyte_adhesion" sem="G#other_name">leukocyte adhesion</cons>; this may be due in part to the suppression of <cons lex="NFkappaB" sem="G#protein_complex">NFkappaB</cons> entry into the <cons lex="nucleus" sem="G#cell_component">nucleus</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97480711</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="molecular_characterization" sem="G#other_name">Molecular characterization</cons> and pattern of <cons lex="tissue_expression" sem="G#other_name">tissue expression</cons> of the gene for <cons lex="neutrophil_gelatinase-associated_lipocalin" sem="G#protein_molecule">neutrophil gelatinase-associated lipocalin</cons> from <cons lex="human" sem="G#multi_cell">humans</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="Neutrophil_gelatinase-associated_lipocalin" sem="G#protein_molecule">Neutrophil gelatinase-associated lipocalin</cons> (<cons lex="NGAL" sem="G#protein_molecule">NGAL</cons>) is a <cons lex="25-kDa_lipocalin" sem="G#protein_molecule">25-kDa lipocalin</cons> first identified as a protein stored in specific <cons lex="granule" sem="G#cell_component">granules</cons> of the <cons lex="human_neutrophil" sem="G#cell_type">human neutrophil</cons>.</sentence>
<sentence>The protein is believed to bind <cons lex="small_lipophilic_substance" sem="G#other_organic_compound">small lipophilic substances</cons> such as <cons lex="bacterial_derived_formylpeptide" sem="G#peptide">bacterial derived formylpeptides</cons> and <cons lex="lipopolysaccharide" sem="G#lipid">lipopolysaccharides</cons> (<cons lex="LPS" sem="G#lipid">LPS</cons>) and might function as a modulator of <cons lex="inflammation" sem="G#other_name">inflammation</cons>.</sentence>
<sentence>To characterize the regulation of <cons lex="NGAL" sem="G#protein_molecule">NGAL</cons> further, we have cloned and sequenced a <cons lex="5869-bp_region" sem="G#DNA_domain_or_region">5869-bp region</cons> of the <cons lex="NGAL_gene" sem="G#DNA_domain_or_region"><cons lex="NGAL" sem="G#protein_molecule">NGAL</cons> gene</cons> including 1695 bp of the <cons lex="5'_nontranscribed_region" sem="G#DNA_domain_or_region">5' nontranscribed region</cons> and a <cons lex="3696-bp_coding_region" sem="G#DNA_domain_or_region">3696-bp coding region</cons> encompassing <cons lex="seven_exons_and_six_introns" sem="G#DNA_domain_or_region">seven exons and six introns</cons>.</sentence>
<sentence>The <cons lex="transcriptional_start_site" sem="G#DNA_family_or_group">transcriptional start sites</cons> were identified by an <cons lex="RNase_protection_assay" sem="G#other_name"><cons lex="RNase" sem="G#protein_molecule">RNase</cons> protection assay</cons>.</sentence>
<sentence>The <cons lex="NGAL" sem="G#protein_molecule">NGAL</cons> gene is highly homologous to the <cons lex="mouse_gene_24p3" sem="G#DNA_domain_or_region">mouse gene 24p3</cons>.</sentence>
<sentence><cons lex="NGAL" sem="G#protein_molecule">NGAL</cons> was expressed in <cons lex="bone_marrow" sem="G#tissue">bone marrow</cons> and in <cons lex="tissue" sem="G#tissue">tissues</cons> that are prone to exposure to <cons lex="microorganism" sem="G#mono_cell">microorganisms</cons>.</sentence>
<sentence>Potential <cons lex="cis-acting_element" sem="G#DNA_family_or_group">cis-acting elements</cons> were identified in the <cons lex="promoter_region" sem="G#DNA_domain_or_region">promoter region</cons> of the <cons lex="NGAL_gene" sem="G#DNA_domain_or_region"><cons lex="NGAL" sem="G#protein_molecule">NGAL</cons> gene</cons> by computer analysis and include <cons lex="binding_site" sem="G#DNA_domain_or_region">binding sites</cons> for <cons lex="CTF/CBP" sem="G#protein_molecule">CTF/CBP</cons>, the <cons lex="hematopoietic_transcription_factor" sem="G#protein_family_or_group">hematopoietic transcription factors</cons> <cons lex="GATA-1" sem="G#protein_molecule">GATA-1</cons> and <cons lex="PU.1" sem="G#protein_molecule">PU.1</cons>, and the <cons lex="LPS-inducible_factor_NF-kappa_B" sem="G#protein_complex"><cons lex="LPS" sem="G#lipid">LPS</cons>-inducible factor <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons></cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97462740</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="human_neutrophil" sem="G#cell_type">Human <cons lex="neutrophil" sem="G#cell_type">neutrophils</cons></cons> express <cons lex="GH-N_gene_transcript" sem="G#RNA_family_or_group"><cons lex="GH-N_gene" sem="G#DNA_domain_or_region">GH-N gene</cons> transcripts</cons> and the <cons lex="pituitary_transcription_factor" sem="G#protein_family_or_group">pituitary transcription factor</cons> <cons lex="Pit-1b" sem="G#protein_molecule">Pit-1b</cons>.</sentence>
</title>
<abstract>
<sentence>Since <cons lex="GH" sem="G#protein_molecule">GH</cons> stimulates the development and function of <cons lex="granulocyte" sem="G#cell_type">granulocytes</cons>, we investigated the expression of <cons lex="GH" sem="G#protein_molecule">GH</cons> in <cons lex="granulocyte_subset" sem="G#cell_type">granulocyte subsets</cons>.</sentence>
<sentence>By <cons lex="immunocytochemistry" sem="G#other_name">immunocytochemistry</cons>, 25 +/- 7% of the <cons lex="human_neutrophil" sem="G#cell_type">human <cons lex="neutrophil" sem="G#cell_type">neutrophils</cons></cons> were shown to express <cons lex="immunoreactive_GH" sem="G#protein_molecule">immunoreactive <cons lex="GH" sem="G#protein_molecule">GH</cons></cons>, whereas <cons lex="eosinophil" sem="G#cell_type">eosinophils</cons> were negative.</sentence>
<sentence><cons lex="reversed_transcription_(RT)-PCR_analysis" sem="G#other_name">Reversed transcription (RT)-PCR analysis</cons> demonstrated <cons lex="GH_mRNA" sem="G#RNA_molecule"><cons lex="GH" sem="G#protein_molecule">GH</cons> mRNA</cons> in <cons lex="neutrophil" sem="G#cell_type">neutrophils</cons>.</sentence>
<sentence><cons lex="restriction_analysis" sem="G#other_name">Restriction analysis</cons> revealed that <cons lex="neutrophil" sem="G#cell_type">neutrophils</cons> express the <cons lex="GH-N_gene" sem="G#DNA_domain_or_region">GH-N gene</cons> but not the <cons lex="GH-V_gene" sem="G#DNA_domain_or_region">GH-V gene</cons>.</sentence>
<sentence>Furthermore, we demonstrated by <cons lex="western_blot_analysis" sem="G#other_name">western blot analysis</cons> that <cons lex="neutrophil" sem="G#cell_type">neutrophils</cons> express an alternatively spliced variant of the <cons lex="pituitary_transcription_factor" sem="G#protein_family_or_group">pituitary transcription factor</cons> <cons lex="Pit-1" sem="G#protein_molecule">Pit-1</cons>, designated <cons lex="Pit-1b" sem="G#protein_molecule">Pit-1b</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97456516</bibliomisc>
</articleinfo>
<title>
<sentence>The ability of <cons lex="BHRF1" sem="G#protein_molecule">BHRF1</cons> to inhibit <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> is dependent on stimulus and cell type.</sentence>
</title>
<abstract>
<sentence>The development of resistance to <cons lex="host_defense_mechanism" sem="G#other_name">host defense mechanisms</cons> such as <cons lex="(AND tumor_necrosis_factor_(TNF)-mediated_apoptosis Fas-mediated_apoptosis)" sem="(AND G#other_name G#other_name)"><cons lex="tumor_necrosis_factor_(TNF)-*">tumor necrosis factor (TNF)-</cons> and <cons lex="Fas-*">Fas-</cons><cons lex="*mediated_apoptosis">mediated apoptosis</cons></cons> of <cons lex="transformed_cell" sem="G#cell_type">transformed</cons> or <cons lex="virus-infected_cell" sem="G#cell_type">virus-infected cells</cons> may be a critical component in the development of disease.</sentence>
<sentence>To find genes that protect cells from <cons lex="apoptosis" sem="G#other_name">apoptosis</cons>, we used an expression cloning strategy and identified <cons lex="BHRF1" sem="G#protein_molecule">BHRF1</cons>, an <cons lex="Epstein-Barr_virus_(EBV)_early-lytic-cycle_protein" sem="G#protein_family_or_group"><cons lex="Epstein-Barr_virus" sem="G#virus">Epstein-Barr virus</cons> (<cons lex="EBV" sem="G#virus">EBV</cons>) early-lytic-cycle protein</cons> with distant homology to <cons lex="Bcl-2" sem="G#protein_molecule">Bcl-2</cons>, as an <cons lex="anti-apoptosis_protein" sem="G#protein_family_or_group">anti-<cons lex="apoptosis" sem="G#other_name">apoptosis</cons> protein</cons>.</sentence>
<sentence>Expression of <cons lex="BHRF1" sem="G#protein_molecule">BHRF1</cons> in <cons lex="MCF-Fas_cell" sem="G#cell_line">MCF-Fas cells</cons> conferred nearly complete resistance against both <cons lex="anti-Fas_antibody" sem="G#protein_family_or_group">anti-Fas antibody</cons> and <cons lex="TNF-mediated_apoptosis" sem="G#other_name">TNF-mediated <cons lex="apoptosis" sem="G#other_name">apoptosis</cons></cons>.</sentence>
<sentence>In addition, <cons lex="BHRF1" sem="G#protein_molecule">BHRF1</cons> protected these cells from <cons lex="monocyte-mediated_killing" sem="G#other_name">monocyte-mediated killing</cons> but failed to protect them from killing mediated by <cons lex="lymphokine-activated_killer_cell" sem="G#cell_type">lymphokine-activated killer cells</cons>.</sentence>
<sentence>The ability of <cons lex="BHRF1" sem="G#protein_molecule">BHRF1</cons> to protect <cons lex="MCF-Fas_cell" sem="G#cell_line">MCF-Fas cells</cons> from <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> induced by various stimuli was identical to that of <cons lex="Bcl-2" sem="G#protein_molecule">Bcl-2</cons> and <cons lex="Bcl-xL" sem="G#protein_molecule">Bcl-xL</cons>.</sentence>
<sentence>Moreover, the mechanism of action of <cons lex="BHRF1" sem="G#protein_molecule">BHRF1</cons> resembled that of <cons lex="Bcl-2" sem="G#protein_molecule">Bcl-2</cons> and <cons lex="Bcl-xL" sem="G#protein_molecule">Bcl-xL</cons> as it inhibited <cons lex="(AND TNF-induced_activation anti-Fas-induced_activation)" sem="(AND G#other_name G#other_name)"><cons lex="TNF-*">TNF-</cons> and <cons lex="anti-Fas-*">anti-Fas-</cons><cons lex="*induced_activation">induced activation</cons></cons> of two enzymes participating in the <cons lex="apoptosis_pathway" sem="G#other_name"><cons lex="apoptosis" sem="G#other_name">apoptosis</cons> pathway</cons>, <cons lex="cytosolic_phospholipase_A2" sem="G#protein_molecule">cytosolic phospholipase A2</cons> and <cons lex="caspase-3/CPP32" sem="G#protein_molecule">caspase-3/CPP32</cons>, but did not interfere with the activation of <cons lex="NF-kappaB-like_transcription_factor" sem="G#protein_family_or_group"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons>-like transcription factors</cons>.</sentence>
<sentence>A putative function of <cons lex="BHRF1" sem="G#protein_molecule">BHRF1</cons> in <cons lex="EBV-infected_epithelial_cell" sem="G#cell_type"><cons lex="EBV" sem="G#virus">EBV</cons>-infected epithelial cells</cons> may be to protect virus-infected cells from <cons lex="(AND/OR TNF-induced_cell_death anti-Fas-induced_cell_death)" sem="(AND/OR G#other_name G#other_name)"><cons lex="TNF-*">TNF-</cons> and/or <cons lex="anti-Fas-*">anti-Fas-</cons> <cons lex="*induced_cell_death">induced cell death</cons></cons> in order to maximize virus production.</sentence>
<sentence>Surprisingly, expression of neither <cons lex="BHRF1" sem="G#protein_molecule">BHRF1</cons> nor <cons lex="Bcl-2" sem="G#protein_molecule">Bcl-2</cons> in a <cons lex="B-cell_line" sem="G#cell_line">B-cell line</cons>, <cons lex="BJAB" sem="G#cell_line">BJAB</cons>, protected the cells from <cons lex="anti-Fas-mediated_apoptosis" sem="G#other_name">anti-Fas-mediated <cons lex="apoptosis" sem="G#other_name">apoptosis</cons></cons> even though they increased the survival of <cons lex="serum-starved_cell" sem="G#cell_type">serum-starved cells</cons>.</sentence>
<sentence>Thus, the protective role of <cons lex="BHRF1" sem="G#protein_molecule">BHRF1</cons> against <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> resembles that of <cons lex="Bcl-2" sem="G#protein_molecule">Bcl-2</cons> in being cell type specific and dependent on the <cons lex="apoptotic_stimulus" sem="G#other_name">apoptotic stimulus</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97445071</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="genomic_organization" sem="G#other_name">Genomic organization</cons>, <cons lex="sequence" sem="G#other_name">sequence</cons>, and <cons lex="transcriptional_regulation" sem="G#other_name">transcriptional regulation</cons> of the <cons lex="human_eotaxin_gene" sem="G#DNA_domain_or_region">human eotaxin gene</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="eotaxin" sem="G#protein_molecule">Eotaxin</cons> is an <cons lex="eosinophil_specific_beta-chemokine" sem="G#protein_family_or_group">eosinophil specific beta-chemokine</cons> assumed to be involved in <cons lex="eosinophilic_inflammatory_disease" sem="G#other_name">eosinophilic <cons lex="inflammatory_disease" sem="G#other_name">inflammatory diseases</cons></cons> such as <cons lex="atopic_dermatitis" sem="G#other_name">atopic dermatitis</cons>, <cons lex="allergic_rhinitis" sem="G#other_name">allergic rhinitis</cons>, <cons lex="asthma" sem="G#other_name">asthma</cons> and <cons lex="parasitic_infection" sem="G#other_name">parasitic infections</cons>.</sentence>
<sentence>Its expression is stimulus- and cell-specific.</sentence>
<sentence>We here describe the <cons lex="genomic_organisation" sem="G#other_name">genomic organisation</cons> (3 <cons lex="exon" sem="G#DNA_domain_or_region">exons</cons> of 132, 112 and 542 bp and 2 <cons lex="intron" sem="G#DNA_domain_or_region">introns</cons> of 1211 and 378 bp) and sequence including 3 kb of DNA from the immediate <cons lex="5'_upstream_region" sem="G#DNA_domain_or_region">5' upstream region</cons> of the <cons lex="human_eotaxin_gene" sem="G#DNA_domain_or_region">human eotaxin gene</cons>.</sentence>
<sentence>Among the <cons lex="regulatory_promoter_element" sem="G#DNA_family_or_group">regulatory promoter elements</cons> potentially regulating <cons lex="eotaxin_gene_expression" sem="G#other_name"><cons lex="eotaxin_gene" sem="G#DNA_domain_or_region">eotaxin gene</cons> expression</cons> and/or mediating the effects of <cons lex="anti-inflammatory_drug" sem="G#other_organic_compound">anti-inflammatory drugs</cons> we identified <cons lex="consensus_sequence" sem="G#DNA_domain_or_region">consensus sequences</cons> known to interact with <cons lex="nuclear_factor" sem="G#protein_family_or_group">nuclear factors</cons> like <cons lex="NF-IL6" sem="G#protein_molecule">NF-IL6</cons>, <cons lex="AP-1" sem="G#protein_molecule">AP-1</cons>, a <cons lex="NF-kappa-B_like_consensus_sequence" sem="G#DNA_domain_or_region">NF-kappa-B like consensus sequence</cons> and <cons lex="(AS_WELL_AS gamma-interferon-_response_element glucocorticoid_response_element)" sem="(AS_WELL_AS G#DNA_domain_or_region G#DNA_domain_or_region)"><cons lex="gamma-interferon-*">gamma-interferon-</cons> as well as <cons lex="glucocorticoid*">glucocorticoid</cons> <cons lex="*response_element">response elements</cons></cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97400349</bibliomisc>
</articleinfo>
<title>
<sentence>Differential interaction of <cons lex="nuclear_factor" sem="G#protein_family_or_group">nuclear factors</cons> with the <cons lex="leukocyte-specific_pp52_promoter" sem="G#DNA_domain_or_region">leukocyte-specific pp52 promoter</cons> in <cons lex="(AND B_cell T_cell)" sem="(AND G#cell_type G#cell_type)"><cons lex="B*">B</cons> and <cons lex="T*">T</cons> <cons lex="*cell">cells</cons></cons>.</sentence>
</title>
<abstract>
<sentence>The leukocyte-specific, cytoskeleton-binding pp52 (LSP-1, WP-34) protein is widely expressed in multiple leukocyte lineages, including <cons lex="(AND B_lymphocyte T_lymphocyte)" sem="(AND G#cell_type G#cell_type)"><cons lex="B*">B</cons> and <cons lex="T*">T</cons> <cons lex="*lymphocyte">lymphocytes</cons></cons>, <cons lex="granulocyte" sem="G#cell_type">granulocytes</cons>, and <cons lex="macrophage" sem="G#cell_type">macrophages</cons>.</sentence>
<sentence>We previously detected a <cons lex="tissue-specific_promoter" sem="G#DNA_domain_or_region">tissue-specific promoter</cons> preceding the exon encoding the <cons lex="N_terminus" sem="G#protein_domain_or_region">N terminus</cons> of the <cons lex="pp52_leukocyte_protein" sem="G#protein_molecule">pp52 leukocyte protein</cons>.</sentence>
<sentence>Here we describe the functional characterization of this promoter and identification of the factors in <cons lex="(AND B_cell T_cell)" sem="(AND G#cell_type G#cell_type)"><cons lex="B*">B</cons> and <cons lex="T*">T</cons> <cons lex="*cell">cells</cons></cons> that regulate its activity.</sentence>
<sentence>The <cons lex="pp52_promoter" sem="G#DNA_domain_or_region">pp52 promoter</cons> contains an initiator specifying the unique <cons lex="5'_terminus" sem="G#DNA_domain_or_region">5' terminus</cons> of <cons lex="pp52_mRNA" sem="G#RNA_molecule">pp52 mRNA</cons>, tandem pairs of <cons lex="(AND Ets_motif SP1_motif)" sem="(AND G#DNA_domain_or_region G#DNA_domain_or_region)"><cons lex="Ets*">Ets</cons> and <cons lex="SP1*">SP1</cons> <cons lex="*motif">motifs</cons></cons>, and a <cons lex="lone_C/EBP_motif" sem="G#DNA_domain_or_region">lone C/EBP motif</cons>.</sentence>
<sentence>All these motifs are essential and collectively control <cons lex="transcriptional_activity" sem="G#other_name">transcriptional activity</cons>.</sentence>
<sentence><cons lex="DNA_binding_study" sem="G#other_name">DNA binding studies</cons> and <cons lex="Ab_supershift_assay" sem="G#other_name">Ab supershift assays</cons> revealed that different combinations of factors interact with these motifs in <cons lex="B_cell" sem="G#cell_type">B cells</cons> vs <cons lex="T_cell" sem="G#cell_type">T cells</cons>.</sentence>
<sentence>The <cons lex="Ets_motif" sem="G#DNA_domain_or_region">Ets motifs</cons> are preferentially bound by <cons lex="PU-1" sem="G#protein_molecule">PU-1</cons> in <cons lex="B_cell_extract" sem="G#other_name">B cell extracts</cons> from all stages of development, whereas a different <cons lex="Ets_family_member" sem="G#protein_family_or_group">Ets family member</cons> reacts with these motifs in <cons lex="T_cell_extract" sem="G#other_name">T cell extracts</cons>.</sentence>
<sentence>The <cons lex="C/EBP_motif" sem="G#DNA_domain_or_region">C/EBP motif</cons> is bound by <cons lex="Ig/EBP-1" sem="G#protein_molecule">Ig/EBP-1</cons> in <cons lex="pre-B_cell_extract" sem="G#other_name">pre-B cell</cons> and <cons lex="T_cell_extract" sem="G#other_name">T cell extracts</cons>, but is replaced by <cons lex="nuclear_factor-IL-6beta" sem="G#protein_molecule">nuclear factor-IL-6beta</cons> or a <cons lex="nuclear_factor-IL-6beta-Ig/EBP-1_heterodimer" sem="G#protein_complex"><cons lex="nuclear_factor-IL-6beta" sem="G#protein_molecule">nuclear factor-IL-6beta</cons><cons lex="Ig/EBP-1" sem="G#protein_molecule">-Ig/EBP-1</cons> heterodimer</cons> in plasmacytoma cell extracts.</sentence>
<sentence>Despite its reported role as a negative regulator of transcription, <cons lex="Ig/EBP-1" sem="G#protein_molecule">Ig/EBP-1</cons> appears to exert a stimulatory effect on this <cons lex="promoter" sem="G#DNA_domain_or_region">promoter</cons>.</sentence>
<sentence>These findings reveal the features controlling the <cons lex="pp52_promoter" sem="G#DNA_domain_or_region">pp52 promoter</cons> in <cons lex="(AND B_cell T_cell)" sem="(AND G#cell_type G#cell_type)"><cons lex="B*">B</cons> and <cons lex="T*">T</cons> <cons lex="*cell">cells</cons></cons> and provide the foundation for determining the regulation of this <cons lex="promoter" sem="G#DNA_domain_or_region">promoter</cons> in other <cons lex="leukocyte_lineage" sem="G#cell_type">leukocyte lineages</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97383366</bibliomisc>
</articleinfo>
<title>
<sentence>Regulation of <cons lex="B-cell_commitment" sem="G#other_name">B-cell commitment</cons> to <cons lex="plasma_cell" sem="G#cell_type">plasma cells</cons> or to <cons lex="memory_B_cells" sem="G#cell_type">memory <cons lex="B_cell" sem="G#cell_type">B cells</cons></cons>.</sentence>
</title>
<abstract>
<sentence>During <cons lex="humoral_immune_response" sem="G#other_name">humoral immune responses</cons>, <cons lex="B-lymphocyte_activation" sem="G#other_name">B-lymphocyte activation</cons> is followed by differentiation along either the <cons lex="plasma_cell_pathway" sem="G#other_name">plasma cell pathway</cons> or the <cons lex="memory_B-cell_pathway" sem="G#other_name">memory B-cell pathway</cons>.</sentence>
<sentence>Recent studies suggest that <cons lex="CD40-CD40_ligand" sem="G#protein_molecule">CD40-CD40 ligand</cons>, <cons lex="OX-OX40_ligand" sem="G#protein_molecule">OX-OX40 ligand</cons>, a group of <cons lex="cytokine" sem="G#protein_family_or_group">cytokines</cons> and intracellular transcriptional factors may all contribute to <cons lex="B-lymphocyte_differentiation_control" sem="G#other_name"><cons lex="B-lymphocyte_differentiation" sem="G#other_name">B-lymphocyte differentiation</cons> control</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97366676</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="transcription_factor_binding_site" sem="G#other_name"><cons lex="transcription_factor" sem="G#protein_family_or_group">Transcription factor</cons> binding sites</cons> downstream of the <cons lex="human_immunodeficiency_virus_type_1_transcription_start_site" sem="G#DNA_domain_or_region"><cons lex="human_immunodeficiency_virus_type_1" sem="G#virus">human immunodeficiency virus type 1</cons> transcription start site</cons> are important for <cons lex="virus_infectivity" sem="G#other_name">virus infectivity</cons>.</sentence>
</title>
<abstract>
<sentence>When transcriptionally active, the <cons lex="human_immunodeficiency_virus" sem="G#virus">human immunodeficiency virus</cons> (<cons lex="HIV" sem="G#virus">HIV</cons>) <cons lex="promoter" sem="G#DNA_domain_or_region">promoter</cons> contains a nucleosome-free region encompassing both the <cons lex="promoter/enhancer_region" sem="G#DNA_domain_or_region"><cons lex="promoter" sem="G#DNA_domain_or_region">promoter</cons>/enhancer region</cons> and a large region (<cons lex="255_nucleotide" sem="G#DNA_domain_or_region">255 nucleotides</cons> [nt]) downstream of the <cons lex="transcription_start_site" sem="G#DNA_domain_or_region">transcription start site</cons>.</sentence>
<sentence>We have previously identified new binding sites for <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> downstream of the <cons lex="transcription_start_site" sem="G#DNA_domain_or_region">transcription start site</cons> (<cons lex="nt_465_to_720" sem="G#DNA_domain_or_region">nt 465 to 720</cons>): three <cons lex="AP-1_site" sem="G#DNA_domain_or_region">AP-1 sites</cons> (I, II, and III), an <cons lex="AP3-like_motif" sem="G#DNA_domain_or_region">AP3-like motif</cons> (<cons lex="AP3-L" sem="G#DNA_domain_or_region">AP3-L</cons>), a <cons lex="downstream_binding_factor_(DBF)_site" sem="G#DNA_domain_or_region">downstream binding factor (DBF) site</cons>, and <cons lex="juxtaposed_Sp1_site" sem="G#DNA_domain_or_region">juxtaposed Sp1 sites</cons>.</sentence>
<sentence>Here, we show that the <cons lex="DBF_site" sem="G#DNA_domain_or_region">DBF site</cons> is an <cons lex="interferon-responsive_factor_(IRF)_binding_site" sem="G#DNA_domain_or_region">interferon-responsive factor (IRF) binding site</cons> and that the <cons lex="AP3-L_motif" sem="G#DNA_domain_or_region"><cons lex="AP3-L" sem="G#DNA_domain_or_region">AP3-L</cons> motif</cons> binds the <cons lex="T-cell-specific_factor" sem="G#protein_family_or_group">T-cell-specific factor</cons> <cons lex="NF-AT" sem="G#protein_molecule">NF-AT</cons>.</sentence>
<sentence>Mutations that abolish the binding of each factor to its cognate site are introduced in an <cons lex="infectious_HIV-1_molecular_clone" sem="G#virus">infectious <cons lex="HIV-1" sem="G#virus">HIV-1</cons> molecular clone</cons> to study their effect on <cons lex="HIV-1_transcription" sem="G#other_name"><cons lex="HIV-1" sem="G#virus">HIV-1</cons> transcription</cons> and replication.</sentence>
<sentence>Individual mutation of the DBF or <cons lex="AP3-L" sem="G#DNA_domain_or_region">AP3-L</cons> site as well as the double <cons lex="mutation_AP-1(III)/AP3-L" sem="G#DNA_domain_or_region">mutation AP-1(III)/<cons lex="AP3-L" sem="G#DNA_domain_or_region">AP3-L</cons></cons> did not affect <cons lex="HIV-1_replication" sem="G#other_name">HIV-1 replication</cons> compared to that of the <cons lex="wild-type_virus" sem="G#virus">wild-type virus</cons>.</sentence>
<sentence>In contrast, proviruses carrying mutations in the <cons lex="Sp1_site" sem="G#DNA_domain_or_region">Sp1 sites</cons> were totally defective in terms of replication.</sentence>
<sentence>Virus production occurred with slightly <cons lex="delayed_kinetics" sem="G#other_name">delayed kinetics</cons> for viruses containing combined mutations in the <cons lex="AP-1(III)" sem="G#DNA_domain_or_region">AP-1(III)</cons>, <cons lex="AP3-L" sem="G#DNA_domain_or_region">AP3-L</cons>, and <cons lex="DBF_site" sem="G#DNA_domain_or_region">DBF sites</cons> and in the <cons lex="AP3-L" sem="G#DNA_domain_or_region">AP3-L</cons> and <cons lex="DBF-site" sem="G#DNA_domain_or_region">DBF-sites</cons>, whereas viruses mutated in the <cons lex="AP-1(I,II,III)" sem="G#DNA_domain_or_region">AP-1(I,II,III)</cons> and <cons lex="AP3-L_site" sem="G#DNA_domain_or_region">AP3-L sites</cons> and in the AP-1(I,II,III), <cons lex="AP3-L" sem="G#DNA_domain_or_region">AP3-L</cons>, and <cons lex="DBF_site" sem="G#DNA_domain_or_region">DBF sites</cons> exhibited a severely defective replicative phenotype.</sentence>
<sentence>No RNA-packaging defect could be measured for any of the mutant viruses as determined by quantification of their <cons lex="HIV_genomic_RNA" sem="G#RNA_family_or_group">HIV genomic RNA</cons>.</sentence>
<sentence>Measurement of the <cons lex="transcriptional_activity" sem="G#other_name">transcriptional activity</cons> of the <cons lex="HIV-1_promoter" sem="G#DNA_domain_or_region"><cons lex="HIV-1" sem="G#virus">HIV-1</cons> promoter</cons> after transient transfection of the <cons lex="HIV-1_provirus_DNA" sem="G#DNA_domain_or_region"><cons lex="HIV-1" sem="G#virus">HIV-1</cons> provirus DNA</cons> or of <cons lex="long_terminal_repeat-luciferase_construct" sem="G#DNA_family_or_group">long terminal repeat-luciferase constructs</cons> showed a positive correlation between the transcriptional and the <cons lex="replication_defect" sem="G#other_name">replication defects</cons> for most mutants.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97379649</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="glucocorticoid_receptor" sem="G#protein_family_or_group">Glucocorticoid receptor</cons> regulates expression of <cons lex="L-selectin" sem="G#protein_molecule">L-selectin</cons> and <cons lex="CD11/CD18" sem="G#protein_molecule">CD11/CD18</cons> on <cons lex="human_neutrophil" sem="G#cell_type">human neutrophils</cons> [see comments]</sentence>
</title>
<abstract>
<sentence>BACKGROUND: Recent studies have raised the hypothesis that <cons lex="glucocorticoid" sem="G#lipid">glucocorticoids</cons> could diminish the ability of <cons lex="endothelial_cell" sem="G#cell_type">endothelial cells</cons> to direct leukocyte traffic into <cons lex="inflamed_tissue" sem="G#tissue">inflamed tissues</cons> by inhibiting expression of the <cons lex="adhesion_molecule" sem="G#protein_family_or_group">adhesion molecules</cons> <cons lex="endothelial-leukocyte_adhesion_molecule-1" sem="G#protein_molecule">endothelial-leukocyte adhesion molecule-1</cons> and <cons lex="intercellular_adhesion_molecule-1" sem="G#protein_molecule">intercellular adhesion molecule-1</cons>.</sentence>
<sentence>The aim of the present study was to investigate whether <cons lex="glucocorticoid" sem="G#lipid">glucocorticoids</cons> also regulate the expression of <cons lex="L-selectin" sem="G#protein_molecule">L-selectin</cons> and <cons lex="CD11/CD18" sem="G#protein_molecule">CD11/CD18</cons> <cons lex="integrin" sem="G#protein_family_or_group">integrins</cons> on <cons lex="human_neutrophil_granulocyte" sem="G#cell_type">human neutrophil <cons lex="granulocyte" sem="G#cell_type">granulocytes</cons></cons>.</sentence>
<sentence>METHODS AND RESULTS: Incubation of <cons lex="human_whole_blood" sem="G#tissue">human whole blood</cons> with <cons lex="platelet-activating_factor" sem="G#protein_molecule">platelet-activating factor</cons> (<cons lex="PAF" sem="G#protein_molecule">PAF</cons>, 1 mumol/L) evoked downregulation of <cons lex="L-selectin" sem="G#protein_molecule">L-selectin</cons> and upregulation of <cons lex="CD11/CD18" sem="G#protein_molecule">CD11/CD18</cons> <cons lex="adhesion_receptor" sem="G#protein_family_or_group">adhesion receptors</cons> on neutrophils as measured by <cons lex="flow_cytometry" sem="G#other_name">flow cytometry</cons>.</sentence>
<sentence>While <cons lex="dexamethasone" sem="G#lipid">dexamethasone</cons> (0.1 nmol/L to 100 mumol/L) did not affect expression of <cons lex="adhesion_molecule" sem="G#protein_family_or_group">adhesion molecules</cons> on <cons lex="resting_neutrophil" sem="G#cell_type">resting neutrophils</cons>, it attenuated the <cons lex="PAF-induced_change" sem="G#other_name"><cons lex="PAF" sem="G#protein_molecule">PAF</cons>-induced changes</cons> in <cons lex="L-selectin" sem="G#protein_molecule">L-selectin</cons> and <cons lex="CD18_expression" sem="G#other_name"><cons lex="CD18" sem="G#protein_molecule">CD18</cons> expression</cons> in a <cons lex="time-_and_concentration-dependent_fashion" sem="G#other_name">time- and concentration-dependent fashion</cons> with <cons lex="IC50_value" sem="G#other_name">IC50 values</cons> of 31 and 13 nmol/L, respectively.</sentence>
<sentence>These effects of <cons lex="dexamethasone" sem="G#lipid">dexamethasone</cons> were completely aborted by <cons lex="RU-486" sem="G#other_organic_compound">RU-486</cons> (10 mumol/L), which blocks transcriptional activation of the <cons lex="glucocorticoid_receptor" sem="G#protein_family_or_group">glucocorticoid receptor</cons>, and by the protein synthesis inhibitor cycloheximide (35.5 mumol/L).</sentence>
<sentence><cons lex="dexamethasone" sem="G#lipid">Dexamethasone</cons>, up to a concentration of 1 mumol/L, neither affected significantly the release of <cons lex="granule_enzyme" sem="G#protein_family_or_group">granule enzymes</cons> nor interfered with <cons lex="PAF" sem="G#protein_molecule">PAF</cons> binding to its <cons lex="membrane_receptor" sem="G#protein_family_or_group">membrane receptors</cons>.</sentence>
<sentence>CONCLUSIONS: Our results show that <cons lex="glucocorticoid" sem="G#lipid">glucocorticoids</cons> at clinically relevant concentrations exert specific actions on expression of <cons lex="adhesion_molecule" sem="G#protein_family_or_group">adhesion molecules</cons> on <cons lex="activated_neutrophil" sem="G#cell_type">activated neutrophils</cons>, which are mediated through ligation of <cons lex="glucocorticoid_receptor" sem="G#protein_family_or_group">glucocorticoid receptors</cons> and induction of protein synthesis, and suggest a novel mechanism by which <cons lex="anti-inflammatory_corticosteroid" sem="G#lipid">anti-inflammatory corticosteroids</cons> may inhibit <cons lex="leukocyte_accumulation" sem="G#other_name">leukocyte accumulation</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97342608</bibliomisc>
</articleinfo>
<title>
<sentence>The immediate-early gene product <cons lex="Egr-1" sem="G#protein_molecule">Egr-1</cons> regulates the <cons lex="human_interleukin-2_receptor_beta-chain_promoter" sem="G#DNA_domain_or_region">human <cons lex="interleukin-2_receptor" sem="G#protein_molecule">interleukin-2 receptor</cons> beta-chain promoter</cons> through <cons lex="(AND noncanonical_Egr_binding_site noncanonical_Sp1_binding_site)" sem="(AND G#DNA_domain_or_region G#DNA_domain_or_region)"><cons lex="noncanonical*">noncanonical</cons> <cons lex="*Egr*">Egr</cons> and <cons lex="*Sp1*">Sp1</cons> <cons lex="*binding_site">binding sites</cons></cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="interleukin-2_IL-2_receptor_beta-chain" sem="G#protein_domain_or_region">interleukin-2 IL-2 receptor beta-chain</cons> (<cons lex="IL-2Rbeta" sem="G#protein_domain_or_region">IL-2Rbeta</cons>) is an essential component of the receptors for <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> and <cons lex="IL-15" sem="G#protein_molecule">IL-15</cons>.</sentence>
<sentence>Although <cons lex="IL-2Rbeta" sem="G#protein_domain_or_region">IL-2Rbeta</cons> is constitutively expressed by lymphocytes, its expression can be further induced by a number of stimuli, including <cons lex="phorbol_12-myristate_13-acetate" sem="G#other_organic_compound">phorbol 12-myristate 13-acetate</cons> (<cons lex="PMA" sem="G#other_organic_compound">PMA</cons>).</sentence>
<sentence>We have now characterized factors that bind to an enhancer region located between <cons lex="nucleotides_-170_and_-139" sem="G#DNA_domain_or_region">nucleotides -170 and -139</cons> of the human <cons lex="IL-2Rbeta_promoter" sem="G#DNA_domain_or_region"><cons lex="IL-2Rbeta" sem="G#protein_molecule">IL-2Rbeta</cons> promoter</cons>.</sentence>
<sentence>Both <cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> and <cons lex="Sp3" sem="G#protein_molecule">Sp3</cons> bound to the <cons lex="5'_portion" sem="G#DNA_domain_or_region">5' portion</cons> of this region, whereas a <cons lex="PMA-inducible_factor" sem="G#protein_family_or_group"><cons lex="PMA" sem="G#other_organic_compound">PMA</cons>-inducible factor</cons> (<cons lex="PIF" sem="G#protein_family_or_group">PIF</cons>) mainly bound to its <cons lex="3'_portion" sem="G#DNA_domain_or_region">3' portion</cons> and bound to the <cons lex="Sp_binding_motif" sem="G#DNA_family_or_group">Sp binding motifs</cons> as well.</sentence>
<sentence>In <cons lex="Jurkat_T_cell" sem="G#cell_line">Jurkat <cons lex="T_cell" sem="G#cell_type">T cells</cons></cons>, induction of <cons lex="PIF_DNA_binding_activity" sem="G#other_name"><cons lex="PIF" sem="G#protein_family_or_group">PIF</cons> DNA binding activity</cons> was rapidly induced, required de novo protein synthesis, and was sustained at a high level for at least 23 h.</sentence>
<sentence>Interestingly, <cons lex="PIF" sem="G#protein_family_or_group">PIF</cons> was constitutively activated in <cons lex="human_T-cell_leukemia_virus_type_1-transformed_MT-2_cell" sem="G#cell_line"><cons lex="human_T-cell_leukemia_virus_type_1" sem="G#virus">human T-cell leukemia virus type 1</cons>-transformed MT-2 cells</cons>.</sentence>
<sentence>In this paper, we demonstrate that <cons lex="PIF" sem="G#protein_family_or_group">PIF</cons> is <cons lex="Egr-1" sem="G#protein_molecule">Egr-1</cons> based on its recognition by anti-<cons lex="Egr-1" sem="G#protein_molecule">Egr-1</cons> antisera in <cons lex="gel_mobility_shift_assay" sem="G#other_name">gel mobility shift assays</cons>, even though the <cons lex="IL-2Rbeta_DNA_binding_motif" sem="G#DNA_domain_or_region"><cons lex="IL-2Rbeta" sem="G#protein_domain_or_region">IL-2Rbeta</cons> DNA binding motif</cons> differed substantially from the canonical <cons lex="Egr-1_binding_site" sem="G#DNA_domain_or_region"><cons lex="Egr-1" sem="G#protein_molecule">Egr-1</cons> binding site</cons>.</sentence>
<sentence>In addition, <cons lex="Egr-1" sem="G#protein_molecule">Egr-1</cons> bound to the <cons lex="Sp_binding_site" sem="G#DNA_domain_or_region">Sp binding site</cons>.</sentence>
<sentence>In <cons lex="Jurkat_cell" sem="G#cell_line">Jurkat cells</cons>, both sites were required for maximal <cons lex="IL-2Rbeta_promoter_activity" sem="G#other_name"><cons lex="IL-2Rbeta" sem="G#protein_domain_or_region">IL-2Rbeta</cons> promoter activity</cons>, and in HeLaS3 cells, transfection of <cons lex="Egr-1" sem="G#protein_molecule">Egr-1</cons> could drive activity of a reporter construct containing both sites.</sentence>
<sentence>Moreover, <cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> and <cons lex="Egr-1" sem="G#protein_molecule">Egr-1</cons> could form a complex with kinetics that correlated with the production of <cons lex="Egr-1" sem="G#protein_molecule">Egr-1</cons> in <cons lex="Jurkat_cell" sem="G#cell_line">Jurkat cells</cons> upon <cons lex="PMA" sem="G#other_organic_compound">PMA</cons> stimulation.</sentence>
<sentence>Thus, <cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> and <cons lex="Egr-1" sem="G#protein_molecule">Egr-1</cons> physically and functionally cooperate to mediate maximal <cons lex="IL-2Rbeta_promoter_activity" sem="G#other_name"><cons lex="IL-2Rbeta_promoter" sem="G#DNA_domain_or_region">IL-2Rbeta promoter</cons> activity</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97326105</bibliomisc>
</articleinfo>
<title>
<sentence>Overexpression of <cons lex="HSF2-beta" sem="G#protein_molecule">HSF2-beta</cons> inhibits <cons lex="hemin-induced_heat_shock_gene_expression" sem="G#other_name"><cons lex="hemin" sem="G#protein_molecule">hemin</cons>-induced heat shock gene expression</cons> and <cons lex="erythroid_differentiation" sem="G#other_name">erythroid differentiation</cons> in <cons lex="K562_cell" sem="G#cell_line">K562 cells</cons>.</sentence>
</title>
<abstract>
<sentence>Acquisition of heat shock factor 2 (HSF2) DNA binding activity is accompanied by induced transcription of <cons lex="heat_shock_gene" sem="G#DNA_family_or_group">heat shock genes</cons> in hemin-treated <cons lex="K562_cell" sem="G#cell_line">K562 cells</cons> undergoing <cons lex="erythroid_differentiation" sem="G#other_name">erythroid differentiation</cons>.</sentence>
<sentence>Previous studies revealed that <cons lex="HSF2" sem="G#protein_molecule">HSF2</cons> consists of two alternatively spliced isoforms, <cons lex="HSF2-alpha" sem="G#protein_molecule">HSF2-alpha</cons> and <cons lex="HSF2-beta" sem="G#protein_molecule">HSF2-beta</cons>, whose relative abundance is developmentally regulated and varies between different tissues.</sentence>
<sentence>To investigate whether the molar ratio of <cons lex="HSF2-alpha" sem="G#protein_molecule">HSF2-alpha</cons> and <cons lex="HSF2-beta" sem="G#protein_molecule">HSF2-beta</cons> isoforms is crucial for the activation of <cons lex="HSF2" sem="G#protein_molecule">HSF2</cons> and whether the <cons lex="HSF2" sem="G#protein_molecule">HSF2</cons> isoforms play functionally distinct roles during the hemin-mediated <cons lex="erythroid_differentiation" sem="G#other_name">erythroid differentiation</cons>, we generated cell clones expressing different levels of <cons lex="HSF2-alpha" sem="G#protein_molecule">HSF2-alpha</cons> and <cons lex="HSF2-beta" sem="G#protein_molecule">HSF2-beta</cons>.</sentence>
<sentence>We show that in parental <cons lex="K562_cell" sem="G#cell_line">K562 cells</cons>, the <cons lex="HSF2-alpha_isoform" sem="G#protein_molecule"><cons lex="HSF2-alpha" sem="G#protein_molecule">HSF2-alpha</cons> isoform</cons> is predominantly expressed and <cons lex="HSF2" sem="G#protein_molecule">HSF2</cons> can be activated upon hemin treatment.</sentence>
<sentence>In contrast, when <cons lex="HSF2-beta" sem="G#protein_molecule">HSF2-beta</cons> is expressed at levels exceeding those of <cons lex="endogenous_HSF2-alpha" sem="G#protein_molecule">endogenous <cons lex="HSF2-alpha" sem="G#protein_molecule">HSF2-alpha</cons></cons>, the hemin-induced DNA binding activity and transcription of <cons lex="heat_shock_gene" sem="G#DNA_family_or_group">heat shock genes</cons> are repressed, whereas overexpression of <cons lex="HSF2-alpha" sem="G#protein_molecule">HSF2-alpha</cons> results in an enhanced <cons lex="hemin_response" sem="G#other_name"><cons lex="hemin" sem="G#protein_molecule">hemin</cons> response</cons>.</sentence>
<sentence>Furthermore, the <cons lex="hemin-induced_accumulation" sem="G#other_name"><cons lex="hemin" sem="G#protein_molecule">hemin</cons>-induced accumulation</cons> of <cons lex="globin" sem="G#protein_complex">globin</cons>, known as a marker of <cons lex="erythroid_differentiation" sem="G#other_name">erythroid differentiation</cons>, is decreased in cells overexpressing <cons lex="HSF2-beta" sem="G#protein_molecule">HSF2-beta</cons>.</sentence>
<sentence>We suggest that <cons lex="HSF2-beta" sem="G#protein_molecule">HSF2-beta</cons> acts as a negative regulator of <cons lex="HSF2" sem="G#protein_molecule">HSF2</cons> activity during <cons lex="hemin-mediated_erythroid_differentiation" sem="G#other_name">hemin-mediated <cons lex="erythroid_differentiation" sem="G#other_name">erythroid differentiation</cons></cons> of <cons lex="K562_cell" sem="G#cell_line">K562 cells</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97307606</bibliomisc>
</articleinfo>
<title>
<sentence>Sequential development of structural and <cons lex="functional_alterations" sem="G#other_name">functional alterations</cons> in <cons lex="T_cell" sem="G#cell_type">T cells</cons> from <cons lex="tumor-bearing_mouse" sem="G#other_artificial_source">tumor-bearing mice</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="(OR TCR_alpha_beta_chain TCR_gamma_delta_chain)" sem="(OR G#protein_subunit G#protein_subunit)"><cons lex="TCR*">TCR</cons> <cons lex="*alpha_beta*">alpha beta</cons> or <cons lex="*gamma_delta*">-gamma delta</cons> <cons lex="*chain">chains</cons></cons> bind the <cons lex="peptide_ligand" sem="G#other_name">peptide ligand</cons>, whereas the associated <cons lex="CD3_delta_epsilon_gamma" sem="G#protein_subunit">CD3 delta epsilon gamma</cons> and <cons lex="TCR_zeta_subunit" sem="G#protein_subunit">TCR zeta subunits</cons> couple the <cons lex="TCR" sem="G#protein_complex">TCR</cons> to intracellular signal transduction components.</sentence>
<sentence>Recently, several groups have described marked alterations in <cons lex="signal_transduction_element" sem="G#other_name">signal transduction elements</cons> in <cons lex="T_cell" sem="G#cell_type">T cells</cons> from <cons lex="cancer_patient" sem="G#multi_cell">cancer patients</cons> or in <cons lex="mouse" sem="G#multi_cell">mice</cons> bearing <cons lex="tumor" sem="G#tissue">tumor</cons> for a few weeks (&gt;26 days).</sentence>
<sentence>The sequence in which these alterations develop is unknown.</sentence>
<sentence>The aim of this study was to explore the kinetics of the development of alterations in <cons lex="signal_transduction_molecule" sem="G#other_name">signal transduction molecules</cons> (<cons lex="TCR_zeta_chain" sem="G#protein_subunit">TCR zeta chain</cons>, <cons lex="NF_kappaB_family_protein" sem="G#protein_family_or_group">NF kappaB family proteins</cons>, and <cons lex="tyrosine_kinase_p56(lck)" sem="G#protein_molecule">tyrosine kinase p56(lck)</cons>) in mice bearing <cons lex="MC38_colon_adenocarcinoma" sem="G#tissue">MC38 colon adenocarcinoma</cons>.</sentence>
<sentence>The results demonstrate that alterations in <cons lex="NF_kappaB_family_protein" sem="G#protein_family_or_group">NF kappaB family proteins</cons>, specifically the failure of <cons lex="p65" sem="G#protein_molecule">p65</cons> translocation to the nucleus, occur earlier and more frequently than the decrease in <cons lex="zeta-chain" sem="G#protein_subunit">zeta-chain</cons>.</sentence>
<sentence>These defects are paralleled by an impaired ability to produce <cons lex="Th1_cytokine" sem="G#protein_family_or_group">Th1 <cons lex="cytokine" sem="G#protein_family_or_group">cytokines</cons></cons> (<cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> and <cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons>).</sentence>
<sentence>These initial changes are followed by the eventual loss of <cons lex="TCR_zeta_chain" sem="G#protein_subunit">TCR zeta chain</cons> and <cons lex="p56(lck)" sem="G#protein_molecule">p56(lck)</cons> and a marked decrease in <cons lex="cytotoxic_function" sem="G#other_name">cytotoxic function</cons>.</sentence>
<sentence>An increased rate of lysosomal degradation is one of the mechanisms responsible for the loss of <cons lex="zeta-chain" sem="G#protein_subunit">zeta-chain</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97289591</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="(AND HLA-DMA_gene_expression HLA-DMB_gene_expression)" sem="(AND G#other_name G#other_name)"><cons lex="HLA-DMA*">HLA-DMA</cons> and <cons lex="HLA-DMB*">HLA-DMB</cons> <cons lex="*gene_expression">gene expression</cons></cons> functions through the conserved <cons lex="S-X-Y_region" sem="G#DNA_domain_or_region">S-X-Y region</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="MHC_class_II_homologous_protein" sem="G#protein_family_or_group">MHC class II homologous proteins</cons> <cons lex="HLA-DMA" sem="G#protein_molecule">HLA-DMA</cons> and <cons lex="HLA-DMB" sem="G#protein_molecule">HLA-DMB</cons> function in the loading of peptides onto <cons lex="class_II_molecule" sem="G#protein_family_or_group">class II molecules</cons>.</sentence>
<sentence>Like the <cons lex="class_II_gene" sem="G#DNA_family_or_group">class II genes</cons>, the <cons lex="HLA-DM_gene" sem="G#DNA_family_or_group">HLA-DM genes</cons> contain upstream regulatory sequences similar to the <cons lex="S-X-Y_regulatory_region" sem="G#DNA_family_or_group">S-X-Y regulatory region</cons> as well as additional putative regulatory sites.</sentence>
<sentence>To determine whether the <cons lex="DM_gene" sem="G#DNA_family_or_group">DM genes</cons> are regulated in a similar manner as <cons lex="class_II_gene" sem="G#DNA_family_or_group">class II genes</cons>, a series of in vivo and in vitro analyses was performed.</sentence>
<sentence><cons lex="deletion_analysis" sem="G#other_name">Deletion analysis</cons> showed that expression from the <cons lex="DM_promoter" sem="G#DNA_family_or_group">DM promoters</cons> is dependent on the conserved <cons lex="S-X-Y_region" sem="G#DNA_domain_or_region">S-X-Y region</cons>.</sentence>
<sentence>The <cons lex="class_II-specific_transcription_factor" sem="G#protein_family_or_group">class II-specific <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons></cons> <cons lex="RFX" sem="G#protein_family_or_group">RFX</cons> and <cons lex="CIITA" sem="G#protein_molecule">CIITA</cons> are also required for expression, as cell lines deficient in these factors failed to allow transcription from the <cons lex="DM_promoter" sem="G#DNA_family_or_group">DM promoters</cons>.</sentence>
<sentence>In addition, in vivo footprint analysis showed the putative <cons lex="(AND X_box Y_box)" sem="(AND G#DNA_domain_or_region G#DNA_domain_or_region)"><cons lex="X*">X</cons> and <cons lex="Y*">Y</cons> <cons lex="*box">boxes</cons></cons> to be occupied by <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> in <cons lex="wild-type_B_cell" sem="G#cell_type">wild-type <cons lex="B_cell" sem="G#cell_type">B cells</cons></cons>, but not in <cons lex="RFX-deficient_B_cell" sem="G#cell_line"><cons lex="RFX" sem="G#protein_family_or_group">RFX</cons>-deficient B cells</cons>.</sentence>
<sentence>In <cons lex="astrocyte" sem="G#cell_type">astrocytes</cons>, <cons lex="IFN-gamma_treatment" sem="G#other_name"><cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons> treatment</cons> induced increased occupancy of these sites.</sentence>
<sentence>None of the other putative regulatory sites was occupied in vivo, indicating that they may not be functional.</sentence>
<sentence>Finally, <cons lex="gel_shift_analysis" sem="G#other_name">gel shift analysis</cons> showed synergistic complex formation between proteins that bind to the putative <cons lex="X_box" sem="G#DNA_family_or_group">X boxes</cons> of the DM genes, as is found for the <cons lex="DRA_gene" sem="G#DNA_family_or_group">DRA gene</cons>.</sentence>
<sentence>Therefore, the <cons lex="DM_gene" sem="G#DNA_family_or_group">DM genes</cons> share a common mechanism of regulation with the <cons lex="class_II_gene" sem="G#DNA_family_or_group">class II genes</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97344875</bibliomisc>
</articleinfo>
<title>
<sentence>Effect of <cons lex="adenovirus_2" sem="G#virus">adenovirus 2</cons> on <cons lex="cellular_gene_activation" sem="G#other_name">cellular gene activation</cons> in <cons lex="blood-derived_monocyte" sem="G#cell_type">blood-derived monocytes</cons> and <cons lex="macrophage" sem="G#cell_type">macrophages</cons>.</sentence>
</title>
<abstract>
<sentence>We have investigated the effect of <cons lex="adenovirus_2_(Ad2)_infection" sem="G#other_name"><cons lex="adenovirus_2" sem="G#virus">adenovirus 2</cons> (<cons lex="Ad2" sem="G#virus">Ad2</cons>) infection</cons> on <cons lex="human_monocyte" sem="G#cell_type">human monocytes</cons> and <cons lex="monocyte-derived_macrophage" sem="G#cell_type">monocyte-derived <cons lex="macrophage" sem="G#cell_type">macrophages</cons></cons> with regard to expression of <cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons> and <cons lex="IL-1_beta" sem="G#protein_molecule">IL-1 beta</cons>.</sentence>
<sentence>In monocytes, the virus was bound to the surface without being internalized.</sentence>
<sentence>On the other hand, <cons lex="Ad2" sem="G#virus">Ad2</cons> was internalized by <cons lex="macrophage" sem="G#cell_type">macrophages</cons>.</sentence>
<sentence>No virus replication and no transcription of the <cons lex="Ad2_early_gene" sem="G#DNA_family_or_group"><cons lex="Ad2" sem="G#virus">Ad2</cons> early genes</cons> was observed in either of the cells.</sentence>
<sentence><cons lex="Ad2_infection" sem="G#other_name"><cons lex="Ad2" sem="G#virus">Ad2</cons> infection</cons> induced transient increase in the <cons lex="mRNA_level" sem="G#other_name"><cons lex="mRNA" sem="G#RNA_family_or_group">mRNA</cons> levels</cons> for <cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons> and <cons lex="IL-1_beta" sem="G#protein_molecule">IL-1 beta</cons> in both <cons lex="monocyte" sem="G#cell_type">monocytes</cons> and in <cons lex="macrophage" sem="G#cell_type">macrophages</cons>, although the kinetics of the <cons lex="transcription" sem="G#other_name">transcription</cons> was slightly different.</sentence>
<sentence>The production of both <cons lex="cytokine" sem="G#protein_family_or_group">cytokines</cons>, measured by <cons lex="ELISA_test" sem="G#other_name">ELISA tests</cons>, was enhanced in <cons lex="monocyte" sem="G#cell_type">monocytes</cons>.</sentence>
<sentence>In <cons lex="macrophage" sem="G#cell_type">macrophages</cons>, a slight enhancement of <cons lex="TNF-alpha_production" sem="G#other_name"><cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons> production</cons> was seen, whereas <cons lex="IL-1_beta" sem="G#protein_molecule">IL-1 beta</cons> was not detected.</sentence>
<sentence>The data indicate that <cons lex="cellular_gene" sem="G#DNA_family_or_group">cellular genes</cons> might be activated by <cons lex="Ad2_virus_infection" sem="G#other_name"><cons lex="Ad2" sem="G#virus">Ad2</cons> virus infection</cons> in nonpermissive cells where no <cons lex="viral_gene_product" sem="G#protein_family_or_group">viral gene products</cons> could be detected.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97281772</bibliomisc>
</articleinfo>
<title>
<sentence>Structure and function analysis of the <cons lex="human_myeloid_cell_nuclear_differentiation_antigen_promoter" sem="G#DNA_domain_or_region">human myeloid cell nuclear differentiation antigen promoter</cons>: evidence for the role of <cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> and not of <cons lex="c-Myb" sem="G#protein_molecule">c-Myb</cons> or <cons lex="PU.1" sem="G#protein_molecule">PU.1</cons> in <cons lex="myelomonocytic_lineage-specific_expression" sem="G#other_name">myelomonocytic lineage-specific expression</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="human_myeloid_nuclear_differentiation_antigen" sem="G#protein_molecule">human myeloid nuclear differentiation antigen</cons> (<cons lex="MNDA" sem="G#protein_molecule">MNDA</cons>) is expressed specifically in <cons lex="maturing_cell" sem="G#cell_type">maturing cells</cons> of the <cons lex="myelomonocytic_lineage" sem="G#other_name">myelomonocytic lineage</cons> and in <cons lex="monocyte" sem="G#cell_type">monocytes</cons> and <cons lex="granulocyte" sem="G#cell_type">granulocytes</cons>.</sentence>
<sentence><cons lex="epitope_enhancement" sem="G#other_name">Epitope enhancement</cons> was used to confirm the strict <cons lex="lineage-_and_stage-specific_expression" sem="G#other_name"><cons lex="lineage-specific_expression" sem="G#other_name">lineage-</cons> and <cons lex="stage-specific_expression" sem="G#other_name">stage-specific expression</cons></cons> of <cons lex="MNDA" sem="G#protein_molecule">MNDA</cons> in <cons lex="bone_marrow" sem="G#tissue">bone marrow</cons> as well as in other <cons lex="paraffin-embedded_fixed_tissue" sem="G#tissue">paraffin-embedded fixed tissues</cons>.</sentence>
<sentence>A <cons lex="1-kb_region" sem="G#DNA_domain_or_region">1-kb region</cons> of the gene that includes <cons lex="5'_flanking_sequence" sem="G#DNA_domain_or_region">5' flanking sequence</cons> was reported earlier to contain <cons lex="functional_promoter_activity" sem="G#other_name">functional promoter activity</cons> and was specifically demethylated in <cons lex="expressing_cell" sem="G#cell_type">expressing cells</cons> in contrast to <cons lex="null_cell" sem="G#cell_type">null cells</cons>.</sentence>
<sentence>Further analysis has revealed that this <cons lex="1-kb_fragment" sem="G#DNA_domain_or_region">1-kb fragment</cons> promotes higher reporter gene activity in <cons lex="MNDA" sem="G#protein_molecule">MNDA</cons><cons lex="expressing_cell" sem="G#cell_type">-expressing cells</cons> than <cons lex="non-expressing_cell" sem="G#cell_type">non-expressing cells</cons>, indicating cell-specific differences in <cons lex="transactivation" sem="G#other_name">transactivation</cons>.</sentence>
<sentence>This sequence contains <cons lex="consensus_element" sem="G#DNA_family_or_group">consensus elements</cons> consistent with <cons lex="myeloid-specific_gene_expression" sem="G#other_name">myeloid-specific gene expression</cons>, including a <cons lex="PU.1_consensus_site" sem="G#DNA_domain_or_region">PU.1 consensus site</cons> near the major <cons lex="transcription_start_site" sem="G#DNA_domain_or_region">transcription start site</cons> and a cluster of <cons lex="c-Myb_site" sem="G#DNA_domain_or_region">c-Myb sites</cons> located several hundred bases upstream of this region.</sentence>
<sentence>However, analysis of <cons lex="deletion_mutant" sem="G#DNA_family_or_group">deletion mutants</cons> localized nearly all of the <cons lex="promoter_activity" sem="G#other_name">promoter activity</cons> to a short region (<cons lex="-73_to_-16" sem="G#DNA_domain_or_region">-73 to -16</cons>) that did not include the cluster of <cons lex="c-Myb_site" sem="G#DNA_domain_or_region">c-Myb sites</cons>.</sentence>
<sentence>A 4-bp mutation of the <cons lex="core_Sp1_consensus_element" sem="G#DNA_domain_or_region">core Sp1 consensus element</cons> (<cons lex="GC_box" sem="G#DNA_domain_or_region">GC box</cons>) (-20) reduced overall <cons lex="promoter_activity" sem="G#other_name">promoter activity</cons> of the <cons lex="1-kb_fragment" sem="G#DNA_domain_or_region">1-kb fragment</cons>.</sentence>
<sentence>Mutation of the <cons lex="PU.1_site" sem="G#DNA_domain_or_region">PU.1 site</cons> did not significantly affect <cons lex="promoter_activity" sem="G#other_name">promoter activity</cons>.</sentence>
<sentence>Only a small region (-35 to +22) including the <cons lex="Sp1_element" sem="G#DNA_domain_or_region">Sp1 element</cons> and <cons lex="transcription_start_site" sem="G#DNA_domain_or_region">transcription start site</cons>, but not the <cons lex="PU.1_site" sem="G#DNA_domain_or_region">PU.1 site</cons> was footprinted.</sentence>
<sentence>The 4-bp mutation of the core <cons lex="Sp1_consensus_element" sem="G#DNA_domain_or_region">Sp1 consensus element</cons> abolished footprinting at the site and an <cons lex="antibody_super-shift_reaction" sem="G#other_name">antibody super-shift reaction</cons> showed that <cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> is one of the factors binding the <cons lex="consensus_site" sem="G#DNA_domain_or_region">consensus site</cons>.</sentence>
<sentence>The <cons lex="Sp1_site" sem="G#DNA_domain_or_region"><cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> site</cons> also co-localizes with a <cons lex="DNase_I_hypersensitive_site" sem="G#DNA_domain_or_region">DNase I hypersensitive site</cons>.</sentence>
<sentence>The results indicate that <cons lex="DNA_methylation" sem="G#other_name">DNA methylation</cons>, <cons lex="chromatin_structure" sem="G#other_name"><cons lex="chromatin" sem="G#DNA_family_or_group">chromatin</cons> structure</cons>, and <cons lex="transactivation" sem="G#other_name">transactivation</cons> at an <cons lex="Sp1_site" sem="G#DNA_domain_or_region"><cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> site</cons> contribute to the highly restricted expression of this <cons lex="myelomonocytic_lineage_specific_gene" sem="G#DNA_domain_or_region">myelomonocytic lineage specific gene</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97407922</bibliomisc>
</articleinfo>
<title>
<sentence>Critical <cons lex="cytoplasmic_domains" sem="G#protein_domain_or_region">cytoplasmic domains</cons> of <cons lex="human_interleukin-9_receptor_alpha_chain" sem="G#protein_subunit">human interleukin-9 receptor alpha chain</cons> in <cons lex="interleukin-9-mediated_cell_proliferation" sem="G#other_name"><cons lex="interleukin" sem="G#protein_family_or_group">interleukin</cons>-9-mediated cell proliferation</cons> and signal transduction.</sentence>
</title>
<abstract>
<sentence><cons lex="Interleukin-9_receptor_(IL-9R)_complex" sem="G#protein_complex">Interleukin-9 receptor (IL-9R) complex</cons> consists of a <cons lex="ligand-specific_alpha_chain" sem="G#protein_subunit">ligand-specific alpha chain</cons> and <cons lex="IL-2R_gamma_chain" sem="G#protein_subunit">IL-2R gamma chain</cons>.</sentence>
<sentence>In this study, two regions in the <cons lex="cytoplasmic_domain" sem="G#protein_domain_or_region">cytoplasmic domain</cons> of <cons lex="human_IL-9Ralpha" sem="G#protein_subunit">human IL-9Ralpha</cons> were found to be important for <cons lex="IL-9-mediated_cell_growth" sem="G#other_name"><cons lex="IL-9" sem="G#protein_molecule">IL-9</cons>-mediated cell growth</cons>.</sentence>
<sentence>A <cons lex="membrane-proximal_region" sem="G#protein_domain_or_region">membrane-proximal region</cons> that contains the <cons lex="BOX1_consensus_sequence" sem="G#protein_domain_or_region">BOX1 consensus sequence</cons> is required for <cons lex="IL-9-induced_cell_proliferation" sem="G#other_name"><cons lex="IL-9" sem="G#protein_molecule">IL-9</cons>-induced cell proliferation</cons> and <cons lex="tyrosine_phosphorylation" sem="G#other_name"><cons lex="tyrosine" sem="G#amino_acid_monomer">tyrosine</cons> phosphorylation</cons> of <cons lex="Janus_kinase" sem="G#protein_family_or_group">Janus kinases</cons> (<cons lex="JAK" sem="G#protein_family_or_group">JAKs</cons>).</sentence>
<sentence>Deletion of this region or internal deletion of the <cons lex="BOX1_motif" sem="G#protein_domain_or_region">BOX1 motif</cons> abrogated <cons lex="IL-9-induced_cell_proliferation" sem="G#other_name"><cons lex="IL-9" sem="G#protein_molecule">IL-9</cons>-induced cell proliferation</cons> and signal transduction.</sentence>
<sentence>However, substitution of the <cons lex="Pro-X-Pro" sem="G#protein_domain_or_region">Pro-X-Pro</cons> in the <cons lex="BOX1_motif" sem="G#protein_domain_or_region">BOX1 motif</cons> with <cons lex="Ala-X-Ala" sem="G#protein_domain_or_region">Ala-X-Ala</cons> failed to abolish <cons lex="IL-9-induced_cell_proliferation" sem="G#other_name"><cons lex="IL-9" sem="G#protein_molecule">IL-9</cons>-induced cell proliferation</cons> but decreased <cons lex="IL-9" sem="G#protein_molecule">IL-9</cons>-mediated <cons lex="tyrosine_phosphorylation" sem="G#other_name"><cons lex="tyrosine" sem="G#amino_acid_monomer">tyrosine</cons> phosphorylation</cons> of <cons lex="JAK_kinase" sem="G#protein_family_or_group">JAK kinases</cons>, <cons lex="insulin_receptor_substrate-2" sem="G#protein_molecule">insulin receptor substrate-2</cons>, and <cons lex="signal_transducer_and_activator_of_transcription_3" sem="G#protein_molecule">signal transducer and activator of transcription 3</cons> (<cons lex="STAT3" sem="G#protein_molecule">STAT3</cons>) and expression of <cons lex="c-myc" sem="G#DNA_domain_or_region">c-myc</cons> and <cons lex="junB" sem="G#DNA_domain_or_region">junB</cons>.</sentence>
<sentence>Another important region is downstream of the <cons lex="BOX1_motif" sem="G#protein_domain_or_region">BOX1 motif</cons> and contains a <cons lex="STAT3_binding_motif" sem="G#DNA_domain_or_region"><cons lex="STAT3" sem="G#protein_molecule">STAT3</cons> binding motif</cons> <cons lex="YLPQ" sem="G#DNA_domain_or_region">YLPQ</cons>.</sentence>
<sentence>Deletion of this region significantly impaired <cons lex="IL-9-induced_cell_growth" sem="G#other_name"><cons lex="IL-9" sem="G#protein_molecule">IL-9</cons>-induced cell growth</cons>, activation of <cons lex="JAK_kinase" sem="G#protein_family_or_group">JAK kinases</cons>, <cons lex="insulin_receptor_substrate-2" sem="G#protein_molecule">insulin receptor substrate-2</cons>, and <cons lex="STAT3" sem="G#protein_molecule">STAT3</cons> and expression of <cons lex="early_response_gene" sem="G#DNA_family_or_group">early response genes</cons>.</sentence>
<sentence>A point mutation changing <cons lex="YLPQ" sem="G#DNA_domain_or_region">YLPQ</cons> into <cons lex="YLPA" sem="G#DNA_domain_or_region">YLPA</cons> greatly reduced <cons lex="IL-9-induced_activation" sem="G#other_name"><cons lex="IL-9" sem="G#protein_molecule">IL-9</cons>-induced activation</cons> of <cons lex="STAT3" sem="G#protein_molecule">STAT3</cons> and expression of <cons lex="c-myc" sem="G#DNA_domain_or_region">c-myc</cons> but did not affect <cons lex="cell_proliferation" sem="G#other_name">cell proliferation</cons>.</sentence>
<sentence>These results suggest that cooperation or cross-talk of signaling molecules associated with different domains of <cons lex="IL-9Ralpha" sem="G#protein_subunit">IL-9Ralpha</cons> other than <cons lex="STAT3" sem="G#protein_molecule">STAT3</cons> is essential for <cons lex="IL-9-mediated_cell_growth" sem="G#other_name"><cons lex="IL-9" sem="G#protein_molecule">IL-9</cons>-mediated cell growth</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97384936</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="Bcl-2_protein" sem="G#protein_molecule">Bcl-2 protein</cons> inhibits <cons lex="bufalin-induced_apoptosis" sem="G#other_name"><cons lex="bufalin" sem="G#other_organic_compound">bufalin</cons>-induced apoptosis</cons> through inhibition of <cons lex="mitogen-activated_protein_kinase_activation" sem="G#other_name"><cons lex="mitogen-activated_protein_kinase" sem="G#protein_family_or_group">mitogen-activated protein kinase</cons> activation</cons> in <cons lex="human_leukemia_U937_cell" sem="G#cell_line">human leukemia U937 cells</cons>.</sentence>
</title>
<abstract>
<sentence>In a previous study, we demonstrated that <cons lex="bufalin" sem="G#other_organic_compound">bufalin</cons>, which is an active principle of <cons lex="Chinese_medicine" sem="G#other_name">Chinese medicine</cons>, <cons lex="chan'su" sem="G#other_name">chan'su</cons>, caused apoptosis in <cons lex="human_leukemia_U937_cell" sem="G#cell_line">human leukemia U937 cells</cons> by anomalous activation of <cons lex="mitogen-activated_protein_kinase" sem="G#protein_family_or_group">mitogen-activated protein kinase</cons> (<cons lex="MAPK" sem="G#protein_family_or_group">MAPK</cons>) via the signaling pathway of <cons lex="Ras" sem="G#protein_molecule">Ras</cons>, <cons lex="Raf-1" sem="G#protein_molecule">Raf-1</cons>, and <cons lex="MAPK_kinase-1" sem="G#protein_molecule"><cons lex="MAPK" sem="G#protein_family_or_group">MAPK</cons> kinase-1</cons>.</sentence>
<sentence>Here, we report the effect of overexpression of <cons lex="bcl-2" sem="G#protein_molecule">bcl-2</cons> in <cons lex="U937_cell" sem="G#cell_line">U937 cells</cons> on the <cons lex="signaling_pathway" sem="G#other_name">signaling pathway</cons> of <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> that is induced by <cons lex="bufalin" sem="G#other_organic_compound">bufalin</cons>.</sentence>
<sentence>The results indicated that the <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> induced by <cons lex="bufalin" sem="G#other_organic_compound">bufalin</cons> in <cons lex="U937_cell" sem="G#cell_line">U937 cells</cons> was significantly inhibited by overexpression of the <cons lex="Bcl-2_protein" sem="G#protein_molecule">Bcl-2 protein</cons>.</sentence>
<sentence>No significant difference was detected in the activation of <cons lex="MAPK_kinase-1" sem="G#protein_molecule"><cons lex="MAPK" sem="G#protein_family_or_group">MAPK</cons> kinase-1</cons> that is induced by <cons lex="bufalin" sem="G#other_organic_compound">bufalin</cons> in wild-type or <cons lex="Bcl-2-overexpressed_U937_cell" sem="G#cell_type">Bcl-2-overexpressed <cons lex="U937_cell" sem="G#cell_line">U937 cells</cons></cons>; however, the activation of <cons lex="MAPK" sem="G#protein_family_or_group">MAPK</cons> by <cons lex="bufalin" sem="G#other_organic_compound">bufalin</cons> was significantly attenuated in the cells overexpressing <cons lex="Bcl-2" sem="G#protein_molecule">Bcl-2</cons>.</sentence>
<sentence>Bufalin treatment <cons lex="activated_activator_protein-1_transcriptional_activity" sem="G#other_name"><cons lex="activated_activator_protein-1" sem="G#protein_molecule">activated activator protein-1</cons> transcriptional activity</cons>; however, this activation was decreased to 40% in <cons lex="bcl-2" sem="G#protein_molecule">bcl-2</cons>-overexpressed <cons lex="U937_cell" sem="G#cell_line">U937 cells</cons>.</sentence>
<sentence>These results indicate that <cons lex="Bcl-2" sem="G#protein_molecule">Bcl-2</cons> acts downstream of <cons lex="MAPK_kinase-1" sem="G#protein_molecule"><cons lex="MAPK" sem="G#protein_family_or_group">MAPK</cons> kinase-1</cons> but upstream of <cons lex="MAPK" sem="G#protein_family_or_group">MAPK</cons> and suggest that, in the <cons lex="signaling_pathway" sem="G#other_name">signaling pathway</cons> of the apoptotic process induced by <cons lex="bufalin" sem="G#other_organic_compound">bufalin</cons>, the transcriptional activity of <cons lex="activator_protein-1" sem="G#protein_molecule">activator protein-1</cons> may be down-regulated through the inhibition of <cons lex="MAPK" sem="G#protein_family_or_group">MAPK</cons> activity by <cons lex="Bcl-2" sem="G#protein_molecule">Bcl-2</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97375347</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="pancreatic_islet_expression_study" sem="G#other_name"><cons lex="pancreatic_islet_expression" sem="G#other_name"><cons lex="pancreatic_islet" sem="G#body_part">Pancreatic islet</cons> expression</cons> studies</cons> and <cons lex="polymorphic_DNA_marker" sem="G#other_name">polymorphic DNA markers</cons> in the genes encoding <cons lex="(AND hepatocyte_nuclear_factor-3alpha hepatocyte_nuclear_factor-3beta hepatocyte_nuclear_factor-3gamma hepatocyte_nuclear_factor-4gamma hepatocyte_nuclear_factor-6)" sem="(AND G#protein_molecule G#protein_molecule G#protein_molecule G#protein_molecule G#protein_molecule)"><cons lex="hepatocyte_nuclear_factor*">hepatocyte nuclear factor</cons><cons lex="*-3alpha">-3alpha</cons>, <cons lex="*-3beta">-3beta</cons>, <cons lex="*-3gamma">-3gamma</cons>, <cons lex="*-4gamma">-4gamma</cons>, and <cons lex="*-6">-6</cons></cons>.</sentence>
</title>
<abstract>
<sentence>The genes encoding the functionally related <cons lex="hepatocyte_nuclear_factor" sem="G#protein_family_or_group">hepatocyte nuclear factors</cons> <cons lex="HNF-1alpha" sem="G#protein_molecule">HNF-1alpha</cons> and <cons lex="HNF-4alpha" sem="G#protein_molecule">HNF-4alpha</cons> play a critical role in normal <cons lex="pancreatic_beta-cell_function" sem="G#other_name">pancreatic beta-cell function</cons>.</sentence>
<sentence>Mutations in these <cons lex="liver-enriched_transcription_factor" sem="G#protein_family_or_group"><cons lex="liver" sem="G#body_part">liver</cons>-enriched transcription factors</cons> result in two forms of <cons lex="early-onset_type_2_diabetes" sem="G#other_name">early-onset type 2 diabetes</cons> (<cons lex="maturity-onset_diabetes" sem="G#other_name">maturity-onset diabetes</cons> of the young [<cons lex="MODY" sem="G#other_name">MODY</cons>]), <cons lex="MODY3" sem="G#other_name">MODY3</cons> and <cons lex="MODY1" sem="G#other_name">MODY1</cons>, which are characterized by impaired <cons lex="glucose-stimulated_insulin_secretion" sem="G#other_name">glucose-stimulated insulin secretion</cons>, early disease onset, and <cons lex="autosomal_dominant_inheritance" sem="G#other_name">autosomal dominant inheritance</cons>.</sentence>
<sentence>The <cons lex="transcriptional_hierarchy" sem="G#other_name">transcriptional hierarchy</cons> of <cons lex="HNF" sem="G#other_name">HNFs</cons> suggests that other proteins of the <cons lex="regulatory_cascade" sem="G#other_name">regulatory cascade</cons> might be responsible for other forms of <cons lex="MODY" sem="G#other_name">MODY</cons> and/or <cons lex="late-onset_type_2_diabetes" sem="G#other_name">late-onset type 2 diabetes</cons>.</sentence>
<sentence>In this study, we show that <cons lex="(AND HNF-3alpha HNF-3beta HNF-3gamma HNF-4gamma HNF-6)" sem="(AND G#protein_molecule G#protein_molecule G#protein_molecule G#protein_molecule G#protein_molecule)"><cons lex="HNF*">HNF</cons><cons lex="*-3alpha">-3alpha</cons>, <cons lex="*-3beta">-3beta</cons>, <cons lex="*-3gamma">-3gamma</cons>, <cons lex="*-4gamma">-4gamma</cons>, and <cons lex="*-6">-6</cons></cons> are expressed in <cons lex="pancreatic_beta-cell" sem="G#cell_type">pancreatic beta-cells</cons>.</sentence>
<sentence>We report the identification and characterization of <cons lex="simple_tandem_repeat_DNA_polymorphism" sem="G#DNA_family_or_group">simple tandem repeat DNA polymorphisms</cons> in the genes encoding <cons lex="HNF-3alpha" sem="G#protein_molecule">HNF-3alpha</cons>, <cons lex="HNF-3beta" sem="G#protein_molecule">-3beta</cons>, <cons lex="HNF-3gamma" sem="G#protein_molecule">-3gamma</cons>, <cons lex="HNF-4gamma" sem="G#protein_molecule">-4gamma</cons>, and <cons lex="HNF-6" sem="G#protein_molecule">-6</cons> and the mapping of <cons lex="HNF-6" sem="G#protein_molecule">HNF-6</cons> to <cons lex="chromosome_band" sem="G#DNA_domain_or_region">chromosome bands</cons> <cons lex="15q21.1-21.2" sem="G#DNA_domain_or_region">15q21.1-21.2</cons> by <cons lex="fluorescence_in_situ_hybridization" sem="G#other_name">fluorescence in situ hybridization</cons>.</sentence>
<sentence>These markers will be useful to study the role of <cons lex="genetic_variation" sem="G#other_name">genetic variation</cons> in these genes in the pathogenesis of <cons lex="type_2_diabetes" sem="G#other_name">type 2 diabetes</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97387731</bibliomisc>
</articleinfo>
<title>
<sentence>Induction of <cons lex="nuclear_factor_kappa_B/Rel_nuclear_activity" sem="G#other_name"><cons lex="nuclear_factor_kappa_B/Rel" sem="G#protein_molecule">nuclear factor kappa B/Rel</cons> nuclear activity</cons> in <cons lex="human_peripheral_blood_T_lymphocyte" sem="G#cell_type">human peripheral blood T lymphocytes</cons> by <cons lex="anti-HLA_class_I_monoclonal_antibody" sem="G#protein_family_or_group">anti-HLA class I monoclonal antibodies</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="monoclonal_antibody" sem="G#other_name">Monoclonal antibodies</cons> against either <cons lex="(OR monomorphic_determinant polymorphic_determinant)" sem="(OR G#other_name G#other_name)"><cons lex="monomorphic*">monomorphic</cons> or <cons lex="polymorphic*">polymorphic</cons> <cons lex="*determinant">determinants</cons></cons> of <cons lex="class_I_antigen" sem="G#protein_family_or_group">class I antigen</cons> induced in <cons lex="PBMC" sem="G#cell_type">PBMC</cons> and highly <cons lex="purified_T_lymphocyte" sem="G#cell_type">purified T lymphocytes</cons> the nuclear activity of <cons lex="NF-kappa_B/Rel_complex" sem="G#protein_complex">NF-kappa B/Rel complexes</cons>.</sentence>
<sentence>These included both <cons lex="p50/p50" sem="G#protein_complex">p50/p50</cons> and <cons lex="p50/p65_dimer" sem="G#protein_complex">p50/p65 dimers</cons>, recognized by <cons lex="specific_antibody" sem="G#protein_family_or_group">specific antibodies</cons> in <cons lex="EMSA" sem="G#other_name">EMSA</cons>.</sentence>
<sentence>The induced <cons lex="complex" sem="G#protein_complex">complexes</cons> were detectable in <cons lex="extract" sem="G#cell_component">extracts</cons> of cells incubated with <cons lex="anti-class_I_monoclonal_antibody" sem="G#protein_family_or_group">anti-class I monoclonal antibody</cons> (<cons lex="mAb" sem="G#protein_family_or_group">mAb</cons>) for 1.5 h; the induction was maximal at 5 h, persistent at 16 h and no longer observed at 40 h.</sentence>
<sentence>The <cons lex="mAb" sem="G#protein_family_or_group">mAb</cons> failed to induce <cons lex="NF-kappa_B/Rel_nuclear_activity" sem="G#other_name"><cons lex="NF-kappa_B/Rel" sem="G#protein_complex">NF-kappa B/Rel</cons> nuclear activity</cons> in cells incubated in the presence of <cons lex="3,4-dichloroisocoumarin" sem="G#other_organic_compound">3,4-dichloroisocoumarin</cons>, an inhibitor of <cons lex="I_kappa_B-alpha_degradation" sem="G#other_name"><cons lex="I_kappa_B-alpha" sem="G#protein_molecule">I kappa B-alpha</cons> degradation</cons>.</sentence>
<sentence>Together, these results suggest that <cons lex="class_I_triggering" sem="G#other_name">class I triggering</cons> can induce the activity of <cons lex="NF-kappa_B/Rel_nuclear_activity" sem="G#other_name"><cons lex="NF-kappa_B/Rel" sem="G#protein_complex">NF-kappa B/Rel</cons> nuclear activity</cons> in <cons lex="peripheral_blood_T_lymphocyte" sem="G#cell_type">peripheral blood T lymphocytes</cons>, thereby modulating the expression of genes regulated by these <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97342767</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="Anti-Ehrlichia_chaffeensis_antibody" sem="G#protein_family_or_group">Anti-Ehrlichia chaffeensis antibody</cons> complexed with <cons lex="E._chaffeensis" sem="G#mono_cell">E. chaffeensis</cons> induces <cons lex="potent_proinflammatory_cytokine_mRNA_expression" sem="G#other_name">potent <cons lex="proinflammatory_cytokine_mRNA" sem="G#RNA_molecule">proinflammatory cytokine mRNA</cons> expression</cons> in <cons lex="human_monocyte" sem="G#cell_type">human monocytes</cons> through sustained reduction of <cons lex="IkappaB-alpha" sem="G#protein_molecule">IkappaB-alpha</cons> and activation of <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="Ehrlichia_chaffeensis" sem="G#mono_cell">Ehrlichia chaffeensis</cons> is an <cons lex="obligatory_intracellular_bacterium" sem="G#mono_cell">obligatory intracellular bacterium</cons> that infects <cons lex="monocyte" sem="G#cell_type">monocytes</cons> and <cons lex="macrophage" sem="G#cell_type">macrophages</cons> and is the etiologic agent of <cons lex="human_ehrlichiosis" sem="G#mono_cell">human ehrlichiosis</cons> in the <cons lex="United_States" sem="G#other_name">United States</cons>.</sentence>
<sentence>Our previous studies showed that the exposure of <cons lex="human_monocyte" sem="G#cell_type">human <cons lex="monocyte" sem="G#cell_type">monocytes</cons></cons> to <cons lex="E._chaffeensis" sem="G#mono_cell">E. chaffeensis</cons> induces the expression of <cons lex="interleukin-1beta" sem="G#protein_molecule">interleukin-1beta</cons> (<cons lex="IL-1beta" sem="G#protein_molecule">IL-1beta</cons>), <cons lex="IL-8" sem="G#protein_molecule">IL-8</cons>, and <cons lex="IL-10_gene" sem="G#DNA_domain_or_region"><cons lex="IL-10" sem="G#protein_molecule">IL-10</cons> genes</cons> in vitro but not the expression of <cons lex="(AND tumor_necrosis_factor_alpha_(TNF-alpha)_mRNA IL-6_mRNA)" sem="(AND G#RNA_molecule G#RNA_molecule)"><cons lex="tumor_necrosis_factor_alpha_(TNF-alpha)*">tumor necrosis factor alpha (TNF-alpha)</cons> and <cons lex="IL-6*">IL-6</cons> <cons lex="*mRNA">mRNAs</cons></cons>.</sentence>
<sentence>In this study, the effect of <cons lex="anti-E." sem="G#protein_molecule">anti-<cons lex="E._chaffeensis" sem="G#mono_cell">E. chaffeensis</cons> antibody</cons> complexed with <cons lex="E._chaffeensis" sem="G#mono_cell">E. chaffeensis</cons> on the expression of <cons lex="major_proinflammatory_cytokine" sem="G#protein_family_or_group">major proinflammatory cytokines</cons> in <cons lex="human_monocyte" sem="G#cell_type">human monocytes</cons> was examined.</sentence>
<sentence><cons lex="human_monocytic_cell_line_THP-1" sem="G#cell_line">Human monocytic cell line THP-1</cons> was treated with <cons lex="E._chaffeensis" sem="G#mono_cell">E. chaffeensis</cons> which had been preincubated with <cons lex="human_anti-E." sem="G#tissue">human anti-<cons lex="E._chaffeensis" sem="G#mono_cell">E. chaffeensis</cons> serum</cons> for 2 h, and the levels of <cons lex="cytokine_mRNA" sem="G#RNA_family_or_group">cytokine mRNAs</cons> were evaluated by competitive <cons lex="reverse_transcription-PCR" sem="G#other_name">reverse transcription-PCR</cons>.</sentence>
<sentence><cons lex="anti-E." sem="G#protein_molecule">Anti-<cons lex="E._chaffeensis" sem="G#mono_cell">E. chaffeensis</cons> antibody</cons> complexed with E. chaffeensis significantly enhanced <cons lex="mRNA_expression" sem="G#other_name">mRNA expression</cons> of <cons lex="IL-1beta" sem="G#protein_molecule">IL-1beta</cons> in <cons lex="THP-1_cell" sem="G#cell_line">THP-1 cells</cons>.</sentence>
<sentence>The expression of <cons lex="(AND TNF-alpha_mRNA IL-6_mRNA)" sem="(AND G#RNA_molecule G#RNA_molecule)"><cons lex="TNF-alpha*">TNF-alpha</cons> and <cons lex="IL-6*">IL-6</cons> <cons lex="*mRNA">mRNAs</cons></cons> was also induced.</sentence>
<sentence>The levels of secreted <cons lex="IL-1beta" sem="G#protein_molecule">IL-1beta</cons>, <cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons>, and <cons lex="IL-6" sem="G#protein_molecule">IL-6</cons> during 24 h of stimulation were comparable to those induced by <cons lex="Escherichia_coli_lipopolysaccharide" sem="G#lipid"><cons lex="Escherichia_coli" sem="G#mono_cell">Escherichia coli</cons> lipopolysaccharide</cons> at 1 microg/ml.</sentence>
<sentence>Fab fragment of <cons lex="anti-E._chaffeensis_immunoglobulin_G" sem="G#protein_molecule">anti-<cons lex="E._chaffeensis" sem="G#mono_cell">E. chaffeensis</cons> immunoglobulin G</cons> complexed with <cons lex="E._chaffeensis" sem="G#mono_cell">E. chaffeensis</cons> did not induce any of these three cytokines, indicating that ehrlichial binding is required for <cons lex="IL-1beta_mRNA_expression" sem="G#other_name"><cons lex="IL-1beta_mRNA" sem="G#RNA_molecule"><cons lex="IL-1beta" sem="G#protein_molecule">IL-1beta</cons> mRNA</cons> expression</cons> and that binding of the <cons lex="immune_complex" sem="G#protein_complex">immune complex</cons> to the <cons lex="Fc_gamma_receptor" sem="G#protein_family_or_group">Fc gamma receptor</cons> is required for <cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons> and <cons lex="IL-6_mRNA_expression" sem="G#other_name"><cons lex="IL-6_mRNA" sem="G#RNA_molecule"><cons lex="IL-6" sem="G#protein_molecule">IL-6</cons> mRNA</cons> expression</cons> and enhanced <cons lex="IL-1beta_mRNA_expression" sem="G#other_name"><cons lex="IL-1beta_mRNA" sem="G#RNA_molecule"><cons lex="IL-1beta" sem="G#protein_molecule">IL-1beta</cons> mRNA</cons> expression</cons>.</sentence>
<sentence>Furthermore, prolonged degradation of <cons lex="IkappaB-alpha" sem="G#protein_molecule">IkappaB-alpha</cons> and activation of <cons lex="NF-kappaB" sem="G#protein_molecule">NF-kappaB</cons> were demonstrated in <cons lex="THP-1_cell" sem="G#cell_line">THP-1 cells</cons> exposed to <cons lex="anti-E._chaffeensis_serum" sem="G#tissue">anti-<cons lex="E._chaffeensis" sem="G#mono_cell">E. chaffeensis</cons> serum</cons> and <cons lex="E._chaffeensis" sem="G#mono_cell">E. chaffeensis</cons>.</sentence>
<sentence>This result implies that development of <cons lex="anti-E._chaffeensis_antibody" sem="G#protein_molecule">anti-<cons lex="E._chaffeensis" sem="G#mono_cell">E. chaffeensis</cons> antibody</cons> in patients can result in the production of <cons lex="major_proinflammatory_cytokine" sem="G#protein_family_or_group">major proinflammatory cytokines</cons>, which may play an important role in the pathophysiology of <cons lex="ehrlichiosis" sem="G#mono_cell">ehrlichiosis</cons> and <cons lex="immune_response" sem="G#other_name">immune responses</cons> to it.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97315348</bibliomisc>
</articleinfo>
<title>
<sentence>The <cons lex="class_II_trans-activator_CIITA" sem="G#protein_molecule">class II trans-activator <cons lex="CIITA" sem="G#protein_molecule">CIITA</cons></cons> interacts with the <cons lex="TBP-associated_factor_TAFII32" sem="G#protein_molecule">TBP-associated factor <cons lex="TAFII32" sem="G#protein_molecule">TAFII32</cons></cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="class_II_trans-activator" sem="G#protein_family_or_group">class II trans- activator</cons> (<cons lex="CIITA" sem="G#protein_molecule">CIITA</cons>) is the main transcriptional co-activator for the expression of <cons lex="MHC_class_II_protein" sem="G#protein_family_or_group">MHC class II proteins</cons>.</sentence>
<sentence>Its <cons lex="N-terminal_125_amino_acid" sem="G#protein_domain_or_region">N-terminal 125 amino acids</cons> function as an <cons lex="independent_transcriptional_activation_domain" sem="G#protein_domain_or_region">independent transcriptional activation domain</cons>.</sentence>
<sentence>Analyses of the <cons lex="primary_amino_acid_sequence" sem="G#protein_domain_or_region">primary amino acid sequence</cons> of the <cons lex="activation_domain" sem="G#protein_domain_or_region">activation domain</cons> predict the presence of three <cons lex="alpha-helice" sem="G#protein_substructure">alpha-helices</cons>, each with a high proportion of <cons lex="acidic_residue" sem="G#amino_acid_monomer">acidic residues</cons>.</sentence>
<sentence>Using site-directed mutagenesis, we found that two of these predicted <cons lex="alpha-helice" sem="G#protein_substructure">alpha-helices</cons> are required for full <cons lex="transcriptional_activation" sem="G#other_name">transcriptional activation</cons> by <cons lex="CIITA" sem="G#protein_molecule">CIITA</cons>.</sentence>
<sentence>Moreover, a <cons lex="CIITA_protein" sem="G#protein_molecule"><cons lex="CIITA" sem="G#protein_molecule">CIITA</cons> protein</cons> in which both functional <cons lex="alpha-helice" sem="G#protein_substructure">alpha-helices</cons> have been deleted displays a <cons lex="dominant_negative_phenotype" sem="G#other_name">dominant negative phenotype</cons>.</sentence>
<sentence>This <cons lex="activation_domain" sem="G#protein_domain_or_region">activation domain</cons> of <cons lex="CIITA" sem="G#protein_molecule">CIITA</cons> interacts with the <cons lex="32_kDa_subunit" sem="G#protein_subunit">32 kDa subunit</cons> of the <cons lex="general_transcription_complex" sem="G#protein_complex">general transcription complex</cons> <cons lex="TFIID" sem="G#protein_complex">TFIID</cons>, <cons lex="TAFII32" sem="G#protein_molecule">TAFII32</cons>.</sentence>
<sentence>Decreased transcriptional activation by <cons lex="N-terminal_deletion" sem="G#protein_domain_or_region">N-terminal deletions</cons> of <cons lex="CIITA" sem="G#protein_molecule">CIITA</cons> is correlated directly with their reduced binding to <cons lex="TAFII32" sem="G#protein_molecule">TAFII32</cons>.</sentence>
<sentence>We conclude that interactions between <cons lex="TAFII32" sem="G#protein_molecule">TAFII32</cons> and <cons lex="CIITA" sem="G#protein_molecule">CIITA</cons> are responsible for activation of <cons lex="class_II_gene" sem="G#DNA_domain_or_region">class II genes</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97309442</bibliomisc>
</articleinfo>
<title>
<sentence>Characterization of <cons lex="interleukin-10_receptor_expression" sem="G#other_name"><cons lex="interleukin-10_receptor" sem="G#protein_molecule">interleukin-10 receptor</cons> expression</cons> on <cons lex="B-cell_chronic_lymphocytic_leukemia_cell" sem="G#cell_line">B-cell chronic lymphocytic leukemia cells</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="B-cell_chronic_lymphocytic_leukemia_(B-CLL)_cell" sem="G#cell_line">B-cell chronic lymphocytic leukemia (B-CLL) cells</cons> accumulate in vivo in the <cons lex="G0/G1_phase" sem="G#other_name">G0/G1 phase</cons> of the <cons lex="cell_cycle" sem="G#other_name">cell cycle</cons>, suggesting that their malignant expansion is due, at least in part, to a delay in <cons lex="cell_death" sem="G#other_name">cell death</cons>.</sentence>
<sentence>However, the cellular or <cons lex="molecular_factor" sem="G#protein_family_or_group">molecular factors</cons> responsible for a delay in <cons lex="B-CLL_cell_death" sem="G#other_name">B-CLL <cons lex="cell_death" sem="G#other_name">cell death</cons></cons> are unknown.</sentence>
<sentence>B-CLL cells do express receptors for <cons lex="interferon-alpha" sem="G#protein_molecule">interferon-alpha</cons> (<cons lex="IFN-alpha" sem="G#protein_molecule">IFN-alpha</cons>) and <cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons>, and activation of both has been shown to <cons lex="promote_B-CLL_survival" sem="G#other_name">promote B-CLL survival</cons> in vitro by preventing <cons lex="apoptosis" sem="G#other_name">apoptosis</cons>.</sentence>
<sentence>The <cons lex="interleukin-10_(IL-10)_receptor" sem="G#protein_molecule">interleukin-10 (IL-10) receptor</cons> is another member of the <cons lex="IFN_receptor_family" sem="G#protein_family_or_group">IFN receptor family</cons>, but its ligand, <cons lex="IL-10" sem="G#protein_molecule">IL-10</cons>, has been reported to induce <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> in <cons lex="B-CLL_cell" sem="G#cell_line">B-CLL cells</cons>.</sentence>
<sentence>In the current study, we undertook a biochemical analysis of <cons lex="IL-10_receptor_expression" sem="G#other_name"><cons lex="IL-10_receptor" sem="G#protein_molecule">IL-10 receptor</cons> expression</cons> on freshly isolated <cons lex="B-CLL_cell" sem="G#cell_line">B-CLL cells</cons> and characterized the functional responsiveness of <cons lex="IL-10" sem="G#protein_molecule">IL-10</cons> binding to its <cons lex="constitutively_expressed_receptor" sem="G#protein_family_or_group">constitutively expressed receptor</cons>.</sentence>
<sentence>We show that <cons lex="B-CLL_cell" sem="G#cell_line">B-CLL cells</cons> bind <cons lex="IL-10" sem="G#protein_molecule">IL-10</cons> with significant specificity and express between 47 and 127 <cons lex="IL-10_receptor_site" sem="G#cell_component"><cons lex="IL-10_receptor" sem="G#protein_molecule">IL-10 receptor</cons> sites</cons> per cell, with a dissociation constant in the range of 168 to 426 x 10(-12) mol/L.</sentence>
<sentence>Ligand binding and activation of the <cons lex="IL-10_receptor" sem="G#protein_molecule">IL-10 receptor</cons> expressed on <cons lex="B-CLL_cell" sem="G#cell_line">B-CLL cells</cons> results in the phosphorylation of <cons lex="signal_transducer_and_activator_of_transcription_1" sem="G#protein_molecule">signal transducer and activator of transcription 1</cons> (<cons lex="STAT1" sem="G#protein_molecule">STAT1</cons>) and <cons lex="STAT3" sem="G#protein_molecule">STAT3</cons> proteins.</sentence>
<sentence>This pattern of <cons lex="STAT_protein_phosphorylation" sem="G#other_name"><cons lex="STAT_protein" sem="G#protein_family_or_group">STAT protein</cons> phosphorylation</cons> is identical to <cons lex="IL-10_receptor_activation" sem="G#other_name"><cons lex="IL-10_receptor" sem="G#protein_molecule">IL-10 receptor</cons> activation</cons> on <cons lex="normal_cell" sem="G#cell_type">normal cells</cons> and similar to <cons lex="IFN-alpha" sem="G#protein_molecule">IFN-alpha</cons> (<cons lex="STAT1" sem="G#protein_molecule">STAT1</cons> and <cons lex="STAT3" sem="G#protein_molecule">STAT3</cons>) and <cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons> (<cons lex="STAT1" sem="G#protein_molecule">STAT1</cons>) <cons lex="receptor_activation" sem="G#other_name">receptor activation</cons> in <cons lex="CLL" sem="G#cell_line">CLL</cons>.</sentence>
<sentence>Further, in consecutive samples of <cons lex="fresh_blood" sem="G#tissue">fresh blood</cons> obtained from patients with <cons lex="B-CLL_cell" sem="G#cell_line">B-CLL cells</cons>, the addition of <cons lex="IL-10" sem="G#protein_molecule">IL-10</cons> inhibited <cons lex="B-CLL_proliferation" sem="G#other_name"><cons lex="B-CLL" sem="G#cell_line">B-CLL</cons> proliferation</cons>, enhanced <cons lex="B-CLL_differentiation" sem="G#other_name"><cons lex="B-CLL" sem="G#cell_line">B-CLL</cons> differentiation</cons>, but did not induce <cons lex="apoptosis" sem="G#other_name">apoptosis</cons>.</sentence>
<sentence>Indeed, <cons lex="IL-10" sem="G#protein_molecule">IL-10</cons>, like <cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons>, was able to significantly reduce the amount of <cons lex="B-CLL_cell_death" sem="G#other_name">B-CLL <cons lex="cell_death" sem="G#other_name">cell death</cons></cons> caused by <cons lex="hydrocortisone-induced_apoptosis" sem="G#other_name">hydrocortisone-induced <cons lex="apoptosis" sem="G#other_name">apoptosis</cons></cons>.</sentence>
<sentence>We conclude that <cons lex="cytokine" sem="G#protein_family_or_group">cytokines</cons>, which signal through the <cons lex="interferon_family" sem="G#protein_family_or_group">interferon family</cons> of receptors, have comparable functional effects on <cons lex="B-CLL_cell" sem="G#cell_line">B-CLL cells</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97293200</bibliomisc>
</articleinfo>
<title>
<sentence>Involvement of the <cons lex="N-terminal_region" sem="G#protein_domain_or_region">N-terminal region</cons> of the <cons lex="human_mineralocorticoid_receptor_hormone-binding_domain" sem="G#protein_domain_or_region">human mineralocorticoid receptor hormone-binding domain</cons> in agonist and antagonist binding as revealed by a <cons lex="new_monoclonal_antibody" sem="G#protein_family_or_group">new monoclonal antibody</cons>.</sentence>
</title>
<abstract>
<sentence>To gain a better understanding of the mechanism of binding to the <cons lex="human_mineralocorticoid_receptor" sem="G#protein_family_or_group">human mineralocorticoid receptor</cons> (<cons lex="hMR" sem="G#protein_family_or_group">hMR</cons>), we developed a new <cons lex="monoclonal_antibody" sem="G#protein_family_or_group">monoclonal antibody</cons> (<cons lex="mAb" sem="G#protein_family_or_group">mAb</cons>) raised against the <cons lex="hormone-binding_domain" sem="G#protein_domain_or_region">hormone-binding domain</cons> (<cons lex="HBD" sem="G#protein_domain_or_region">HBD</cons>).</sentence>
<sentence>For this purpose, <cons lex="mouse" sem="G#multi_cell">mice</cons> were immunized with a <cons lex="fusion_protein" sem="G#protein_complex">fusion protein</cons> including the sequence <cons lex="Thr729-Lys984" sem="G#protein_domain_or_region">Thr729-Lys984</cons> of <cons lex="hMR" sem="G#protein_family_or_group">hMR</cons>.</sentence>
<sentence>After <cons lex="ELISA_screening" sem="G#other_name">ELISA screening</cons>, <cons lex="mAb_18C7" sem="G#protein_molecule">mAb 18C7</cons> was selected for its specificity towards the <cons lex="HBD" sem="G#protein_domain_or_region">HBD</cons>.</sentence>
<sentence>This antibody recognized both the denatured and <cons lex="native_MR_form" sem="G#protein_family_or_group">native MR forms</cons>, as well as the <cons lex="hetero-oligomeric_MR_form" sem="G#protein_molecule">hetero-oligomeric MR form</cons> and the <cons lex="transformed_MR_state" sem="G#protein_molecule">transformed MR state</cons>.</sentence>
<sentence>By using several <cons lex="HBD_subfragment" sem="G#protein_subunit">HBD subfragments</cons>, the <cons lex="mAb_18C7_epitope" sem="G#protein_domain_or_region"><cons lex="mAb_18C7" sem="G#protein_molecule">mAb 18C7</cons> epitope</cons> was located in the <cons lex="N-terminal_region" sem="G#protein_domain_or_region">N-terminal region</cons> of the <cons lex="HBD" sem="G#protein_domain_or_region">HBD</cons> from <cons lex="Thr729_to_Leu765" sem="G#protein_domain_or_region">Thr729 to Leu765</cons>.</sentence>
<sentence>We then studied the effect of the antibody on <cons lex="aldosterone" sem="G#lipid">aldosterone</cons> and <cons lex="progesterone" sem="G#lipid">progesterone</cons> binding to the <cons lex="hMR" sem="G#protein_family_or_group">hMR</cons>.</sentence>
<sentence>When <cons lex="18C7" sem="G#protein_molecule">18C7</cons> was incubated with <cons lex="liganded_MR" sem="G#protein_molecule">liganded MR</cons>, it was able to partly displace (20%) the hormone from its binding site.</sentence>
<sentence>When <cons lex="18C7" sem="G#protein_molecule">18C7</cons> was incubated with <cons lex="MR" sem="G#protein_molecule">MR</cons> before <cons lex="aldosterone" sem="G#lipid">aldosterone</cons> or <cons lex="progesterone" sem="G#lipid">progesterone</cons>, the antibody inhibited 75-80% of the binding.</sentence>
<sentence>The effect of <cons lex="18C7" sem="G#protein_molecule">18C7</cons> on the binding was similar with both hormones.</sentence>
<sentence>A sucrose gradient analysis indicated the simultaneous presence of two kinds of receptor complexes: the <cons lex="steroid-MR_complex" sem="G#protein_complex">steroid-MR complex</cons> and the <cons lex="antibody-MR_complex" sem="G#protein_complex">antibody-MR complex</cons>.</sentence>
<sentence>After its associated proteins, especially the <cons lex="heat-shock_protein_hsp90" sem="G#protein_molecule">heat-shock protein hsp90</cons>, had been cross-linked with the <cons lex="hMR" sem="G#protein_family_or_group">hMR</cons> by <cons lex="dimethylpimelimidate" sem="G#other_organic_compound">dimethylpimelimidate</cons>, <cons lex="18C7" sem="G#protein_molecule">18C7</cons> was still able to react with the receptor.</sentence>
<sentence>Our results indicated that the <cons lex="epitope" sem="G#protein_domain_or_region">epitope</cons> recognized by <cons lex="18C7" sem="G#protein_molecule">18C7</cons> was directly implicated in hormone binding.</sentence>
<sentence>The lack of steroid binding of <cons lex="HBD" sem="G#protein_domain_or_region">HBD</cons> mutants with the <cons lex="Thr729-Leu765_sequence" sem="G#protein_domain_or_region">Thr729-Leu765 sequence</cons> deleted [Jalaguier, Mesnier, Leger and Auzou (1996) J.Steroid Biochem.Mol.Biol.57, 43-50] supports this hypothesis.</sentence>
<sentence>Because of the similar behaviours of <cons lex="aldosterone" sem="G#lipid">aldosterone</cons> and <cons lex="progesterone" sem="G#lipid">progesterone</cons>, we conclude that the <cons lex="N-terminal_Thr729-Leu765_region" sem="G#protein_domain_or_region">N-terminal Thr729-Leu765 region</cons> of the <cons lex="HBD" sem="G#protein_domain_or_region">HBD</cons> is similarly involved in the binding of both hormones.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97277292</bibliomisc>
</articleinfo>
<title>
<sentence>Molecular cloning of <cons lex="SLAP-130" sem="G#protein_molecule">SLAP-130</cons>, an <cons lex="SLP-76-associated_substrate" sem="G#protein_molecule">SLP-76-associated substrate</cons> of the <cons lex="T_cell_antigen_receptor-stimulated_protein_tyrosine_kinase" sem="G#protein_family_or_group">T cell antigen receptor-stimulated protein <cons lex="tyrosine" sem="G#amino_acid_monomer">tyrosine</cons> kinases</cons>.</sentence>
</title>
<abstract>
<sentence>Previous work has demonstrated that <cons lex="SLP-76" sem="G#protein_molecule">SLP-76</cons>, a <cons lex="Grb2-associated_tyrosine-phosphorylated_protein" sem="G#protein_molecule">Grb2-associated <cons lex="tyrosine" sem="G#amino_acid_monomer">tyrosine</cons>-phosphorylated protein</cons>, augments <cons lex="Interleukin-2_promoter_activity" sem="G#other_name"><cons lex="Interleukin-2_promoter" sem="G#DNA_domain_or_region">Interleukin-2 promoter</cons> activity</cons> when overexpressed in the <cons lex="Jurkat_T_cell_line" sem="G#cell_line">Jurkat T cell line</cons>.</sentence>
<sentence>This activity requires regions of <cons lex="SLP-76" sem="G#protein_molecule">SLP-76</cons> that mediate <cons lex="protein-protein_interactions" sem="G#other_name">protein-protein interactions</cons> with other molecules in <cons lex="T_cell" sem="G#cell_type">T cells</cons>, suggesting that <cons lex="SLP-76" sem="G#protein_molecule">SLP-76</cons>-associated proteins also function to regulate signal transduction.</sentence>
<sentence>Here we describe the molecular cloning of <cons lex="SLAP-130" sem="G#protein_molecule">SLAP-130</cons>, a <cons lex="SLP-76-associated_phosphoprotein" sem="G#protein_molecule"><cons lex="SLP-76" sem="G#protein_molecule">SLP-76</cons>-associated phosphoprotein</cons> of 130 kDa.</sentence>
<sentence>We demonstrate that <cons lex="SLAP-130" sem="G#protein_molecule">SLAP-130</cons> is hematopoietic cell-specific and associates with the <cons lex="SH2_domain" sem="G#protein_domain_or_region">SH2 domain</cons> of <cons lex="SLP-76" sem="G#protein_molecule">SLP-76</cons>.</sentence>
<sentence>Additionally, we show that <cons lex="SLAP-130" sem="G#protein_molecule">SLAP-130</cons> is a substrate of the <cons lex="T_cell_antigen_receptor-induced_protein" sem="G#protein_molecule">T cell antigen receptor-induced protein</cons> <cons lex="tyrosine_kinase" sem="G#protein_family_or_group"><cons lex="tyrosine" sem="G#amino_acid_monomer">tyrosine</cons> kinases</cons>.</sentence>
<sentence>Interestingly, we find that in contrast to <cons lex="SLP-76" sem="G#protein_molecule">SLP-76</cons>, overexpression of <cons lex="SLAP-130" sem="G#protein_molecule">SLAP-130</cons> diminishes <cons lex="T_cell_antigen_receptor-induced_activation" sem="G#other_name"><cons lex="T_cell_antigen_receptor" sem="G#protein_family_or_group">T cell antigen receptor</cons>-induced activation</cons> of the <cons lex="interleukin-2_promoter" sem="G#DNA_domain_or_region">interleukin-2 promoter</cons> in <cons lex="Jurkat_T_cell" sem="G#cell_line">Jurkat T cells</cons> and interferes with the augmentation of <cons lex="interleukin-2_promoter" sem="G#DNA_domain_or_region">interleukin-2 promoter</cons> activity seen when <cons lex="SLP-76" sem="G#protein_molecule">SLP-76</cons> is overexpressed in these cells.</sentence>
<sentence>These data suggest that <cons lex="SLP-76" sem="G#protein_molecule">SLP-76</cons> recruits a negative regulator, <cons lex="SLAP-130" sem="G#protein_molecule">SLAP-130</cons>, as well as positive regulators of <cons lex="signal_transduction" sem="G#other_name">signal transduction</cons> in <cons lex="T_cell" sem="G#cell_type">T cells</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97287044</bibliomisc>
</articleinfo>
<title>
<sentence>Molecular actions of <cons lex="prolactin" sem="G#peptide">prolactin</cons> in the <cons lex="immune_system" sem="G#body_part">immune system</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="immunoregulatory_property" sem="G#other_name"><cons lex="immunoregulatory_cytokine" sem="G#protein_family_or_group">immunoregulatory</cons> properties</cons> of <cons lex="prolactin" sem="G#peptide">prolactin</cons>, a <cons lex="pituitary_peptide_hormone" sem="G#peptide">pituitary peptide hormone</cons>, have received renewed attention.</sentence>
<sentence>The <cons lex="prolactin_receptor" sem="G#protein_molecule"><cons lex="prolactin" sem="G#peptide">prolactin</cons> receptor</cons>, a member of the <cons lex="hematopoietin/cytokine_receptor_superfamily" sem="G#protein_family_or_group">hematopoietin/cytokine receptor superfamily</cons>, is ubiquitously expressed by cells in the <cons lex="immune_system" sem="G#body_part">immune system</cons>.</sentence>
<sentence>Certain subpopulations of <cons lex="lymphocyte" sem="G#cell_type">lymphocytes</cons> synthesize and secrete biologically active <cons lex="prolactin" sem="G#amino_acid_monomer"><cons lex="prolactin" sem="G#peptide">prolactin</cons></cons>, which suggests that <cons lex="prolactin" sem="G#peptide">prolactin</cons> can act as an autocrine and/or paracrine factor to modulate the activities of cells of the <cons lex="immune_system" sem="G#body_part">immune system</cons>.</sentence>
<sentence>This review focuses on the <cons lex="molecular_action" sem="G#other_name">molecular actions</cons> of <cons lex="prolactin" sem="G#amino_acid_monomer"><cons lex="prolactin" sem="G#peptide">prolactin</cons></cons> in the <cons lex="immune_system" sem="G#body_part">immune system</cons>.</sentence>
<sentence>Emphasis is given to recent information about the <cons lex="molecular_mechanism" sem="G#other_name">molecular mechanisms</cons> of <cons lex="prolactin_receptor_signal_transduction" sem="G#other_name"><cons lex="prolactin" sem="G#amino_acid_monomer"><cons lex="prolactin" sem="G#peptide">prolactin</cons></cons> receptor signal transduction</cons>, and the <cons lex="signaling_molecule" sem="G#protein_family_or_group">signaling molecules</cons> and <cons lex="prolactin-inducible_target_gene" sem="G#DNA_domain_or_region"><cons lex="prolactin" sem="G#amino_acid_monomer"><cons lex="prolactin" sem="G#peptide">prolactin</cons></cons>-inducible target genes</cons> that participate in these responses.</sentence>
<sentence>In particular, the <cons lex="prolactin-inducible_interferon_regulatory_factor-1_gene" sem="G#DNA_domain_or_region"><cons lex="prolactin" sem="G#peptide">prolactin</cons>-inducible interferon regulatory factor-1 gene</cons> and its roles in <cons lex="mediating_diverse_immune_response" sem="G#other_name">mediating diverse immune responses</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97436422</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="transcriptional_regulation" sem="G#other_name">Transcriptional regulation</cons> during <cons lex="myelopoiesis" sem="G#other_name">myelopoiesis</cons>.</sentence>
</title>
<abstract>
<sentence>The coordinated production of all <cons lex="blood_cell" sem="G#cell_type">blood cells</cons> from a <cons lex="common_stem_cell" sem="G#cell_type">common stem cell</cons> is a highly regulated process involving successive stages of commitment and differentiation.</sentence>
<sentence>From analyses of <cons lex="mouse" sem="G#multi_cell">mice</cons> deficient in <cons lex="transcription_factor_gene" sem="G#DNA_family_or_group">transcription factor genes</cons> and from the characterizations of <cons lex="chromosome_breakpoint" sem="G#DNA_domain_or_region">chromosome breakpoints</cons> in <cons lex="human_leukemia" sem="G#other_name">human leukemias</cons>, it has become evident that <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> are important regulators of <cons lex="hematopoiesis" sem="G#other_name">hematopoiesis</cons>.</sentence>
<sentence>During myelopoiesis, which includes the development of <cons lex="(AND granulocytic_lineage monocytic_lineage)" sem="(AND G#cell_type G#cell_type)"><cons lex="granulocytic*">granulocytic</cons> and <cons lex="monocytic*">monocytic</cons> <cons lex="*lineage">lineages</cons></cons>, <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> from several families are active, including <cons lex="AML1/CBF_beta" sem="G#DNA_family_or_group">AML1/CBF beta</cons>, <cons lex="C/EBP" sem="G#DNA_family_or_group">C/EBP</cons>, <cons lex="Ets" sem="G#DNA_family_or_group">Ets</cons>, <cons lex="c-Myb" sem="G#DNA_family_or_group">c-Myb</cons>, <cons lex="HOX" sem="G#DNA_family_or_group">HOX</cons>, and <cons lex="MZF-1" sem="G#DNA_family_or_group">MZF-1</cons>.</sentence>
<sentence>Few of these factors are expressed exclusively in <cons lex="myeloid_cell" sem="G#cell_type">myeloid cells</cons>; instead it appears that they cooperatively regulate transcription of <cons lex="myeloid-specific_gene" sem="G#DNA_family_or_group">myeloid-specific genes</cons>.</sentence>
<sentence>Here we discuss recent advances in <cons lex="transcriptional_regulation" sem="G#other_name">transcriptional regulation</cons> during <cons lex="myelopoiesis" sem="G#other_name">myelopoiesis</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97420486</bibliomisc>
</articleinfo>
<title>
<sentence>Activation of transcription factor <cons lex="NF-kappa_Bo" sem="G#protein_complex">NF-kappa B</cons> by phagocytic stimuli in human neutrophils.</sentence>
</title>
<abstract>
<sentence>Phagocytosis represents an important physiological trigger for the inducible expression of several genes in <cons lex="human_neutrophil" sem="G#cell_type">human neutrophils</cons>.</sentence>
<sentence>Here, we report that a DNA-binding activity primarily consisting of the classical <cons lex="NF-kappa_B_heterodimer" sem="G#protein_complex"><cons lex="NF-kappa_Bo" sem="G#protein_complex">NF-kappa B</cons> heterodimer</cons>, <cons lex="p50/RelA" sem="G#protein_complex">p50/RelA</cons>, is induced in <cons lex="phagocytosing_neutrophil" sem="G#cell_type">phagocytosing neutrophils</cons>.</sentence>
<sentence>Under these conditions, <cons lex="NF-kappa_B_activation" sem="G#other_name"><cons lex="NF-kappa_Bo" sem="G#protein_complex">NF-kappa B</cons> activation</cons> was found to be a rapid and transient response, reaching a maximum by 10-15 min, and returning to near-basal levels by 30 min.</sentence>
<sentence>In neutrophils undergoing the <cons lex="phagocytosis" sem="G#other_name">phagocytosis</cons> of <cons lex="opsonized_yeast" sem="G#mono_cell">opsonized yeasts</cons>, the onset of <cons lex="NF-kappa_B_activation" sem="G#other_name"><cons lex="NF-kappa_Bo" sem="G#protein_complex">NF-kappa B</cons> activation</cons> was paralleled by a decline in <cons lex="immunoreactive_I_kappa_B-alpha_protein_levels" sem="G#other_name">immunoreactive <cons lex="I_kappa_B-alpha" sem="G#protein_molecule">I kappa B-alpha</cons> protein levels</cons>, and the <cons lex="cellular_I_kappa_B-alpha_pool" sem="G#other_name">cellular <cons lex="I_kappa_B" sem="G#protein_molecule">I kappa B</cons>-alpha pool</cons> was replenished by 30 min, in agreement with our gel shift data.</sentence>
<sentence>We conclude that <cons lex="NF-kappa_B_activation" sem="G#other_name"><cons lex="NF-kappa_Bo" sem="G#protein_complex">NF-kappa B</cons> activation</cons> could constitute one of the mechanisms whereby the expression of <cons lex="kappa_B-responsive_gene" sem="G#DNA_family_or_group">kappa B-responsive genes</cons> is enhanced in <cons lex="phagocytosing_neutrophil" sem="G#cell_type">phagocytosing neutrophils</cons>.</sentence>
<sentence>To our knowledge, this represents the first demonstration that <cons lex="phagocytic_stimuli" sem="G#other_name">phagocytic stimuli</cons> can induce <cons lex="NF-kappa_B_activatio" sem="G#other_name"><cons lex="NF-kappa_Bo" sem="G#protein_complex">NF-kappa B</cons> activation</cons> in <cons lex="human_neutrophil" sem="G#cell_type">human neutrophils</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97379394</bibliomisc>
</articleinfo>
<title>
<sentence>Induction of <cons lex="human_immunodeficiency_virus_type_1_expression" sem="G#other_name"><cons lex="human_immunodeficiency_virus_type_1" sem="G#virus">human immunodeficiency virus type 1</cons> expression</cons> in <cons lex="monocytic_cell" sem="G#cell_type">monocytic cells</cons> by <cons lex="Cryptococcus_neoformans" sem="G#mono_cell">Cryptococcus neoformans</cons> and <cons lex="Candida_albicans" sem="G#mono_cell">Candida albicans</cons>.</sentence>
</title>
<abstract>
<sentence>Because <cons lex="candidiasis" sem="G#mono_cell">candidiasis</cons> and <cons lex="cryptococcosis" sem="G#mono_cell">cryptococcosis</cons> are common in <cons lex="human_immunodeficiency_virus_(HIV)-infected_person" sem="G#multi_cell"><cons lex="human_immunodeficiency_virus" sem="G#virus">human immunodeficiency virus</cons> (<cons lex="HIV" sem="G#virus">HIV</cons>)-infected persons</cons>, the effect of <cons lex="Cryptococcus_neoformans" sem="G#mono_cell">Cryptococcus neoformans</cons> and <cons lex="Candida_albicans" sem="G#mono_cell">Candida albicans</cons> on <cons lex="HIV_expression" sem="G#other_name">HIV expression</cons> in <cons lex="monocytic_cell" sem="G#cell_type">monocytic cells</cons> was examined.</sentence>
<sentence>Stimulation of the latently <cons lex="HIV-infected_myelomonocytic_cell_line" sem="G#cell_line">HIV-infected myelomonocytic cell line</cons> OM-10.1 with <cons lex="C._neoformans" sem="G#mono_cell">C. neoformans</cons> and <cons lex="C._albicans" sem="G#mono_cell">C. albicans</cons> in the presence of pooled human serum caused a ratio-dependent increase in <cons lex="HIV_production" sem="G#other_name"><cons lex="HIV" sem="G#virus">HIV</cons> production</cons>.</sentence>
<sentence>Induction of <cons lex="HIV" sem="G#virus">HIV</cons> by <cons lex="C._neoformans" sem="G#mono_cell">C. neoformans</cons> was enhanced by <cons lex="anti-capsular_antibody" sem="G#protein_family_or_group">anti-capsular antibody</cons>, while induction by both organisms was inhibited by <cons lex="anti-TNF-alpha_antibody" sem="G#protein_family_or_group">anti-TNF-alpha antibody</cons>.</sentence>
<sentence>In THP-1 cells transfected with <cons lex="HIV_plasmid_construct" sem="G#DNA_family_or_group"><cons lex="HIV" sem="G#virus">HIV</cons> plasmid constructs</cons>, both organisms induced transcription from the <cons lex="HIV_long_terminal_repeat" sem="G#DNA_domain_or_region"><cons lex="HIV" sem="G#virus">HIV</cons> long terminal repeat</cons> that was dependent on intact <cons lex="NF-kappaB_binding_sequences" sem="G#DNA_domain_or_region"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> binding sequences</cons>.</sentence>
<sentence>Thus, <cons lex="C._neoformans" sem="G#mono_cell">C. neoformans</cons> and <cons lex="C._albicans" sem="G#mono_cell">C. albicans</cons> enhance <cons lex="HIV_expression" sem="G#other_name"><cons lex="HIV" sem="G#virus">HIV</cons> expression</cons> in <cons lex="monocytic_cell" sem="G#cell_type">monocytic cells</cons> through a <cons lex="(AND TNF-alpha-dependent_mechanism NF-kappaB-dependent_mechanism)" sem="(AND G#other_name G#other_name)"><cons lex="TNF-alpha-*">TNF-alpha-</cons> and <cons lex="NF-kappaB-*">NF-kappaB-</cons><cons lex="*dependent_mechanism">dependent mechanism</cons></cons>.</sentence>
<sentence>In <cons lex="HIV-infected_patient" sem="G#multi_cell"><cons lex="HIV" sem="G#virus">HIV</cons>-infected patients</cons>, such enhancement may further <cons lex="impair_host_immunity" sem="G#other_name">impair host immunity</cons> and could accelerate the course of <cons lex="HIV_disease" sem="G#other_name"><cons lex="HIV" sem="G#virus">HIV</cons> disease</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97398336</bibliomisc>
</articleinfo>
<title>
<sentence>Nuclear levels of <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> correlate with syncytium-forming capacity of <cons lex="8e51_cell" sem="G#cell_line">8e51 cells</cons>, expressing a defective <cons lex="HIV_virus" sem="G#virus">HIV virus</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="double_NF-kappaB_site" sem="G#DNA_domain_or_region">double NF-kappaB site</cons> identified in the <cons lex="LTR" sem="G#DNA_domain_or_region">LTR</cons> of the <cons lex="human_immunodeficiency_virus-1" sem="G#virus">human immunodeficiency virus-1</cons> (<cons lex="HIV-1" sem="G#virus">HIV-1</cons>) has been demonstrated to be necessary for efficient <cons lex="viral_transcription" sem="G#other_name">viral transcription</cons>.</sentence>
<sentence>In this report we present the characterisation of <cons lex="NF-kappaB_subunit" sem="G#protein_subunit">NF-kappaB subunits</cons> engaged in complexes binding to the <cons lex="HIV-1_NF-kappaB_site" sem="G#DNA_domain_or_region">HIV-1 NF-kappaB site</cons> in <cons lex="human_8e51_T-cells" sem="G#cell_line">human 8e51 T-cells</cons>, that harbour a <cons lex="defective_HIV-1" sem="G#virus">defective HIV-1</cons>.</sentence>
<sentence>At least four different specific <cons lex="NF-kappaB_complex" sem="G#protein_complex">NF-kappaB complexes</cons> are present in the <cons lex="nucleus" sem="G#cell_component">nucleus</cons> of these cells.</sentence>
<sentence>With the use of <cons lex="specific_antibody" sem="G#protein_family_or_group">specific antibodies</cons> we have determined the composition of each complex using <cons lex="electrophoretic_mobility_shift_assay" sem="G#other_name">electrophoretic mobility shift assays</cons>.</sentence>
<sentence>The results show the presence of several <cons lex="NF-kappaB_family_member" sem="G#protein_family_or_group">NF-kappaB family members,</cons> with the transactivating <cons lex="RelA" sem="G#protein_molecule">RelA</cons> being engaged in multiple complexes.</sentence>
<sentence>The importance of <cons lex="NF-kappaB_complex" sem="G#protein_complex">NF-kappaB complexes</cons> in viral functions has been established comparing the level of NF-kappaB DNA-binding complexes with syncytia-forming activity of <cons lex="8e51_cell" sem="G#cell_line">8e51 cells</cons>.</sentence>
<sentence>In fact, <cons lex="8e51_cell" sem="G#cell_line">8e51 cells</cons> that had almost lost their <cons lex="syncytia-forming_capacity" sem="G#other_name">syncytia-forming capacity</cons> were found to contain at least 10 times less active <cons lex="NF-kappaB_DNA-binding_complex" sem="G#protein_complex">NF-kappaB DNA-binding complex</cons> than the <cons lex="actively_fusing_cell" sem="G#cell_type">actively fusing cells</cons>.</sentence>
<sentence>The correlation is specific as the level of at least three other <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> did not change.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97377031</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="c-Myb" sem="G#DNA_family_or_group">c-Myb</cons> and <cons lex="Ets_protein" sem="G#protein_family_or_group">Ets proteins</cons> synergize to overcome <cons lex="transcriptional_repression" sem="G#other_name">transcriptional repression</cons> by <cons lex="ZEB" sem="G#protein_molecule">ZEB</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="Zfh_family" sem="G#protein_family_or_group">Zfh family</cons> of <cons lex="zinc_finger/homeodomain_protein" sem="G#protein_family_or_group">zinc finger/homeodomain proteins</cons> was first identified in Drosophila where it is required for differentiation of tissues such as the <cons lex="central_nervous_system" sem="G#body_part">central nervous system</cons> and <cons lex="muscle" sem="G#tissue">muscle</cons>.</sentence>
<sentence><cons lex="ZEB" sem="G#protein_molecule">ZEB</cons>, a vertebrate homolog of <cons lex="Zfh-1" sem="G#protein_molecule">Zfh-1</cons>, binds a subset of <cons lex="E_box" sem="G#DNA_family_or_group">E boxes</cons> and blocks myogenesis through <cons lex="transcriptional_repression" sem="G#other_name">transcriptional repression</cons> of <cons lex="muscle_gene" sem="G#DNA_family_or_group"><cons lex="muscle" sem="G#tissue">muscle</cons> genes</cons>.</sentence>
<sentence>We present evidence here that <cons lex="ZEB" sem="G#protein_molecule">ZEB</cons> also has an important role in <cons lex="controlling_hematopoietic_gene_transcription" sem="G#other_name">controlling <cons lex="hematopoietic_gene" sem="G#DNA_domain_or_region">hematopoietic gene</cons> transcription</cons>.</sentence>
<sentence>Two families of <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> that are required for normal <cons lex="hematopoiesis" sem="G#other_name">hematopoiesis</cons> are <cons lex="c-Myb" sem="G#protein_molecule">c-Myb</cons> and <cons lex="Ets" sem="G#protein_molecule">Ets</cons>.</sentence>
<sentence>These factors act synergistically to activate transcription, and this synergy is required for transcription of at least several important <cons lex="hematopoietic_gene" sem="G#DNA_family_or_group">hematopoietic genes</cons>.</sentence>
<sentence><cons lex="ZEB" sem="G#protein_molecule">ZEB</cons> blocks the activity of <cons lex="c-Myb" sem="G#protein_molecule">c-Myb</cons> and <cons lex="Ets" sem="G#protein_molecule">Ets</cons> individually, but together the factors synergize to resist this repression.</sentence>
<sentence>Such repression imposes a requirement for both <cons lex="c-Myb" sem="G#protein_molecule">c-Myb</cons> and <cons lex="Ets" sem="G#protein_molecule">Ets</cons> for transcriptional activity, providing one explanation for why synergy between these factors is important.</sentence>
<sentence>The balance between repression by <cons lex="ZEB" sem="G#protein_molecule">ZEB</cons> and <cons lex="transcriptional_activation" sem="G#other_name">transcriptional activation</cons> by <cons lex="c-Myb" sem="G#protein_molecule">c-Myb</cons><cons lex="Ets" sem="G#protein_molecule">/Ets</cons> provides a flexible regulatory mechanism for controlling <cons lex="gene_expression" sem="G#other_name">gene expression</cons> in <cons lex="hematopoietic_cell" sem="G#cell_type">hematopoietic cells</cons>.</sentence>
<sentence>We demonstrate that one target of this <cons lex="positive/negative_regulation" sem="G#other_name">positive/negative regulation</cons> in vivo is the <cons lex="alpha4_integrin" sem="G#protein_molecule">alpha4 integrin</cons>, which play a key role in normal <cons lex="hematopoiesis" sem="G#other_name">hematopoiesis</cons> and function of <cons lex="mature_leukocyte" sem="G#cell_type">mature leukocytes</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97342603</bibliomisc>
</articleinfo>
<title>
<sentence>Comparison of the <cons lex="transactivation_domain" sem="G#protein_domain_or_region">transactivation domains</cons> of <cons lex="Stat5" sem="G#protein_molecule">Stat5</cons> and <cons lex="Stat6" sem="G#protein_molecule">Stat6</cons> in <cons lex="lymphoid_cell" sem="G#cell_type">lymphoid cells</cons> and <cons lex="mammary_epithelial_cell" sem="G#cell_type">mammary epithelial cells</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="Stat" sem="G#protein_family_or_group">Stat</cons> (<cons lex="signal_transducers_and_activators_of_transcription" sem="G#protein_family_or_group">signal transducers and activators of transcription</cons>) and <cons lex="Jak" sem="G#protein_family_or_group">Jak</cons> (<cons lex="Janus_kinase" sem="G#protein_family_or_group">Janus kinases</cons>) proteins are central components in the <cons lex="signal_transduction_event" sem="G#other_name">signal transduction events</cons> in <cons lex="(AND hematopoietic_cell epithelial_cell)" sem="(AND G#cell_type G#cell_type)"><cons lex="hematopoietic*">hematopoietic</cons> and <cons lex="epithelial*">epithelial</cons> <cons lex="*cell">cells</cons></cons>.</sentence>
<sentence>They are rapidly activated by various <cons lex="cytokine" sem="G#protein_family_or_group">cytokines</cons>, <cons lex="hormone" sem="G#other_organic_compound">hormones</cons>, and growth factors.</sentence>
<sentence>Upon ligand binding and <cons lex="cytokine_receptor_dimerization" sem="G#other_name"><cons lex="cytokine_receptor" sem="G#protein_family_or_group">cytokine receptor</cons> dimerization</cons>, <cons lex="Stat_protein" sem="G#protein_family_or_group">Stat proteins</cons> are phosphorylated on <cons lex="tyrosine_residue" sem="G#amino_acid_monomer">tyrosine residues</cons> by <cons lex="Jak_kinase" sem="G#protein_family_or_group">Jak kinases</cons>.</sentence>
<sentence>Activated <cons lex="Stat_protein" sem="G#protein_family_or_group">Stat proteins</cons> form homo- or heterodimers, translocate to the <cons lex="nucleus" sem="G#cell_component">nucleus</cons>, and induce transcription from responsive genes.</sentence>
<sentence><cons lex="Stat5" sem="G#protein_molecule">Stat5</cons> and <cons lex="Stat6" sem="G#protein_molecule">Stat6</cons> are <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> active in <cons lex="mammary_epithelial_cell" sem="G#cell_type">mammary <cons lex="epithelial_cell" sem="G#cell_type">epithelial cells</cons></cons> and immune cells.</sentence>
<sentence>Prolactin activates <cons lex="Stat5" sem="G#protein_molecule">Stat5</cons>, and <cons lex="interleukin-4" sem="G#protein_molecule">interleukin-4</cons> (<cons lex="IL-4" sem="G#protein_molecule">IL-4</cons>) activates <cons lex="Stat6" sem="G#protein_molecule">Stat6</cons>.</sentence>
<sentence>Both <cons lex="cytokine" sem="G#protein_family_or_group">cytokines</cons> are able to stimulate cell proliferation, differentiation, and survival.</sentence>
<sentence>We investigated the transactivation potential of <cons lex="Stat6" sem="G#protein_molecule">Stat6</cons> and found that it is not restricted to lymphocytes.</sentence>
<sentence><cons lex="IL-4-dependent_activation" sem="G#other_name"><cons lex="IL-4" sem="G#protein_molecule">IL-4</cons>-dependent activation</cons> of <cons lex="Stat6" sem="G#protein_molecule">Stat6</cons> was also observed in <cons lex="HC11_mammary_epithelial_cells" sem="G#cell_line">HC11 <cons lex="mammary_epithelial_cell" sem="G#cell_type">mammary epithelial cells</cons></cons>.</sentence>
<sentence>In these cells, <cons lex="Stat6" sem="G#protein_molecule">Stat6</cons> activation led to the induction of the <cons lex="beta-casein_gene_promoter" sem="G#DNA_domain_or_region">beta-casein gene promoter</cons>.</sentence>
<sentence>The induction of this promoter was confirmed in <cons lex="COS7_cell" sem="G#cell_line">COS7 cells</cons>.</sentence>
<sentence>The <cons lex="glucocorticoid_receptor" sem="G#protein_family_or_group">glucocorticoid receptor</cons> was able to further enhance <cons lex="IL-4-induced_gene_transcription" sem="G#other_name"><cons lex="IL-4" sem="G#protein_molecule">IL-4</cons>-induced gene transcription</cons> through the action of <cons lex="Stat6" sem="G#protein_molecule">Stat6</cons>.</sentence>
<sentence>Deletion analysis of the <cons lex="carboxyl-terminal_region" sem="G#protein_domain_or_region">carboxyl-terminal region</cons> of <cons lex="Stat6" sem="G#protein_molecule">Stat6</cons> and recombination of this region with a <cons lex="heterologous_DNA_binding_domain" sem="G#protein_domain_or_region">heterologous DNA binding domain</cons> allowed the delimitation and characterization of the transactivation domain of <cons lex="Stat6" sem="G#protein_molecule">Stat6</cons>.</sentence>
<sentence>The potencies of the <cons lex="transactivation_domain" sem="G#protein_domain_or_region">transactivation domains</cons> of <cons lex="Stat5" sem="G#protein_molecule">Stat5</cons>, <cons lex="Stat6" sem="G#protein_molecule">Stat6</cons>, and <cons lex="viral_protein_VP16" sem="G#protein_molecule">viral protein VP16</cons> were compared.</sentence>
<sentence><cons lex="Stat6" sem="G#protein_molecule">Stat6</cons> had a transactivation domain which was about 10-fold stronger than that of <cons lex="Stat5" sem="G#protein_molecule">Stat5</cons>.</sentence>
<sentence>In <cons lex="pre-B_cell" sem="G#cell_type">pre-B cells</cons> (Ba/F3), the transactivation domain of <cons lex="Stat6" sem="G#protein_molecule">Stat6</cons> was <cons lex="IL-4" sem="G#protein_molecule">IL-4</cons> regulated, independently from its <cons lex="DNA_binding_function" sem="G#other_name">DNA binding function</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97334204</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="ETS1" sem="G#protein_molecule">ETS1</cons>, <cons lex="NFkappaB" sem="G#protein_complex">NFkappaB</cons> and <cons lex="AP1" sem="G#protein_molecule">AP1</cons> synergistically transactivate the <cons lex="human_GM-CSF_promoter" sem="G#DNA_domain_or_region">human GM-CSF promoter</cons>.</sentence>
</title>
<abstract>
<sentence>Activation of <cons lex="helper_T_cell" sem="G#cell_type">helper T cells</cons> results in coordinate expression of a number of <cons lex="cytokine" sem="G#protein_family_or_group">cytokines</cons> involved in differentiation, proliferation and activation of the <cons lex="haematopoietic_system" sem="G#body_part">haematopoietic system</cons>.</sentence>
<sentence><cons lex="granulocyte-macrophage_colony_stimulating_factor" sem="G#protein_molecule">Granulocyte-macrophage colony stimulating factor</cons> (<cons lex="GM-CSF" sem="G#protein_molecule">GM-CSF</cons>) is one such <cons lex="cytokine" sem="G#protein_family_or_group">cytokine</cons>, whose increased expression results mostly from increases in transcription.</sentence>
<sentence><cons lex="Cis-acting_element" sem="G#DNA_family_or_group">Cis-acting elements</cons> with <cons lex="(AND NFkappaB-like_binding_motif AP1-like_binding_motif ETS-like_binding_motif)" sem="(AND G#DNA_domain_or_region G#DNA_domain_or_region G#DNA_domain_or_region)"><cons lex="NFkappaB*">NFkappaB</cons>, <cons lex="AP1*">AP1</cons> and <cons lex="ETS*">ETS</cons><cons lex="*-like_binding_motif">-like binding motifs</cons></cons> have been identified in the promoter region of the <cons lex="GM-CSF_gene" sem="G#DNA_domain_or_region"><cons lex="GM-CSF" sem="G#protein_molecule">GM-CSF</cons> gene</cons>, and are important or essential for transcriptional activity following <cons lex="T_cell_activation" sem="G#other_name">T cell activation</cons>.</sentence>
<sentence><cons lex="ETS1" sem="G#protein_molecule">ETS1</cons> is a <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> of the <cons lex="ETS_family" sem="G#protein_family_or_group">ETS family</cons> that is expressed in <cons lex="T_cell" sem="G#cell_type">T cells</cons>.</sentence>
<sentence>We have previously shown that <cons lex="ETS1" sem="G#protein_molecule">ETS1</cons> can transactivate <cons lex="GM-CSF" sem="G#protein_molecule">GM-CSF</cons> in <cons lex="Jurkat_T_cell" sem="G#cell_line">Jurkat <cons lex="T_cell" sem="G#cell_type">T cells</cons></cons>, but only after the cells have been stimulated by treatment with PMA and ionomycin, agents that mimic <cons lex="T_cell_activation" sem="G#other_name">T cell activation</cons>.</sentence>
<sentence>Thus we proposed that <cons lex="ETS1" sem="G#protein_molecule">ETS1</cons>, which is expressed constitutively in <cons lex="Jurkat_cell" sem="G#cell_line">Jurkat cells</cons>, may act in concert with <cons lex="PMA/ionomycin_inducible_factor" sem="G#protein_family_or_group">PMA/ionomycin inducible factors</cons>.</sentence>
<sentence>Here we show that <cons lex="ETS1" sem="G#protein_molecule">ETS1</cons> can transactivate a <cons lex="GM-CSF_reporter_construct" sem="G#DNA_molecule"><cons lex="GM-CSF" sem="G#protein_molecule">GM-CSF</cons> reporter construct</cons> in unstimulated <cons lex="Jurkat_cell" sem="G#cell_line">Jurkat cells</cons>, providing that either <cons lex="NFkappaB" sem="G#protein_complex">NFkappaB</cons> or <cons lex="AP1" sem="G#protein_molecule">AP1</cons> <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> are supplied by co-transfection.</sentence>
<sentence>We confirm that binding of endogenous <cons lex="NFkappaB" sem="G#protein_complex">NFkappaB</cons> and <cons lex="AP1" sem="G#protein_molecule">AP1</cons> is induced following <cons lex="PMA/ionomycin_treatment" sem="G#other_name"><cons lex="PMA" sem="G#other_organic_compound">PMA</cons><cons lex="ionomycin" sem="G#other_organic_compound">/ionomycin</cons> treatment</cons> of <cons lex="T_cell" sem="G#cell_type">T cells</cons>.</sentence>
<sentence>Transactivation by <cons lex="ETS1" sem="G#protein_molecule">ETS1</cons>, <cons lex="NFkappaB" sem="G#protein_complex">NFkappaB</cons> and <cons lex="AP1" sem="G#protein_molecule">AP1</cons> is synergistic, and mutation of the individual binding sites reveals that the transcriptional activities of these factors are interdependent.</sentence>
<sentence>Our results suggest that constitutive <cons lex="ETS1" sem="G#protein_molecule">ETS1</cons>, and inducible <cons lex="NFkappaB" sem="G#protein_complex">NFkappaB</cons> and <cons lex="AP1" sem="G#protein_molecule">AP1</cons>, cooperate as part of a higher order <cons lex="transcriptional_complex" sem="G#protein_complex">transcriptional complex</cons> in activated <cons lex="T_cell" sem="G#cell_type">T cells</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97307577</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="abnormal_T_lymphocyte_development" sem="G#other_name">Abnormal <cons lex="T_lymphocyte" sem="G#cell_type">T lymphocyte</cons> development</cons> induced by targeted overexpression of <cons lex="IkappaB_alpha" sem="G#protein_molecule">IkappaB alpha</cons>.</sentence>
</title>
<abstract>
<sentence>A role in thymic maturation for factors of the <cons lex="NF-kappaB_family" sem="G#protein_family_or_group">NF-kappaB family</cons> has long been suspected, but not yet proven.</sentence>
<sentence><cons lex="transgenic_mouse" sem="G#other_artificial_source">Transgenic <cons lex="mouse" sem="G#multi_cell">mice</cons></cons> with a lymphocyte-specific defect in <cons lex="NF-kappaB_activation" sem="G#other_name"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> activation</cons> were produced by targeted expression of human <cons lex="IkappaB_alpha" sem="G#protein_molecule">IkappaB alpha</cons>.</sentence>
<sentence>The thymic cellularity of these <cons lex="mouse" sem="G#multi_cell">mice</cons> was significantly decreased.</sentence>
<sentence>The proportion of mature, <cons lex="TCRhigh_thymocyte" sem="G#cell_type">TCRhigh thymocytes</cons> of the <cons lex="alphabeta_lineage" sem="G#cell_type">alphabeta lineage</cons> was reduced, and the remaining <cons lex="TCRhigh_population" sem="G#cell_type">TCRhigh population</cons> contained an unusually high proportion of <cons lex="double-positive_cell" sem="G#cell_line">double-positive cells</cons>.</sentence>
<sentence>This defect in maturation resulted in a transgene dose-dependent reduction in <cons lex="peripheral_T_lymphocyte" sem="G#cell_type">peripheral T lymphocytes</cons>, with the <cons lex="CD8_lineage" sem="G#cell_type">CD8 lineage</cons> being more severely affected.</sentence>
<sentence>These data provide direct evidence for the involvement of <cons lex="NF-kappaB/Rel_family_protein" sem="G#protein_family_or_group"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons>/Rel family proteins</cons> in late stages of <cons lex="T_lymphocyte_development" sem="G#other_name"><cons lex="T_lymphocyte" sem="G#cell_type">T lymphocyte</cons> development</cons>, coincident with positive and negative selection.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97289574</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="CD40" sem="G#protein_molecule">CD40</cons> is a functional <cons lex="activation_antigen" sem="G#protein_family_or_group">activation antigen</cons> and <cons lex="B7-independent_T_cell_costimulatory_molecule" sem="G#protein_family_or_group">B7-independent T cell costimulatory molecule</cons> on normal <cons lex="human_lung_fibroblast" sem="G#cell_type">human lung fibroblasts</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="CD40" sem="G#protein_molecule">CD40</cons> is an important signaling and activation Ag found on certain <cons lex="bone_marrow-derived_cell" sem="G#cell_type">bone marrow-derived cells</cons>.</sentence>
<sentence>Recently, <cons lex="CD40" sem="G#protein_molecule">CD40</cons> also has been shown to be expressed by <cons lex="mesenchymal_cell" sem="G#cell_type">mesenchymal cells</cons>, including <cons lex="human_fibroblast" sem="G#cell_type">human fibroblasts</cons>.</sentence>
<sentence>Little is known about the role of <cons lex="CD40" sem="G#protein_molecule">CD40</cons> in <cons lex="fibroblast" sem="G#cell_type">fibroblasts</cons>.</sentence>
<sentence>The current study investigates the hypothesis that <cons lex="CD40" sem="G#protein_molecule">CD40</cons> expressed on <cons lex="lung_fibroblast" sem="G#cell_type">lung fibroblasts</cons> is an activation structure and mechanism for interaction with <cons lex="hemopoietic_cell" sem="G#cell_type">hemopoietic cells</cons>.</sentence>
<sentence>Communication between resident tissue <cons lex="fibroblast" sem="G#cell_type">fibroblasts</cons> and <cons lex="T_cell" sem="G#cell_type">T cells</cons> is necessary for normal wound healing, and can be pathologic, resulting in <cons lex="tissue_fibrosis" sem="G#other_name">tissue fibrosis</cons>.</sentence>
<sentence>Signaling through <cons lex="CD40" sem="G#protein_molecule">CD40</cons> with soluble <cons lex="CD40" sem="G#protein_molecule">CD40</cons> ligand stimulated <cons lex="fibroblast_activation" sem="G#other_name">fibroblast activation</cons>, as evidenced by mobilization of nuclear factor-kappaB and by induction of the proinflammatory and chemoattractant <cons lex="cytokine" sem="G#protein_family_or_group">cytokines</cons> <cons lex="IL-6" sem="G#protein_molecule">IL-6</cons> and <cons lex="IL-8" sem="G#protein_molecule">IL-8</cons>.</sentence>
<sentence><cons lex="IFN-gamma-primed_lung_fibroblast" sem="G#cell_line">IFN-gamma-primed lung <cons lex="fibroblast" sem="G#cell_type">fibroblasts</cons></cons> costimulate <cons lex="T_lymphocyte_proliferation" sem="G#other_name">T lymphocyte proliferation</cons> utilizing <cons lex="CD40" sem="G#protein_molecule">CD40</cons>, but not the well-studied <cons lex="costimulatory_molecule" sem="G#protein_family_or_group">costimulatory molecules</cons> <cons lex="B7-1" sem="G#protein_molecule">B7-1</cons> and <cons lex="B7-2" sem="G#protein_molecule">B7-2</cons>.</sentence>
<sentence>Data reported herein support the hypothesis that cognate interactions between <cons lex="tissue_fibroblast" sem="G#cell_type">tissue fibroblasts</cons> and infiltrating T lymphocytes, via the <cons lex="CD40/CD40L_pathway" sem="G#other_name"><cons lex="CD40" sem="G#protein_molecule">CD40</cons><cons lex="CD40L" sem="G#protein_molecule">/CD40L</cons> pathway</cons>, augment inflammation and may promote <cons lex="fibrogenesis" sem="G#other_name">fibrogenesis</cons> by activating both cell types.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97338567</bibliomisc>
</articleinfo>
<title>
<sentence>Biphasic control of <cons lex="NF-kappa_Bo" sem="G#protein_complex">NF-kappa B</cons> activation induced by the triggering of <cons lex="HLA-DR_antigen" sem="G#protein_family_or_group">HLA-DR antigens</cons> expressed on <cons lex="B_cell" sem="G#cell_type">B cells</cons>.</sentence>
</title>
<abstract>
<sentence>The regulation of <cons lex="NF-kappa_Bo" sem="G#protein_complex">NF-kappa B</cons> activation following the triggering of <cons lex="HLA-DR_antigen" sem="G#protein_family_or_group">HLA-DR antigens</cons> by <cons lex="mAb_L243" sem="G#protein_molecule">mAb L243</cons> has been studied at various times in <cons lex="Raji_cell" sem="G#cell_line">Raji cells</cons>.</sentence>
<sentence>Electrophoretic mobility shift assays demonstrated a strong increase of <cons lex="NF-kappa_B_DNA_binding" sem="G#other_name"><cons lex="NF-kappa_Bo" sem="G#protein_complex">NF-kappa B</cons> DNA binding</cons> after triggering of <cons lex="HLA-DR_antigen" sem="G#protein_family_or_group">HLA-DR antigens</cons>.</sentence>
<sentence>Using <cons lex="TNF-alpha-activity_neutralizing_antibodie" sem="G#protein_family_or_group">TNF-alpha-activity neutralizing antibodies</cons>, the authors demonstrated that the upregulation of <cons lex="NF-kappa_Bo" sem="G#protein_complex">NF-kappa B</cons> was found to depend, at later time point, on an autocrine effect of <cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons> secreted following triggering of <cons lex="HLA-DR_antigen" sem="G#protein_family_or_group">HLA-DR antigens</cons>.</sentence>
<sentence>In contrast, it was found to be <cons lex="TNF-alpha_independent" sem="G#other_name"><cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons> independent</cons> in the early time point.</sentence>
<sentence>Moreover, the upregulation of <cons lex="NF-kappa_B_binding_activity" sem="G#other_name"><cons lex="NF-kappa_Bo" sem="G#protein_complex">NF-kappa B</cons> binding activity</cons> is regulated by the triggering of selected <cons lex="epitope" sem="G#protein_domain_or_region">epitopes</cons> of <cons lex="HLA-DR_antigen" sem="G#protein_family_or_group">HLA-DR antigens</cons>.</sentence>
<sentence>In fact, <cons lex="mAb_L243" sem="G#protein_molecule">mAb L243</cons> but not the <cons lex="staphylococcal_superantigen" sem="G#protein_family_or_group">staphylococcal superantigens</cons>, <cons lex="staphylococcal_exotoxin_toxic_shock_syndrome_toxin-I" sem="G#protein_molecule">staphylococcal exotoxin toxic shock syndrome toxin-I</cons> or <cons lex="staphylococcal_enterotoxin_B" sem="G#protein_molecule">staphylococcal enterotoxin B</cons>, regulate the <cons lex="NF-kappa_B_binding_activity" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> binding activity</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97426442</bibliomisc>
</articleinfo>
<title>
<sentence>Regulation of <cons lex="inosine-5'-monophosphate_dehydrogenase_type_II" sem="G#protein_molecule"><cons lex="inosine-5'-monophosphate_dehydrogenase" sem="G#protein_molecule">inosine-5'-monophosphate dehydrogenase</cons> type II</cons> gene expression in <cons lex="human_T_cell" sem="G#cell_type">human T cells</cons>.</sentence>
<sentence>Role for a novel <cons lex="5'_palindromic_octamer_sequence" sem="G#DNA_domain_or_region">5' palindromic octamer sequence</cons>.</sentence>
</title>
<abstract>
<sentence>Expression of the gene encoding <cons lex="human_inosine-_5'-monophosphate_dehydrogenase_(IMPDH)_type_II" sem="G#protein_molecule">human inosine- 5'-monophosphate dehydrogenase (IMPDH) type II</cons>, an <cons lex="enzyme" sem="G#protein_family_or_group">enzyme</cons> catalyzing the rate-limiting step in the generation of <cons lex="guanine_nucleotide" sem="G#nucleotide">guanine nucleotides</cons>, is increased more than 10-fold in <cons lex="activated_peripheral_blood_T_lymphocyte" sem="G#cell_type">activated peripheral blood T lymphocytes</cons> and is required for <cons lex="T_cell_activation" sem="G#other_name">T cell activation</cons>.</sentence>
<sentence>We have examined the <cons lex="5'-regulatory_sequence" sem="G#DNA_domain_or_region">5'-regulatory sequences</cons> that are important for the transcriptional regulation of this gene in <cons lex="T_cell" sem="G#cell_type">T cells</cons>.</sentence>
<sentence><cons lex="DNase_I_mapping" sem="G#other_name"><cons lex="DNase_I" sem="G#protein_molecule">DNase I</cons> mapping</cons> of <cons lex="genomic_DNA" sem="G#DNA_family_or_group">genomic DNA</cons> identified a <cons lex="hypersensitive_element" sem="G#DNA_domain_or_region">hypersensitive element</cons> near the <cons lex="transcription_initiation_site" sem="G#DNA_domain_or_region">transcription initiation site</cons>.</sentence>
<sentence>Fine mapping by in vivo footprinting demonstrated five transcription factor binding sites that are occupied in both resting and <cons lex="activated_peripheral_blood_T_lymphocyte" sem="G#cell_type">activated peripheral blood T lymphocytes</cons>; these are <cons lex="tandem_CRE_motif" sem="G#DNA_domain_or_region">tandem CRE motifs</cons>, a <cons lex="Sp1_site" sem="G#DNA_domain_or_region">Sp1 site</cons>, an overlapping <cons lex="Egr-1/Sp1_site" sem="G#DNA_domain_or_region">Egr-1/<cons lex="Sp1_site" sem="G#DNA_domain_or_region">Sp1 site</cons></cons>, and a novel <cons lex="palindromic_octamer_sequence" sem="G#DNA_domain_or_region">palindromic octamer sequence</cons> (<cons lex="POS" sem="G#DNA_domain_or_region">POS</cons>).</sentence>
<sentence>The tandem <cons lex="(AND CRE_site POS_site)" sem="(AND G#DNA_domain_or_region G#DNA_domain_or_region)"><cons lex="CRE*">CRE</cons> and <cons lex="POS*">POS</cons> <cons lex="*site">sites</cons></cons> are of major functional importance as judged by mutational and <cons lex="electrophoretic_mobility_shift_analysis" sem="G#other_name">electrophoretic mobility shift analyses</cons>.</sentence>
<sentence>These data provide evidence that expression of the <cons lex="human_IMPDH_type_II_gene" sem="G#DNA_domain_or_region">human IMPDH type II gene</cons> is predominantly regulated by the <cons lex="nuclear_factor" sem="G#protein_family_or_group">nuclear factors</cons> <cons lex="ATF-2" sem="G#protein_molecule">ATF-2</cons> and an as yet unidentified <cons lex="POS-binding_protein" sem="G#protein_molecule"><cons lex="POS" sem="G#DNA_domain_or_region">POS</cons>-binding protein</cons>.</sentence>
<sentence>Additional major <cons lex="protein-DNA_interaction" sem="G#other_name">protein-DNA interactions</cons> do not occur within the promoter region after <cons lex="T_lymphocyte_activation" sem="G#other_name">T lymphocyte activation</cons>, indicating a requirement for <cons lex="additional_protein-protein_interaction" sem="G#other_name">additional protein-protein interactions</cons> and/or <cons lex="post-translational_modification" sem="G#other_name">post-translational modifications</cons> of <cons lex="pre-bound_transcription_factor" sem="G#protein_family_or_group">pre-bound transcription factors</cons> to account for the observed increase in <cons lex="IMPDH_type_II_gene_expression" sem="G#other_name">IMPDH type II gene expression</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97423557</bibliomisc>
</articleinfo>
<title>
<sentence>Distinct mechanisms for <cons lex="N-acetylcysteine_inhibition" sem="G#other_name"><cons lex="N-acetylcysteine" sem="G#amino_acid_monomer">N-acetylcysteine</cons> inhibition</cons> of <cons lex="cytokine-induced_E-selectin" sem="G#protein_molecule">cytokine-induced E-selectin</cons> and <cons lex="VCAM-1_expression" sem="G#other_name"><cons lex="VCAM-1" sem="G#protein_molecule">VCAM-1</cons> expression</cons>.</sentence>
</title>
<abstract>
<sentence>We have examined the effects of <cons lex="N-acetyl-L-cysteine" sem="G#amino_acid_monomer">N-acetyl-L-cysteine</cons> (<cons lex="NAC" sem="G#amino_acid_monomer">NAC</cons>), a well-characterized, <cons lex="thiol-containing_antioxidant" sem="G#other_name">thiol-containing antioxidant</cons>, on <cons lex="agonist-induced_monocytic_cell_adhesion" sem="G#other_name">agonist-induced monocytic cell adhesion</cons> to <cons lex="endothelial_cell" sem="G#cell_type">endothelial cells</cons> (<cons lex="EC" sem="G#cell_type">EC</cons>).</sentence>
<sentence><cons lex="NAC" sem="G#amino_acid_monomer">NAC</cons> inhibited <cons lex="interleukin-1" sem="G#protein_molecule">interleukin-1</cons> (<cons lex="IL-1_beta" sem="G#protein_molecule">IL-1 beta</cons>)-induced, but not basal, adhesion with 50% inhibition at approximately 20 mM.</sentence>
<sentence><cons lex="monocytic_cell_adhesion" sem="G#other_name">Monocytic cell adhesion</cons> to <cons lex="EC" sem="G#cell_type">EC</cons> in response to <cons lex="tumor_necrosis_factor-alpha" sem="G#protein_molecule">tumor necrosis factor-alpha</cons> (<cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons>), <cons lex="lipopolysaccharide" sem="G#lipid">lipopolysaccharide</cons> (<cons lex="LPS" sem="G#lipid">LPS</cons>), <cons lex="alpha-thrombin" sem="G#protein_molecule">alpha-thrombin</cons>, or <cons lex="phorbol_12-myristate_13-acetate" sem="G#other_organic_compound">phorbol 12-myristate 13-acetate</cons> (<cons lex="PMA" sem="G#other_organic_compound">PMA</cons>) was similarly inhibited by <cons lex="NAC" sem="G#amino_acid_monomer">NAC</cons>.</sentence>
<sentence>Unlike published studies with <cons lex="pyrrolidinedithiocarbamate" sem="G#other_organic_compound">pyrrolidinedithiocarbamate</cons>, which specifically inhibited <cons lex="vascular_cell_adhesion_molecule_1" sem="G#protein_molecule">vascular cell adhesion molecule 1</cons> (<cons lex="VCAM-1" sem="G#protein_molecule">VCAM-1</cons>), <cons lex="NAC" sem="G#amino_acid_monomer">NAC</cons> inhibited <cons lex="IL-1_beta-induced_mRNA" sem="G#RNA_family_or_group"><cons lex="IL-1_beta" sem="G#protein_molecule">IL-1 beta</cons>-induced mRNA</cons> and cell surface expression of both <cons lex="E-selectin" sem="G#protein_molecule">E-selectin</cons> and <cons lex="VCAM-1" sem="G#protein_molecule">VCAM-1</cons>.</sentence>
<sentence><cons lex="NAC" sem="G#amino_acid_monomer">NAC</cons> had no effect on the half-life of <cons lex="(OR E-selectin_mRNA VCAM-1_mRNA)" sem="(OR G#RNA_molecule G#RNA_molecule)"><cons lex="E-selectin*">E-selectin</cons> or <cons lex="VCAM-1*">VCAM-1</cons> <cons lex="*mRNA">mRNA</cons></cons>.</sentence>
<sentence>Although <cons lex="NAC" sem="G#amino_acid_monomer">NAC</cons> reduced <cons lex="nuclear_factor-kappa_B_(NF-kappa_B)_activation" sem="G#other_name"><cons lex="nuclear_factor-kappa_B" sem="G#protein_complex">nuclear factor-kappa B</cons> (<cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons>) activation</cons> in <cons lex="EC" sem="G#cell_type">EC</cons> as measured by <cons lex="gel-shift_assay" sem="G#other_name">gel-shift assays</cons> using an <cons lex="oligonucleotide_probe" sem="G#DNA_family_or_group">oligonucleotide probe</cons> corresponding to the consensus <cons lex="NF-kappa_B_binding_sites" sem="G#DNA_domain_or_region"><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> binding sites</cons> of the <cons lex="VCAM-1_gene" sem="G#DNA_domain_or_region"><cons lex="VCAM-1" sem="G#protein_molecule">VCAM-1</cons> gene</cons> (<cons lex="VCAM-NF-kappa_B" sem="G#protein_complex">VCAM-<cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons></cons>), the antioxidant had no appreciable effect when an oligomer corresponding to the <cons lex="consensus_NF-kappa_B_binding_site" sem="G#DNA_domain_or_region">consensus <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> binding site</cons> of the <cons lex="E-selectin_gene" sem="G#DNA_domain_or_region"><cons lex="E-selectin" sem="G#protein_molecule">E-selectin</cons> gene</cons> (<cons lex="E-selectin" sem="G#protein_molecule">E-selectin</cons><cons lex="NF-kappa_B" sem="G#protein_complex">-NF-kappa B</cons>) was used.</sentence>
<sentence>Because <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> has been reported to be redox sensitive, we studied the effects of <cons lex="NAC" sem="G#amino_acid_monomer">NAC</cons> on the <cons lex="EC_redox_environment" sem="G#other_name"><cons lex="EC" sem="G#cell_type">EC</cons> redox environment</cons>.</sentence>
<sentence><cons lex="NAC" sem="G#amino_acid_monomer">NAC</cons> caused an expected dramatic increase in the <cons lex="reduced_glutathione_(GSH)_level" sem="G#other_name"><cons lex="reduced_glutathione" sem="G#peptide">reduced glutathione</cons> (<cons lex="GSH" sem="G#peptide">GSH</cons>) levels</cons> in <cons lex="EC" sem="G#cell_type">EC</cons>.</sentence>
<sentence>In vitro studies demonstrated that whereas the binding affinity of <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> to the <cons lex="VCAM-NF-kappa_B_oligomer" sem="G#DNA_molecule">VCAM-<cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> oligomer</cons> peaked at a <cons lex="GSH-to-oxidized_glutathione_(GSSG)_ratio" sem="G#other_name"><cons lex="GSH" sem="G#peptide">GSH</cons>-to-oxidized <cons lex="glutathione" sem="G#peptide">glutathione</cons> (<cons lex="GSSG" sem="G#peptide">GSSG</cons>) ratio</cons> of approximately 200 and decreased at higher ratios, the binding to the <cons lex="E-selectin-NF-kappa_B_oligomer" sem="G#DNA_molecule"><cons lex="E-selectin" sem="G#protein_molecule">E-selectin</cons><cons lex="NF-kappa_B" sem="G#protein_complex">-NF-kappa B</cons> oligomer</cons> appeared relatively unaffected even at ratios &gt; 400, i.e., those achieved in <cons lex="EC" sem="G#cell_type">EC</cons> treated with 40 mM <cons lex="NAC" sem="G#amino_acid_monomer">NAC</cons>.</sentence>
<sentence>These results suggest that <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> binding to its consensus sequences in the <cons lex="VCAM-1" sem="G#protein_molecule">VCAM-1</cons> and <cons lex="E-selectin_gene" sem="G#DNA_domain_or_region"><cons lex="E-selectin" sem="G#protein_molecule">E-selectin</cons> gene</cons> exhibits marked differences in redox sensitivity, allowing for differential gene expression regulated by the same transcription factor.</sentence>
<sentence>Our data also demonstrate that <cons lex="NAC" sem="G#amino_acid_monomer">NAC</cons> increases the <cons lex="GSH-to-GSSG_ratio" sem="G#other_name"><cons lex="GSH" sem="G#peptide">GSH</cons>-to-<cons lex="GSSG" sem="G#peptide">GSSG</cons> ratio</cons> within the <cons lex="EC" sem="G#cell_type">EC</cons> suggesting one possible mechanism through which this antioxidant inhibits <cons lex="agonist-induced_monocyte_adhesion" sem="G#other_name">agonist-induced monocyte adhesion</cons> to <cons lex="EC" sem="G#cell_type">EC</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97378061</bibliomisc>
</articleinfo>
<title>
<sentence>Opposite effects of the <cons lex="acute_promyelocytic_leukemia_PML-retinoic_acid_receptor_alpha" sem="G#protein_molecule">acute promyelocytic leukemia PML-retinoic acid receptor alpha</cons> (<cons lex="RAR_alpha" sem="G#protein_molecule">RAR alpha</cons>) and <cons lex="PLZF-RAR_alpha_fusion_protein" sem="G#protein_molecule">PLZF-RAR alpha fusion proteins</cons> on <cons lex="retinoic_acid_signalling" sem="G#other_name"><cons lex="retinoic_acid" sem="G#other_organic_compound">retinoic acid</cons> signalling</cons>.</sentence>
</title>
<abstract>
<sentence>Fusion proteins involving the <cons lex="retinoic_acid" sem="G#other_organic_compound">retinoic acid</cons> <cons lex="receptor_alpha" sem="G#protein_molecule">receptor alpha</cons> (<cons lex="RAR_alpha" sem="G#protein_molecule">RAR alpha</cons>) and the <cons lex="PML" sem="G#protein_molecule">PML</cons> or <cons lex="PLZF_nuclear_protein" sem="G#protein_molecule">PLZF nuclear protein</cons> are the genetic markers of <cons lex="acute_promyelocytic_leukemia" sem="G#other_name">acute promyelocytic leukemias</cons> (<cons lex="APL" sem="G#other_name">APLs</cons>).</sentence>
<sentence><cons lex="APL" sem="G#other_name">APLs</cons> with the <cons lex="PML-RAR_alpha" sem="G#protein_molecule">PML-RAR alpha</cons> or the <cons lex="PLZF-RAR_alpha_fusion_protein" sem="G#protein_molecule"><cons lex="PLZF-RAR_alpha" sem="G#protein_molecule">PLZF-RAR alpha</cons> fusion protein</cons> are phenotypically indistinguishable except that they differ in their sensitivity to <cons lex="retinoic_acid_(RA)-induced_differentiation" sem="G#other_name"><cons lex="retinoic_acid" sem="G#other_organic_compound">retinoic acid</cons> (RA)-induced differentiation</cons>: <cons lex="PML-RAR_alpha" sem="G#protein_molecule">PML-RAR alpha</cons> blasts are sensitive to <cons lex="RA" sem="G#other_organic_compound">RA</cons> and patients enter disease remission after <cons lex="RA_treatment" sem="G#other_name"><cons lex="RA" sem="G#other_organic_compound">RA</cons> treatment</cons>, while patients with <cons lex="PLZF-RAR_alpha" sem="G#protein_molecule">PLZF-RAR alpha</cons> do not.</sentence>
<sentence>We here report that (i) like <cons lex="PML-RAR_alpha_expression" sem="G#other_name"><cons lex="PML-RAR_alpha" sem="G#protein_molecule">PML-RAR alpha</cons> expression</cons>, <cons lex="PLZF-RAR_alpha_expression" sem="G#other_name"><cons lex="PLZF-RAR_alpha" sem="G#protein_molecule">PLZF-RAR alpha</cons> expression</cons> blocks terminal differentiation of <cons lex="hematopoietic_precursor_cell_line" sem="G#other_name">hematopoietic precursor cell lines</cons> (<cons lex="U937" sem="G#cell_line">U937</cons> and <cons lex="HL-60" sem="G#cell_line">HL-60</cons>) in response to different stimuli (<cons lex="vitamin_D3" sem="G#other_organic_compound">vitamin D3</cons>, transforming growth factor <cons lex="beta1" sem="G#other_organic_compound">beta1</cons>, and <cons lex="dimethyl_sulfoxide" sem="G#other_organic_compound">dimethyl sulfoxide</cons>); (ii) <cons lex="PML-RAR_alpha" sem="G#protein_molecule">PML-RAR alpha</cons>, but not <cons lex="PLZF-RAR_alpha" sem="G#protein_molecule">PLZF-RAR alpha</cons>, increases <cons lex="RA_sensitivity" sem="G#other_name">RA sensitivity</cons> of <cons lex="hematopoietic_precursor_cell" sem="G#cell_type">hematopoietic precursor cells</cons> and restores <cons lex="RA_sensitivity" sem="G#other_name">RA sensitivity</cons> of <cons lex="RA-resistant_hematopoietic_cell" sem="G#cell_type">RA-resistant hematopoietic cells</cons>; (iii) <cons lex="PML-RAR_alpha" sem="G#protein_molecule">PML-RAR alpha</cons> and <cons lex="PLZF-RAR_alpha" sem="G#protein_molecule">PLZF-RAR alpha</cons> have similar <cons lex="RA" sem="G#other_organic_compound">RA</cons> binding affinities; and (iv) <cons lex="PML-RAR_alpha" sem="G#protein_molecule">PML-RAR alpha</cons> enhances the <cons lex="RA" sem="G#other_organic_compound">RA</cons> response of <cons lex="RA_target_gene" sem="G#DNA_family_or_group"><cons lex="RA" sem="G#other_organic_compound">RA</cons> target genes</cons> (those for <cons lex="RAR_beta" sem="G#protein_molecule">RAR beta</cons>, <cons lex="RAR_gamma" sem="G#protein_molecule">RAR gamma</cons>, and <cons lex="transglutaminase_type_II" sem="G#protein_molecule">transglutaminase type II</cons> [<cons lex="TGase" sem="G#protein_molecule">TGase</cons>]) in vivo, while <cons lex="PLZF-RAR_alpha_expression" sem="G#other_name"><cons lex="PLZF-RAR_alpha" sem="G#protein_molecule">PLZF-RAR alpha</cons> expression</cons> has either no effect (<cons lex="RAR_beta" sem="G#protein_molecule">RAR beta</cons>) or an inhibitory activity (<cons lex="RAR_gamma" sem="G#protein_molecule">RAR gamma</cons> and <cons lex="type_II_TGase" sem="G#protein_molecule">type II <cons lex="TGase" sem="G#protein_molecule">TGase</cons></cons>).</sentence>
<sentence>These data demonstrate that <cons lex="PML-RAR_alpha" sem="G#protein_molecule">PML-RAR alpha</cons> and <cons lex="PLZF-RAR_alpha" sem="G#protein_molecule">PLZF-RAR alpha</cons> have similar (inhibitory) effects on <cons lex="RA-independent_differentiation" sem="G#other_name">RA-independent differentiation</cons> and opposite (stimulatory or inhibitory) effects on <cons lex="RA-dependent_differentiation" sem="G#other_name"><cons lex="RA" sem="G#other_organic_compound">RA</cons>-dependent differentiation</cons> and that they behave in vivo as <cons lex="RA-dependent_enhancer" sem="G#DNA_domain_or_region"><cons lex="RA" sem="G#other_organic_compound">RA</cons>-dependent enhancers</cons> or inhibitors of <cons lex="RA-responsive_gene" sem="G#DNA_family_or_group"><cons lex="RA" sem="G#other_organic_compound">RA</cons>-responsive genes</cons>, respectively.</sentence>
<sentence>Their different activities on the <cons lex="RA_signalling_pathway" sem="G#other_name"><cons lex="RA" sem="G#other_organic_compound">RA</cons> signalling pathway</cons> might underlie the different responses of <cons lex="PML-RAR_alpha" sem="G#protein_molecule">PML-RAR alpha</cons> and <cons lex="PLZF-RAR_alpha" sem="G#protein_molecule">PLZF-RAR alpha</cons> <cons lex="APL" sem="G#other_name">APLs</cons> to <cons lex="RA_treatment" sem="G#other_name">RA treatment</cons>.</sentence>
<sentence>The <cons lex="PLZF-RAR_alpha_fusion_protein" sem="G#protein_molecule"><cons lex="PLZF-RAR_alpha" sem="G#protein_molecule">PLZF-RAR alpha</cons> fusion protein</cons> contains an approximately <cons lex="120-amino-acid_N-terminal_motif" sem="G#protein_domain_or_region">120-amino-acid N-terminal motif</cons> (called the <cons lex="POZ_domain" sem="G#protein_domain_or_region">POZ domain</cons>), which is also found in a variety of zinc finger proteins and a group of <cons lex="poxvirus_protein" sem="G#protein_family_or_group"><cons lex="poxvirus" sem="G#virus">poxvirus</cons> proteins</cons> and which mediates <cons lex="protein-protein_interaction" sem="G#other_name">protein-protein interactions</cons>.</sentence>
<sentence>Deletion of the <cons lex="PLZF_POZ_domain" sem="G#protein_domain_or_region">PLZF <cons lex="POZ_domain" sem="G#protein_domain_or_region">POZ domain</cons></cons> partially abrogated the inhibitory effect of <cons lex="PLZF-RAR_alpha" sem="G#protein_molecule">PLZF-RAR alpha</cons> on <cons lex="RA-induced_differentiation" sem="G#other_name">RA-induced differentiation</cons> and on <cons lex="RA-mediated_type_II_TGase_up-regulation" sem="G#other_name">RA-mediated <cons lex="type_II_TGase" sem="G#protein_family_or_group">type II TGase</cons> up-regulation</cons>, suggesting that <cons lex="POZ-mediated_protein_interaction" sem="G#other_name">POZ-mediated protein interactions</cons> might be responsible for the inhibitory transcriptional activities of <cons lex="PLZF-RAR_alpha" sem="G#protein_molecule">PLZF-RAR alpha</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97379437</bibliomisc>
</articleinfo>
<title>
<sentence>A human homologue of the <cons lex="Drosophila_Toll_protein" sem="G#protein_molecule">Drosophila Toll protein</cons> signals activation of adaptive immunity [see comments]</sentence>
</title>
<abstract>
<sentence>Induction of the <cons lex="adaptive_immune_response" sem="G#other_name">adaptive immune response</cons> depends on the expression of <cons lex="co-stimulatory_molecule" sem="G#protein_family_or_group">co-stimulatory molecules</cons> and <cons lex="cytokine" sem="G#protein_family_or_group">cytokines</cons> by <cons lex="antigen-presenting_cell" sem="G#cell_type">antigen-presenting cells</cons>.</sentence>
<sentence>The mechanisms that control the initial induction of these signals upon infection are poorly understood.</sentence>
<sentence>It has been proposed that their expression is controlled by the non-clonal, or innate, component of immunity that preceded in evolution the development of an <cons lex="adaptive_immune_system" sem="G#body_part">adaptive immune system</cons> in <cons lex="vertebrate" sem="G#multi_cell">vertebrates</cons>.</sentence>
<sentence>We report here the cloning and characterization of a <cons lex="human_homologue" sem="G#protein_family_or_group">human homologue</cons> of the <cons lex="Drosophila_toll_protein" sem="G#protein_molecule">Drosophila toll protein</cons> (<cons lex="Toll" sem="G#protein_molecule">Toll</cons>) which has been shown to induce the innate immune response in adult <cons lex="Drosophila" sem="G#multi_cell">Drosophila</cons>.</sentence>
<sentence>Like <cons lex="Drosophila" sem="G#multi_cell">Drosophila</cons> <cons lex="Toll" sem="G#protein_molecule">Toll</cons>, <cons lex="human_Toll" sem="G#protein_molecule">human Toll</cons> is a type I transmembrane protein with an extracellular domain consisting of a <cons lex="leucine-rich_repeat_(LRR)_domain" sem="G#protein_domain_or_region">leucine-rich repeat (<cons lex="LRR" sem="G#protein_domain_or_region">LRR</cons>) domain</cons>, and a cytoplasmic domain homologous to the <cons lex="cytoplasmic_domain" sem="G#protein_domain_or_region">cytoplasmic domain</cons> of the <cons lex="human_interleukin_(IL)-1_receptor" sem="G#protein_molecule">human interleukin (IL)-1 receptor</cons>.</sentence>
<sentence>Both <cons lex="Drosophila" sem="G#multi_cell">Drosophila</cons> <cons lex="Toll" sem="G#protein_molecule">Toll</cons> and the IL-1 receptor are known to signal through the <cons lex="NF-kappaB_pathway" sem="G#other_name"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> pathway</cons>.</sentence>
<sentence>We show that a constitutively active mutant of <cons lex="human_Toll" sem="G#protein_molecule">human <cons lex="Toll" sem="G#protein_molecule">Toll</cons></cons> transfected into human cell lines can induce the activation of <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> and the expression of <cons lex="NF-kappaB-controlled_gene" sem="G#DNA_family_or_group"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons>-controlled genes</cons> for the <cons lex="inflammatory_cytokine" sem="G#protein_family_or_group">inflammatory <cons lex="cytokine" sem="G#protein_family_or_group">cytokines</cons></cons> <cons lex="IL-1" sem="G#protein_molecule">IL-1</cons>, <cons lex="IL-6" sem="G#protein_molecule">IL-6</cons> and <cons lex="IL-8" sem="G#protein_molecule">IL-8</cons>, as well as the expression of the <cons lex="co-stimulatory_molecule" sem="G#protein_family_or_group">co-stimulatory molecule</cons> <cons lex="B7.1" sem="G#protein_molecule">B7.1</cons>, which is required for the activation of <cons lex="naive_T_cell" sem="G#cell_type">naive <cons lex="T_cell" sem="G#cell_type">T cells</cons></cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97344237</bibliomisc>
</articleinfo>
<title>
<sentence>Role of <cons lex="ascorbate" sem="G#other_organic_compound">ascorbate</cons> in the activation of <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> by <cons lex="tumour_necrosis_factor-alpha" sem="G#protein_molecule">tumour necrosis factor-alpha</cons> in <cons lex="T-cell" sem="G#cell_type">T-cells</cons>.</sentence>
</title>
<abstract>
<sentence>The first product of <cons lex="ascorbate" sem="G#other_organic_compound">ascorbate</cons> oxidation, the <cons lex="ascorbate_free_radical" sem="G#other_organic_compound"><cons lex="ascorbate" sem="G#other_organic_compound">ascorbate</cons> free radical</cons> (<cons lex="AFR" sem="G#other_organic_compound">AFR</cons>), acts in biological systems mainly as an oxidant, and through its role in the <cons lex="plasma_membrane_redox_system" sem="G#cell_component">plasma membrane redox system</cons> exerts different effects on the cell.</sentence>
<sentence>We have investigated the role of <cons lex="ascorbate,_AFR" sem="G#other_organic_compound"><cons lex="ascorbate" sem="G#other_organic_compound">ascorbate</cons>, <cons lex="AFR" sem="G#other_organic_compound">AFR</cons></cons> and <cons lex="dehydroascorbate" sem="G#other_organic_compound">dehydroascorbate</cons> (<cons lex="DHA" sem="G#other_organic_compound">DHA</cons>) in the activation of the <cons lex="NF-kappaB_transcription_factor" sem="G#protein_molecule"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> transcription factor</cons> in <cons lex="Jurkat_T-cell" sem="G#cell_line">Jurkat T-cells</cons> stimulated by <cons lex="tumour_necrosis_factor-alpha" sem="G#protein_molecule">tumour necrosis factor-alpha</cons> (<cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons>).</sentence>
<sentence>Here we show, by <cons lex="electrophoretic_mobility_shift_assay" sem="G#other_name">electrophoretic mobility shift assays</cons>, that <cons lex="ascorbate" sem="G#other_organic_compound">ascorbate</cons> increases the binding of <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> to DNA in <cons lex="TNF-alpha-stimulated_Jurkat_cell" sem="G#cell_line"><cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons>-stimulated Jurkat cells</cons>.</sentence>
<sentence>The ability of <cons lex="ascorbate" sem="G#other_organic_compound">ascorbate</cons> to enhance <cons lex="cytoplasmic_inhibitory_IkBalpha_protein_degradation" sem="G#other_name">cytoplasmic inhibitory <cons lex="IkBalpha_protein" sem="G#protein_molecule">IkBalpha protein</cons> degradation</cons> correlates completely with its capacity to induce <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> binding to DNA and to potentiate <cons lex="NF-kappaB-mediated_transactivation" sem="G#other_name"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons>-mediated transactivation</cons> of the <cons lex="HIV-1_long_terminal_repeat_promoter" sem="G#DNA_domain_or_region">HIV-1 long terminal repeat promoter</cons> in <cons lex="TNF-alpha-stimulated_Jurkat_cell" sem="G#cell_line"><cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons>-stimulated Jurkat cells</cons> but not in cells stimulated with <cons lex="PMA" sem="G#other_organic_compound">PMA</cons> plus <cons lex="ionomycin" sem="G#other_organic_compound">ionomycin</cons>.</sentence>
<sentence><cons lex="AFR" sem="G#other_organic_compound">AFR</cons> behaves like <cons lex="ascorbate" sem="G#other_organic_compound">ascorbate</cons>, while <cons lex="DHA" sem="G#other_organic_compound">DHA</cons> and <cons lex="ascorbate" sem="G#other_organic_compound">ascorbate</cons> phosphate do not affect <cons lex="TNF-alpha-mediated_NF-kappaB_activation" sem="G#other_name"><cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons>-mediated <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> activation</cons>.</sentence>
<sentence>These results provide new evidence for a possible relationship between the activation of the <cons lex="electron-transport_system" sem="G#cell_component">electron-transport system</cons> at the <cons lex="plasma_membrane" sem="G#cell_component">plasma membrane</cons> by <cons lex="ascorbate" sem="G#other_organic_compound">ascorbate</cons> or its free radical and <cons lex="redox-dependent_gene_transcription" sem="G#other_name">redox-dependent gene transcription</cons> in <cons lex="T-cell" sem="G#cell_type">T-cells</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97332417</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="Human_cytomegalovirus" sem="G#virus">Human cytomegalovirus</cons> induces <cons lex="interleukin-8_production" sem="G#other_name"><cons lex="interleukin-8" sem="G#protein_molecule">interleukin-8</cons> production</cons> by a <cons lex="human_monocytic_cell_line" sem="G#cell_line">human monocytic cell line</cons>, <cons lex="THP-1" sem="G#cell_line">THP-1</cons>, through acting concurrently on <cons lex="(AND AP-1-binding_site NF-kappaB-binding_site)" sem="(AND G#DNA_domain_or_region G#DNA_domain_or_region)"><cons lex="AP-1-*">AP-1-</cons> and <cons lex="NF-kappaB-*">NF-kappaB-</cons><cons lex="*binding_site">binding sites</cons></cons> of the <cons lex="interleukin-8_gene" sem="G#DNA_domain_or_region"><cons lex="interleukin-8" sem="G#protein_molecule">interleukin-8</cons> gene</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="cytomegalovirus_(CMV)_infection" sem="G#other_name"><cons lex="cytomegalovirus" sem="G#virus">Cytomegalovirus</cons> (CMV) infection</cons> induced <cons lex="interleukin-8_(IL-8)_gene_transcription" sem="G#other_name"><cons lex="interleukin-8" sem="G#protein_molecule">interleukin-8</cons> (<cons lex="IL-8" sem="G#protein_molecule">IL-8</cons>) gene transcription</cons> in a <cons lex="human_monocytic_cell_line" sem="G#cell_line">human monocytic cell line</cons>, <cons lex="THP-1_cell" sem="G#cell_line">THP-1 cells</cons>, leading to <cons lex="IL-8_secretion" sem="G#other_name"><cons lex="IL-8" sem="G#protein_molecule">IL-8</cons> secretion</cons>.</sentence>
<sentence>The functional analysis of the <cons lex="IL-8_gene" sem="G#DNA_domain_or_region"><cons lex="IL-8" sem="G#protein_molecule">IL-8</cons> gene</cons> revealed that both <cons lex="(AND AP-1-binding_element NF-kappaB_factor-binding_element)" sem="(AND G#DNA_domain_or_region G#DNA_domain_or_region)"><cons lex="AP-1-*">AP-1-</cons> and <cons lex="NF-kappaB_factor-*">NF-kappaB factor-</cons><cons lex="*binding_element">binding elements</cons></cons> were involved in conferring the responsiveness to <cons lex="CMV" sem="G#virus">CMV</cons>.</sentence>
<sentence>Moreover, <cons lex="electrophoretic_mobility_shift_assay" sem="G#other_name">electrophoretic mobility shift assays</cons> demonstrated that <cons lex="CMV" sem="G#virus">CMV</cons> induced the formation of <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> and <cons lex="AP-1_complex" sem="G#protein_complex">AP-1 complexes</cons>.</sentence>
<sentence>These results suggest that <cons lex="CMV" sem="G#virus">CMV</cons> activates these <cons lex="transcriptional_factor" sem="G#protein_family_or_group">transcriptional factors</cons>, resulting in <cons lex="IL-8_gene_expression" sem="G#other_name"><cons lex="IL-8" sem="G#protein_molecule">IL-8</cons> gene expression</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97333610</bibliomisc>
</articleinfo>
<title>
<sentence>Construction and biological characterization of an <cons lex="interleukin-12_fusion_protein" sem="G#protein_molecule">interleukin-12 fusion protein</cons> (<cons lex="Flexi-12" sem="G#protein_molecule">Flexi-12</cons>): delivery to <cons lex="acute_myeloid_leukemic_blast" sem="G#cell_type">acute myeloid leukemic blasts</cons> using <cons lex="adeno-associated_virus" sem="G#virus">adeno-associated virus</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="Interleukin-12" sem="G#protein_molecule">Interleukin-12</cons> (<cons lex="IL-12" sem="G#protein_molecule">IL-12</cons>) is a <cons lex="cytokine" sem="G#protein_family_or_group">cytokine</cons> that exhibits <cons lex="pleiotropic_effect" sem="G#other_name">pleiotropic effects</cons> on <cons lex="lymphocyte" sem="G#cell_type">lymphocytes</cons> and <cons lex="natural_killer_cell" sem="G#cell_type">natural killer cells</cons> and has been shown to have promise for the immunotherapy of cancer.</sentence>
<sentence>The combination of the <cons lex="immune_costimulatory_molecule" sem="G#protein_molecule">immune costimulatory molecule</cons> <cons lex="B7.1" sem="G#protein_molecule">B7.1</cons> and <cons lex="IL-12" sem="G#protein_molecule">IL-12</cons> has been shown to be synergistic for <cons lex="T_cell_activation" sem="G#other_name">T cell activation</cons>.</sentence>
<sentence>By transfecting tumor cells with both <cons lex="(AND IL-12_cDNA B7.1_cDNA)" sem="(AND G#DNA_molecule G#DNA_molecule)"><cons lex="IL-12*">IL-12</cons> and <cons lex="B7.1*">B7.1</cons> <cons lex="*cDNA">cDNAs</cons></cons>, it may be possible to use these modified targets as <cons lex="vaccine" sem="G#other_name">vaccines</cons>.</sentence>
<sentence>A major obstacle in designing a vector to deliver these genes results from the structure of <cons lex="IL-12" sem="G#protein_molecule">IL-12</cons>.</sentence>
<sentence>Functional <cons lex="IL-12" sem="G#protein_molecule">IL-12</cons> is a <cons lex="heterodimer" sem="G#protein_complex">heterodimer</cons> composed of two distinct subunits that are encoded by separate genes on different chromosomes.</sentence>
<sentence>Production of <cons lex="functional_IL-12" sem="G#protein_molecule">functional <cons lex="IL-12" sem="G#protein_molecule">IL-12</cons></cons> requires the coordinated expression of both genes.</sentence>
<sentence>This presents several problems in vectors, particularly those in which additional genes, either a <cons lex="co-stimulatory_gene" sem="G#DNA_family_or_group">co-stimulatory gene</cons> or a selectable marker, are inserted.</sentence>
<sentence>Therefore, we have constructed a single <cons lex="cDNA" sem="G#DNA_family_or_group">cDNA</cons> that encodes a <cons lex="single-chain_protein" sem="G#protein_family_or_group">single-chain protein</cons>, called <cons lex="Flexi-12" sem="G#protein_molecule">Flexi-12</cons>, which retains all of the biological characteristics of recombinant <cons lex="IL-12" sem="G#protein_molecule">IL-12</cons> (<cons lex="rIL-12" sem="G#protein_molecule">rIL-12</cons>).</sentence>
<sentence>The monomeric polypeptide <cons lex="Flexi-12" sem="G#protein_molecule">Flexi-12</cons> is able to induce the proliferation of <cons lex="phytohemagglutinin_(PHA)_blast" sem="G#cell_line"><cons lex="phytohemagglutinin" sem="G#protein_molecule">phytohemagglutinin</cons> (<cons lex="PHA" sem="G#protein_molecule">PHA</cons>) blasts</cons>, induce <cons lex="PHA_blast" sem="G#cell_line"><cons lex="PHA" sem="G#protein_molecule">PHA</cons> blasts</cons> to secrete <cons lex="interferon-gamma" sem="G#protein_molecule">interferon-gamma</cons> (<cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons>) and additionally, by preincubation, enhance the killing of <cons lex="K562_target" sem="G#other_name">K562 targets</cons> by <cons lex="PBL" sem="G#cell_type">PBLs</cons>.</sentence>
<sentence>These phenomena are in a dose-dependent manner comparable to that seen with <cons lex="rIL-12" sem="G#protein_molecule">rIL-12</cons>.</sentence>
<sentence>We have also shown that tyrosine phosphorylation of the <cons lex="STAT_4_transcription_factor" sem="G#protein_molecule">STAT 4 transcription factor</cons>, which has been shown to be unique to the <cons lex="IL-12" sem="G#protein_molecule">IL-12</cons> signaling pathway, occurs with <cons lex="Flexi-12" sem="G#protein_molecule">Flexi-12</cons> at levels similar to those seen with <cons lex="rIL-12" sem="G#protein_molecule">rIL-12</cons>.</sentence>
<sentence>We have packaged <cons lex="Flexi-12" sem="G#protein_molecule">Flexi-12</cons> into a <cons lex="recombinant_adeno-associated_virus" sem="G#virus">recombinant adeno-associated virus</cons> (<cons lex="AAV" sem="G#virus">AAV</cons>) and used this vector to infect <cons lex="acute_myeloid_leukemic_(AML)_blast" sem="G#cell_type">acute myeloid leukemic (AML) blasts</cons>.</sentence>
<sentence>Infected <cons lex="AML_blast" sem="G#cell_type">AML blasts</cons> produced between 2 and 6 ng of IL-12/10(6) cells per ml per 48 hr.</sentence>
<sentence>These studies also confirm that <cons lex="AAV" sem="G#virus">AAV</cons> is an efficient delivery vehicle for <cons lex="cytokine" sem="G#protein_family_or_group">cytokines</cons> to leukemic cells.</sentence>
<sentence>Direct analysis of these modified cells acting as <cons lex="tumor_vaccine" sem="G#other_name">tumor vaccines</cons> is underway.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97292307</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="plasma_sialyltransferase_level" sem="G#other_name">Plasma <cons lex="sialyltransferase" sem="G#protein_molecule">sialyltransferase</cons> levels</cons> in <cons lex="psychiatric_disorder" sem="G#other_name">psychiatric disorders</cons> as a possible indicator of <cons lex="HPA_axis_function" sem="G#other_name"><cons lex="HPA_axis" sem="G#body_part">HPA axis</cons> function</cons>.</sentence>
</title>
<abstract>
<sentence>A <cons lex="dysfunction" sem="G#other_name">dysfunction</cons> in the regulation of the <cons lex="hypothalamic-pituitary-adrenal_(HPA)_axis" sem="G#body_part">hypothalamic-pituitary-adrenal (HPA) axis</cons>, possibly attributed to a change in <cons lex="glucocorticoid_receptor_(GR)_functionality" sem="G#other_name"><cons lex="glucocorticoid_receptor" sem="G#protein_family_or_group">glucocorticoid receptor</cons> (<cons lex="GR" sem="G#protein_family_or_group">GR</cons>) functionality</cons>, has been implicated in depression.</sentence>
<sentence>We have measured both <cons lex="lymphocyte_GR_receptor_binding_parameter" sem="G#other_name"><cons lex="lymphocyte_GR" sem="G#protein_molecule">lymphocyte GR</cons> receptor binding parameters</cons> and <cons lex="plasma_sialyltransferase_activity" sem="G#other_name">plasma <cons lex="sialyltransferase" sem="G#protein_molecule">sialyltransferase</cons> activity</cons>, as a biochemical marker of <cons lex="GR_function" sem="G#other_name"><cons lex="GR" sem="G#protein_family_or_group">GR</cons> function</cons>, in two groups of <cons lex="patient" sem="G#multi_cell">patients</cons> suffering from <cons lex="depression" sem="G#other_name">depression</cons> or <cons lex="schizophrenia" sem="G#other_name">schizophrenia</cons> and in a group of age- and sex-matched controls.</sentence>
<sentence>While there was a significant increase in <cons lex="plasma_cortisol_level" sem="G#other_name">plasma cortisol levels</cons> in the depressed group, there were no changes in the lymphocyte <cons lex="GR_binding_parameter" sem="G#other_name"><cons lex="GR" sem="G#protein_family_or_group">GR</cons> binding parameters</cons> (K(m) and Bmax).</sentence>
<sentence>There was, however, a significant decrease in the <cons lex="plasma_sialyltransferase" sem="G#protein_molecule">plasma <cons lex="sialyltransferase" sem="G#protein_molecule">sialyltransferase</cons>:</cons> cortisol ratio in the depressed group suggesting an inability of the <cons lex="raised_cortisol_level" sem="G#other_name">raised <cons lex="cortisol" sem="G#lipid">cortisol</cons> levels</cons> to induce <cons lex="enzyme_expression" sem="G#other_name">enzyme expression</cons> and this ratio may provide a useful biochemical marker of <cons lex="cortisol" sem="G#lipid">cortisol</cons> receptor function.</sentence>
<sentence>Although there was an increase in the plasma activity of the <cons lex="alpha_2,6_sialyltransferase_isozyme" sem="G#protein_molecule">alpha 2,6 <cons lex="sialyltransferase" sem="G#protein_molecule">sialyltransferase</cons> isozyme</cons> in the <cons lex="schizophrenic_group" sem="G#other_name">schizophrenic group</cons>, no other changes were determined.</sentence>
<sentence>Therefore, while the total <cons lex="plasma_sialyltransferase" sem="G#protein_molecule">plasma <cons lex="sialyltransferase" sem="G#protein_molecule">sialyltransferase</cons></cons>:<cons lex="cortisol" sem="G#lipid">cortisol</cons> ratio reflects <cons lex="HPA_axis_function" sem="G#other_name"><cons lex="HPA_axis" sem="G#body_part">HPA axis</cons> function</cons>, alterations in specific isozyme activity may also be associated with other <cons lex="CNS_disease_state" sem="G#other_name">CNS disease states</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97289567</bibliomisc>
</articleinfo>
<title>
<sentence>Regulation of <cons lex="CD95_(Fas)_ligand_expression" sem="G#other_name"><cons lex="CD95_(Fas)_ligand" sem="G#protein_molecule">CD95 (Fas) ligand</cons> expression</cons> by <cons lex="TCR-mediated_signaling_event" sem="G#other_name"><cons lex="TCR" sem="G#protein_family_or_group">TCR</cons>-mediated signaling events</cons>.</sentence>
</title>
<abstract>
<sentence>Stimulation of <cons lex="mature_peripheral_T_cell" sem="G#cell_type">mature peripheral T cells</cons> by <cons lex="TCR_engagement" sem="G#other_name"><cons lex="TCR" sem="G#protein_family_or_group">TCR</cons> engagement</cons> results in activation of signals that drive induction of <cons lex="cytokine_gene_expression" sem="G#other_name"><cons lex="cytokine" sem="G#protein_family_or_group">cytokine</cons> gene expression</cons> and <cons lex="clonal_expansion" sem="G#other_name">clonal expansion</cons>.</sentence>
<sentence>However, under some conditions, engagement of the <cons lex="TCR" sem="G#protein_family_or_group">TCR</cons> leads instead to apoptosis.</sentence>
<sentence>Recent studies demonstrate that <cons lex="TCR-stimulated_apoptosis" sem="G#other_name"><cons lex="TCR" sem="G#protein_family_or_group">TCR</cons>-stimulated apoptosis</cons> requires expression of <cons lex="CD95_ligand" sem="G#protein_molecule">CD95 ligand</cons> on <cons lex="activated_T_cell" sem="G#cell_type">activated T cells</cons> followed by an interaction between <cons lex="CD95_ligand" sem="G#protein_molecule">CD95 ligand</cons> and the <cons lex="CD95_receptor" sem="G#protein_molecule">CD95 receptor</cons> also expressed on this population.</sentence>
<sentence>The experiments reported in this study were designed to address the signaling events triggered by <cons lex="TCR_engagement" sem="G#other_name"><cons lex="TCR" sem="G#protein_family_or_group">TCR</cons> engagement</cons> that are important for regulating <cons lex="CD95_ligand_gene_expression" sem="G#other_name"><cons lex="CD95_ligand" sem="G#protein_molecule">CD95 ligand</cons> gene expression</cons>.</sentence>
<sentence>To approach this, we generated a <cons lex="luciferase_reporter_construct" sem="G#DNA_molecule"><cons lex="luciferase" sem="G#protein_molecule">luciferase</cons> reporter construct</cons> containing elements of the <cons lex="CD95_ligand" sem="G#protein_molecule">CD95 ligand</cons> promoter.</sentence>
<sentence>Using a previously described mutant of the <cons lex="Jurkat_T_cell_line" sem="G#cell_line">Jurkat T cell line</cons>, we show that proximal signaling events dependent on the presence of the <cons lex="CD45_tyrosine_phosphatase" sem="G#protein_molecule">CD45 tyrosine phosphatase</cons> are required for <cons lex="TCR-stimulated_CD95_ligand_expression" sem="G#other_name"><cons lex="TCR" sem="G#protein_family_or_group">TCR</cons>-stimulated <cons lex="CD95_ligand" sem="G#protein_molecule">CD95 ligand</cons> expression</cons>.</sentence>
<sentence>Transient transfection studies demonstrate further that <cons lex="TCR" sem="G#protein_family_or_group">TCR</cons>-stimulated activation of the <cons lex="Ras_signaling_pathway" sem="G#other_name"><cons lex="Ras" sem="G#protein_molecule">Ras</cons> signaling pathway</cons> is required for optimal activation of <cons lex="CD95_ligand" sem="G#protein_molecule">CD95 ligand</cons>.</sentence>
<sentence>Next, in an effort to determine critical <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> that regulate <cons lex="CD95_ligand" sem="G#protein_molecule">CD95 ligand</cons> expression, we demonstrate a <cons lex="cyclosporin_A-sensitive_nuclear_factor-AT_response_element" sem="G#DNA_domain_or_region">cyclosporin A-sensitive nuclear factor-AT response element</cons> in the <cons lex="promoter_region" sem="G#DNA_domain_or_region">promoter region</cons> of this gene that is critical for optimal <cons lex="CD95_ligand_reporter_activity" sem="G#other_name"><cons lex="CD95_ligand" sem="G#protein_molecule">CD95 ligand</cons> reporter activity</cons> in <cons lex="stimulated_T_cell" sem="G#cell_type">stimulated T cells</cons>.</sentence>
<sentence>Together, these studies begin a dissection of the biochemical events that lead to expression of <cons lex="CD95_ligand" sem="G#protein_molecule">CD95 ligand</cons>, a required step for <cons lex="TCR-induced_apoptosis" sem="G#other_name"><cons lex="TCR" sem="G#protein_family_or_group">TCR</cons>-induced apoptosis</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97321386</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="reactive_oxygen_specie" sem="G#other_organic_compound">Reactive oxygen species</cons> and <cons lex="antioxidant" sem="G#other_organic_compound">antioxidants</cons> in <cons lex="inflammatory_disease" sem="G#other_name">inflammatory diseases</cons>.</sentence>
</title>
<abstract>
<sentence>This paper aims to review the role of free radical-induced tissue damage and antioxidant defence mechanisms in <cons lex="inflammatory_disease" sem="G#other_name">inflammatory diseases</cons> that involve <cons lex="pathogenic_process" sem="G#other_name">pathogenic processes</cons> similar to the <cons lex="periodontal_disease" sem="G#other_name">periodontal diseases</cons>.</sentence>
<sentence>There is a clearly defined and substantial role for <cons lex="free_radical" sem="G#other_organic_compound">free radicals</cons> or <cons lex="reactive_oxygen_specie" sem="G#other_organic_compound">reactive oxygen species</cons> (<cons lex="ROS" sem="G#other_organic_compound">ROS</cons>) in <cons lex="periodontitis" sem="G#tissue">periodontitis</cons>, but little research has been performed in this area.</sentence>
<sentence>This paper reviews the considerable data available relating <cons lex="ROS" sem="G#other_organic_compound">ROS</cons> activity and antioxidant defence to <cons lex="inflammatory_disease" sem="G#other_name">inflammatory diseases</cons> and attempts to draw parallels with <cons lex="periodontitis" sem="G#tissue">periodontitis</cons>, in an effort to stimulate more periodontal research in this important area.</sentence>
<sentence>The recent discovery of the <cons lex="transcription_factor_nuclear_factor_kappa_B" sem="G#protein_complex">transcription factor nuclear factor kappa B</cons> (<cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons>) is reviewed and several potential pathways for <cons lex="cytokine-induced_periodontal_tissue_damage" sem="G#other_name"><cons lex="cytokine" sem="G#protein_family_or_group">cytokine</cons>-induced periodontal tissue damage</cons>, mediated by <cons lex="NF-kappa_B1" sem="G#protein_molecule">NF-kappa B1</cons> are discussed.</sentence>
<sentence>Emphasis is placed on <cons lex="cytokine" sem="G#protein_family_or_group">cytokines</cons> that have been studied in <cons lex="periodontitis" sem="G#tissue">periodontitis</cons>, principally <cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons>, <cons lex="IL-1" sem="G#protein_molecule">IL-1</cons>, <cons lex="IL-6" sem="G#protein_molecule">IL-6</cons>, <cons lex="IL-8" sem="G#protein_molecule">IL-8</cons> and <cons lex="beta-interferon" sem="G#protein_molecule">beta-interferon</cons>.</sentence>
<sentence>The link between cellular production of such important mediators of <cons lex="inflammation" sem="G#other_name">inflammation</cons> and the <cons lex="antioxidant_(AO)_thiol" sem="G#other_organic_compound">antioxidant (AO) thiols</cons>, <cons lex="cysteine" sem="G#amino_acid_monomer">cysteine</cons> and <cons lex="reduced_glutathione" sem="G#peptide">reduced glutathione</cons> (<cons lex="GSH" sem="G#peptide">GSH</cons>), is discussed and it is hypothesised that <cons lex="NF-kappa_B_antagonist" sem="G#other_organic_compound"><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> antagonists</cons> may offer important <cons lex="therapeutic_benefit" sem="G#other_name">therapeutic benefits</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97449161</bibliomisc>
</articleinfo>
<title>
<sentence>Mutations in the <cons lex="TSC2_gene" sem="G#DNA_domain_or_region">TSC2 gene</cons>: analysis of the complete coding sequence using the <cons lex="protein_truncation_test" sem="G#other_name">protein truncation test</cons> (<cons lex="PTT" sem="G#other_name">PTT</cons>).</sentence>
</title>
<abstract>
<sentence>Mutations in the <cons lex="TSC2_gene" sem="G#DNA_domain_or_region">TSC2 gene</cons> on <cons lex="chromosome_16p13.3" sem="G#DNA_molecule">chromosome 16p13.3</cons> are responsible for approximately 50% of <cons lex="familial_tuberous_sclerosis" sem="G#other_name">familial tuberous sclerosis</cons> (<cons lex="TSC" sem="G#other_name">TSC</cons>).</sentence>
<sentence>The gene has <cons lex="41_small_exon" sem="G#DNA_domain_or_region">41 small exons</cons> spanning <cons lex="45_kb" sem="G#DNA_domain_or_region">45 kb</cons> of <cons lex="genomic_DNA" sem="G#DNA_family_or_group">genomic DNA</cons> and encoding a <cons lex="5.5_kb_mRNA" sem="G#RNA_molecule">5.5 kb mRNA</cons>.</sentence>
<sentence>Large germline deletions of <cons lex="TSC2" sem="G#DNA_domain_or_region">TSC2</cons> occur in &lt;5% of cases, and a number of small intragenic mutations have been described.</sentence>
<sentence>We analysed mRNA from 18 unrelated cases of <cons lex="TSC" sem="G#other_name">TSC</cons> for <cons lex="TSC2_mutation" sem="G#DNA_domain_or_region">TSC2 mutations</cons> using the <cons lex="protein_truncation_test" sem="G#other_name">protein truncation test</cons> (<cons lex="PTT" sem="G#other_name">PTT</cons>).</sentence>
<sentence>Three cases were predicted to be <cons lex="TSC2_mutation" sem="G#DNA_domain_or_region">TSC2 mutations</cons> on the basis of linkage analysis or because a hamartoma from the patient showed loss of heterozygosity for <cons lex="16p13.3_marker" sem="G#DNA_domain_or_region">16p13.3 markers</cons>.</sentence>
<sentence>Three overlapping <cons lex="PCR_product" sem="G#DNA_molecule">PCR products</cons>, covering the complete coding sequence of <cons lex="mRNA" sem="G#RNA_family_or_group">mRNA</cons>, were generated from <cons lex="lymphoblastoid_cell_line" sem="G#cell_line">lymphoblastoid cell lines</cons>, translated into <cons lex="35S-methionine_labelled_protein" sem="G#protein_molecule">35S-methionine labelled protein</cons>, and analysed by <cons lex="SDS-PAGE" sem="G#other_name">SDS-PAGE</cons>.</sentence>
<sentence><cons lex="PCR_product" sem="G#DNA_molecule">PCR products</cons> showing <cons lex="PTT" sem="G#other_name">PTT</cons> shifts were directly sequenced, and mutations confirmed by <cons lex="restriction_enzyme_digestion" sem="G#other_name">restriction enzyme digestion</cons> where possible.</sentence>
<sentence>Six <cons lex="PTT_shift" sem="G#other_name"><cons lex="PTT" sem="G#other_name">PTT</cons> shifts</cons> were identified.</sentence>
<sentence>Five of these were caused by mutations predicted to produce a <cons lex="truncated_protein" sem="G#protein_family_or_group">truncated protein</cons>: (i) a sporadic case showed a <cons lex="32_bp_deletion" sem="G#DNA_domain_or_region">32 bp deletion</cons> in <cons lex="exon_11" sem="G#RNA_domain_or_region">exon 11</cons>, and a <cons lex="mutant_mRNA" sem="G#RNA_molecule">mutant mRNA</cons> without <cons lex="exon_11" sem="G#RNA_domain_or_region">exon 11</cons> was produced; the normal exon 10 was also spliced out; (ii) a sporadic case had a <cons lex="1_bp_deletion" sem="G#DNA_domain_or_region">1 bp deletion</cons> in <cons lex="exon_12" sem="G#RNA_domain_or_region">exon 12</cons> (<cons lex="1634delT" sem="G#RNA_domain_or_region">1634delT</cons>); (iii) a <cons lex="TSC2-linked_mother_and_daughter_pair" sem="G#RNA_domain_or_region"><cons lex="TSC2" sem="G#DNA_domain_or_region">TSC2</cons>-linked mother and daughter pair</cons> had a G--&gt;T <cons lex="transversion" sem="G#other_name">transversion</cons> in <cons lex="exon_23" sem="G#RNA_domain_or_region">exon 23</cons> (<cons lex="G2715T" sem="G#RNA_domain_or_region">G2715T</cons>) introducing a cryptic splice site causing a 29 bp truncation of mRNA from <cons lex="exon_23" sem="G#RNA_domain_or_region">exon 23</cons>; (iv) a sporadic case showed a <cons lex="2_bp_deletion" sem="G#DNA_domain_or_region">2 bp deletion</cons> in <cons lex="exon_36" sem="G#RNA_domain_or_region">exon 36</cons>; (v) a sporadic case showed a <cons lex="1_bp_insertion" sem="G#DNA_domain_or_region">1 bp insertion</cons> disrupting the donor splice site of <cons lex="exon_37" sem="G#RNA_domain_or_region">exon 37</cons> (<cons lex="5007+2insA" sem="G#RNA_domain_or_region">5007+2insA</cons>), resulting in the use of an <cons lex="upstream_exonic_cryptic_splice_site" sem="G#RNA_domain_or_region">upstream exonic cryptic splice site</cons> to cause a <cons lex="29_bp_truncation" sem="G#RNA_domain_or_region">29 bp truncation</cons> of <cons lex="mRNA" sem="G#RNA_family_or_group">mRNA</cons> from <cons lex="exon_37" sem="G#RNA_domain_or_region">exon 37</cons>.</sentence>
<sentence>In one case, the <cons lex="PTT" sem="G#other_name">PTT</cons> shift was explained by in-frame splicing out of <cons lex="exon_10" sem="G#RNA_domain_or_region">exon 10</cons>, in the presence of a <cons lex="normal_exon_10_genomic_sequence" sem="G#DNA_domain_or_region">normal exon 10 genomic sequence</cons>.</sentence>
<sentence>Alternative splicing of <cons lex="exon_10" sem="G#RNA_domain_or_region">exon 10</cons> of the <cons lex="TSC2_gene" sem="G#DNA_domain_or_region">TSC2 gene</cons> may be a normal variant.</sentence>
<sentence>Three <cons lex="3rd_base_substitution_polymorphism" sem="G#other_name">3rd base substitution polymorphisms</cons> were also detected during direct sequencing of <cons lex="PCR_product" sem="G#DNA_molecule">PCR products</cons>.</sentence>
<sentence>Confirmed mutations were identified in 28% of the families studied and on the assumption that half of the sporadic cases should have <cons lex="TSC2_mutation" sem="G#DNA_domain_or_region">TSC2 mutations</cons>, a crude estimate of the detection rate would be 60%.</sentence>
<sentence>This compares favourably with other screening methods used for <cons lex="TSC2" sem="G#DNA_domain_or_region">TSC2</cons>, notably <cons lex="SSCP" sem="G#other_name">SSCP</cons>, and since <cons lex="PTT" sem="G#other_name">PTT</cons> involves much less work it may be the method of choice.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97423536</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="alpha-Tocopheryl_succinate" sem="G#other_organic_compound">alpha-Tocopheryl succinate</cons> inhibits <cons lex="monocytic_cell_adhesion" sem="G#other_name">monocytic cell adhesion</cons> to <cons lex="endothelial_cell" sem="G#cell_type">endothelial cells</cons> by suppressing <cons lex="NF-kappa_B_mobilization" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> mobilization</cons>.</sentence>
</title>
<abstract>
<sentence>The adherence of <cons lex="monocyte" sem="G#cell_type">monocytes</cons> to <cons lex="activated_endothelium" sem="G#tissue">activated endothelium</cons> is an early event in <cons lex="atherogenesis" sem="G#other_name">atherogenesis</cons>.</sentence>
<sentence>Because antioxidants have been considered to be of <cons lex="antiatherosclerotic_potential" sem="G#other_name">antiatherosclerotic potential</cons>, we investigated the effects of <cons lex="alpha-tocopherol" sem="G#other_organic_compound">alpha-tocopherol</cons> (<cons lex="TCP" sem="G#other_organic_compound">TCP</cons>) and its acetate and succinate esters on <cons lex="monocyte_adhesion" sem="G#other_name">monocyte adhesion</cons> to <cons lex="cytokine-stimulated_human_umbilical_vein_endothelial_cells" sem="G#cell_line">cytokine-stimulated human umbilical vein <cons lex="endothelial_cell" sem="G#cell_type">endothelial cells</cons></cons> (<cons lex="HUVEC" sem="G#cell_line">HUVEC</cons>).</sentence>
<sentence><cons lex="endothelial_cell" sem="G#cell_type">Endothelial cells</cons> were treated with <cons lex="TCP" sem="G#other_organic_compound">TCP</cons>, <cons lex="alpha-tocopherol_acetate" sem="G#other_organic_compound">alpha-tocopherol acetate</cons> (<cons lex="TCP_acetate" sem="G#other_organic_compound">TCP acetate</cons>), or <cons lex="alpha-tocopheryl_succinate" sem="G#other_organic_compound">alpha-tocopheryl succinate</cons> (<cons lex="TCP_succinate" sem="G#other_organic_compound">TCP succinate</cons>) before stimulation with <cons lex="tumor_necrosis_factor-alpha" sem="G#protein_molecule">tumor necrosis factor-alpha</cons> (<cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons>; 10 U/ml, 6 h) or <cons lex="interleukin-1_beta" sem="G#protein_molecule">interleukin-1 beta</cons> (<cons lex="IL-1_beta" sem="G#protein_molecule">IL-1 beta</cons>; 10 U/ml, 6 h).</sentence>
<sentence>Cytokine-stimulated cell surface expression of <cons lex="vascular_cell_adhesion_molecule-1" sem="G#protein_molecule">vascular cell adhesion molecule-1</cons> (<cons lex="VCAM-1" sem="G#protein_molecule">VCAM-1</cons>, <cons lex="CD106" sem="G#protein_molecule">CD106</cons>) and <cons lex="E-selectin" sem="G#protein_molecule">E-selectin</cons> (<cons lex="ELAM-1" sem="G#protein_molecule">ELAM-1</cons>, <cons lex="CD62E" sem="G#protein_molecule">CD62E</cons>), but not of <cons lex="intercellular_adhesion_molecule-1" sem="G#protein_molecule">intercellular adhesion molecule-1</cons> (<cons lex="ICAM-1" sem="G#protein_molecule">ICAM-1</cons>, <cons lex="CD54" sem="G#protein_molecule">CD54</cons>), was time- and dose-dependently inhibited by <cons lex="TCP_succinate" sem="G#other_organic_compound">TCP succinate</cons> but not by <cons lex="TCP" sem="G#other_organic_compound">TCP</cons> or <cons lex="TCP_acetate" sem="G#other_organic_compound">TCP acetate</cons>.</sentence>
<sentence><cons lex="TCP_succinate" sem="G#other_organic_compound">TCP succinate</cons> (200 microM, 24 h) reduced <cons lex="TNF-induced_VCAM-1" sem="G#protein_molecule">TNF-induced <cons lex="VCAM-1" sem="G#protein_molecule">VCAM-1</cons></cons> and <cons lex="E-selectin" sem="G#protein_molecule">E-selectin</cons> expression from a <cons lex="specific_mean_fluorescence_intensity" sem="G#other_name">specific mean fluorescence intensity</cons> of 151 +/- 28 to 12 +/- 4 channels and from 225 +/- 38 to 79 +/- 21 channels, respectively.</sentence>
<sentence><cons lex="succinate" sem="G#other_organic_compound">Succinate</cons> alone had no effect.</sentence>
<sentence>Decreased <cons lex="adhesion_molecule_expression" sem="G#other_name"><cons lex="adhesion_molecule" sem="G#protein_family_or_group">adhesion molecule</cons> expression</cons> was associated with a reduction of <cons lex="monocytic_cell_adhesion" sem="G#other_name">monocytic cell adhesion</cons>.</sentence>
<sentence><cons lex="TCP_succinate" sem="G#other_organic_compound">TCP succinate</cons> (20 microM, 72 h), but not <cons lex="TCP" sem="G#other_organic_compound">TCP</cons> (200 microM, 72 h), reduced <cons lex="U-937_cell_adhesion" sem="G#other_name"><cons lex="U-937_cell" sem="G#cell_line">U-937 cell</cons> adhesion</cons> to <cons lex="TNF-alpha-stimulated_(10_U/ml,_6_h)_HUVEC" sem="G#cell_line"><cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons>-stimulated (10 U/ml, 6 h) <cons lex="HUVEC" sem="G#cell_line">HUVEC</cons></cons> by 30% (P &lt; 0.025) and to <cons lex="IL-1_beta-stimulated_HUVEC" sem="G#cell_line"><cons lex="IL-1_beta" sem="G#protein_molecule">IL-1 beta</cons>-stimulated <cons lex="HUVEC" sem="G#cell_line">HUVEC</cons></cons> by 56% (P &lt; 0.010).</sentence>
<sentence><cons lex="electrophoretic_mobility-shift_assay" sem="G#other_name">Electrophoretic mobility-shift assays</cons> of <cons lex="HUVEC" sem="G#cell_line">HUVEC</cons> <cons lex="nuclear_protein" sem="G#protein_family_or_group">nuclear proteins</cons> revealed a decrease in <cons lex="TNF-alpha-stimulated_nuclear_factor-kappa_B" sem="G#protein_molecule"><cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons>-stimulated nuclear factor-kappa B</cons> (<cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons>) activation after pretreatment of <cons lex="HUVEC" sem="G#cell_line">HUVEC</cons> with <cons lex="TCP_succinate" sem="G#other_organic_compound"><cons lex="TCP" sem="G#other_organic_compound">TCP</cons> succinate</cons> but not with <cons lex="TCP" sem="G#other_organic_compound">TCP</cons>, <cons lex="TCP_acetate" sem="G#other_organic_compound">TCP acetate</cons>, or <cons lex="succinate" sem="G#other_organic_compound">succinate</cons> alone.</sentence>
<sentence>In conclusion, we demonstrate that the <cons lex="vitamin_E_derivative" sem="G#other_organic_compound">vitamin E derivative</cons> <cons lex="TCP_succinate" sem="G#other_organic_compound">TCP succinate</cons> prevents <cons lex="monocytic_cell_adhesion" sem="G#other_name">monocytic cell adhesion</cons> to cytokine-stimulated <cons lex="endothelial_cell" sem="G#cell_type">endothelial cells</cons> by inhibiting the activation of <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons>, further emphasizing the <cons lex="antiatherosclerotic_potential" sem="G#other_name">antiatherosclerotic potential</cons> of <cons lex="lipid_soluble_antioxidant" sem="G#other_organic_compound">lipid soluble antioxidants</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97378046</bibliomisc>
</articleinfo>
<title>
<sentence>The product of the <cons lex="murine_homolog" sem="G#DNA_family_or_group">murine homolog</cons> of the <cons lex="Drosophila_extra_sex_combs_gene" sem="G#DNA_domain_or_region">Drosophila extra sex combs gene</cons> displays <cons lex="transcriptional_repressor_activity" sem="G#other_name"><cons lex="transcriptional_repressor" sem="G#protein_family_or_group">transcriptional repressor</cons> activity</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="heterogeneous_nuclear_ribonucleoprotein_K_protein" sem="G#protein_molecule">heterogeneous nuclear ribonucleoprotein K protein</cons> represents a novel class of proteins that may act as docking platforms that orchestrate cross-talk among molecules involved in <cons lex="signal_transduction" sem="G#other_name">signal transduction</cons> and <cons lex="gene_expression" sem="G#other_name">gene expression</cons>.</sentence>
<sentence>Using a fragment of <cons lex="K_protein" sem="G#protein_molecule">K protein</cons> as bait in the <cons lex="yeast_two-hybrid_screen" sem="G#other_name">yeast two-hybrid screen</cons>, we isolated a <cons lex="cDNA" sem="G#DNA_family_or_group">cDNA</cons> that encodes a protein whose primary structure has extensive similarity to the <cons lex="Drosophila_melanogaster_extra_sex_combs_(esc)_gene_product" sem="G#protein_molecule"><cons lex="Drosophila_melanogaster" sem="G#multi_cell">Drosophila melanogaster</cons> extra sex combs (esc) gene product</cons>, <cons lex="Esc" sem="G#protein_molecule">Esc</cons>, a putative silencer of <cons lex="homeotic_gene" sem="G#DNA_family_or_group">homeotic genes</cons>.</sentence>
<sentence>The <cons lex="cDNA" sem="G#DNA_family_or_group">cDNA</cons> that we isolated is identical to the <cons lex="cDNA" sem="G#DNA_family_or_group">cDNA</cons> of the recently positionally cloned <cons lex="mouse_embryonic_ectoderm_development_gene" sem="G#DNA_domain_or_region">mouse embryonic ectoderm development gene</cons>, eed.</sentence>
<sentence>Like <cons lex="Esc" sem="G#protein_molecule">Esc</cons>, <cons lex="Eed" sem="G#protein_molecule">Eed</cons> contains six <cons lex="WD-40_repeat" sem="G#protein_substructure">WD-40 repeats</cons> in the <cons lex="C-terminal_half" sem="G#protein_domain_or_region">C-terminal half</cons> of the protein and is thought to repress <cons lex="homeotic_gene_expression" sem="G#other_name">homeotic <cons lex="gene_expression" sem="G#other_name">gene expression</cons></cons> during <cons lex="mouse_embryogenesis" sem="G#other_name">mouse embryogenesis</cons>.</sentence>
<sentence><cons lex="Eed" sem="G#protein_molecule">Eed</cons> binds to <cons lex="K_protein" sem="G#protein_molecule">K protein</cons> through a domain in its <cons lex="N_terminus" sem="G#protein_domain_or_region">N terminus</cons>, but interestingly, this domain is not found in the <cons lex="Drosophila" sem="G#multi_cell">Drosophila</cons> <cons lex="Esc" sem="G#protein_molecule">Esc</cons>.</sentence>
<sentence><cons lex="Gal4-Eed_fusion_protein" sem="G#protein_molecule">Gal4-<cons lex="Eed" sem="G#protein_molecule">Eed</cons> fusion protein</cons> represses transcription of a reporter gene driven by a promoter that contains <cons lex="Gal4-binding_DNA_element" sem="G#DNA_family_or_group">Gal4-binding DNA elements</cons>.</sentence>
<sentence><cons lex="Eed" sem="G#protein_molecule">Eed</cons> also represses transcription when recruited to a target promoter by <cons lex="Gal4-K_protein" sem="G#protein_molecule">Gal4-<cons lex="K_protein" sem="G#protein_molecule">K protein</cons></cons>.</sentence>
<sentence>Point mutations within the eed gene that are responsible for severe <cons lex="embryonic_development_abnormality" sem="G#other_name">embryonic development abnormalities</cons> abolished the <cons lex="transcriptional_repressor_activity" sem="G#other_name"><cons lex="transcriptional_repressor" sem="G#protein_family_or_group">transcriptional repressor</cons> activity</cons> of <cons lex="Eed" sem="G#protein_molecule">Eed</cons>.</sentence>
<sentence>Results of this study suggest that <cons lex="Eed-restricted_homeotic_gene_expression" sem="G#other_name"><cons lex="Eed" sem="G#protein_molecule">Eed</cons>-restricted homeotic gene expression</cons> during <cons lex="embryogenesis" sem="G#other_name">embryogenesis</cons> reflects the action of <cons lex="Eed" sem="G#protein_molecule">Eed</cons> as a <cons lex="transcriptional_repressor" sem="G#protein_family_or_group">transcriptional repressor</cons>.</sentence>
<sentence>The <cons lex="Eed-mediated_transcriptional_effects" sem="G#other_name"><cons lex="Eed" sem="G#protein_molecule">Eed</cons>-mediated transcriptional effects</cons> are likely to reflect the interaction of <cons lex="Eed" sem="G#protein_molecule">Eed</cons> with multiple molecular partners, including <cons lex="K_protein" sem="G#protein_molecule">K protein</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97361636</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="interferon" sem="G#protein_family_or_group">Interferons</cons> up-regulate <cons lex="STAT1" sem="G#protein_molecule">STAT1</cons>, <cons lex="STAT2" sem="G#protein_molecule">STAT2</cons>, and <cons lex="IRF_family_transcription_factor_gene_expression" sem="G#other_name"><cons lex="IRF" sem="G#protein_molecule">IRF</cons> family transcription factor gene expression</cons> in <cons lex="human_peripheral_blood_mononuclear_cell" sem="G#cell_type">human peripheral blood mononuclear cells</cons> and <cons lex="macrophage" sem="G#cell_type">macrophages</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="IFN_signaling" sem="G#other_name"><cons lex="IFN" sem="G#protein_family_or_group">IFN</cons> signaling</cons> is mediated by binding of <cons lex="IFN" sem="G#protein_family_or_group">IFNs</cons> to their receptors and subsequent activation of <cons lex="Janus_tyrosine_kinase_(JAK)-STAT_signaling_pathway" sem="G#other_name">Janus tyrosine kinase (<cons lex="JAK" sem="G#protein_family_or_group">JAK</cons>)-<cons lex="STAT" sem="G#protein_family_or_group">STAT</cons> signaling pathway</cons>.</sentence>
<sentence>Stimulation of cells with <cons lex="IFN-alpha" sem="G#protein_molecule">IFN-alpha</cons> leads to the assembly of <cons lex="IFN-stimulated_gene_factor_3_transcription_factor_complex" sem="G#protein_complex">IFN-stimulated gene factor 3 transcription factor complex</cons> formed by <cons lex="STAT1" sem="G#protein_molecule">STAT1</cons>, <cons lex="STAT2" sem="G#protein_molecule">STAT2</cons>, and <cons lex="p48_protein" sem="G#protein_molecule">p48 protein</cons>.</sentence>
<sentence><cons lex="IFN-gamma_signalin" sem="G#other_name"><cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons> signaling</cons> is mediated by <cons lex="homodimeric_STAT1_protein" sem="G#protein_complex">homodimeric <cons lex="STAT1" sem="G#protein_molecule">STAT1</cons> protein</cons>.</sentence>
<sentence>Although these signaling molecules are expressed constitutively, there is also evidence of <cons lex="transcriptional_regulation" sem="G#other_name">transcriptional regulation</cons> by <cons lex="IFN" sem="G#protein_family_or_group">IFNs</cons>.</sentence>
<sentence>We have characterized the expression of <cons lex="STAT_and_IFN_regulatory_factor_(IRF)_family_transcription_factor" sem="G#protein_family_or_group">STAT and IFN regulatory factor (IRF) family transcription factors</cons> in <cons lex="primary_human_blood_mononuclear_cell" sem="G#cell_type">primary human blood mononuclear cells</cons> and <cons lex="macrophage" sem="G#cell_type">macrophages</cons> in response to <cons lex="(AND IFN-alpha_stimulation IFN-gamma_stimulation)" sem="(AND G#other_name G#other_name)"><cons lex="IFN-alpha*">IFN-alpha</cons> and <cons lex="IFN-gamma*">IFN-gamma</cons> <cons lex="*stimulation">stimulation</cons></cons>.</sentence>
<sentence>We show that <cons lex="IFN-alpha" sem="G#protein_molecule">IFN-alpha</cons> and <cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons> rapidly and efficiently enhanced <cons lex="STAT1" sem="G#protein_molecule">STAT1</cons>, <cons lex="STAT2" sem="G#protein_molecule">STAT2</cons>, <cons lex="p48" sem="G#protein_molecule">p48</cons>, and <cons lex="IRF-1_gene_expression" sem="G#other_name"><cons lex="IRF-1_gene" sem="G#DNA_domain_or_region"><cons lex="IRF-1" sem="G#protein_molecule">IRF-1</cons> gene</cons> expression</cons>.</sentence>
<sentence><cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons> induced <cons lex="IRF-1_gene_expression" sem="G#other_name"><cons lex="IRF-1_gene" sem="G#DNA_domain_or_region"><cons lex="IRF-1" sem="G#protein_molecule">IRF-1</cons> gene</cons> expression</cons> more strongly than <cons lex="IFN-alpha" sem="G#protein_molecule">IFN-alpha</cons>.</sentence>
<sentence>Stimulation experiments in the presence of protein synthesis inhibitor, <cons lex="cycloheximide" sem="G#other_organic_compound">cycloheximide</cons>, suggested that these genes were activated directly by <cons lex="IFN" sem="G#protein_family_or_group">IFNs</cons>.</sentence>
<sentence><cons lex="IRF-2_gene" sem="G#DNA_domain_or_region">IRF-2 gene</cons> was apparently only weakly responsive to <cons lex="IFN" sem="G#protein_family_or_group">IFNs</cons> in these cells.</sentence>
<sentence>When <cons lex="macrophage" sem="G#cell_type">macrophages</cons> were pretreated with low doses of <cons lex="IFN-gamma" sem="G#protein_molecule">IFN-gamma</cons> and then stimulated with <cons lex="IFN-alpha" sem="G#protein_molecule">IFN-alpha</cons>, clearly enhanced formation of specific <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> complexes was detected.</sentence>
<sentence>This suggests that higher intracellular levels of <cons lex="STAT1" sem="G#protein_molecule">STAT1</cons>, <cons lex="STAT2" sem="G#protein_molecule">STAT2</cons>, and <cons lex="p48_protein" sem="G#protein_molecule"><cons lex="p48" sem="G#protein_molecule">p48</cons> protein</cons> may result in enhanced <cons lex="signal_transduction" sem="G#other_name">signal transduction</cons> for <cons lex="cytokine" sem="G#protein_family_or_group">cytokines</cons> utilizing these <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97367500</bibliomisc>
</articleinfo>
<title>
<sentence>The role of <cons lex="nuclear_factor-kappa_B" sem="G#protein_complex">nuclear factor-kappa B</cons> in <cons lex="cytokine_gene_regulation" sem="G#other_name"><cons lex="cytokine_gene" sem="G#DNA_family_or_group">cytokine gene</cons> regulation</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="transcription_factor" sem="G#protein_family_or_group">Transcription factors</cons> are <cons lex="DNA-binding_protein" sem="G#protein_family_or_group">DNA-binding proteins</cons> that regulate <cons lex="gene_expression" sem="G#other_name">gene expression</cons>.</sentence>
<sentence><cons lex="nuclear_factor-kappa_B" sem="G#protein_complex">Nuclear factor-kappa B</cons> (<cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons>) is a critical <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> for maximal expression of many <cons lex="cytokine" sem="G#protein_family_or_group">cytokines</cons> that are involved in the pathogenesis of <cons lex="inflammatory_disease" sem="G#other_name">inflammatory diseases</cons>, such as <cons lex="adult_respiratory_distress_syndrome" sem="G#other_name">adult respiratory distress syndrome</cons> (<cons lex="ARDS" sem="G#other_name">ARDS</cons>) and <cons lex="sepsis_syndrome" sem="G#other_name">sepsis syndrome</cons>.</sentence>
<sentence>Activation and regulation of <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> are tightly controlled by a group of <cons lex="inhibitory_protein" sem="G#protein_family_or_group">inhibitory proteins</cons> (<cons lex="I_kappa_B" sem="G#protein_molecule">I kappa B</cons>) that sequester <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> in the <cons lex="cytoplasm" sem="G#cell_component">cytoplasm</cons> of <cons lex="immune/inflammatory_effector_cell" sem="G#cell_type">immune/inflammatory effector cells</cons>.</sentence>
<sentence><cons lex="NF-kappa_B_activation" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> activation</cons> involves <cons lex="signaled_phosphorylation" sem="G#other_name">signaled phosphorylation</cons>, <cons lex="ubiquitination" sem="G#other_name">ubiquitination</cons>, and <cons lex="proteolysis" sem="G#other_name">proteolysis</cons> of <cons lex="I_kappa_B" sem="G#protein_molecule">I kappa B</cons>.</sentence>
<sentence>Liberated <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> migrates to the <cons lex="nucleus" sem="G#cell_component">nucleus</cons>, where it binds to <cons lex="specific_promoter_site" sem="G#DNA_domain_or_region">specific promoter sites</cons> and activates <cons lex="gene_transcription" sem="G#other_name">gene transcription</cons>.</sentence>
<sentence>The activation of <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> initiates both extracellular and intracellular <cons lex="regulatory_event" sem="G#other_name">regulatory events</cons> that result in autoregulation of the <cons lex="inflammatory_cascade" sem="G#other_name">inflammatory cascade</cons> through modulation of <cons lex="NF-kappa_B_activation" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> activation</cons>.</sentence>
<sentence>Recently, activation of <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> has been linked to <cons lex="ARDS" sem="G#other_name">ARDS</cons> and has been shown to be a critical proximal step in the initiation of <cons lex="neutrophilic_inflammation" sem="G#other_name">neutrophilic inflammation</cons> in <cons lex="animal_model" sem="G#multi_cell">animal models</cons>.</sentence>
<sentence>Activation of <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> can be inhibited in vivo by treatment with <cons lex="antioxidant" sem="G#other_organic_compound">antioxidants</cons>, <cons lex="corticosteroid" sem="G#lipid">corticosteroids</cons>, and the induction of <cons lex="endotoxin_tolerance" sem="G#other_name"><cons lex="endotoxin" sem="G#protein_family_or_group">endotoxin</cons> tolerance</cons>.</sentence>
<sentence>Identification of more specific and efficacious inhibitors of <cons lex="NF-kappa_B" sem="G#protein_complex">NF-kappa B</cons> activation might prove beneficial for the treatment of <cons lex="cytokine-mediated_inflammatory_disease" sem="G#other_name">cytokine-mediated <cons lex="inflammatory_disease" sem="G#other_name">inflammatory diseases</cons></cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97349094</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="chimeric_oncoprotein" sem="G#protein_family_or_group">Chimeric oncoprotein</cons> <cons lex="E2a-Pbx1" sem="G#protein_molecule">E2a-Pbx1</cons> induces <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> of <cons lex="hematopoietic_cell" sem="G#cell_type">hematopoietic cells</cons> by a <cons lex="p53-independent_mechanism" sem="G#other_name"><cons lex="p53" sem="G#protein_molecule">p53</cons>-independent mechanism</cons> that is suppressed by <cons lex="Bcl-2" sem="G#protein_molecule">Bcl-2</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="chimeric_oncoprotein" sem="G#protein_family_or_group">chimeric oncoprotein</cons> <cons lex="E2a-Pbx1" sem="G#protein_molecule">E2a-Pbx1</cons> results from fusion of the <cons lex="(AND E2A_gene PBX1_gene)" sem="(AND G#DNA_domain_or_region G#DNA_domain_or_region)"><cons lex="E2A*">E2A</cons> and <cons lex="PBX1*">PBX1</cons> <cons lex="*gene">genes</cons></cons> following <cons lex="t(1;19)_chromosomal_translocation" sem="G#DNA_domain_or_region">t(1;19) chromosomal translocations</cons> in <cons lex="B_cell_precursor_acute_leukemia" sem="G#other_name">B cell precursor acute leukemias</cons>.</sentence>
<sentence>Experimentally <cons lex="B_cell_progenitor" sem="G#cell_type">B cell progenitors</cons> do not tolerate constitutive expression of <cons lex="E2a-Pbx1" sem="G#protein_molecule">E2a-Pbx1</cons> which contrasts with transformation of several other cell types following its stable expression both in vitro and in vivo.</sentence>
<sentence>To further investigate the effects of <cons lex="E2a-Pbx1" sem="G#protein_molecule">E2a-Pbx1</cons> on the <cons lex="B_cell_progenitor" sem="G#cell_type">B cell progenitors</cons>, we conditionally expressed <cons lex="E2a-Pbx1" sem="G#protein_molecule">E2a-Pbx1</cons> under control of a metal response element in <cons lex="hematopoietic_precursor_cell_line" sem="G#cell_line">hematopoietic precursor cell lines</cons> in vitro.</sentence>
<sentence>Inducible expression of <cons lex="E2a-Pbx1" sem="G#protein_molecule">E2a-Pbx1</cons> resulted in cell death with the morphologic and molecular features of <cons lex="apoptosis" sem="G#other_name">apoptosis</cons>.</sentence>
<sentence>A structure-function analysis demonstrated that induction of <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> was not a dominant-negative effect of the <cons lex="E2a_moiety" sem="G#protein_domain_or_region">E2a moiety</cons> but, rather, required the <cons lex="DNA-binding_homeodomain" sem="G#protein_domain_or_region">DNA-binding homeodomain</cons> of <cons lex="Pbx1" sem="G#protein_molecule">Pbx1</cons>.</sentence>
<sentence>E2a-<cons lex="Pbx1" sem="G#protein_molecule">Pbx1</cons>-induced <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> proceeded through a <cons lex="BCL2-responsive_checkpoint" sem="G#other_name"><cons lex="BCL2" sem="G#protein_molecule">BCL2</cons>-responsive checkpoint</cons> eventuating in <cons lex="PARP_inactivation" sem="G#other_name"><cons lex="PARP" sem="G#protein_molecule">PARP</cons> inactivation</cons> but did require <cons lex="p53" sem="G#protein_molecule">p53</cons>.</sentence>
<sentence>Constitutive expression of <cons lex="E2a-Pbx1" sem="G#protein_molecule">E2a-<cons lex="Pbx1" sem="G#protein_molecule">Pbx1</cons></cons> did not induce <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> or continued cycling of <cons lex="Rat-1_fibroblast" sem="G#cell_line">Rat-1 fibroblasts</cons> in <cons lex="low_serum_condition" sem="G#other_name">low serum conditions</cons>.</sentence>
<sentence>These studies demonstrate that <cons lex="E2a-Pbx1" sem="G#protein_molecule">E2a-<cons lex="Pbx1" sem="G#protein_molecule">Pbx1</cons></cons> initiates <cons lex="programmed_cell_death" sem="G#other_name">programmed cell death</cons> of <cons lex="hematopoietic_precurser" sem="G#cell_type">hematopoietic precursers</cons> by a mechanism that requires its chimeric transcriptional properties, but, unlike other <cons lex="nuclear_oncoprotein" sem="G#protein_family_or_group">nuclear oncoproteins</cons>, is independent of <cons lex="p53" sem="G#protein_molecule">p53</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:97322395</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="CCAAT/enhancer_binding_protein_epsilon" sem="G#protein_molecule">CCAAT/enhancer binding protein epsilon</cons> is preferentially up-regulated during <cons lex="granulocytic_differentiation" sem="G#other_name">granulocytic differentiation</cons> and its functional versatility is determined by alternative use of <cons lex="promoter" sem="G#DNA_family_or_group">promoters</cons> and <cons lex="differential_splicing" sem="G#other_name">differential splicing</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="CCAAT/enhancer_binding_protein_(C/EBP)_epsilon" sem="G#protein_molecule">CCAAT/enhancer binding protein (C/EBP) epsilon</cons> is a recently cloned member of the <cons lex="C/EBP_family" sem="G#protein_family_or_group">C/EBP family</cons> of <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> and is expressed exclusively in cells of hematopoietic origin.</sentence>
<sentence>The <cons lex="human_C/EBPepsilon_gene" sem="G#DNA_domain_or_region">human C/EBPepsilon gene</cons> is transcribed by two alternative <cons lex="promoter" sem="G#DNA_family_or_group">promoters</cons>, <cons lex="Palpha" sem="G#DNA_domain_or_region">Palpha</cons> and <cons lex="Pbeta" sem="G#DNA_domain_or_region">Pbeta</cons>.</sentence>
<sentence>A combination of <cons lex="differential_splicing" sem="G#other_name">differential splicing</cons> and alternative use of <cons lex="promoter" sem="G#DNA_family_or_group">promoters</cons> generates four <cons lex="mRNA_isoforms" sem="G#RNA_family_or_group"><cons lex="mRNA" sem="G#RNA_family_or_group">mRNA</cons> isoforms</cons>, of 2.6 kb and 1.3-1.5 kb in size.</sentence>
<sentence>These transcripts can encode three proteins of calculated <cons lex="molecular_mass" sem="G#other_name">molecular mass</cons> <cons lex="32.2_kDa" sem="G#RNA_molecule">32.2 kDa</cons>, <cons lex="27.8_kDa" sem="G#RNA_molecule">27.8 kDa</cons>, and <cons lex="14.3_kDa" sem="G#RNA_molecule">14.3 kDa</cons>.</sentence>
<sentence>Accordingly, <cons lex="Western_blot" sem="G#other_name">Western blots</cons> with <cons lex="antibody" sem="G#protein_family_or_group">antibodies</cons> specific for the <cons lex="DNA-binding_domain" sem="G#other_name">DNA-binding domain</cons>, that is common to all forms, identify multiple proteins.</sentence>
<sentence><cons lex="C/EBPepsilon_mRNA" sem="G#RNA_molecule">C/EBPepsilon mRNA</cons> was greatly induced during in vitro <cons lex="granulocytic_differentiation" sem="G#other_name">granulocytic differentiation</cons> of <cons lex="human_primary_CD34(+)_cell" sem="G#cell_type">human primary CD34(+) cells</cons>.</sentence>
<sentence><cons lex="retinoic_acid" sem="G#other_organic_compound">Retinoic acid</cons> treatment of <cons lex="HL60_promyelocytic_leukemia_cell" sem="G#cell_line">HL60 promyelocytic leukemia cells</cons> for 24 hr induced <cons lex="C/EBPepsilon_mRNA" sem="G#RNA_molecule">C/EBPepsilon mRNA</cons> levels by 4-fold, while prolonged treatment gradually reduced <cons lex="mRNA_expression" sem="G#other_name">mRNA expression</cons> to pretreatment levels.</sentence>
<sentence>Transient transfection experiments with expression vectors for two of the isoforms demonstrated that the <cons lex="32.2-kDa_protein" sem="G#protein_molecule">32.2-kDa protein</cons> is an activator of transcription of <cons lex="granulocyte_colony-stimulating_factor_receptor_promoter" sem="G#DNA_domain_or_region">granulocyte colony-stimulating factor receptor promoter</cons>, while the <cons lex="14.3-kDa_protein" sem="G#protein_molecule">14.3-kDa protein</cons> is not.</sentence>
<sentence>Thus, <cons lex="C/EBPepsilon" sem="G#protein_molecule">C/EBPepsilon</cons> is regulated in a complex fashion and may play a role in the regulation of genes involved in <cons lex="myeloid_differentiation" sem="G#other_name">myeloid differentiation</cons>.</sentence>
</abstract>
</article>



</set>